vigabatrin/NN carbamazepine/NN use/NN seizures/NNS absence/NN
vigabatrin/NN carbamazepine/NN use/NN seizures/NNS
carbamazepine/NN use/NN seizures/NNS absence/NN
carbamazepine/NN use/NN seizures/NNS
vigabatrin/NN Carbamazepine/NN contraindicated/VBN seizures/NNS absence/NN
vigabatrin/NN Carbamazepine/NN contraindicated/VBN seizures/NNS
Carbamazepine/NN contraindicated/VBN seizures/NNS absence/NN
Carbamazepine/NN contraindicated/VBN seizures/NNS
carbamazepine/NN two/CD jerks/NNS myoclonic/JJ
carbamazepine/NN two/CD jerks/NNS
carbamazepine/NN withdrawal/NN resolved/VBN jerks/NNS myoclonic/JJ
carbamazepine/NN withdrawal/NN resolved/VBN jerks/NNS
testosterone/NN screened/VBN basis/NN desire/NN low/JJ
testosterone/NN screened/VBN basis/NN desire/NN sexual/JJ
testosterone/NN screened/VBN basis/NN desire/NN
testosterone/NN gynecomastia/NN desire/NN low/JJ
testosterone/NN gynecomastia/NN desire/NN sexual/JJ
testosterone/NN gynecomastia/NN desire/NN
testosterone/NN Determining/VBG cases/NNS desire/NN low/JJ
testosterone/NN Determining/VBG cases/NNS desire/NN sexual/JJ
testosterone/NN Determining/VBG cases/NNS desire/NN
testosterone/NN missed/VBN Determining/VBG cases/NNS desire/NN low/JJ
testosterone/NN missed/VBN Determining/VBG cases/NNS desire/NN sexual/JJ
testosterone/NN missed/VBN Determining/VBG cases/NNS desire/NN
testosterone/VBP determined/VBN cases/NNS desire/NN low/JJ
testosterone/VBP determined/VBN cases/NNS desire/NN sexual/JJ
testosterone/VBP determined/VBN cases/NNS desire/NN
testosterone/NN desire/NN low/JJ
testosterone/NN desire/NN sexual/JJ
testosterone/NN desire/NN
LiCl/NNP contained/VBD diet/NN consuming/VBG rats/NNS developed/VBD polyuria/NN
Lidocaine/NNP induced/VBN asystole/NN cardiac/JJ
Lidocaine/NNP induced/VBN asystole/NN
ouabain/NN administered/VBN tachycardias/NNS ventricular/NN
ouabain/NN administered/VBN tachycardias/NNS
CBDCA/NNP use/NN cause/VB damage/NN peripheral/JJ
CBDCA/NNP use/NN cause/VB damage/NN nervous/JJ
CBDCA/NNP use/NN cause/VB damage/NN system/NN
CBDCA/NNP use/NN cause/VB damage/NN
CBDCA/NNP dose/NN neurotoxicity/NN peripheral/JJ
CBDCA/NNP dose/NN neurotoxicity/NN
cocaine/NN kindled/NNS steroids/NNS efficacy/NN seizures/NNS
cocaine/NN engendered/VBN administration/NN kindling/NN seizure/NN
cocaine/NN administration/NN kindling/NN seizure/NN
cocaine/NN development/NN seizures/NNS
cocaine/NN administration/NN induced/VBN seizures/NNS
doxorubicin/NN cardiomyopathy/NN
doxorubicin/NN produced/VBN cardiomyopathy/NN
doxorubicin/NN produced/VBN cardiomyopathy/NN CM/NNP
doxorubicin/NN produced/VBN cardiomyopathy/NN provides/VBZ opportunity/NN analyze/VB dose/NN relationships/NNS development/NN disease/NN myocardial/JJ
doxorubicin/NN produced/VBN cardiomyopathy/NN provides/VBZ opportunity/NN analyze/VB dose/NN relationships/NNS development/NN disease/NN
DXR/NNP doxorubicin/NN produced/VBN cardiomyopathy/NN
DXR/NNP doxorubicin/NN produced/VBN cardiomyopathy/NN CM/NNP
DXR/NNP doxorubicin/NN produced/VBN cardiomyopathy/NN provides/VBZ opportunity/NN analyze/VB dose/NN relationships/NNS development/NN disease/NN myocardial/JJ
DXR/NNP doxorubicin/NN produced/VBN cardiomyopathy/NN provides/VBZ opportunity/NN analyze/VB dose/NN relationships/NNS development/NN disease/NN
Adriamycin/NNP doxorubicin/NN produced/VBN cardiomyopathy/NN
Adriamycin/NNP doxorubicin/NN produced/VBN cardiomyopathy/NN CM/NNP
Adriamycin/NNP doxorubicin/NN produced/VBN cardiomyopathy/NN provides/VBZ opportunity/NN analyze/VB dose/NN relationships/NNS development/NN disease/NN myocardial/JJ
Adriamycin/NNP doxorubicin/NN produced/VBN cardiomyopathy/NN provides/VBZ opportunity/NN analyze/VB dose/NN relationships/NNS development/NN disease/NN
DXR/NNP proportional/JJ damage/NN CM/NNP
DXR/NNP proportional/JJ damage/NN myocardial/JJ
DXR/NNP proportional/JJ damage/NN
DXR/NNP dose/NN insult/NN degree/NN proportional/JJ damage/NN CM/NNP
DXR/NNP dose/NN insult/NN degree/NN proportional/JJ damage/NN myocardial/JJ
DXR/NNP dose/NN insult/NN degree/NN proportional/JJ damage/NN
propranolol/JJ toxicity/NN associated/VBN syndrome/NN Amnestic/JJ
propranolol/JJ toxicity/NN associated/VBN syndrome/NN
streptozotocin/NN vincristine/NN induced/VBN hyperalgesia/NN
streptozotocin/NN vincristine/NN induced/VBN hyperalgesia/NN model/NN chemotherapy/JJ diabetic/JJ
streptozotocin/NN vincristine/NN induced/VBN hyperalgesia/NN model/NN neuropathy/JJ
vincristine/NN induced/VBN hyperalgesia/NN
vincristine/NN produced/VBN hyperalgesia/NN
streptozotocin/NN induced/VBN hyperalgesia/NN
streptozotocin/NN participates/VBZ seemed/VBD bradykinin/NN hyperalgesia/NN
vincristine/NN seemed/VBD participates/VBZ streptozotocin/NN induced/VBN hyperalgesia/NN
vincristine/NN seemed/VBD bradykinin/NN hyperalgesia/NN
Cocaine/NNP induced/VBN seizures/NNS
Antidepressant/NNP mania/NN
Antidepressant/NNP mania/NN patients/NNS bipolar/NNP
antidepressants/NNS associated/VBN mania/NN
antidepressants/NNS associated/VBN mania/NN switching/VBG risks/NNS Concerns/NNS continue/VBP interfere/VB establishment/NN paradigm/NN depression/NN bipolar/NNP
antidepressants/NNS associated/VBN mania/NN switching/VBG risks/NNS Concerns/NNS continue/VBP interfere/VB establishment/NN paradigm/NN depression/NN
antidepressant/JJ therapy/NN type/NN diagnosis/NN structured/VBN Patients/NNS experienced/VBD compared/VBN switch/NN manic/JJ
antidepressant/JJ therapy/NN type/NN diagnosis/NN structured/VBN Patients/NNS experienced/VBD compared/VBN switch/NN manic/JJ hypomanic/JJ
antidepressant/JJ therapy/NN type/NN diagnosis/NN II/NNP vs/NN DSM/SYM
antidepressant/JJ therapy/NN type/NN diagnosis/NN II/NNP vs/NN IV/NNP
antidepressant/JJ therapy/NN type/NN diagnosis/NN II/NNP vs/NN bipolar/NNP
antidepressant/JJ therapy/NN type/NN diagnosis/NN II/NNP vs/NN I/NN
antidepressant/JJ therapy/NN type/NN diagnosis/NN II/NNP bipolar/NNP
antidepressant/JJ therapy/NN type/NN diagnosis/NN II/NNP
antidepressant/JJ therapy/NN type/NN diagnosis/NN number/NN episodes/NNS manic/JJ
antidepressant/JJ drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN structured/VBN Patients/NNS experienced/VBD compared/VBN switch/NN manic/JJ
antidepressant/JJ drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN structured/VBN Patients/NNS experienced/VBD compared/VBN switch/NN manic/JJ hypomanic/JJ
antidepressant/JJ drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP vs/NN DSM/SYM
antidepressant/JJ drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP vs/NN IV/NNP
antidepressant/JJ drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP vs/NN bipolar/NNP
antidepressant/JJ drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP vs/NN I/NN
antidepressant/JJ drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP bipolar/NNP
antidepressant/JJ drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP
antidepressant/JJ drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN number/NN episodes/NNS manic/JJ
serotonin/NN inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN structured/VBN Patients/NNS experienced/VBD compared/VBN switch/NN manic/JJ
reuptake/NN inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN structured/VBN Patients/NNS experienced/VBD compared/VBN switch/NN manic/JJ
inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN structured/VBN Patients/NNS experienced/VBD compared/VBN switch/NN manic/JJ
serotonin/NN inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN structured/VBN Patients/NNS experienced/VBD compared/VBN switch/NN manic/JJ hypomanic/JJ
reuptake/NN inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN structured/VBN Patients/NNS experienced/VBD compared/VBN switch/NN manic/JJ hypomanic/JJ
inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN structured/VBN Patients/NNS experienced/VBD compared/VBN switch/NN manic/JJ hypomanic/JJ
serotonin/NN inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP vs/NN DSM/SYM
serotonin/NN inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP vs/NN IV/NNP
serotonin/NN inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP vs/NN bipolar/NNP
serotonin/NN inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP vs/NN I/NN
reuptake/NN inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP vs/NN DSM/SYM
reuptake/NN inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP vs/NN IV/NNP
reuptake/NN inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP vs/NN bipolar/NNP
reuptake/NN inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP vs/NN I/NN
inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP vs/NN DSM/SYM
inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP vs/NN IV/NNP
inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP vs/NN bipolar/NNP
inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP vs/NN I/NN
serotonin/NN inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP bipolar/NNP
serotonin/NN inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP
reuptake/NN inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP bipolar/NNP
reuptake/NN inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP
inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP bipolar/NNP
inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP
serotonin/NN inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN number/NN episodes/NNS manic/JJ
reuptake/NN inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN number/NN episodes/NNS manic/JJ
inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN number/NN episodes/NNS manic/JJ
SSRIs/NNPS -RSB-/NNP inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN structured/VBN Patients/NNS experienced/VBD compared/VBN switch/NN manic/JJ
SSRIs/NNPS -RSB-/NNP inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN structured/VBN Patients/NNS experienced/VBD compared/VBN switch/NN manic/JJ hypomanic/JJ
SSRIs/NNPS -RSB-/NNP inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP vs/NN DSM/SYM
SSRIs/NNPS -RSB-/NNP inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP vs/NN IV/NNP
SSRIs/NNPS -RSB-/NNP inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP vs/NN bipolar/NNP
SSRIs/NNPS -RSB-/NNP inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP vs/NN I/NN
SSRIs/NNPS -RSB-/NNP inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP bipolar/NNP
SSRIs/NNPS -RSB-/NNP inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN II/NNP
SSRIs/NNPS -RSB-/NNP inhibitors/NNS drugs/NNS vs/NNP therapy/NN type/NN diagnosis/NN number/NN episodes/NNS manic/JJ
SSRIs/NNP -LSB-/NNP treated/NNS subgroup/NN %/NN //CD patients/NNS %/NN occurred/VBD Switches/NNP hypomania/NN
SSRIs/NNP -LSB-/NNP treated/NNS subgroup/NN %/NN //CD patients/NNS %/NN occurred/VBD Switches/NNP hypomania/NN mania/NN
SSRIs/NNP -LSB-/NNP treated/NNS subgroup/NN %/NN //CD patients/NNS %/NN occurred/VBD experienced/VBD episodes/NNS manic/JJ
SSRIs/NNP -LSB-/NNP treated/NNS subgroup/NN %/NN //CD patients/NNS %/NN occurred/VBD experienced/VBD experienced/VBD episodes/NNS hypomanic/JJ
dietary/JJ supplementation/NN effect/NN importantly/RB contributes/VBZ treated/VBD rats/NNS hypertensive/JJ
sodium/NN supplementation/NN effect/NN importantly/RB contributes/VBZ treated/VBD rats/NNS hypertensive/JJ
chloride/NN supplementation/NN effect/NN importantly/RB contributes/VBZ treated/VBD rats/NNS hypertensive/JJ
dietary/JJ supplementation/NN effect/NN hypertensive/JJ
sodium/NN supplementation/NN effect/NN hypertensive/JJ
chloride/NN supplementation/NN effect/NN hypertensive/JJ
dietary/JJ increase/NN
dietary/JJ increase/NN eliminated/VBD MAP/NNP in/IN
dietary/JJ increase/NN eliminated/VBD MAP/NNP
sodium/NN increase/NN
sodium/NN increase/NN eliminated/VBD MAP/NNP in/IN
sodium/NN increase/NN eliminated/VBD MAP/NNP
chloride/NN increase/NN
chloride/NN increase/NN eliminated/VBD MAP/NNP in/IN
chloride/NN increase/NN eliminated/VBD MAP/NNP
Pethidine/NNP associated/VBN seizure/NN
pethidine/NN associated/VBN seizure/NN
combined/VBN contraceptives/NNS women/NNS thromboembolism/NN' thromboembolism/NN venous/JJ
combined/VBN contraceptives/NNS women/NNS thromboembolism/NN' thromboembolism/NN
oral/JJ contraceptives/NNS women/NNS thromboembolism/NN' thromboembolism/NN venous/JJ
oral/JJ contraceptives/NNS women/NNS thromboembolism/NN' thromboembolism/NN
contraceptives/NNS women/NNS thromboembolism/NN' thromboembolism/NN venous/JJ
contraceptives/NNS women/NNS thromboembolism/NN' thromboembolism/NN
combined/VBN contraceptives/NNS women/NNS thromboembolism/NN' thromboembolism/NN VTE/NNP
oral/JJ contraceptives/NNS women/NNS thromboembolism/NN' thromboembolism/NN VTE/NNP
contraceptives/NNS women/NNS thromboembolism/NN' thromboembolism/NN VTE/NNP
COCs/NNP thromboembolism/NN venous/JJ
COCs/NNP thromboembolism/NN
COCs/NNP thromboembolism/NN VTE/NNP
COCs/NNP had/VBN while/NN VTE/NNP
COCs/NNP women/NNS years/NNS 2/CD years/NNS COCs/NNP 1/CD women/NNS risk/NN VTE/NNP
COCs/NNP 1/CD women/NNS risk/NN VTE/NNP
COCs/NNP women/NNS VTE/NNP
BZDs/NNP RDs/NNP use/NN associated/VBN dizziness/NN
BZDs/NNP RDs/NNP use/NN associated/VBN sleep/VB awaking/VBG night/NN tiredness/NNS
BZDs/NNP RDs/NNP use/NN associated/VBN dizziness/NN inability/NN
BZDs/NNP RDs/NNP use/NN associated/VBN sleep/VB to/TO
BZDs/NNP RDs/NNP use/NN associated/VBN sleep/VB
BZDs/NNP RDs/NNP use/NN associated/VBN sleep/VB awaking/VBG symptoms/NNS depressive/NN
BZDs/NNP RDs/NNP use/NN associated/VBN sleep/VB awaking/VBG symptoms/NNS
Puromycin/NNP aminonucleoside/NNP administered/VBN induce/VB proteinuria/NN
aminonucleoside/NNP administered/VBN induce/VB proteinuria/NN
PAN/NNP aminonucleoside/NNP administered/VBN induce/VB proteinuria/NN
capecitabine/NN effects/NNS diarrhea/NN vomiting/NN
capecitabine/NN effects/NNS diarrhea/NN
capecitabine/NN effects/NNS diarrhea/NN stomatitis/NN
capecitabine/NN effects/NNS diarrhea/NN hand/NN
capecitabine/NN effects/NNS diarrhea/NN syndrome/NN foot/NN
capecitabine/NN effects/NNS diarrhea/NN syndrome/NN
capecitabine/NN effects/NNS diarrhea/NN nausea/NN
Haloperidol/NNP induced/VBN rigidity/NN muscle/NN
Haloperidol/NNP induced/VBN rigidity/NN
haloperidol/NN diminished/NNS rigidity/NN muscle/NN
haloperidol/NN diminished/NNS rigidity/NN
alfentanil/NN increases/NNS rigidity/NN
alfentanil/NN rigidity/NN
alfentanil/NN used/VBN prevented/VBN rigidity/NN
azidothymidine/NN mice/NNS treatment/NN produces/VBZ myelodysplasia/NN
AZT/NNP treatment/NN produces/VBZ myelodysplasia/NN
AZT/NNP induced/VBN anemia/NN macrocytic/JJ
AZT/NNP induced/VBN anemia/NN
AZT/NNP therapy/NNP induced/VBN anemia/NN macrocytic/JJ
AZT/NNP therapy/NNP induced/VBN anemia/NN
AZT/NNP incorporation/NNP induced/VBN mentioned/VBD cells/NNS known/VBN seen/VBN syndrome/NN myelodysplastic/JJ
AZT/NNP incorporation/NNP induced/VBN mentioned/VBD cells/NNS known/VBN seen/VBN syndrome/NN
fluoxetine/JJ medication/NN Increase/VB disability/NN Parkinson/NNP
fluoxetine/JJ medication/NN Increase/VB disability/NN
fluoxetine/NN exposure/NN disease/NN patients/NNS disability/NN motor/NN
fluoxetine/NN exposure/NN disease/NN patients/NNS disability/NN
ribavirin/NN interferon/NN therapy/NN events/NNS one/CD anemia/NNP Hemolytic/NNP
ribavirin/NN interferon/NN therapy/NN events/NNS one/CD anemia/NNP
interferon/NN therapy/NN events/NNS one/CD anemia/NNP Hemolytic/NNP
interferon/NN therapy/NN events/NNS one/CD anemia/NNP
ribavirin/NNP anemia/NN hemolytic/JJ
ribavirin/NNP anemia/NN
rifampicin/NN administration/NN subsequent/JJ Acute/VB
rifampicin/NN administration/NN subsequent/JJ failure/NN renal/JJ
rifampicin/NN administration/NN subsequent/JJ failure/NN
dilevalol/NN mechanism/NN hepatitis/NN
dilevalol/NN mechanism/NN reaction/NN Hypersensitivity/RB
dilevalol/NN assess/VB induced/VBN injury/NN liver/NN
dilevalol/NN assess/VB induced/VBN injury/NN
dilevalol/JJ antigens/NNS containing/VBG serum/VB assess/VB induced/VBN injury/NN liver/NN
dilevalol/JJ antigens/NNS containing/VBG serum/VB assess/VB induced/VBN injury/NN
dilevalol/NN case/NN antigens/NNS containing/VBG serum/VB assess/VB induced/VBN injury/NN liver/NN
dilevalol/NN case/NN antigens/NNS containing/VBG serum/VB assess/VB induced/VBN injury/NN
dilevalol/NN diagnosis/NN woman/NN year/NN injury/NN liver/NN
dilevalol/NN diagnosis/NN woman/NN year/NN injury/NN
dilevalol/JJ antigens/NNS prepared/VBN used/VBN injury/NN liver/NN
dilevalol/JJ antigens/NNS prepared/VBN used/VBN injury/NN
dilevalol/NN mechanism/NN involvement/NN suggesting/VBG prepared/VBN used/VBN injury/NN liver/NN
dilevalol/NN mechanism/NN involvement/NN suggesting/VBG prepared/VBN used/VBN injury/NN
cocaine/NN Absence/VB associated/JJ hemorrhage/NN subarachnoid/JJ
cocaine/NN Absence/VB associated/JJ hemorrhage/NN
cocaine/NN patients/NNS angiograms/NNS obtained/VBN associated/JJ hemorrhage/NN subarachnoid/JJ
cocaine/NN patients/NNS angiograms/NNS obtained/VBN associated/JJ hemorrhage/NN
cocaine/NN patients/NNS angiograms/NNS obtained/VBN associated/JJ hemorrhage/NN SAH/NNP
cocaine/NN use/NN underwent/VBD hemorrhage/NN subarachnoid/JJ
cocaine/NN use/NN underwent/VBD hemorrhage/NN
cocaine/NN use/NN underwent/VBD hemorrhage/NN SAH/NNP
cocaine/NN toxicology/NN identified/VBD screened/VBD retrospectively/NN SAH/NNP
cocaine/NN use/NN associated/VBN SAH/NNP
cocaine/NN use/NN associated/VBN SAH/NNP aneurysmal/NNP
nicotine/NN role/NN disease/NN cardiovascular/JJ
nicotine/NN role/NN disease/NN
Nicotine/NNP activates/VBZ contribute/VB disease/NN cardiovascular/JJ
Nicotine/NNP activates/VBZ contribute/VB disease/NN
nicotine/NN play/VB role/NN atherosclerosis/NNS
5/CD undergoing/VBG assess/VB incidence/NN changes/NNS ischemic/JJ
FU/NNP infusion/NNP 5/CD undergoing/VBG assess/VB incidence/NN changes/NNS ischemic/JJ
5/CD infusion/NNP angina/VBN rare/JJ episodes/NNS Anginal/JJ
FU/NNP infusion/NNP angina/VBN rare/JJ episodes/NNS Anginal/JJ
5/CD infusion/NNP angina/VBN
FU/NNP infusion/NNP angina/VBN
5/CD 02/CD 0/NN 13/CD 0/CD +/VBD 0/NNP incidence/NN episodes/NNS ischemic/JJ
FU/NNP 0/NN 13/CD 0/CD +/VBD 0/NNP incidence/NN episodes/NNS ischemic/JJ
5/CD 03/CD +/VBD 0/NNP incidence/NN episodes/NNS ischemic/JJ
FU/NNP infusion/NNP 0/NNP incidence/NN episodes/NNS ischemic/JJ
5/CD hour/NN minutes/NNS +/NNS duration/NN less/JJR P/VB infusion/NNP 0/NNP incidence/NN episodes/NNS ischemic/JJ
FU/RB v/NN +/CD minutes/NNS +/NNS duration/NN less/JJR P/VB infusion/NNP 0/NNP incidence/NN episodes/NNS ischemic/JJ
5/CD hour/NN patient/NN minutes/NNS +/CD minutes/NNS +/NNS duration/NN less/JJR P/VB infusion/NNP 0/NNP incidence/NN episodes/NNS ischemic/JJ
FU/NNP P/NNP minutes/NNS +/CD minutes/NNS +/NNS duration/NN less/JJR P/VB infusion/NNP 0/NNP incidence/NN episodes/NNS ischemic/JJ
5/CD infusion/NN associated/VBN increase/NN ischemia/NN
-/NNP infusion/NN associated/VBN increase/NN ischemia/NN
FU/NNP infusion/NN associated/VBN increase/NN ischemia/NN
ibuprofen/NN use/NN associated/VBN described/VBN child/NN developed/VBD Stevens/NNP
ibuprofen/NN use/NN associated/VBN described/VBN syndrome/NN Johnson/NNP
ibuprofen/NN use/NN associated/VBN described/VBN syndrome/NN
dexamethasone/NN atorvastatin/NN effects/NNS Anti/NNP hypertension/NN
Dexamethasone/NNP characterized/VBN hypertension/NN
Dex/NNP Dexamethasone/NNP characterized/VBN hypertension/NN
clozapine/NN associated/VBN myocarditis/NNS
clozapine/NN commencement/NN associated/VBN myocarditis/NNS
clozapine/NN commencement/NN developed/VBD onset/NN myocarditis/NNS
clozapine/NN use/NN associated/VBN complication/NN Myocarditis/NNP
paracetamol/NNP doses/NNS associated/VBN hepatotoxicity/NN
acetaminophen/NNP BACKGROUND/NNP role/NN alcohol/NN development/NN hepatotoxicity/NN
paracetamol/NNP 3/CD developed/VBD failure/NN liver/NN
paracetamol/NNP 3/CD developed/VBD failure/NN
paracetamol/NNP doses/NNS treated/VBN patients/NNS hepatotoxicity/NN
penicillamine/NN Immunopathology/NNP disease/NN glomerular/NN
penicillamine/NN Immunopathology/NNP disease/NN
D/NNP developed/VBD proteinuria/NN
penicillamine/NN D/NNP developed/VBD proteinuria/NN
morphine/NN trinitrate/NN effect/NN induced/VBN evaluated/VBN patients/NNS sphincter/NN
morphine/NN trinitrate/NN effect/NN induced/VBN evaluated/VBN patients/NNS sphincter/NN dyskinesia/NNP of/IN
morphine/NN trinitrate/NN effect/NN induced/VBN evaluated/VBN patients/NNS sphincter/NN dyskinesia/NNP Oddi/NNP
morphine/NN trinitrate/NN effect/NN induced/VBN evaluated/VBN patients/NNS sphincter/NN dyskinesia/NNP
prostigmine/NN morphine/NN trinitrate/NN effect/NN induced/VBN evaluated/VBN patients/NNS sphincter/NN
prostigmine/NN morphine/NN trinitrate/NN effect/NN induced/VBN evaluated/VBN patients/NNS sphincter/NN dyskinesia/NNP of/IN
prostigmine/NN morphine/NN trinitrate/NN effect/NN induced/VBN evaluated/VBN patients/NNS sphincter/NN dyskinesia/NNP Oddi/NNP
prostigmine/NN morphine/NN trinitrate/NN effect/NN induced/VBN evaluated/VBN patients/NNS sphincter/NN dyskinesia/NNP
morphine/JJ provocation/NN caused/VBD indicating/VBG spasm/NN
Prostigmine/NNP RESULTS/NNS caused/VBD indicating/VBG spasm/NN
morphine/NN effect/NN overcome/VB able/JJ relevance/NN treatment/NN sphincter/NN
morphine/NN effect/NN overcome/VB able/JJ relevance/NN treatment/NN sphincter/NN dyskinesia/NNP of/IN
morphine/NN effect/NN overcome/VB able/JJ relevance/NN treatment/NN sphincter/NN dyskinesia/NNP Oddi/NNP
morphine/NN effect/NN overcome/VB able/JJ relevance/NN treatment/NN sphincter/NN dyskinesia/NNP
dobutamine/JJ stress/NN spasm/NN coronary/JJ
dobutamine/JJ stress/NN spasm/NN artery/NN
dobutamine/JJ stress/NN spasm/NN
dobutamine/NN induced/VBN ischemia/NN due/JJ spasm/NN coronary/JJ
dobutamine/NN induced/VBN ischemia/NN due/JJ spasm/NN
dobutamine/NN provoke/VB patients/NNS angina/NN coronary/JJ
dobutamine/NN provoke/VB patients/NNS angina/NN spastic/JJ
dobutamine/NN provoke/VB patients/NNS angina/NN
dobutamine/NN provoke/VB spasm/NN coronary/JJ
dobutamine/NN provoke/VB spasm/NN
Vasopressin/NNP hypotension/NN
milrinone/NN treatment/NN Vasopressin/NNP hypotension/NN
milrinone/NN inhibitors/NNS use/NN restricted/VBN cause/VBP vasodilation/NN hypotension/NN
vasopressin/NN doses/NNS restored/VBD patients/NNS failure/NN hypotension/NN
milrinone/NN treatment/NN hypotension/NN
milrinone/NN effect/NN inhibiting/VBG restored/VBD patients/NNS failure/NN hypotension/NN
metronidazole/NN lesion/VBN colliculus/NNS inferior/JJ
metronidazole/NN lesion/VBN colliculus/NNS
metronidazole/NN lesion/VBN
metronidazole/NN lesion/VBN encephalopathy/NN
metronidazole/NN lesions/NNS inferior/JJ
metronidazole/NN lesions/NNS colliculus/NN
metronidazole/NN lesions/NNS
metronidazole/NN lesions/NNS induced/VBN encephalopathy/RB
metronidazole/VBD induced/VBN encephalopathy/RB
metronidazole/NN characteristic/NN considered/VBN lesions/NNS inferior/JJ
metronidazole/NN characteristic/NN considered/VBN lesions/NNS colliculus/NNS
metronidazole/NN characteristic/NN considered/VBN lesions/NNS
metronidazole/NN characteristic/NN considered/VBN lesions/NNS CONCLUSIONS/NNS encephalopathy/NN
PAN/NN nephrosis/NNS
Puromycin/NNP nephrosis/NNS
aminonucleoside/NN nephrosis/NNS
puromycin/NN aminonucleoside/NN injection/NN induced/VBN nephrosis/NNS
aminonucleoside/NN injection/NN induced/VBN nephrosis/NNS
PAN/NNP BW/VBP injection/NN induced/VBN nephrosis/NNS
PAN/NNP injection/NN days/NNS as/RB include/VB phase/NN proteinuria/NN
PAN/NNP injection/NN days/NNS as/RB include/VB phase/NN proteinuria/NN associated/VBN effacement/NN phase/NN proteinuria/NN
gentamicin/NN L/NNP induced/VBD loss/NN hearing/NN
gentamicin/NN L/NNP induced/VBD loss/NN
acetaminophen/NN hepatotoxicity/NN
acetaminophen/NN hepatitis/NN
acetaminophen/NN suffering/VBG suggesting/VBG involves/VBZ injury/NN liver/NN
acetaminophen/NN suffering/VBG suggesting/VBG involves/VBZ injury/NN
AAP/NNP acetaminophen/NN hepatitis/NN
AAP/NNP acetaminophen/NN suffering/VBG suggesting/VBG involves/VBZ injury/NN liver/NN
AAP/NNP acetaminophen/NN suffering/VBG suggesting/VBG involves/VBZ injury/NN
AAP/NNP injury/NN involves/VBZ suggesting/VBG suffering/VBG acetaminophen/NN hepatitis/NN
AAP/NNP injury/NN liver/NN
AAP/NNP injury/NN
AAP/NNP hepatitis/NNP
ethanol/NN consumption/NN influence/NN evaluates/VBZ investigates/VBZ effects/NNS diet/NN substrate/NN acts/VBZ hepatitis/NNP
AAP/NNP presence/NN measured/VBN inhibited/VBN damage/NN liver/NN
AAP/NNP presence/NN measured/VBN inhibited/VBN damage/NN
ethanol/NN caused/VBN exacerbation/NN inhibited/VBN damage/NN liver/NN
ethanol/NN caused/VBN exacerbation/NN inhibited/VBN damage/NN
ethanol/NN inhibited/VBN damage/NN liver/NN
ethanol/NN inhibited/VBN damage/NN
AAP/NNP mice/NNS given/VBN observed/JJ reduction/NN hepatitis/NN
ethanol/JJ mice/NNS given/VBN observed/JJ reduction/NN hepatitis/NN
AAP/NNP hepatitis/NNP
ethanol/NN exacerbation/NN AAP/NNP hepatitis/NNP
acetaminophen/NN preparations/NNS use/NN see/VBP avoid/VB damage/NN hepatic/JJ
acetaminophen/NN preparations/NNS use/NN see/VBP avoid/VB damage/NN
Cyclophosphamide/NNP induced/VBN cystitis/NNS
Cyclophosphamide/NNP used/VBN induce/VB cystitis/NNS
CP/NNP Cyclophosphamide/NNP used/VBN induce/VB cystitis/NNS
CP/NNP model/NN induced/VBN model/NN allowing/VBG understanding/NN syndromes/NNS painful/JJ
CP/NNP model/NN induced/VBN model/NN allowing/VBG understanding/NN syndromes/NNS
CP/NNP model/NN induced/VBN model/NN cystitis/NNS
methysergide/NNP woman/NN ingestion/NN secondary/JJ described/VBN case/NN vasospasm/NN
ergot/NN history/NN discussion/NN includes/VBZ caused/VBN ages/NNS role/NN management/NN headache/NN migraine/JJ
ergot/NN history/NN discussion/NN includes/VBZ caused/VBN ages/NNS role/NN management/NN headache/NN
ergot/NN preparations/NNS continue/VBP play/VB therapy/NN migraine/JJ
steroid/JJ therapy/NN term/NN defect/NN ventricular/NN
steroid/JJ therapy/NN term/NN defect/NN septal/NN
steroid/JJ therapy/NN term/NN defect/NN
steroid/VBD ventricular/VBP
steroid/VBD ventricular/VBP rupture/NN septal/JJ
steroid/VBD ventricular/VBP rupture/NN
steroid/JJ therapy/NN rupture/NN septal/NN
steroid/JJ therapy/NN rupture/NN
Carmofur/NNP induced/VBN disorders/NNS organic/JJ
Carmofur/NNP induced/VBN disorders/NNS mental/JJ
Carmofur/NNP induced/VBN disorders/NNS
carmofur/NN onset/NN female/NN year/NN observed/VBN disorder/NN Organic/NNP
carmofur/NN onset/NN female/NN year/NN observed/VBN disorder/NN mental/JJ
carmofur/NN onset/NN female/NN year/NN observed/VBN disorder/NN
carmofur/NN onset/NN female/NN year/NN induced/VBN leukoencephalopathy/RB
carmofur/NN leukoencephalopathy/NN
raloxifene/JJ years/NNS associated/VBN risk/NN thromboembolism/NN venous/JJ
raloxifene/JJ years/NNS associated/VBN risk/NN thromboembolism/NN
Raloxifene/NNP associated/VBN risk/NN thromboembolism/NN venous/JJ
Raloxifene/NNP associated/VBN risk/NN thromboembolism/NN
Clarithromycin/NNP associated/VBN hallucinations/NNS visual/JJ
Clarithromycin/NNP associated/VBN hallucinations/NNS
clarithromycin/NN antibiotic/NN occurring/VBG hallucinations/NNS visual/JJ
clarithromycin/NN antibiotic/NN occurring/VBG hallucinations/NNS
cholesterol/NN diffusion/NN generation/NN modulating/VBG hemorrhage/NN ulcer/NN
vitamin/NN D/NNP coadministration/NN induced/VBN atherosclerosis/NNS rats/NNS modulating/VBG hemorrhage/NN ulcer/NN
D/NNP coadministration/NN induced/VBN atherosclerosis/NNS rats/NNS modulating/VBG hemorrhage/NN ulcer/NN
2/CD D/NNP coadministration/NN induced/VBN atherosclerosis/NNS rats/NNS modulating/VBG hemorrhage/NN ulcer/NN
vitamin/NN D/NNP coadministration/NN induced/VBN atherosclerosis/NNS rats/NNS modulating/VBG hemorrhage/NN gastric/JJ
vitamin/NN D/NNP coadministration/NN induced/VBN atherosclerosis/NNS rats/NNS modulating/VBG hemorrhage/NN
D/NNP coadministration/NN induced/VBN atherosclerosis/NNS rats/NNS modulating/VBG hemorrhage/NN gastric/JJ
D/NNP coadministration/NN induced/VBN atherosclerosis/NNS rats/NNS modulating/VBG hemorrhage/NN
2/CD D/NNP coadministration/NN induced/VBN atherosclerosis/NNS rats/NNS modulating/VBG hemorrhage/NN gastric/JJ
2/CD D/NNP coadministration/NN induced/VBN atherosclerosis/NNS rats/NNS modulating/VBG hemorrhage/NN
cholesterol/NN diffusion/NN generation/NN modulating/VBG rats/NNS atherosclerosis/NNS
vitamin/NN D/NNP coadministration/NN induced/VBN atherosclerosis/NNS
D/NNP coadministration/NN induced/VBN atherosclerosis/NNS
2/CD D/NNP coadministration/NN induced/VBN atherosclerosis/NNS
cholesterol/NN diffusion/NN generation/NN modulating/VBG hemorrhage/NN gastric/JJ
cholesterol/NN diffusion/NN generation/NN modulating/VBG hemorrhage/NN
cholesterol/NN induce/VB atherosclerosis/NNS
vitamin/NNP D/NNP containing/VBG oil/NN kg/NN cholesterol/NN induce/VB atherosclerosis/NNS
D/NNP containing/VBG oil/NN kg/NN cholesterol/NN induce/VB atherosclerosis/NNS
2/CD D/NNP containing/VBG oil/NN kg/NN cholesterol/NN induce/VB atherosclerosis/NNS
cholesterol/NN calcium/NN concentration/NN parameters/NNS atherosclerotic/JJ
cholesterol/NN calcium/NN concentration/NN parameters/NNS obtained/VBN rats/NNS atherosclerotic/JJ
paracetamol/NNP survivors/NNS Long/NNP induced/NNP failure/NN acute/JJ
paracetamol/NNP survivors/NNS Long/NNP induced/NNP failure/NN liver/NN
paracetamol/NNP survivors/NNS Long/NNP induced/NNP failure/NN
paracetamol/NNP survivors/NNS prognosis/NN BACKGROUND/NNP induced/VBD remains/VBZ failure/NN acute/JJ
paracetamol/NNP survivors/NNS prognosis/NN BACKGROUND/NNP induced/VBD remains/VBZ failure/NN liver/NN
paracetamol/NNP survivors/NNS prognosis/NN BACKGROUND/NNP induced/VBD remains/VBZ failure/NN
paracetamol/NNP induced/VBN increases/NNS acute/JJ
paracetamol/NNP induced/VBN increases/NNS liver/NN
paracetamol/NNP induced/VBN increases/NNS failure/NN
paracetamol/NNS caused/VBN ratio/NN acute/JJ
paracetamol/NNS caused/VBN ratio/NN liver/NN
paracetamol/NNS caused/VBN ratio/NN failure/NN
paracetamol/NNS caused/VBN higher/JJR age/VBP age/NN died/VBD survivors/NNS failure/NN acute/JJ
paracetamol/NNS caused/VBN higher/JJR age/VBP age/NN died/VBD survivors/NNS failure/NN liver/NN
paracetamol/NNS caused/VBN higher/JJR age/VBP age/NN died/VBD survivors/NNS failure/NN
Paracetamol/NNP CONCLUSIONS/NNS affect/VB failure/NN acute/JJ
Paracetamol/NNP CONCLUSIONS/NNS affect/VB failure/NN liver/NN
Paracetamol/NNP CONCLUSIONS/NNS affect/VB failure/NN
heparin/NN treatment/NN ancrod/NN Failure/NN thrombosis/NNS
heparin/NN associated/VBN remain/VBP thrombosis/NNS
heparin/NN used/VBN prophylaxis/NNS development/NN thrombosis/NNS
heparin/NN used/VBN defined/VBN success/NN patients/NNS developed/VBN syndrome/NN thrombosis/JJ
heparin/NN require/VBP aggregation/NN induced/VBN heparin/NN used/VBN prophylaxis/NNS development/NN thrombosis/NNS
heparin/NN require/VBP aggregation/NN induced/VBN heparin/NN used/VBN defined/VBN success/NN patients/NNS developed/VBN syndrome/NN thrombosis/JJ
heparin/NN patient/NN present/VBP thrombosis/NNS
Chlorpropamide/NNP induced/VBN neuropathy/NN optic/JJ
Chlorpropamide/NNP induced/VBN neuropathy/NN
chlorpropamide/NN treated/VBN diabetes/NN had/VBD neuropathy/NN toxic/JJ
chlorpropamide/NN treated/VBN diabetes/NN had/VBD neuropathy/NN optic/JJ
chlorpropamide/NN treated/VBN diabetes/NN had/VBD neuropathy/NN
Diabenese/NNP diabetes/NN had/VBD neuropathy/NN toxic/JJ
Diabenese/NNP diabetes/NN had/VBD neuropathy/NN optic/JJ
Diabenese/NNP diabetes/NN had/VBD neuropathy/NN
chlorpropamide/JJ therapy/NN discontinuation/NN resolved/VBN neuropathy/NN toxic/JJ
chlorpropamide/JJ therapy/NN discontinuation/NN resolved/VBN neuropathy/NN optic/JJ
chlorpropamide/JJ therapy/NN discontinuation/NN resolved/VBN neuropathy/NN
succinylcholine/NN myalgia/NN Postoperative/JJ
succinylcholine/NN myalgia/NN
succinylcholine/NN associated/VBN effect/NN myalgia/NN postoperative/JJ
succinylcholine/NN associated/VBN effect/NN myalgia/NN
succinylcholine/NN incidence/NN determined/VBN myalgia/NN
succinylcholine/NN pretreated/VBN patients/NNS determined/VBN myalgia/NN
succinylcholine/NN origin/NN evidence/NN myalgia/NN
succinylcholine/NN effective/JJ Administration/NNP IMPLICATIONS/NNS induced/VBN myalgia/NN postoperative/JJ
succinylcholine/NN effective/JJ Administration/NNP IMPLICATIONS/NNS induced/VBN myalgia/NN
succinylcholine/NN severity/NN incidence/NN decreasing/VBG effective/JJ Administration/NNP IMPLICATIONS/NNS induced/VBN myalgia/NN postoperative/JJ
succinylcholine/NN severity/NN incidence/NN decreasing/VBG effective/JJ Administration/NNP IMPLICATIONS/NNS induced/VBN myalgia/NN
succinylcholine/NN prevent/VB myalgia/NN postoperative/JJ
succinylcholine/NN prevent/VB myalgia/NN
dexamethasone/NN oxidase/NN Role/NNP hypertension/NN
dexamethasone/NN hypertension/NN
dexamethasone/NN hypertension/NN dex/NN HT/NNP
dex/NN hypertension/NN
dex/NN HT/NNP
Dex/VB SBP/NN increased/VBN
Dex/VB SBP/NN
Dex/VB SBP/NN thymus/NNS decreased/VBN
Dex/VB SBP/NN thymus/NNS
Dex/VB SBP/NN thymus/NNS 001/NN P/NNP
Dex/VB SBP/NN thymus/NNS 001/NN </NNP
Dex/VB SBP/NN thymus/NNS 001/NN 0/NNP
Dex/VB SBP/NN thymus/NNS 001/NN
Dex/VB SBP/NN and/CC
Dex/VB SBP/NN bodyweights/NNS
dex/NN prevent/VB HT/VBP
testosterone/NN associated/VBN atherosclerosis/NNS
testosterone/JJ therapy/NN estrogen/NN women/NNS atherosclerosis/NNS
testosterone/NN therapy/NN affect/VB atherosclerosis/NNS
pilocarpine/JJ model/NN epilepsy/NN temporal/JJ
pilocarpine/JJ model/NN epilepsy/NN lobe/NN
pilocarpine/JJ model/NN epilepsy/NN
PILO/NNP model/NN TLE/NNP
5/CD initiation/NN
5/CD initiation/NN induced/VBN
5/CD initiation/NN induced/VBN carcinogens/NNS by/IN
5/CD initiation/NN induced/VBN carcinogens/NNS
azacytidine/JJ initiation/NN
azacytidine/JJ initiation/NN induced/VBN
azacytidine/JJ initiation/NN induced/VBN carcinogens/NNS by/IN
azacytidine/JJ initiation/NN induced/VBN carcinogens/NNS
N/NNP pyrene/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN
N/NNP pyrene/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN of/IN
N/NNP pyrene/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN carcinogenic/JJ
N/NNP pyrene/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN
methyl/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN
methyl/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN of/IN
methyl/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN carcinogenic/JJ
methyl/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN
N/NNP methyl/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN
N/NNP methyl/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN of/IN
N/NNP methyl/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN carcinogenic/JJ
N/NNP methyl/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN
nitrosourea/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN
nitrosourea/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN of/IN
nitrosourea/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN carcinogenic/JJ
nitrosourea/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN
benzo/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN
benzo/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN of/IN
benzo/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN carcinogenic/JJ
benzo/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN
-LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN
-LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN of/IN
-LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN carcinogenic/JJ
-LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN
a/DT -RSB-/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN
a/DT -RSB-/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN of/IN
a/DT -RSB-/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN carcinogenic/JJ
a/DT -RSB-/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN
-RSB-/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN
-RSB-/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN of/IN
-RSB-/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN carcinogenic/JJ
-RSB-/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN
pyrene/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN
pyrene/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN of/IN
pyrene/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN carcinogenic/JJ
pyrene/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN
5/CD given/VBN test/VB plays/VBZ role/NN initiation/NN
5/CD given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN of/IN
5/CD given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN carcinogenic/JJ
5/CD given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN
azacytidine/NN 5/CD given/VBN test/VB plays/VBZ role/NN initiation/NN
azacytidine/NN 5/CD given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN of/IN
azacytidine/NN 5/CD given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN carcinogenic/JJ
azacytidine/NN 5/CD given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN
5/CD azacytidine/NN 5/CD given/VBN test/VB plays/VBZ role/NN initiation/NN
5/CD azacytidine/NN 5/CD given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN of/IN
5/CD azacytidine/NN 5/CD given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN carcinogenic/JJ
5/CD azacytidine/NN 5/CD given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN
AzC/NNP 5/CD azacytidine/NN 5/CD given/VBN test/VB plays/VBZ role/NN initiation/NN
AzC/NNP 5/CD azacytidine/NN 5/CD given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN of/IN
AzC/NNP 5/CD azacytidine/NN 5/CD given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN carcinogenic/JJ
AzC/NNP 5/CD azacytidine/NN 5/CD given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN
1/CD nitrosourea/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN
1/CD nitrosourea/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN of/IN
1/CD nitrosourea/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN carcinogenic/JJ
1/CD nitrosourea/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN
2/CD 1/CD nitrosourea/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN
2/CD 1/CD nitrosourea/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN of/IN
2/CD 1/CD nitrosourea/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN carcinogenic/JJ
2/CD 1/CD nitrosourea/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN
dimethylhydrazine/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN
dimethylhydrazine/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN of/IN
dimethylhydrazine/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN carcinogenic/JJ
dimethylhydrazine/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN
1/CD dimethylhydrazine/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN
1/CD dimethylhydrazine/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN of/IN
1/CD dimethylhydrazine/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN carcinogenic/JJ
1/CD dimethylhydrazine/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN
2/CD 1/CD dimethylhydrazine/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN
2/CD 1/CD dimethylhydrazine/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN of/IN
2/CD 1/CD dimethylhydrazine/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN carcinogenic/JJ
2/CD 1/CD dimethylhydrazine/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN
DMH/NNP 1/CD dimethylhydrazine/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN
DMH/NNP 1/CD dimethylhydrazine/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN of/IN
DMH/NNP 1/CD dimethylhydrazine/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN carcinogenic/JJ
DMH/NNP 1/CD dimethylhydrazine/NN -LSB-/NNS carcinogens/NNS induced/VBN synthesis/NN phase/NN given/VBN test/VB plays/VBZ role/NN initiation/NN process/NN
risperidone/NN Treatment/NNP hyperprolactinemia/NN
Risperidone/NNP associated/VBN hyperprolactinemia/NN
risperidone/NN treatment/NN report/VBP induced/VBN hyperprolactinemia/NN
risperidone/NN children/NNS review/NN hyperprolactinemia/NN
risperidone/NN treatment/NN hyperprolactinemia/NN
penicillin/NN potassium/NN induced/VBN focus/NN epileptic/JJ
G/NNP potassium/NN induced/VBN focus/NN epileptic/JJ
potassium/NN induced/VBN focus/NN epileptic/JJ
diclofenac/VBN etoricoxib/NN lower/JJR rate/NN due/JJ AEs/NNP GI/NNP
diclofenac/VBN etoricoxib/NN lower/JJR rate/NN due/JJ AEs/NNP
etoricoxib/NN higher/JJR incidence/NN discontinuations/NNS hypertension/NN
etoricoxib/NN %/NN 0/NNP 001/NNP hypertension/NN
etoricoxib/NN higher/JJR incidence/NN discontinuations/NNS related/VBN oedema/JJ
etoricoxib/NN %/NN 0/NNP 001/NNP 01/NNP oedema/NN
diclofenac/JJ Discontinuations/NNP AEs/NNP GI/NNP
diclofenac/JJ Discontinuations/NNP AEs/NNP
diclofenac/JJ Discontinuations/NNP AEs/NNP higher/JJR common/JJ discontinuations/NNS AEs/NNP GI/NNP
diclofenac/JJ Discontinuations/NNP AEs/NNP higher/JJR common/JJ discontinuations/NNS AEs/NNP
metformin/NN use/NN associated/VBN jaundice/NN Cholestatic/JJ
metformin/NN use/NN associated/VBN jaundice/NN
metformin/NN hydrochloride/NN developed/VBD jaundice/NN cholestatic/JJ
metformin/NN hydrochloride/NN developed/VBD jaundice/NN
hydrochloride/NN developed/VBD jaundice/NN cholestatic/JJ
hydrochloride/NN developed/VBD jaundice/NN
methamphetamine/NN abusing/VBG patients/NNS present/VB hygiene/NN caries/NNS
methamphetamine/NN use/NN reported/VBD experienced/VBN episodes/NNS carious/NNS
methamphetamine/NN use/NN reported/VBD experienced/VBN episodes/NNS
isoproterenol/NN attenuation/NN dose/NN induced/VBN tachycardia/NN
succinylcholine/JJ apnoea/NN
succinylcholine/NN hours/NNS apnoea/NN
succinylcholine/JJ apnoea/NN
doxorubicin/NN +/NN daunorubicin/NN Sensitivity/NNP investigated/VBN toxicity/NN hematologic/JJ
doxorubicin/NN +/NN daunorubicin/NN Sensitivity/NNP investigated/VBN toxicity/NN
daunorubicin/NN Sensitivity/NNP investigated/VBN toxicity/NN hematologic/JJ
daunorubicin/NN Sensitivity/NNP investigated/VBN toxicity/NN
etoposide/NN daunorubicin/NN Sensitivity/NNP investigated/VBN toxicity/NN hematologic/JJ
etoposide/NN daunorubicin/NN Sensitivity/NNP investigated/VBN toxicity/NN
etoposide/NN daunorubicin/NN reduced/VBD loss/NN myelosuppression/NN weight/NN
etoposide/NN daunorubicin/NN reduced/VBD loss/NN
etoposide/NN daunorubicin/NN reduced/VBD antagonized/VBD dexrazoxane/VB myelosuppression/NN loss/NN weight/NN
etoposide/NN daunorubicin/NN reduced/VBD antagonized/VBD dexrazoxane/VB myelosuppression/NN loss/NN
doxorubicin/NN cytotoxicity/NN myelosuppression/NN dexrazoxane/VB antagonized/VBD reduced/VBD loss/NN myelosuppression/NN weight/NN
doxorubicin/NN cytotoxicity/NN myelosuppression/NN dexrazoxane/VB antagonized/VBD reduced/VBD loss/NN
doxorubicin/NN cytotoxicity/NN myelosuppression/NN loss/NN weight/NN
doxorubicin/NN cytotoxicity/NN myelosuppression/NN loss/NN
daunorubicin/NN reduced/VBD loss/NN myelosuppression/NN weight/NN
daunorubicin/NN reduced/VBD loss/NN
daunorubicin/NN reduced/VBD antagonized/VBD dexrazoxane/VB myelosuppression/NN loss/NN weight/NN
daunorubicin/NN reduced/VBD antagonized/VBD dexrazoxane/VB myelosuppression/NN loss/NN
etoposide/NN doses/NNS combining/VBG metastases/NNS patients/NNS trials/NNS ongoing/JJ aim/NN improving/VBG toxicity/NN hematologic/JJ
etoposide/NN doses/NNS combining/VBG metastases/NNS patients/NNS trials/NNS ongoing/JJ aim/NN improving/VBG toxicity/NN
dacarbazine/JJ therapy/NN disease/NN Veno/NNP
dacarbazine/JJ therapy/NN disease/NN occlusive/JJ
dacarbazine/JJ therapy/NN disease/NN liver/NN
dacarbazine/JJ therapy/NN disease/NN
DTIC/NNP therapy/NN disease/NN Veno/NNP
DTIC/NNP therapy/NN disease/NN occlusive/JJ
DTIC/NNP therapy/NN disease/NN liver/NN
DTIC/NNP therapy/NN disease/NN
dacarbazine/JJ therapy/NN reported/VBN disease/NN case/NN veno/NN
dacarbazine/JJ therapy/NN reported/VBN disease/NN occlusive/JJ
dacarbazine/JJ therapy/NN reported/VBN disease/NN
dacarbazine/JJ therapy/NN reported/VBN disease/NN liver/NN of/IN
dacarbazine/JJ therapy/NN reported/VBN disease/NN liver/NN the/DT
dacarbazine/JJ therapy/NN reported/VBN disease/NN liver/NN
DTIC/NNP therapy/NN reported/VBN disease/NN case/NN veno/NN
DTIC/NNP therapy/NN reported/VBN disease/NN occlusive/JJ
DTIC/NNP therapy/NN reported/VBN disease/NN
DTIC/NNP therapy/NN reported/VBN disease/NN liver/NN of/IN
DTIC/NNP therapy/NN reported/VBN disease/NN liver/NN the/DT
DTIC/NNP therapy/NN reported/VBN disease/NN liver/NN
phenacetin/NN consumption/NN associated/VBN cancer/NN necrosis/NNS renal/JJ
phenacetin/NN consumption/NN associated/VBN cancer/NN necrosis/NNS papillary/NN
phenacetin/NN consumption/NN associated/VBN cancer/NN necrosis/NNS
phenacetin/NN consumption/NN fold/JJ 20/CD increased/VBN risk/NN necrosis/NNS renal/JJ
phenacetin/NN consumption/NN fold/JJ 20/CD increased/VBN risk/NN necrosis/NNS papillary/NN
phenacetin/NN consumption/NN fold/JJ 20/CD increased/VBN risk/NN necrosis/NNS
isosorbide/JJ dinitrate/NN administration/NN infarction/NN Myocardial/JJ
isosorbide/JJ dinitrate/NN administration/NN infarction/NN
dinitrate/NN administration/NN infarction/NN Myocardial/JJ
dinitrate/NN administration/NN infarction/NN
isosorbide/JJ dinitrate/NN administration/NN wall/NN infarction/NN myocardial/JJ
isosorbide/JJ dinitrate/NN administration/NN wall/NN infarction/NN
dinitrate/NN administration/NN wall/NN infarction/NN myocardial/JJ
dinitrate/NN administration/NN wall/NN infarction/NN
tacrolimus/NNS Cyclosporine/NNS microangiopathy/NN thrombotic/JJ
tacrolimus/NNS Cyclosporine/NNS microangiopathy/NN
Cyclosporine/NNS microangiopathy/NN thrombotic/JJ
Cyclosporine/NNS microangiopathy/NN
cyclosporine/NN use/NN associated/VBN microangiopathy/NN thrombotic/JJ
cyclosporine/NN use/NN associated/VBN microangiopathy/NN
cyclosporine/NN use/NN associated/VBN microangiopathy/NN TMA/NNP
tacrolimus/NNS switching/VBG reported/VBN option/NN TMA/NNP
cyclosporine/NN setting/NN option/NN TMA/NNP
tacrolimus/NNS application/NN recognized/VBN TMA/NNP
tacrolimus/NNS application/NN recognized/VBN TMA/NNP
tacrolimus/NNS cyclosporine/NN exposed/VBN patients/NNS TMA/NNP
cyclosporine/NN exposed/VBN patients/NNS TMA/NNP
cyclosporine/NN developed/VBD recipient/NNS case/NN TMA/NNP
cyclosporine/NN withdrawal/NN responded/VBD TMA/NNP
tacrolimus/NNS Introduction/NNP resulted/VBD recurrence/NN TMA/NNP
tacrolimus/NNS switched/VBN Patients/NNS monitored/VBN signs/NNS TMA/NNP
cyclosporine/NN switched/VBN Patients/NNS monitored/VBN signs/NNS TMA/NNP
amiodarone/NN secondary/JJ hypothyroidism/NN
amiodarone/NN CHF/NNP Patients/NNS suffer/VB hypothyroidism/NN
simvastatin/NN ezetimibe/NN published/VBN events/NNS hepatotoxic/JJ
ezetimibe/NN ezetimibe/NN published/VBN events/NNS hepatotoxic/JJ
simvastatin/VB 70/CD developed/VBD failure/NN fulminant/JJ
simvastatin/VB 70/CD developed/VBD failure/NN hepatic/JJ
simvastatin/VB 70/CD developed/VBD failure/NN
10/CD mg/NN simvastatin/VB 70/CD developed/VBD failure/NN fulminant/JJ
10/CD mg/NN simvastatin/VB 70/CD developed/VBD failure/NN hepatic/JJ
10/CD mg/NN simvastatin/VB 70/CD developed/VBD failure/NN
mg/NN simvastatin/VB 70/CD developed/VBD failure/NN fulminant/JJ
mg/NN simvastatin/VB 70/CD developed/VBD failure/NN hepatic/JJ
mg/NN simvastatin/VB 70/CD developed/VBD failure/NN
ezetimibe/RB mg/CD mg/NN simvastatin/VB 70/CD developed/VBD failure/NN fulminant/JJ
ezetimibe/RB mg/CD mg/NN simvastatin/VB 70/CD developed/VBD failure/NN hepatic/JJ
ezetimibe/RB mg/CD mg/NN simvastatin/VB 70/CD developed/VBD failure/NN
40/CD mg/CD mg/NN simvastatin/VB 70/CD developed/VBD failure/NN fulminant/JJ
40/CD mg/CD mg/NN simvastatin/VB 70/CD developed/VBD failure/NN hepatic/JJ
40/CD mg/CD mg/NN simvastatin/VB 70/CD developed/VBD failure/NN
mg/CD mg/NN simvastatin/VB 70/CD developed/VBD failure/NN fulminant/JJ
mg/CD mg/NN simvastatin/VB 70/CD developed/VBD failure/NN hepatic/JJ
mg/CD mg/NN simvastatin/VB 70/CD developed/VBD failure/NN
Simvastatinezetimibe/NN discontinued/VBN excluded/VBN causes/NNS hepatotoxicity/NN
simvastatinezetimibe/NN induced/VBN hepatotoxicity/RB
simvastatin/NN hepatotoxicity/NN
ezetimibe/JJ aware/JJ hepatotoxicity/NN
Serotonergic/NNP antidepressants/VBZ incontinence/VBP urinary/RB
Serotonergic/NNP antidepressants/VBZ incontinence/VBP
antidepressants/VBZ incontinence/VBP urinary/RB
antidepressants/VBZ incontinence/VBP
venlafaxine/NN taking/VBG experienced/VBD incontinence/NN
sertraline/JJ paroxetine/JJ inhibitors/NNS incontinence/JJ
paroxetine/JJ inhibitors/NNS incontinence/JJ
venlafaxine/NN developed/VBD third/JJ patients/NNS developed/VBD inhibitors/NNS incontinence/JJ
lithium/NN carbonate/NN blockers/NNS contributed/VBN incontinence/NN
carbonate/NN blockers/NNS contributed/VBN incontinence/NN
serotonergic/JJ antidepressants/NNS incontinence/JJ
antidepressants/NNS incontinence/JJ
metoprolol/NN administration/NN Angioedema/NNP
lisinopril/JJ therapy/NN angioedema/NN
metoprolol/NN given/VBN resulting/VBG angioedema/NN
bupropion/NN hydrochloride/NN increasing/VBG Effect/NN seizures/NNS
hydrochloride/NN increasing/VBG Effect/NN seizures/NNS
bupropion/NN relationship/NN seizures/NNS
bupropion/NNP HCl/NNP mg/NN kg/NN dose/NN convulsive/JJ
HCl/NNP mg/NN kg/NN dose/NN convulsive/JJ
bupropion/NNP HCl/NNP mg/NN induced/VBN convulsions/NNS
HCl/NNP mg/NN induced/VBN convulsions/NNS
bupropion/NN severity/NN kg/NN dose/NN convulsive/JJ
bupropion/NN severity/NN kg/NN mg/NN induced/VBN convulsions/NNS
bupropion/JJ mg/NN administration/NN kg/NN induced/VBN convulsions/NNS
HCl/NN mg/NN administration/NN kg/NN induced/VBN convulsions/NNS
bupropion/JJ mg/NN administration/NN associated/VBN odds/NNS convulsions/NNS
HCl/NN mg/NN administration/NN associated/VBN odds/NNS convulsions/NNS
bupropion/JJ mg/NN time/NN increasing/VBG revealed/VBD group/NN induced/VBN convulsions/NNS
HCl/NN mg/NN time/NN increasing/VBG revealed/VBD group/NN induced/VBN convulsions/NNS
bupropion/JJ mg/NN time/NN increasing/VBG revealed/VBD group/NN induced/VBN kg/NN administration/NN associated/VBN odds/NNS convulsions/NNS
HCl/NN mg/NN time/NN increasing/VBG revealed/VBD group/NN induced/VBN kg/NN administration/NN associated/VBN odds/NNS convulsions/NNS
bupropion/NN dose/NN fixed/JJ convulsive/JJ
bupropion/NN dose/NN risk/NN convulsions/NNS
metoclopramide/NN arrest/NN Cardiac/NNP
metoclopramide/NN arrest/NN
metoclopramide/NN arrest/NN case/NN injections/NNS metoclopramide/NN causing/VBG episodes/NNS arrest/NN cardiac/JJ
metoclopramide/NN arrest/NN case/NN injections/NNS metoclopramide/NN causing/VBG episodes/NNS arrest/NN
metoclopramide/NN injections/NNS case/NN arrest/NN Cardiac/NNP
metoclopramide/NN injections/NNS case/NN arrest/NN
metoclopramide/NN causing/VBG episodes/NNS arrest/NN cardiac/JJ
metoclopramide/NN causing/VBG episodes/NNS arrest/NN
metoclopramide/NN injection/NN followed/VBN asystole/NN
metoclopramide/NN administration/NN followed/VBN asystole/NN
metoclopramide/NN caused/VBN arrest/NN cardiac/JJ
metoclopramide/NN caused/VBN arrest/NN
valproate/VB added/VBD induced/VBN Encephalopathy/RB
levetiracetam/NN induced/VBN Encephalopathy/RB
levetiracetam/NN manifestation/NN report/NN encephalopathy/JJ
LEV/NNP levetiracetam/NN manifestation/NN report/NN encephalopathy/JJ
folic/JJ acid/NN activity/NN induces/VBZ SLE/NNP
acid/NN activity/NN induces/VBZ SLE/NNP
folic/JJ acid/NN SLE/NNP
acid/NN SLE/NNP
folic/JJ acid/NN dose/NN barrier/NN triggered/VBD disease/NN drug/NN lupus/NNS
acid/NN dose/NN barrier/NN triggered/VBD disease/NN drug/NN lupus/NNS
folic/JJ acid/NN dose/NN barrier/NN triggered/VBD cluster/NN seizures/NNS
acid/NN dose/NN barrier/NN triggered/VBD cluster/NN seizures/NNS
nimesulide/NN Tolerability/NNP urticaria/NN angioedema/NN
NSAID/NNP Tolerability/NNP urticaria/NN angioedema/NN
paracetamol/NN nimesulide/NN Tolerability/NNP urticaria/NN angioedema/NN
nimesulide/NN angioedema/NN
NSAID/NNP history/NN number/NN paracetamol/JJ nimesulide/NN angioedema/NN
paracetamol/JJ nimesulide/NN angioedema/NN
nimesulide/NN procedure/NN applied/VBN patients/NNS history/NN angioedema/NN
NSAID/NNP angioedema/NN
paracetamol/NN nimesulide/NN procedure/NN applied/VBN patients/NNS history/NN angioedema/NN
NSAID/NNP history/NN subjects/NNS %/NN induced/VBN angioedema/NN
NSAID/NNP history/NN subjects/NNS %/NN induced/VBN angioedema/NN angioedema/NN
nimesulide/NN tolerability/NN confirm/VBP patients/NNS experienced/VBD angioedema/NN
NSAIDs/NNP caused/VBN angioedema/NN
paracetamol/NN nimesulide/NN tolerability/NN confirm/VBP patients/NNS experienced/VBD angioedema/NN
NSAID/NNP history/NN angioedema/NN
enflurane/NN resulted/VBD seizures/NNS
enflurane/NN delineated/VBN foci/NNS ablated/VBN seizure/JJ
MZ/NNP use/NN caused/VBN hypoxia/NN presented/VBD event/NN hypoxia/NN
MZ/NNP use/NN caused/VBN hypoxia/NN presented/VBD hypoxia/NN
MZ/NNP use/NN caused/VBN hypoxia/NN
streptomycin/VB sensitive/JJ indicating/VBG occurred/VBD occurred/VBD movements/NNS Abnormal/JJ
streptomycin/VB sensitive/JJ indicating/VBG occurred/VBD occurred/VBD movements/NNS
streptomycin/VB site/NN responsible/JJ dyskinesias/NNS
streptomycin/VB sensitive/JJ indicating/VBG occurred/VBD occurred/VBD movements/NNS deafness/NNS
fluphenazine/JJ enanthate/NN induced/VBN parkinsonism/NN
enanthate/NN induced/VBN parkinsonism/NN
benztropine/NN treated/VBD had/VBD increase/NN dyskinesia/NN tardive/JJ
benztropine/NN treated/VBD had/VBD increase/NN dyskinesia/NN
benztropine/NN treated/VBD had/VBD condition/NN anxiety/NN depression/NN
benztropine/NN treated/VBD had/VBD condition/NN anxiety/NN
cimetidine/JJ was/VBD only/RB dementia/NN
cimetidine/JJ levels/NNS had/VBD disease/NN liver/NN was/VBD only/RB dementia/NN
cimetidine/NN levels/NNS induce/VB dementia/NN
terbutaline/JJ treatment/NN associated/VBN complications/NNS Cardiovascular/NNP
terbutaline/JJ treatment/NN associated/VBN complications/NNS
terbutaline/NN treated/VBN patients/NNS eight/CD occurred/VBD complications/NNS cardiovascular/JJ
terbutaline/NN treated/VBN patients/NNS eight/CD occurred/VBD complications/NNS
Ticlopidine/NNP induced/VBN anemia/NN aplastic/JJ
Ticlopidine/NNP induced/VBN anemia/NN
ticlopidine/NN induced/VBN anemia/NN aplastic/JJ
ticlopidine/NN induced/VBN anemia/NN
ticlopidine/NN initiation/NN weeks/NNS recommended/VBN occurred/VBD Agranulocytosis/NNS
ticlopidine/NN induced/VBN anemia/NN aplastic/JJ
ticlopidine/NN induced/VBN anemia/NN
doxorubicin/NN nephrosis/NNS
morphine/NN administration/NN induced/VBN learning/VBG impairment/NN
morphine/NN administration/NN induced/VBN learning/VBG of/IN
morphine/NN administration/NN induced/VBN learning/VBG
morphine/NN administration/NN learning/VBG
morphine/NN administration/NN learning/VBG impairment/NN
puromycin/NN aminonucleoside/NN hypoxia/NN syndrome/NN nephrotic/JJ
puromycin/NN aminonucleoside/NN hypoxia/NN syndrome/NN
aminonucleoside/NN hypoxia/NN syndrome/NN nephrotic/JJ
aminonucleoside/NN hypoxia/NN syndrome/NN
puromycin/NN aminonucleoside/NN hypoxia/NN
aminonucleoside/NN hypoxia/NN
puromycin/NN aminonucleoside/NN hypoxia/NN hypoxia/NN
aminonucleoside/NN hypoxia/NN hypoxia/NN
puromycin/NN model/NN weeks/NNS fold/CD reaching/VBG increased/VBD Expression/NNP hypoxia/NN
aminonucleoside/NN model/NN weeks/NNS fold/CD reaching/VBG increased/VBD Expression/NNP hypoxia/NN
norfloxacin/JJ ciprofloxacin/JJ rats/NNS showed/VBD behaviour/NN anxious/JJ
norfloxacin/JJ ciprofloxacin/JJ rats/NNS showed/VBD behaviour/NN
ciprofloxacin/JJ rats/NNS showed/VBD behaviour/NN anxious/JJ
ciprofloxacin/JJ rats/NNS showed/VBD behaviour/NN
didanosine/NN normal/JJ returned/VBD mild/JJ developed/VBD characteristic/NN glucose/NN
didanosine/NN normal/JJ returned/VBD mild/JJ developed/VBD characteristic/NN tolerance/NN
didanosine/NN normal/JJ returned/VBD mild/JJ developed/VBD characteristic/NN curves/NNS
ACE/NNP inhibitors/NNS due/JJ Angioedema/NNP
inhibitors/NNS due/JJ Angioedema/NNP
angiotensin/NN incidence/NN angioedema/NN
converting/VBG 1/CD incidence/NN angioedema/NN
enzyme/JJ treatment/NN converting/VBG 1/CD incidence/NN angioedema/NN
ACE/NNP enzyme/JJ treatment/NN converting/VBG 1/CD incidence/NN angioedema/NN
inhibitor/NN treatment/NN converting/VBG 1/CD incidence/NN angioedema/NN
ketamine/NN combinations/NNS induced/JJ potentiation/NN Catalepsy/RB
morphine/NN ketamine/NN combinations/NNS induced/JJ potentiation/NN Catalepsy/RB
ketamine/JJ induced/NN analgesia/JJ catalepsy/JJ
morphine/JJ ketamine/JJ induced/NN analgesia/JJ catalepsy/JJ
ketamine/NN treatment/NN Pre/NNP tolerance/VBZ ketamine/VB augmented/VB response/NN cataleptic/JJ
ketamine/VB augmented/VB response/NN cataleptic/JJ
morphine/VB tolerance/JJ cross/NN produced/VBN treatment/NN Pre/NNP tolerance/VBZ ketamine/VB augmented/VB response/NN cataleptic/JJ
morphine/NN pretreatment/NN induce/VB produced/VBN treatment/NN Pre/NNP tolerance/VBZ ketamine/VB augmented/VB response/NN cataleptic/JJ
morphine/NN attributed/VBN tolerance/VBZ ketamine/VB augmented/VB response/NN cataleptic/JJ
ribavirin/NNP prodrug/NN liver/NN has/VBZ potential/NN maintain/VB decreasing/VBG risk/NN anemia/NN hemolytic/JJ
ribavirin/NNP prodrug/NN liver/NN has/VBZ potential/NN maintain/VB decreasing/VBG risk/NN anemia/NN
ribavirin/NNP efficacy/NN maintain/VB decreasing/VBG risk/NN anemia/NN hemolytic/JJ
ribavirin/NNP efficacy/NN maintain/VB decreasing/VBG risk/NN anemia/NN
chlorhexidine/NN factor/NN digluconate/NN associated/VBN cystitis/NNS
digluconate/NN associated/VBN cystitis/NNS
kanamycin/NN percentage/NN iodine/VBP associated/VBN cystitis/NNS
povidone/NN colistin/NN percentage/NN iodine/VBP associated/VBN cystitis/NNS
iodine/VBP associated/VBN cystitis/NNS
colistin/NN percentage/NN iodine/VBP associated/VBN cystitis/NNS
doxorubicin/NN damage/NN myocardial/JJ
doxorubicin/NN damage/NN
doxorubicin/NN damage/NN markers/NNS I/NN Evaluation/NNP rats/NNS cardiomyopathy/NN
doxorubicin/NN model/NN damage/NN myocardial/JJ
doxorubicin/NN model/NN damage/NN
doxorubicin/NN model/NN damage/NN diagnosis/NN investigated/VBD induced/VBN cardiomyopathy/RB
DOX/NNP doxorubicin/NN model/NN damage/NN myocardial/JJ
DOX/NNP doxorubicin/NN model/NN damage/NN
DOX/NNP doxorubicin/NN model/NN damage/NN diagnosis/NN investigated/VBD induced/VBN cardiomyopathy/RB
DOX/NNP injury/NN markers/NNS showed/VBD detect/VB damage/NN myocardial/JJ
DOX/NNP injury/NN markers/NNS showed/VBD detect/VB damage/NN
caffeine/NN men/NNS hypertension/NN
caffeine/NN actions/NNS enhanced/VBN persons/NNS hypertensive/JJ
caffeine/NN ingestion/NN achieved/VBD levels/NNS hypertensive/JJ
caffeine/NN were/VBD men/NNS hypertensive/NN
caffeine/NN were/VBD replicated/VBN protocols/CD representative/NN hypertensives/NNS
docetaxel/JJ cancer/NN combination/NN thromboembolism/VBP frequency/NN venous/NNS
docetaxel/JJ cancer/NN combination/NN thromboembolism/VBP
thalidomide/JJ docetaxel/JJ cancer/NN combination/NN thromboembolism/VBP frequency/NN venous/NNS
thalidomide/JJ docetaxel/JJ cancer/NN combination/NN thromboembolism/VBP
docetaxel/NN treated/VBN cancer/NN frequency/NN thromboembolism/NN venous/JJ
docetaxel/NN treated/VBN cancer/NN frequency/NN thromboembolism/NN
docetaxel/NN treated/VBN cancer/NN frequency/NN thromboembolism/NN VTE/NNP
thalidomide/NN treated/VBN cancer/NN frequency/NN thromboembolism/NN venous/JJ
thalidomide/NN treated/VBN cancer/NN frequency/NN thromboembolism/NN
thalidomide/NN treated/VBN cancer/NN frequency/NN thromboembolism/NN VTE/NNP
docetaxel/NN developed/VBD VTE/NNP
docetaxel/NN developed/VBD developed/VBD VTE/NNP
docetaxel/JJ thalidomide/NN received/VBD patients/NNS 9/CD developed/VBD developed/VBD VTE/NNP
docetaxel/JJ thalidomide/NN received/VBD patients/NNS 9/CD developed/VBD VTE/NNP
thalidomide/NN received/VBD patients/NNS 9/CD developed/VBD developed/VBD VTE/NNP
thalidomide/NN received/VBD patients/NNS 9/CD developed/VBD VTE/NNP
docetaxel/VB addition/NN CONCLUSION/NNP increases/VBZ frequency/NN VTE/NNP
thalidomide/NN addition/NN CONCLUSION/NNP increases/VBZ frequency/NN VTE/NNP
levomepromazine/JJ treatment/NN induced/VBN Seizures/NNS
fluvoxamine/NN treatment/NN induced/VBN Seizures/NNS
levomepromazine/NN induced/VBN seizures/NNS
fluvoxamine/JJ treatment/NN levomepromazine/NN induced/VBN seizures/NNS
tramadol/NN intake/NN Nightmares/NNS hallucinations/NNS
tramadol/NN drugs/NNS hallucinations/NNS
telithromycin/NN attack/VBP hepatitis/NNP
telithromycin/NN usage/NN occurred/VBD hepatitis/NN
telithromycin/NN cause/NN hepatitis/NN
telithromycin/NN cause/NN suggested/VBD drug/NN induced/VBN hepatitis/NN toxic/JJ
telithromycin/NN cause/NN suggested/VBD drug/NN induced/VBN hepatitis/NN
telithromycin/NN prescribed/VBN physician/NN communicated/VBN avoided/VBN Recurrence/NNP attack/NN hepatitis/NN
telithromycin/NN administration/NN associated/VBN hepatitis/NN
metrizoate/NN lower/JJR Frequencies/NNS fibrillation/NN ventricular/NN
metrizoate/NN lower/JJR Frequencies/NNS fibrillation/NN
paracetamol/NNP aspirin/NNP developed/VBD necrosis/NNS Renal/JJ
paracetamol/NNP aspirin/NNP developed/VBD necrosis/NNS papillary/NN
paracetamol/NNP aspirin/NNP developed/VBD necrosis/NNS
paracetamol/NNP aspirin/NNP developed/VBD necrosis/NNS RPN/NNP
aspirin/NNP developed/VBD necrosis/NNS Renal/JJ
aspirin/NNP developed/VBD necrosis/NNS papillary/NN
aspirin/NNP developed/VBD necrosis/NNS
aspirin/NNP developed/VBD necrosis/NNS RPN/NNP
methamphetamine/NN hyperthermia/NN
ropivacaine/JJ levobupivacaine/JJ seizures/NNS
levobupivacaine/JJ seizures/NNS
ropivacaine/NN doses/NNS smaller/JJR doses/NNS levobupivacaine/NN produced/VBD dysrhythmias/JJ
levobupivacaine/NN produced/VBD dysrhythmias/JJ
levobupivacaine/NN produced/VBD dysrhythmias/JJ asystole/JJ
ropivacaine/NN doses/NNS smaller/JJR doses/NNS levobupivacaine/NN produced/VBD dysrhythmias/JJ asystole/JJ
levobupivacaine/NN toxicity/NN intermediate/JJ conclude/VBP appears/VBZ arrest/NN cardiac/JJ
levobupivacaine/NN toxicity/NN intermediate/JJ conclude/VBP appears/VBZ arrest/NN
levobupivacaine/NN bupivacaine/NN induced/VBN that/DT treatment/NN susceptible/JJ appears/VBZ arrest/NN cardiac/JJ
levobupivacaine/NN bupivacaine/NN induced/VBN that/DT treatment/NN susceptible/JJ appears/VBZ arrest/NN
ropivacaine/NN that/DT intermediate/JJ conclude/VBP appears/VBZ arrest/NN cardiac/JJ
ropivacaine/NN that/DT intermediate/JJ conclude/VBP appears/VBZ arrest/NN
ropivacaine/NN rate/NN administered/VBN intermediate/JJ conclude/VBP appears/VBZ arrest/NN cardiac/JJ
ropivacaine/NN rate/NN administered/VBN intermediate/JJ conclude/VBP appears/VBZ arrest/NN
Triamterene/NNP nephrolithiasis/VBZ
triamterene/JJ nephrolithiasis/NNS
triamterene/JJ nephrolithiasis/NNS
pimecrolimus/NNS tacrolimus/NNS immunomodulators/NNS use/NN regarded/VBN cause/NN dermatitis/NNS
SRL/NNP seems/VBZ nephrotoxic/JJ
SRL/NNP seems/VBZ act/VB displaying/VBG effects/NNS nephrotoxic/JJ
SRL/NNP combined/VBN number/NN described/VBN indications/NNS effect/NN nephrotoxic/JJ
SRL/NNP CsA/NNP effect/NN nephrotoxic/JJ
SRL/NNP 506/NNP tolerated/JJ demonstrated/VBN effect/NN nephrotoxic/JJ
FK/NNP 506/NNP tolerated/JJ demonstrated/VBN effect/NN nephrotoxic/JJ
506/NNP tolerated/JJ demonstrated/VBN effect/NN nephrotoxic/JJ
CsA/NNP effect/NN nephrotoxic/JJ
metoprolol/JJ treatment/NN SR/NNP block/VBP shock/NN heart/NN
metoprolol/JJ treatment/NN SR/NNP block/VBP
verapamil/NNP SR/NNP block/VBP shock/NN heart/NN
verapamil/NNP SR/NNP block/VBP
metoprolol/NN use/NN verapamil/NN seventy/NN eight/CD year/NN woman/NN presented/VBN block/NN heart/NN
metoprolol/NN use/NN verapamil/NN seventy/NN eight/CD year/NN woman/NN presented/VBN block/NN
verapamil/NN seventy/NN eight/CD year/NN woman/NN presented/VBN block/NN heart/NN
verapamil/NN seventy/NN eight/CD year/NN woman/NN presented/VBN block/NN
verapamil/NN seventy/NN eight/CD year/NN woman/NN presented/VBN block/NN hypotension/NN
metoprolol/NN use/NN verapamil/NN seventy/NN eight/CD year/NN woman/NN presented/VBN block/NN hypotension/NN
FK/NNP A/NN Nephrotoxicity/NNP
506/CD FK/NNP A/NN Nephrotoxicity/NNP
cyclosporin/NN A/NN Nephrotoxicity/NNP
A/NN Nephrotoxicity/NNP
FK/NNP CsA/NNP 506/NNP effects/NNS nephrotoxic/JJ
506/NNP effects/NNS nephrotoxic/JJ
CsA/NNP 506/NNP effects/NNS nephrotoxic/JJ
puromycin/NN aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
puromycin/NN aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
puromycin/NN aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS
puromycin/NN aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
puromycin/NN aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
puromycin/NN aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS
aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
PAN/NNP aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
PAN/NNP aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
PAN/NNP aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS
PAN/NNP aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
PAN/NNP aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
PAN/NNP aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
2/CD butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
2/CD butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
2/CD butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS
2/CD butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
2/CD butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
2/CD butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
bromoethylamine/NN administration/NN produced/VBN models/NNS
bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
BEA/NNP bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
BEA/NNP bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
BEA/NNP bromoethylamine/NN administration/NN produced/VBN models/NNS
BEA/NNP bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
BEA/NNP bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
BEA/NNP bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
hexachloro/JJ bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
hexachloro/JJ bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
hexachloro/JJ bromoethylamine/NN administration/NN produced/VBN models/NNS
hexachloro/JJ bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
hexachloro/JJ bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
hexachloro/JJ bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
1/CD 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
1/CD 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
1/CD 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS
1/CD 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
1/CD 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
1/CD 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS
3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS
butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
HCBD/NNP butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
HCBD/NNP butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
HCBD/NNP butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS
HCBD/NNP butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
HCBD/NNP butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
HCBD/NNP butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
droperidol/JJ administration/NN associated/VBN Angioedema/NNP
droperidol/NN dose/NN administration/NN minutes/NNS developed/VBN protrusion/NN year/NN man/NN allergies/NNS angioedema/NN
ciprofloxacin/NN associated/VBN thrombocytopenia/NN anaemia/NN haemolytic/JJ
ciprofloxacin/NN associated/VBN thrombocytopenia/NN anaemia/NN
ciprofloxacin/NN associated/VBN thrombocytopenia/NN
ciprofloxacin/NN administration/NN 30/CD man/NN reported/VBN pain/NN abdominal/JJ
ciprofloxacin/NN administration/NN 30/CD man/NN reported/VBN pain/NN
ciprofloxacin/NN administration/NN 30/CD man/NN reported/VBN pain/NN jaundice/NN
ciprofloxacin/NN precipitate/VB life/NN thrombocytopenia/NN anaemia/NN haemolytic/JJ
ciprofloxacin/NN precipitate/VB life/NN thrombocytopenia/NN anaemia/NN
ciprofloxacin/NN precipitate/VB life/NN thrombocytopenia/NN
ethambutol/NN induced/VBN neuropathy/NN optic/JJ
ethambutol/NN induced/VBN neuropathy/NN
ethambutol/NN map/VB induced/VBN neuropathy/NN optic/JJ
ethambutol/NN map/VB induced/VBN neuropathy/NN
ethambutol/NN complication/NN neuropathy/NN optic/JJ
ethambutol/NN complication/NN neuropathy/NN
ethambutol/NN history/NN subjects/NNS METHODS/NNP long/RB administered/VBN deficits/NNS visual/JJ
ethambutol/NN history/NN subjects/NNS METHODS/NNP long/RB administered/VBN deficits/NNS
EMB/NNP ethambutol/NN history/NN subjects/NNS METHODS/NNP long/RB administered/VBN deficits/NNS visual/JJ
EMB/NNP ethambutol/NN history/NN subjects/NNS METHODS/NNP long/RB administered/VBN deficits/NNS
ethambutol/NN history/NN subjects/NNS METHODS/NNP induced/VBN neuropathy/NN optic/JJ
ethambutol/NN history/NN subjects/NNS METHODS/NNP induced/VBN neuropathy/NN
EMB/NNP ethambutol/NN history/NN subjects/NNS METHODS/NNP induced/VBN neuropathy/NN optic/JJ
EMB/NNP ethambutol/NN history/NN subjects/NNS METHODS/NNP induced/VBN neuropathy/NN
EMB/NNP history/NN subjects/NNS was/VBD loss/NN A/NN recovery/NN patient/JJ B/NNP deficits/NNS visual/JJ
EMB/NNP history/NN subjects/NNS was/VBD loss/NN A/NN recovery/NN patient/JJ B/NNP deficits/NNS
EMB/NNP history/NN subjects/NNS was/VBD loss/NN A/NN recovery/NN deficits/NNS visual/JJ
EMB/NNP history/NN subjects/NNS was/VBD loss/NN A/NN recovery/NN deficits/NNS
EMB/NNP history/NN neuropathy/NN optic/JJ
EMB/NNP history/NN neuropathy/NN
EMB/NNP patients/NNS results/NNS CONCLUSIONS/NNS induced/VBN show/VB neuropathy/NN optic/JJ
EMB/NNP patients/NNS results/NNS CONCLUSIONS/NNS induced/VBN show/VB neuropathy/NN
EMB/NNP induced/VBN neuropathy/NN optic/JJ
EMB/NNP induced/VBN neuropathy/NN
ethambutol/JJ dosing/NN manage/VB important/JJ terms/NNS management/NN EMB/NNP induced/VBN neuropathy/NN optic/JJ
ethambutol/JJ dosing/NN manage/VB important/JJ terms/NNS management/NN EMB/NNP induced/VBN neuropathy/NN
norepinephrine/NN caused/VBN bradycardia/NN
norepinephrine/NN had/VBD enhanced/VBN bradycardia/NN
norepinephrine/NN caused/VBN bradycardia/NN
norepinephrine/VB decreased/VBD bradycardia/NN
prostaglandin/NN E/NN Epidural/VB trimethaphan/VB hypotension/NN
E/NN Epidural/VB trimethaphan/VB hypotension/NN
1/CD E/NN Epidural/VB trimethaphan/VB hypotension/NN
trimethaphan/VB hypotension/NN
prostaglandin/NN E/NN trimethaphan/NN induced/VBN hypotension/NN
E/NN trimethaphan/NN induced/VBN hypotension/NN
1/CD E/NN trimethaphan/NN induced/VBN hypotension/NN
PGE/NNP 1/CD E/NN trimethaphan/NN induced/VBN hypotension/NN
1/CD PGE/NNP 1/CD E/NN trimethaphan/NN induced/VBN hypotension/NN
trimethaphan/NN induced/VBN hypotension/NN
TMP/NNP trimethaphan/NN induced/VBN hypotension/NN
PGE/NNP starting/VBG decreased/VBD remained/VBD degree/NN hypotension/NN
1/CD PGE/NNP starting/VBG decreased/VBD remained/VBD degree/NN hypotension/NN
PGE/NNP due/JJ hypotension/NN
1/CD PGE/NNP due/JJ hypotension/NN
TMP/NNP PGE/NNP starting/VBG decreased/VBD remained/VBD degree/NN hypotension/NN
PGE/NNP preferable/JJ TMP/VB anaesthesia/NN hypotensive/JJ
1/CD PGE/NNP preferable/JJ TMP/VB anaesthesia/NN hypotensive/JJ
TMP/VB anaesthesia/NN hypotensive/JJ
TMP/NNP decreased/VBD preferable/JJ TMP/VB anaesthesia/NN hypotensive/JJ
methylprednisolone/NN cause/VB was/VBD mention/NN possibility/NN myopathy/NN
methylprednisolone/NN offers/VBZ protection/NN recording/NN recovers/VBZ myopathy/NN
methylprednisolone/NN offers/VBZ protection/NN recording/NN recovery/NN myopathy/NN
methylprednisolone/NN cause/VB myopathy/NN
Simvastatin/NNP induced/VBN syndrome/NN compartment/NN
Simvastatin/NNP induced/VBN syndrome/NN
simvastatin/NN thyroxine/NN presented/VBN syndrome/NN compartment/NN
simvastatin/NN thyroxine/NN presented/VBN syndrome/NN
Fucoidan/NNP treated/VBN exhibited/VBD evidence/NN blood/NN impaired/VBN
Fucoidan/NNP treated/VBN exhibited/VBD evidence/NN blood/NN
Fucoidan/NNP treated/VBN exhibited/VBD evidence/NN blood/NN clotting/VBG
Fucoidan/NNP treated/VBN exhibited/VBD evidence/NN blood/NN hemodilution/NN
Dexamethasone/NNP induced/VBN hypertension/NN ocular/NN
Dexamethasone/NNP induced/VBN hypertension/NN
dexamethasone/NN treated/VBD thickened/VBN eyes/NNS hypertensive/JJ
dexamethasone/NN treated/VBD thickened/VBN eyes/NNS
Dexamethasone/JJ treatment/NN eyes/NNS led/VBN generation/NN hypertension/NN ocular/NN
Dexamethasone/JJ treatment/NN eyes/NNS led/VBN generation/NN hypertension/NN
dexamethasone/NN %/NN led/VBN generation/NN hypertension/NN ocular/NN
dexamethasone/NN %/NN led/VBN generation/NN hypertension/NN
acitretin/NN dysphonia/NN
acitretin/NN treated/VBN complaining/VBG dysphonia/NN
acitretin/NN case/NN dysphonia/NN
puromycin/NN aminonucleoside/NN course/NN induced/VBN nephropathy/RB
aminonucleoside/NN course/NN induced/VBN nephropathy/RB
puromycin/NN aminonucleoside/NN pathogenesis/NNS implicated/VBN induced/VBN antioxidants/NNS reducing/VBG proteinuria/NN
aminonucleoside/NN pathogenesis/NNS implicated/VBN induced/VBN antioxidants/NNS reducing/VBG proteinuria/NN
PAN/NNP aminonucleoside/NN pathogenesis/NNS implicated/VBN induced/VBN antioxidants/NNS reducing/VBG proteinuria/NN
puromycin/NN aminonucleoside/NN pathogenesis/NNS implicated/VBN induced/VBN nephropathy/RB
aminonucleoside/NN pathogenesis/NNS implicated/VBN induced/VBN nephropathy/RB
PAN/NNP aminonucleoside/NN pathogenesis/NNS implicated/VBN induced/VBN nephropathy/RB
PAN/NNP injury/NN proteinuric/JJ
PAN/NNP injury/NN
PAN/NNP injury/NN mediating/VBG nephropathy/RB
etomidate/NN reduces/VBZ myoclonus/NNS
etomidate/NN induction/NN compare/VB incidence/NN myoclonus/NNS
etomidate/JJ administration/NN associated/VBN incidence/NN myoclonus/NNS
etomidate/JJ induction/NN reduced/VBD myoclonus/NNS
etomidate/JJ administration/NN increased/VBD incidence/NN myoclonus/NNS
paracetamol/NNP overdose/NN survived/VBD failure/NN fulminant/JJ
paracetamol/NNP overdose/NN survived/VBD failure/NN hepatic/JJ
paracetamol/NNP overdose/NN survived/VBD failure/NN
paracetamol/NNP overdose/NN survived/VBD increased/VBN patients/NNS failure/NN fulminant/JJ
paracetamol/NNP overdose/NN survived/VBD increased/VBN patients/NNS failure/NN hepatic/JJ
paracetamol/NNP overdose/NN survived/VBD increased/VBN patients/NNS failure/NN
Reserpine/NNP produced/VBD chewing/VBG mice/NNS signs/NNS dyskinesia/NN tardive/JJ
Reserpine/NNP produced/VBD chewing/VBG mice/NNS signs/NNS dyskinesia/NN
Reserpine/NNP produced/VBD tremor/NN catalepsy/NN
Reserpine/NNP produced/VBD tremor/NN
reserpine/NN induced/VBN catalepsy/RB
reserpine/NN produced/VBN increase/NN tremor/NN
reserpine/JJ induced/NNS increases/VBZ tremor/NN catalepsy/NN
reserpine/JJ induced/NNS increases/VBZ tremor/NN
reserpine/NN induced/VBN catalepsy/NN
reserpine/NN induced/VBN catalepsy/NN tremor/NN
reserpine/JJ protrusion/NN increases/NNS tremor/NN catalepsy/NN
reserpine/NN effects/NNS reversed/VBD Pretreatment/NNP protrusion/NN increases/NNS tremor/NN catalepsy/NN
reserpine/JJ protrusion/NN increases/NNS tremor/NN
reserpine/NN effects/NNS reversed/VBD Pretreatment/NNP protrusion/NN increases/NNS tremor/NN
reserpine/NN produces/VBZ movements/NNS different/JJ abnormal/JJ
reserpine/NN produces/VBZ movements/NNS
reserpine/NN produces/VBZ considered/VBN like/VB tardive/VB
reserpine/NN produces/VBZ considered/VBN like/VB signs/NNS dsykinesia/NN
magnesium/NN blockade/NN Neuromuscular/JJ
magnesium/NN blockade/NN
sulfate/VBP blockade/NN Neuromuscular/JJ
sulfate/VBP blockade/NN
nifedipine/VBP sulfate/VBP blockade/NN Neuromuscular/JJ
nifedipine/VBP sulfate/VBP blockade/NN
magnesium/NN sulfate/NN mg/NN administered/VBN developed/VBD blockade/NN neuromuscular/NN
magnesium/NN sulfate/NN mg/NN administered/VBN developed/VBD blockade/NN
sulfate/NN mg/NN administered/VBN developed/VBD blockade/NN neuromuscular/NN
sulfate/NN mg/NN administered/VBN developed/VBD blockade/NN
nifedipine/NN received/VBD patient/NN developed/VBD blockade/NN neuromuscular/NN
nifedipine/NN received/VBD patient/NN developed/VBD blockade/NN
Selegiline/NNP hypotension/NN postural/JJ
Selegiline/NNP hypotension/NN
selegiline/NNP therapy/NN associated/VBN hypotension/NN systolic/JJ
selegiline/NNP therapy/NN associated/VBN hypotension/NN orthostatic/JJ
selegiline/NNP therapy/NN associated/VBN hypotension/NN
selegiline/NN withdrawal/NN abolished/VBN hypotension/NN systolic/JJ
selegiline/NN withdrawal/NN abolished/VBN hypotension/NN orthostatic/JJ
selegiline/NN withdrawal/NN abolished/VBN hypotension/NN
selegiline/NN stopping/VBG shed/VB mechanisms/NNS causes/VBZ hypotension/NN orthostatic/JJ
selegiline/NN stopping/VBG shed/VB mechanisms/NNS causes/VBZ hypotension/NN
selegiline/NN marked/VBN hypotension/NN systolic/JJ
selegiline/NN marked/VBN hypotension/NN orthostatic/JJ
selegiline/NN marked/VBN hypotension/NN
selegiline/NN withdrawal/NN ameliorated/VBN hypotension/NN Orthostatic/JJ
selegiline/NN withdrawal/NN ameliorated/VBN hypotension/NN
selegiline/NN Stopping/VBG reduced/VBD
selegiline/NN Stopping/VBG reduced/VBD blood/NN the/DT
selegiline/NN Stopping/VBG reduced/VBD blood/NN supine/JJ
selegiline/NN Stopping/VBG reduced/VBD blood/NN systolic/JJ
selegiline/NN Stopping/VBG reduced/VBD blood/NN systolic/JJ and/CC
selegiline/NN Stopping/VBG reduced/VBD blood/NN systolic/JJ diastolic/JJ
selegiline/NN Stopping/VBG reduced/VBD blood/NN
selegiline/NN Stopping/VBG pressures/NNS
selegiline/VBP finding/NN confirms/VBZ associated/VBN hypotension/NN orthostatic/JJ
selegiline/VBP finding/NN confirms/VBZ associated/VBN hypotension/NN
levodopa/NN Worsening/NN dyskinesias/NNS
apomorphine/NN dose/NN administration/NN dyskinesia/NN study/NN included/VBN patients/NNS had/VBD dyskinesia/NN
apomorphine/NN dose/NN administration/NN dyskinesia/NN
levodopa/NN stimulation/NN dyskinesias/NNS
methamphetamine/NN induced/VBN neurotoxicity/RB
METH/NNP reverse/VB dihydroxyphenylalanine/VBP show/VBP confounded/VBN neurotoxicity/RB
METH/VB neurotoxicity/RB
METH/NNP effects/NNS preserved/VBN long/RB METH/VB neurotoxicity/RB
METH/NNP development/NN essential/JJ neurotoxicity/RB
Cocaine/NNP induced/VBN disorder/NN mood/NN
Cocaine/NNP induced/VBN disorder/NN
cocaine/NN induced/VBN disorder/NN mood/NN
cocaine/NN induced/VBN disorder/NN
cocaine/NN induced/VBN disorder/NN mood/NN
cocaine/NN induced/VBN disorder/NN
cocaine/NN induced/VBN disorder/NN disorders/NNS mood/NN
cocaine/NN induced/VBN disorder/NN disorders/NNS
cocaine/NN compared/VBN disorder/NN mood/NN
cocaine/NN compared/VBN disorder/NN
cocaine/NN outpatients/NNS cocaine/NN induced/VBN disorder/NN mood/NN
cocaine/NN outpatients/NNS cocaine/NN induced/VBN disorder/NN
cocaine/NN outpatients/NNS cocaine/NN induced/VBN disorder/NN disorders/NNS mood/NN
cocaine/NN outpatients/NNS cocaine/NN induced/VBN disorder/NN disorders/NNS
cocaine/NN outpatients/NNS cocaine/NN compared/VBN disorder/NN mood/NN
cocaine/NN outpatients/NNS cocaine/NN compared/VBN disorder/NN
naproxen/NN due/JJ necrosis/VBZ Renal/NNP
naproxen/NN due/JJ necrosis/VBZ papillary/RB
naproxen/NN due/JJ necrosis/VBZ
naproxen/NN therapy/NN institution/NN developed/VBD necrosis/NNS renal/JJ
naproxen/NN therapy/NN institution/NN developed/VBD necrosis/NNS papillary/NN
naproxen/NN therapy/NN institution/NN developed/VBD necrosis/NNS
naproxen/NN therapy/NN institution/NN developed/VBD necrosis/NNS RPN/NNP
All/DT induced/VBN nodosum/NN erythema/NN
All/DT induced/VBN nodosum/NN
trans/NNS All/DT induced/VBN nodosum/NN erythema/NN
trans/NNS All/DT induced/VBN nodosum/NN
retinoic/JJ acid/NN trans/NNS All/DT induced/VBN nodosum/NN erythema/NN
retinoic/JJ acid/NN trans/NNS All/DT induced/VBN nodosum/NN
acid/NN trans/NNS All/DT induced/VBN nodosum/NN erythema/NN
acid/NN trans/NNS All/DT induced/VBN nodosum/NN
all/DT acid/NN associated/VBN nodosum/NNP Erythema/NNP
all/DT acid/NN associated/VBN nodosum/NNP
trans/JJ acid/NN associated/VBN nodosum/NNP Erythema/NNP
trans/JJ acid/NN associated/VBN nodosum/NNP
retinoic/JJ acid/NN associated/VBN nodosum/NNP Erythema/NNP
retinoic/JJ acid/NN associated/VBN nodosum/NNP
acid/NN associated/VBN nodosum/NNP Erythema/NNP
acid/NN associated/VBN nodosum/NNP
ATRA/NNP acid/NN associated/VBN nodosum/NNP Erythema/NNP
ATRA/NNP acid/NN associated/VBN nodosum/NNP
ATRA/NNP therapy/NN developed/VBD nodosum/NN erythema/NN
ATRA/NNP therapy/NN developed/VBD nodosum/NN
ATRA/NNP therapy/NN developed/VBD nodules/NNS erythematous/NN
ATRA/NNP therapy/NN developed/VBD nodules/NNS
ATRA/NNP therapy/NN developed/VBD nodules/NNS Fever/NN
ATRA/NNP seemed/VBD etiology/NN nodosum/NN erythema/NN
ATRA/NNP seemed/VBD etiology/NN nodosum/NN
ATRA/NNP effective/JJ induced/VBN nodosum/NN erythema/NN
ATRA/NNP effective/JJ induced/VBN nodosum/NN
ziprasidone/NN induced/VBN syndrome/NN Neuroleptic/JJ
ziprasidone/NN induced/VBN syndrome/NN malignant/JJ
ziprasidone/NN induced/VBN syndrome/NN
ziprasidone/NN use/NN associated/VBN syndrome/NN neuroleptic/JJ
ziprasidone/NN use/NN associated/VBN syndrome/NN malignant/JJ
ziprasidone/NN use/NN associated/VBN syndrome/NN
ziprasidone/NN use/NN associated/VBN syndrome/NN NMS/NNP
ziprasidone/NN drugs/NNS cause/NN associated/VBN NMS/NNP
ziprasidone/NN dose/NN developed/VBD signs/NNS NMS/NNP
ziprasidone/VB due/JJ NMS/VBP
caffeine/NN concentration/NN containing/VBG consuming/VBG developed/VBD fibrillation/NN ventricular/NN
caffeine/NN concentration/NN containing/VBG consuming/VBG developed/VBD fibrillation/NN
nicotine/NN necessary/JJ induced/VBN seizures/NNS
nicotine/NN Binding/VBG series/NN behaviors/NNS go/VBP seizures/NNS
nicotine/NN examined/VBD homozygous/VBZ seizures/NNS
nicotine/NN effects/NNS sensitive/JJ //VBG induced/VBN seizures/NNS
nicotine/NN measured/VBN doses/NNS sensitive/JJ' sensitive/JJ //VBG induced/VBN seizures/NNS
nicotine/NN induced/VBN seizures/NNS
nicotine/NN mediators/NNS induced/VBN seizures/NNS
GVG/NN effects/NNS dopamine/NN explored/VBD success/NN risk/NN defects/NNS visual/JJ
GVG/NN effects/NNS dopamine/NN explored/VBD success/NN risk/NN defects/NNS field/NN
GVG/NN effects/NNS dopamine/NN explored/VBD success/NN risk/NN defects/NNS
GVG/NN effects/NNS dopamine/NN explored/VBD success/NN risk/NN defects/NNS VFD/NNP
lignocaine/NN involving/VBG anaesthesia/NN back/VB Leg/VB
lignocaine/NN involving/VBG anaesthesia/NN back/VB Leg/VB and/CC
lignocaine/NN involving/VBG anaesthesia/NN back/VB
lignocaine/NN involving/VBG anaesthesia/NN back/VB pain/NN
lignocaine/NN use/NN associated/VBN Leg/NNP
lignocaine/NN use/NN associated/VBN Leg/NNP and/CC
lignocaine/NN use/NN associated/VBN Leg/NNP //NNP
lignocaine/NN use/NN associated/VBN Leg/NNP or/CC
lignocaine/NN use/NN associated/VBN Leg/NNP pain/NN back/JJ
lignocaine/NN use/NN associated/VBN Leg/NNP pain/NN
tamoxifen/NN use/NN association/NN cancer/NN endometrial/JJ
tamoxifen/NN use/NN association/NN cancer/NN
tamoxifen/NN received/VBN Women/NNP likely/JJ have/VB cancer/NN endometrial/JJ
tamoxifen/NN received/VBN Women/NNP likely/JJ have/VB cancer/NN
tamoxifen/NN received/VBN had/VBD cancer/NN endometrial/JJ
tamoxifen/NN received/VBN had/VBD cancer/NN
tamoxifen/NN received/VBN had/VBD Women/NNP had/VBD those/DT cancer/NN endometrial/JJ
tamoxifen/NN received/VBN had/VBD Women/NNP had/VBD those/DT cancer/NN
tamoxifen/NN role/NN suggest/VBP cancer/NN endometrial/JJ
tamoxifen/NN role/NN suggest/VBP cancer/NN
tamoxifen/NN treated/VBN women/NNS diagnosed/VBN cancers/NNS Endometrial/JJ
tamoxifen/NN treated/VBN women/NNS diagnosed/VBN cancers/NNS
Ro/NNP blocker/NN induced/VBN alterations/NNS cardiovascular/JJ
Ro/NNP blocker/NN induced/VBN alterations/NNS
40/CD Ro/NNP blocker/NN induced/VBN alterations/NNS cardiovascular/JJ
40/CD Ro/NNP blocker/NN induced/VBN alterations/NNS
5967/CD Ro/NNP blocker/NN induced/VBN alterations/NNS cardiovascular/JJ
5967/CD Ro/NNP blocker/NN induced/VBN alterations/NNS
verapamil/JJ significant/JJ observed/VBN incidence/NN malformations/NNS cardiovascular/JJ
verapamil/JJ significant/JJ observed/VBN incidence/NN malformations/NNS
nifedipine/JJ verapamil/JJ significant/JJ observed/VBN incidence/NN malformations/NNS cardiovascular/JJ
nifedipine/JJ verapamil/JJ significant/JJ observed/VBN incidence/NN malformations/NNS
cyclophosphamide/NN mice/NNS mediators/NNS expression/NN induced/VBN cystitis/NNS
CYP/NNP expression/NN induced/VBN cystitis/NNS
cyclophosphamide/NN cystitis/NNS
CYP/NNP cyclophosphamide/NN cystitis/NNS
CYP/NNP VIP/VB induced/VB cystitis/NNS
Tac/NN nephrotoxicity/NN
Tac/NN toxicity/NN CsA/NN CsA/NN nephrotoxicity/NN
CsA/NN nephrotoxicity/NN
CsA/NN CsA/NN nephrotoxicity/NN
methadone/NN treated/VBN patients/NNS prolongation/VBN Syncope/NNP
methadone/NN treated/VBN patients/NNS prolongation/VBN Syncope/NNP QT/NNP
methadone/NN treated/VBN patients/NNS prolongation/VBN
methadone/NN effect/NN caused/VBN attribute/VB episodes/NNS syncope/NN
methadone/JJ dose/NN syncope/NN
methadone/NN treated/VBN subjects/NNS had/VBD interval/NN prolonged/JJ
methadone/NN treated/VBN subjects/NNS had/VBD interval/NN QTc/NN
methadone/NN treated/VBN subjects/NNS had/VBD interval/NN
methadone/NN dose/NN mg/VBP associated/VBN odds/NNS syncope/NN
Methadone/NNP associated/VBN prolongation/NNP reporting/NN syncope/NN
Methadone/NNP associated/VBN prolongation/NNP QT/NNP
Methadone/NNP associated/VBN prolongation/NNP
Prednisolone/NNP induced/VBN caused/VBN dysfunction/NN muscle/NN
Prednisolone/NNP induced/VBN caused/VBN dysfunction/NN
prednisolone/NN dysfunction/NN dose/NN derives/VBZ atrophy/NN muscle/NN
prednisolone/NN dysfunction/NN dose/NN derives/VBZ atrophy/NN
bupivacaine/NN triamcinolone/NN injection/NN caused/VBN syndrome/NN cauda/NN
bupivacaine/NN triamcinolone/NN injection/NN caused/VBN syndrome/NN equina/NN
bupivacaine/NN triamcinolone/NN injection/NN caused/VBN syndrome/NN
suprofen/NN associated/VBN development/NN failure/NN acute/JJ
suprofen/NN associated/VBN development/NN failure/NN renal/JJ
suprofen/NN associated/VBN development/NN failure/NN
suprofen/NN causes/VBZ declines/NNS acute/JJ
suprofen/NN causes/VBZ declines/NNS
suprofen/NN causes/VBZ declines/NNS function/NN in/IN
suprofen/NN causes/VBZ declines/NNS function/NN renal/JJ
suprofen/NN causes/VBZ declines/NNS function/NN
aminonucleoside/JJ existing/VBG captopril/NN Effect/NN proteinuria/NN
puromycin/NN aminonucleoside/NN invoked/VBN proteinuria/NN
aminonucleoside/NN invoked/VBN proteinuria/NN
haloperidol/NN efficacy/NN studies/NNS model/NN catalepsy/NN
risperidone/NN reduction/NN developed/VBD RS/NNP
risperidone/NN profile/NN related/VBN mechanism/NN development/NN RS/NNP
adriamycin/NN mitochondria/NN impairment/NN Structural/JJ
adriamycin/NN mitochondria/NN impairment/NN Structural/JJ and/CC
adriamycin/NN mitochondria/NN impairment/NN Structural/JJ functional/JJ
adriamycin/NN mitochondria/NN impairment/NN
adriamycin/NN mitochondria/NN of/IN
adriamycin/NN mitochondria/NN
ADR/NNP treatment/NN caused/VBD arrhythmias/NNS characterized/VBN bradycardia/NN
ADR/NNP effects/NNS involve/VBP impairment/NN mitochondrial/JJ
ADR/NNP effects/NNS involve/VBP impairment/NN structural/JJ
ADR/NNP effects/NNS involve/VBP impairment/NN structural/JJ and/CC
ADR/NNP effects/NNS involve/VBP impairment/NN structural/JJ functional/JJ
ADR/NNP effects/NNS involve/VBP impairment/NN
methamphetamine/NN induced/VBN NRA/NNP hyperactivity/NN
MAP/NNP methamphetamine/NN induced/VBN NRA/NNP hyperactivity/NN
NRA/NNP 0160/NNP induced/VBN catalepsy/RB
0160/NNP induced/VBN catalepsy/RB
clozapine/NN 0160/NNP induced/VBN catalepsy/RB
Cefotetan/NNP induced/VBN anemia/NN hemolytic/JJ
Cefotetan/NNP induced/VBN anemia/NN
cocaine/NN user/NN man/NN presented/VBD occasions/NNS history/NN priapism/NN
cocaine/NN use/NN presented/VBD occasions/NNS history/NN priapism/NN
Oxytocin/NNP uterotonic/NN cause/VB hypotension/NN
Oxytocin/NNP attributed/VBN hypotension/NN
oxytocin/NN response/NN Hypotension/NNP
Clotiazepam/NNP induced/VBN hepatitis/NN
clotiazepam/NN administration/NN onset/NN developed/VBD hepatitis/NN
clotiazepam/NN related/VBN administration/NN interfere/VB induce/VB relapse/NN hepatitis/NN
clotiazepam/NN induce/VB hepatitis/NN
clotiazepam/NN induce/VB shows/VBZ suggests/VBZ is/VBZ hepatotoxicity/NN
clotiazepam/NN benzodiazepines/NNS hepatotoxicity/NN is/VBZ suggests/VBZ shows/VBZ induce/VB hepatitis/NN
clotiazepam/NN benzodiazepines/NNS hepatotoxicity/NN
Pentamidine/JJ isethionate/NN associated/VBN pointes/NNS torsade/JJ
Pentamidine/JJ isethionate/NN associated/VBN pointes/NNS de/NNP
Pentamidine/JJ isethionate/NN associated/VBN pointes/NNS
isethionate/NN associated/VBN pointes/NNS torsade/JJ
isethionate/NN associated/VBN pointes/NNS de/NNP
isethionate/NN associated/VBN pointes/NNS
Pentamidine/NNP induced/VBN related/VBN pointes/NNS torsade/JJ
Pentamidine/NNP induced/VBN related/VBN pointes/NNS de/NNP
Pentamidine/NNP induced/VBN related/VBN pointes/NNS
pentamidine/NN occurred/VBD pointes/NNS Torsade/NNP
pentamidine/NN occurred/VBD pointes/NNS de/NNP
pentamidine/NN occurred/VBD pointes/NNS
pentamidine/NN discontinuation/NN recognized/VBD treated/VBN pointes/NNS Torsade/NNP
pentamidine/NN discontinuation/NN recognized/VBD treated/VBN pointes/NNS de/NNP
pentamidine/NN discontinuation/NN recognized/VBD treated/VBN pointes/NNS
Warfarin/NNP induced/VBN palsy/NN femoral/JJ
Warfarin/NNP induced/VBN palsy/NN nerve/NN
Warfarin/NNP induced/VBN palsy/NN
warfarin/NN therapy/NN man/NN 28/CD case/NN sustained/VBD tear/NN muscle/NN
warfarin/NN therapy/NN man/NN 28/CD case/NN sustained/VBD tear/NN
warfarin/NN form/NN represents/VBZ palsy/NN femoral/JJ
warfarin/NN form/NN represents/VBZ palsy/NN nerve/NN
warfarin/NN form/NN represents/VBZ palsy/NN
diltiazem/NN threatening/VBG induced/VBN tetany/RB
diltiazem/NN infusion/NN developed/VBD tetany/RB
diltiazem/NN administration/NN accompany/VB life/NN tetany/NN
haloperidol/NN treatments/NNS change/VBP uptake/VB dyskinesia/NN orofacial/JJ
haloperidol/NN treatments/NNS change/VBP uptake/VB dyskinesia/NN
reserpine/JJ treatments/NNS change/VBP uptake/VB dyskinesia/NN orofacial/JJ
reserpine/JJ treatments/NNS change/VBP uptake/VB dyskinesia/NN
haloperidol/JJ Reserpine/JJ dyskinesia/NNS orofacial/NN
haloperidol/JJ Reserpine/JJ dyskinesia/NNS
haloperidol/JJ Reserpine/JJ dyskinesia/NNS models/NNS dyskinesia/NN tardive/JJ
haloperidol/JJ Reserpine/JJ dyskinesia/NNS models/NNS dyskinesia/NN
haloperidol/JJ Reserpine/JJ dyskinesia/NNS models/NNS TD/NNP
Reserpine/JJ dyskinesia/NNS orofacial/NN
Reserpine/JJ dyskinesia/NNS
Reserpine/JJ dyskinesia/NNS models/NNS dyskinesia/NN tardive/JJ
Reserpine/JJ dyskinesia/NNS models/NNS dyskinesia/NN
Reserpine/JJ dyskinesia/NNS models/NNS TD/NNP
haloperidol/JJ administration/NN reserpine/NN induced/VBN dyskinesia/NN orofacial/JJ
haloperidol/JJ administration/NN reserpine/NN induced/VBN dyskinesia/NN
reserpine/NN induced/VBN dyskinesia/NN orofacial/JJ
reserpine/NN induced/VBN dyskinesia/NN
bupropion/VBN release/NN associated/VBN Seizure/JJ
bupropion/NN use/VBP describes/VBZ seizure/NN
bupropion/NN use/NN weeks/NNS experienced/VBD seizure/NN
bupropion/NN risk/NN seizures/NNS
cyclosporine/NN drug/NN cause/NN microangiopathy/NN thrombotic/JJ
cyclosporine/NN drug/NN cause/NN microangiopathy/NN
Amiodarone/NNP induced/VBN block/NN sinoatrial/JJ
Amiodarone/NNP induced/VBN block/NN
amiodarone/NN administration/NN observed/VBD block/NN sinoatrial/JJ
amiodarone/NN administration/NN observed/VBD block/NN
amiodarone/NN dosage/NN Reduction/NN resulted/VBD disappearance/NN block/NN sinoatrial/JJ
amiodarone/NN dosage/NN Reduction/NN resulted/VBD disappearance/NN block/NN
phenobarbital/JJ therapy/NN term/NN Hepatonecrosis/NNS cholangitis/NNS
Phenobarbital/NNP has/VBZ believed/VBN indicate/VB development/NN disease/NN liver/NN
Phenobarbital/NNP has/VBZ believed/VBN indicate/VB development/NN disease/NN
PB/NNP Phenobarbital/NNP has/VBZ believed/VBN indicate/VB development/NN disease/NN liver/NN
PB/NNP Phenobarbital/NNP has/VBZ believed/VBN indicate/VB development/NN disease/NN
PB/NNP indicate/VB development/NN disease/NN liver/NN
PB/NNP indicate/VB development/NN disease/NN
PB/NNP associated/VBN damage/NN liver/NN
PB/NNP associated/VBN damage/NN
haloperidol/NN models/NNS catalepsy/NN
reserpine/NN model/NN catalepsy/NN models/NNS akinesia/NN
gentamicin/NN died/VBD failure/NN acute/JJ
gentamicin/NN died/VBD failure/NN renal/JJ
gentamicin/NN died/VBD failure/NN
carbamazepine/NN induced/VBN block/NN patient/JJ bradycardia/NN
carbamazepine/NN induced/VBN block/NN patient/JJ bradycardia/NN atrioventricular/NN
carbamazepine/NN induced/VBN block/NN
carbamazepine/NN overdose/NN setting/NN developed/VBD tachycardias/NNS sinus/JJ
carbamazepine/NN overdose/NN setting/NN developed/VBD tachycardias/NNS
carbamazepine/JJ levels/NNS elevated/VBD developed/VBD threatening/JJ delay/NN bradyarrhythmias/JJ
carbamazepine/JJ levels/NNS elevated/VBD developed/VBD threatening/JJ delay/NN bradyarrhythmias/JJ atrioventricular/NN
carbamazepine/JJ levels/NNS elevated/VBD developed/VBD threatening/JJ delay/NN conduction/NN
carbamazepine/JJ levels/NNS elevated/VBD developed/VBD threatening/JJ delay/NN
tamoxifen/NN induced/VBN erythrocytes/NNS Hemolysis/NNS
Tamoxifen/NNP induces/VBZ changes/NNS shape/NN erythrocytes/NNS anemia/NN hemolytic/JJ
Tamoxifen/NNP induces/VBZ changes/NNS shape/NN erythrocytes/NNS anemia/NN
TAM/NNP Tamoxifen/NNP induces/VBZ changes/NNS shape/NN erythrocytes/NNS anemia/NN hemolytic/JJ
TAM/NNP Tamoxifen/NNP induces/VBZ changes/NNS shape/NN erythrocytes/NNS anemia/NN
TAM/NNP effects/NNS evaluates/VBZ erythrocytes/NNS induced/VBG anemia/NN hemolytic/JJ
TAM/NNP effects/NNS evaluates/VBZ erythrocytes/NNS induced/VBG anemia/NN
TAM/NNP mechanisms/NNS identify/VB attempting/VBG erythrocytes/NNS induced/VBG anemia/NN hemolytic/JJ
TAM/NNP mechanisms/NNS identify/VB attempting/VBG erythrocytes/NNS induced/VBG anemia/NN
TAM/NNP induces/VBZ hemolysis/NNS
TAM/NN induces/VBZ variable/NN extension/NN hemolysis/NNS
TAM/NN induces/VBZ hemolysis/NNS
TAM/NNP effect/NN hemolytic/JJ
TAM/NNP effect/NN prevented/VBN indicating/VBG related/VBN TAM/NNP hemolysis/NNS
TAM/NNP related/VBN indicating/VBG prevented/VBN effect/NN hemolytic/JJ
TAM/NNP hemolysis/NNS
TAM/NNP determined/VBN consumption/NN hemolysis/NNS
TAM/NNP caused/VBN Hemolysis/NNS
TAM/NNP caused/VBN Hemolysis/NNS preceded/VBN excluding/VBG colloid/NN mechanism/NN hemolysis/NNS
TAM/NNP incorporation/NN related/VBN protection/NN hemolysis/NNS
TAM/NNP results/NNS hemolysis/NNS
TAM/NNP promoted/VBN stability/NN decreased/VBD resulting/VBG anemia/NN hemolytic/JJ
TAM/NNP promoted/VBN stability/NN decreased/VBD resulting/VBG anemia/NN
vitamin/NNP C/NNP increase/VB risk/NN cardiovascular/JJ
vitamin/NNP C/NNP increase/VB risk/NN disease/NN
C/NNP increase/VB risk/NN cardiovascular/JJ
C/NNP increase/VB risk/NN disease/NN
vitamin/NNP intake/NNP relation/NN examine/VB disease/NN cardiovascular/JJ
vitamin/NNP intake/NNP relation/NN examine/VB disease/NN
C/NNP intake/NNP relation/NN examine/VB disease/NN cardiovascular/JJ
C/NNP intake/NNP relation/NN examine/VB disease/NN
vitamin/NNP intake/NN relation/NN mortality/NN disease/NN cardiovascular/JJ
vitamin/NNP intake/NN relation/NN mortality/NN disease/NN
C/NNP intake/NN relation/NN mortality/NN disease/NN cardiovascular/JJ
C/NNP intake/NN relation/NN mortality/NN disease/NN
vitamin/NNP intake/NN quintiles/NNS 0/CD </VBG trend/NN P/NNP 1/CD adjustment/NN factors/NNS cardiovascular/JJ
vitamin/NNP intake/NN quintiles/NNS 0/CD </VBG trend/NN P/NNP 1/CD adjustment/NN factors/NNS disease/NN
C/NNP intake/NN quintiles/NNS 0/CD </VBG trend/NN P/NNP 1/CD adjustment/NN factors/NNS cardiovascular/JJ
C/NNP intake/NN quintiles/NNS 0/CD </VBG trend/NN P/NNP 1/CD adjustment/NN factors/NNS disease/NN
vitamin/NNP intake/NN quintiles/NNS 0/CD </VBG trend/NN P/NNP 1/CD type/NN medication/NN intakes/NNS carotene/NN mortality/NN adjusted/VBN risks/NNS disease/NN cardiovascular/JJ
vitamin/NNP intake/NN quintiles/NNS 0/CD </VBG trend/NN P/NNP 1/CD type/NN medication/NN intakes/NNS carotene/NN mortality/NN adjusted/VBN risks/NNS disease/NN
C/NNP intake/NN quintiles/NNS 0/CD </VBG trend/NN P/NNP 1/CD type/NN medication/NN intakes/NNS carotene/NN mortality/NN adjusted/VBN risks/NNS disease/NN cardiovascular/JJ
C/NNP intake/NN quintiles/NNS 0/CD </VBG trend/NN P/NNP 1/CD type/NN medication/NN intakes/NNS carotene/NN mortality/NN adjusted/VBN risks/NNS disease/NN
Vitamin/NNP intake/NNP unrelated/JJ disease/NN cardiovascular/JJ
Vitamin/NNP intake/NNP unrelated/JJ disease/NN
C/NNP intake/NNP unrelated/JJ disease/NN cardiovascular/JJ
C/NNP intake/NNP unrelated/JJ disease/NN
vitamin/NNP intake/NN associated/VBN risk/NN mortality/NN cardiovascular/JJ
vitamin/NNP intake/NN associated/VBN risk/NN mortality/NN disease/NN
C/NNP intake/NN associated/VBN risk/NN mortality/NN cardiovascular/JJ
C/NNP intake/NN associated/VBN risk/NN mortality/NN disease/NN
pilocarpine/JJ rats/NNS seizures/NNS
trihexyphenidyl/JJ Bradycardia/NNP
hydrochloride/VBP Bradycardia/NNP
alcohol/NN ingestion/NN hour/NN developed/VBD flushing/VBG face/NN tachycardia/NN
alcohol/NN ingestion/NN hour/NN developed/VBD flushing/VBG face/NN dyspnea/NN
alcohol/NN ingestion/NN hour/NN developed/VBD flushing/VBG
alcohol/NN ingestion/NN hour/NN developed/VBD flushing/VBG face/NN of/IN
alcohol/NN ingestion/NN hour/NN developed/VBD flushing/VBG face/NN the/DT
alcohol/NN ingestion/NN hour/NN developed/VBD flushing/VBG face/NN
troleandomycin/NN cholestasis/VBZ
troleandomycin/NN induced/VBN hepatitis/NN
troleandomycin/NN case/NN report/VBP followed/VBN cholestasis/NNS
troleandomycin/NN case/NN report/VBP followed/VBN hepatitis/NNP
troleandomycin/NN administration/NN occurred/VBD Jaundice/NNP
troleandomycin/NN administration/NN occurred/VBD associated/VBN hypereosinophilia/NN
troleandomycin/NN follow/VB cholestasis/NNS
troleandomycin/NN induced/VBN hepatitis/NN
clozapine/JJ treatment/NN Delirium/NNP
clozapine/JJ treatment/NN delirium/NN
clozapine/NN treated/VBN reviewed/VBN incidence/NN delirium/NN
clozapine/NN %/NN found/VBN Delirium/NNP
flumazenil/JJ group/NN nausea/NN vomiting/VBG
flumazenil/JJ group/NN nausea/NN
flumazenil/JJ group/NN nausea/NN
azathioprine/JJ therapy/NN injury/NN cholestasis/VBZ
azathioprine/JJ therapy/NN injury/NN bile/NN
azathioprine/JJ therapy/NN injury/NN duct/NN
azathioprine/JJ therapy/NN injury/NN
azathioprine/JJ therapy/NN initiation/NN developed/VBD features/NNS cholestasis/NNS
azathioprine/NN case/NN cholestasis/NNS
azathioprine/NN case/NN cholestasis/NNS associated/VBN evidence/NN injury/NN bile/NN
azathioprine/NN case/NN cholestasis/NNS associated/VBN evidence/NN injury/NN duct/NN
azathioprine/NN case/NN cholestasis/NNS associated/VBN evidence/NN injury/NN
cefotetan/NN use/NN associated/VBN anemia/NN hemolytic/JJ
cefotetan/NN use/NN associated/VBN anemia/NN
cefotetan/NN cephalosporins/NNS associated/VBN anemia/NN hemolytic/JJ
cefotetan/NN cephalosporins/NNS associated/VBN anemia/NN
cefotetan/NN cases/NNS anemias/NNS hemolytic/JJ
cefotetan/NN cases/NNS anemias/NNS
cefotetan/NN prophylactically/NN received/VBN patients/NNS 10/CD cases/NNS anemias/NNS hemolytic/JJ
cefotetan/NN prophylactically/NN received/VBN patients/NNS 10/CD cases/NNS anemias/NNS
pentobarbital/NN caused/VBD Learning/NNP rats/NNS amnesia/NN
pentobarbital/NN produced/VBN amnesia/NN
Acetaminophen/NNP induced/VBN hypotension/NN
acetaminophen/NN demonstrated/VBN produce/VB symptoms/NNS anaphylaxis/NNS hypotension/NN
acetaminophen/NN administration/NN developed/VBN episodes/NNS hypotension/NN
acetaminophen/NN consider/VB patients/NNS hypotension/NN
Methamphetamine/NNP causes/VBZ alterations/NNS pathways/NNS display/VBP aggressiveness/NN
methamphetamine/JJ abusers/NNS common/JJ suffer/VBP patients/NNS reported/VBN behaviors/NNS Aggressive/JJ
methamphetamine/JJ abusers/NNS common/JJ suffer/VBP patients/NNS reported/VBN behaviors/NNS
methamphetamine/JJ abusers/NNS common/JJ suffer/VBP disorders/NNS psychiatric/JJ
methamphetamine/JJ abusers/NNS common/JJ suffer/VBP disorders/NNS
METH/NNP abusers/NNS common/JJ suffer/VBP patients/NNS reported/VBN behaviors/NNS Aggressive/JJ
METH/NNP abusers/NNS common/JJ suffer/VBP patients/NNS reported/VBN behaviors/NNS
METH/NNP abusers/NNS common/JJ suffer/VBP disorders/NNS psychiatric/JJ
METH/NNP abusers/NNS common/JJ suffer/VBP disorders/NNS
METH/NNP injections/NNS increased/VBD aggressiveness/NN
METH/VB secondary/JJ increase/NN aggressiveness/NN
WR/NNP postinjection/NN noted/VBN hemoglobinuria/NN
242511/CD WR/NNP postinjection/NN noted/VBN hemoglobinuria/NN
contrast/NN media/NNS Risk/NN nephropathy/NN
media/NNS Risk/NN nephropathy/NN
contrast/NN media/NNS reports/NNS nephropathy/NN
media/NNS reports/NNS nephropathy/NN
contrast/NN media/NNS reports/NNS nephropathy/NN CIN/NNP
media/NNS reports/NNS nephropathy/NN CIN/NNP
iohexol/JJ iopromide/JJ incidence/NN CIN/NNP
contrast/NN media/NNS CIN/NNP
media/NNS CIN/NNP
CM/NNP media/NNS CIN/NNP
CM/NNP type/NN compared/VBD determined/VBD incidence/NN CIN/NNP
iopromide/JJ incidence/NN CIN/NNP
CM/NNP dosage/NN received/VBD those/DT 33/NNP patients/NNS CIN/NNP
CM/NNP dosage/NN received/VBD those/DT increased/VBD those/DT received/VBD difference/NN incidence/NN CIN/NNP
CM/NNP dosages/NNS related/VBN CIN/NNP incidence/NN difference/NN received/VBD those/DT increased/VBD those/DT 33/NNP patients/NNS CIN/NNP
CM/NNP dosages/NNS related/VBN CIN/NNP
CM/NN type/NN depends/VBZ' depends/VBZ needed/VBN reversible/JJ CIN/NNP
dipyridamole/NN hyperemia/NN
dipyridamole/NN implications/NNS dipyridamole/NN hyperemia/NN
pentoxifylline/NN derivative/NN improve/VB claudication/NN intermittent/JJ
pentoxifylline/NN derivative/NN improve/VB claudication/NN
Trental/NNP pentoxifylline/NN derivative/NN improve/VB claudication/NN intermittent/JJ
Trental/NNP pentoxifylline/NN derivative/NN improve/VB claudication/NN
dipyridamole/JJ inhibits/VBZ thallium/VBP induced/VBN hyperemia/NN
dipyridamole/NN stopped/VBN induced/VBN hyperemia/NN
dipyridamole/NN hyperemia/NN
dipyridamole/NN induced/VBN hyperemia/NN
doxorubicin/NN protects/VBZ demonstrate/VBP apoptosis/VBZ extent/NN failure/NN heart/NN
doxorubicin/NN protects/VBZ demonstrate/VBP apoptosis/VBZ extent/NN failure/NN
Risperidone/NNP disturbances/NNS visual/JJ
Risperidone/NNP disturbances/NNS
risperidone/NN starting/VBG appeared/VBD disturbances/NNS visual/JJ
risperidone/NN starting/VBG appeared/VBD disturbances/NNS
Risperidone/JJ administration/NN continued/VBN wore/VBD disturbances/NNS visual/JJ
Risperidone/JJ administration/NN continued/VBN wore/VBD disturbances/NNS
acetazolamide/NN patients/NNS developed/VBD calculi/NNS renal/JJ
acetazolamide/NN patients/NNS developed/VBD calculi/NNS
FK/NNP 506/NNP Microangiopathic/JJ
FK/NNP 506/NNP hemolytic/JJ
FK/NNP 506/NNP anemia/NN
506/NNP Microangiopathic/JJ
506/NNP hemolytic/JJ
506/NNP anemia/NN
tacrolimus/NNS 506/NNP Microangiopathic/JJ
tacrolimus/NNS 506/NNP hemolytic/JJ
tacrolimus/NNS 506/NNP anemia/NN
FK/NNP therapy/NN recipients/NNS anemia/NN microangiopathic/JJ
FK/NNP therapy/NN recipients/NNS anemia/NN hemolytic/JJ
FK/NNP therapy/NN recipients/NNS anemia/NN
506/NNP therapy/NN recipients/NNS anemia/NN microangiopathic/JJ
506/NNP therapy/NN recipients/NNS anemia/NN hemolytic/JJ
506/NNP therapy/NN recipients/NNS anemia/NN
FK/NNP therapy/NN recipients/NNS anemia/NN MAHA/NNP
506/NNP therapy/NN recipients/NNS anemia/NN MAHA/NNP
tacrolimus/NNS therapy/NN recipients/NNS anemia/NN microangiopathic/JJ
tacrolimus/NNS therapy/NN recipients/NNS anemia/NN hemolytic/JJ
tacrolimus/NNS therapy/NN recipients/NNS anemia/NN
tacrolimus/NNS therapy/NN recipients/NNS anemia/NN MAHA/NNP
FK/NNP discontinuation/NN led/VBD resolution/NN MAHA/NNP
506/CD FK/NNP discontinuation/NN led/VBD resolution/NN MAHA/NNP
FK/NNP reintroduction/NN led/VBD recurrence/NN MAHA/NNP
506/CD FK/NNP reintroduction/NN led/VBD recurrence/NN MAHA/NNP
FK/NN associated/VBN rare/JJ MAHA/NNP
506/CD FK/NN associated/VBN rare/JJ MAHA/NNP
FK/NNP 506/NNP seem/VB experience/NN react/VBP A/NNP immuno/NN drug/NN known/VBN induce/VB MAHA/NNP
506/NNP seem/VB experience/NN react/VBP A/NNP immuno/NN drug/NN known/VBN induce/VB MAHA/NNP
bupivacaine/NN activity/NN modified/VBN decreased/VBD time/NN convulsions/NNS
bupivacaine/NN obtain/VB latency/JJ convulsions/NNS
diltiazem/NN overdose/NN arrest/NN asystolic/JJ
diltiazem/NN overdose/NN arrest/NN cardiac/JJ
diltiazem/NN overdose/NN arrest/NN
diltiazem/NN overdose/NN
diltiazem/NN nitrate/NN g/NN 8/CD overdose/NN
diltiazem/NN therapy/NN overdose/VBP onset/NN asystole/NN
diltiazem/NN therapy/NN overdose/VBP
diltiazem/NN overdose/NN considered/VBN early/RB cases/NNS arrest/NN cardiac/JJ
diltiazem/NN overdose/NN considered/VBN early/RB cases/NNS arrest/NN
diltiazem/NN overdose/NN
paclitaxel/JJ stent/NN implantation/NN aneurysm/VB Coronary/RB
paclitaxel/JJ stent/NN implantation/NN aneurysm/VB
paclitaxel/NN receiving/VBG months/NNS developed/VBD aneurysm/NN coronary/JJ
paclitaxel/NN receiving/VBG months/NNS developed/VBD aneurysm/NN
propofol/VB obtund/VB response/NN hypotensive/JJ
propofol/NN ephedrine/NN addition/NN appears/VBZ method/NN obtunding/VBG response/NN hypotensive/JJ
propofol/VB obtunding/VBG response/NN hypotensive/JJ
propofol/NN associated/VBN tachycardia/NN
ephedrine/NN use/NN associated/VBN tachycardia/NN
propofol/JJ use/NN recommend/VB risk/NN tachycardia/NN
ephedrine/NN any/DT patients/NNS use/NN recommend/VB risk/NN tachycardia/NN
epinephrine/NN induced/VBN thrombosis/NNS
EP/NNP epinephrine/NN induced/VBN thrombosis/NNS
cocaine/NN actions/NNS stimulatory/NN convulsive/JJ
cocaine/NN SM/NNP convulsions/NNS
lindane/NN toxic/JJ
lindane/NN toxic/JJ system/NN to/TO
lindane/NN toxic/JJ system/NN the/DT
lindane/NN toxic/JJ system/NN central/JJ
lindane/NN toxic/JJ system/NN nervous/JJ
lindane/NN toxic/JJ system/NN
lindane/NN toxic/JJ accumulating/VBG associated/VBN anaemia/NN aplastic/JJ
lindane/NN toxic/JJ accumulating/VBG associated/VBN anaemia/NN
Mitomycin/NNP C/NNP associated/JJ syndrome/NN hemolytic/JJ
Mitomycin/NNP C/NNP associated/JJ syndrome/NN uremic/JJ
Mitomycin/NNP C/NNP associated/JJ syndrome/NN
C/NNP associated/JJ syndrome/NN hemolytic/JJ
C/NNP associated/JJ syndrome/NN uremic/JJ
C/NNP associated/JJ syndrome/NN
Mitomycin/NNP C/NNP associated/VBN Syndrome/NNP Hemolytic/NNP
Mitomycin/NNP C/NNP associated/VBN Syndrome/NNP Uremic/NNP
Mitomycin/NNP C/NNP associated/VBN Syndrome/NNP
C/NNP associated/VBN Syndrome/NNP Hemolytic/NNP
C/NNP associated/VBN Syndrome/NNP Uremic/NNP
C/NNP associated/VBN Syndrome/NNP
Mitomycin/NNP C/NNP associated/VBN Syndrome/NNP HUS/NNP
C/NNP associated/VBN Syndrome/NNP HUS/NNP
mitomycin/JJ treatment/NN associated/VBN failure/NN renal/JJ
mitomycin/JJ treatment/NN associated/VBN failure/NN
C/NNP treatment/NN associated/VBN failure/NN renal/JJ
C/NNP treatment/NN associated/VBN failure/NN
mitomycin/JJ treatment/NN start/NN mth/NN 8/CD develops/VBZ failure/NN renal/JJ
mitomycin/JJ treatment/NN start/NN mth/NN 8/CD develops/VBZ failure/NN
C/NNP treatment/NN start/NN mth/NN 8/CD develops/VBZ failure/NN renal/JJ
C/NNP treatment/NN start/NN mth/NN 8/CD develops/VBZ failure/NN
mitomycin/JJ treatment/NN start/NN mth/NN 8/CD develops/VBZ %/NN failure/NN renal/JJ
mitomycin/JJ treatment/NN start/NN mth/NN 8/CD develops/VBZ %/NN failure/NN
C/NNP treatment/NN start/NN mth/NN 8/CD develops/VBZ %/NN failure/NN renal/JJ
C/NNP treatment/NN start/NN mth/NN 8/CD develops/VBZ %/NN failure/NN
mitomycin/NNP C/NNP developed/VBD failure/NN renal/JJ
mitomycin/NNP C/NNP developed/VBD failure/NN
C/NNP developed/VBD failure/NN renal/JJ
C/NNP developed/VBD failure/NN
Lithium/NNP associated/VBN deficits/NNS cognitive/JJ
Lithium/NNP associated/VBN deficits/NNS cognitive/JJ and/CC
Lithium/NNP associated/VBN deficits/NNS cognitive/JJ functional/JJ
Lithium/NNP associated/VBN deficits/NNS
lithium/NN effects/NNS management/NN written/VBN remain/VBP effects/NNS deficits/NNS cognitive/JJ
lithium/NN effects/NNS management/NN written/VBN remain/VBP effects/NNS deficits/NNS
lithium/NN effects/NNS management/NN written/VBN remain/VBP effects/NNS deficits/NNS loss/NN
lithium/NN effects/NNS management/NN written/VBN remain/VBP effects/NNS deficits/NNS loss/NN creativity/NN of/IN
lithium/NN effects/NNS management/NN written/VBN remain/VBP effects/NNS deficits/NNS loss/NN creativity/NN
lithium/NN effects/NNS management/NN written/VBN remain/VBP effects/NNS deficits/NNS impairments/NNS functional/JJ
lithium/NN effects/NNS management/NN written/VBN remain/VBP effects/NNS deficits/NNS impairments/NNS
lithium/NN effects/NNS deficits/NNS cognitive/JJ
lithium/NN effects/NNS deficits/NNS
lithium/NN effects/NNS deficits/NNS loss/NN
lithium/NN effects/NNS deficits/NNS loss/NN creativity/NN of/IN
lithium/NN effects/NNS deficits/NNS loss/NN creativity/NN
lithium/NN effects/NNS deficits/NNS impairments/NNS functional/JJ
lithium/NN effects/NNS deficits/NNS impairments/NNS
lithium/NN switching/VBG divalproex/VB alleviate/VB impairments/NNS cognitive/JJ
lithium/NN switching/VBG divalproex/VB alleviate/VB impairments/NNS cognitive/JJ and/CC
lithium/NN switching/VBG divalproex/VB alleviate/VB impairments/NNS cognitive/JJ functional/JJ
lithium/NN switching/VBG divalproex/VB alleviate/VB impairments/NNS
lithium/NN substitution/NN helpful/JJ reducing/VBG cognitive/NN
lithium/NN substitution/NN helpful/JJ reducing/VBG cognitive/NN motivational/JJ
lithium/NN substitution/NN helpful/JJ reducing/VBG cognitive/NN or/CC
lithium/NN substitution/NN helpful/JJ reducing/VBG cognitive/NN deficits/NNS creative/JJ
lithium/NN substitution/NN helpful/JJ reducing/VBG cognitive/NN deficits/NNS
lithium/NN attributed/VBN deficits/NNS cognitive/NN
lithium/NN attributed/VBN deficits/NNS cognitive/NN motivational/JJ
lithium/NN attributed/VBN deficits/NNS cognitive/NN or/CC
lithium/NN attributed/VBN deficits/NNS creative/JJ
lithium/NN attributed/VBN deficits/NNS
lithium/NN patients/NNS experiencing/VBG deficits/NNS cognitive/JJ
lithium/NN patients/NNS experiencing/VBG deficits/NNS
lithium/NN patients/NNS experiencing/VBG deficits/NNS loss/NN
lithium/NN patients/NNS experiencing/VBG deficits/NNS loss/NN creativity/NN of/IN
lithium/NN patients/NNS experiencing/VBG deficits/NNS loss/NN creativity/NN
lithium/NN patients/NNS experiencing/VBG deficits/NNS impairments/NNS functional/JJ
lithium/NN patients/NNS experiencing/VBG deficits/NNS impairments/NNS
Doxorubicin/NNP agent/NN known/VBN cause/VB cardiomyopathy/NN
angiotensin/NN introduction/NN converting/VBG reported/VBN cases/NNS hypotension/NN
converting/VBG reported/VBN cases/NNS hypotension/NN
enzyme/JJ inhibitors/NNS converting/VBG reported/VBN cases/NNS hypotension/NN
ACE/NNP inhibitors/NNS converting/VBG reported/VBN cases/NNS hypotension/NN
inhibitors/NNS converting/VBG reported/VBN cases/NNS hypotension/NN
prazosin/JJ multicenter/JJ trial/NN designed/VBN compared/VBD incidence/NN hypotension/NN
ACE/NNP enalapril/NN safety/NN assess/VB designed/VBN compared/VBD incidence/NN hypotension/NN
inhibitor/NN enalapril/NN safety/NN assess/VB designed/VBN compared/VBD incidence/NN hypotension/NN
prazosin/NN received/VBD patients/NNS enalapril/VBP hypotension/NN
ciprofloxacin/NN treatment/NN described/VBN followed/VBD failure/NN acute/JJ
ciprofloxacin/NN treatment/NN described/VBN followed/VBD failure/NN renal/JJ
ciprofloxacin/NN treatment/NN described/VBN followed/VBD failure/NN
ciprofloxacin/NN diagnosis/NN supports/VBZ followed/VBD improvement/NN induced/VBN failure/NN acute/JJ
ciprofloxacin/NN diagnosis/NN supports/VBZ followed/VBD improvement/NN induced/VBN failure/NN renal/JJ
ciprofloxacin/NN diagnosis/NN supports/VBZ followed/VBD improvement/NN induced/VBN failure/NN
methamphetamine/NN antagonist/NN action/NN associated/VBN decrease/NN hyperthermia/NN
methamphetamine/NN hyperthermia/NN
methamphetamine/NN reduction/NN associated/VBN induced/VBN induced/VBN' decrease/NN hyperthermia/NN
Diazepam/NNP facilitates/VBZ bradycardia/NN
adrenaline/NN infusion/NN produced/VBN bradycardia/NN
diazepam/NN rats/NNS pretreatment/NN enhance/VB adrenaline/NN induced/VBN bradycardia/NN
adrenaline/NN change/NN effect/NN causing/VBG pretreatment/NN enhance/VB adrenaline/NN induced/VBN bradycardia/NN
adrenaline/NN induced/VBN bradycardia/NN
diazepam/NN enhancement/NN adrenaline/NN induced/VBN bradycardia/NN
adrenaline/NN induced/VBN bradycardia/NN
diazepam/NN acts/VBZ facilitate/VB bradycardia/NN
trazodone/NN dose/NN block/NN heart/NN
trazodone/NN dose/NN block/NN
trazodone/NN dose/NN receiving/VBG minutes/NNS developed/VBD block/NN heart/NN
trazodone/NN dose/NN receiving/VBG minutes/NNS developed/VBD block/NN
Methimazole/NNP induced/VBN jaundice/NN cholestatic/JJ
Methimazole/NNP induced/VBN jaundice/NN
methimazole/NN had/VBD jaundice/NN itching/NN
DES/NNP adenocarcinoma/NN clear/JJ
DES/NNP adenocarcinoma/NN cell/NN
DES/NNP adenocarcinoma/NN
Levodopa/NNP induced/VBN dyskinesia/NN
Levodopa/NNP alleviated/VBN dyskinesia/NN
levodopa/NN induced/VBN dyskinesias/NNS
Phenylephrine/NNP reduces/VBZ
Phenylephrine/NNP reduces/VBZ oxygenation/NN frontal/JJ
Phenylephrine/NNP reduces/VBZ oxygenation/NN lobe/NN
Phenylephrine/NNP reduces/VBZ oxygenation/NN
acetaminophen/NN associated/VBN deaths/NNS apoptotic/JJ necrotic/JJ
acetaminophen/NN associated/VBN induced/VBN nephrotoxicity/RB
doxorubicin/NN toxicity/NN amiodarone/NN associated/VBN deaths/NNS apoptotic/JJ necrotic/JJ
doxorubicin/NN toxicity/NN amiodarone/NN induced/VBN cardiotoxicity/RB
amiodarone/NN associated/VBN deaths/NNS apoptotic/JJ necrotic/JJ
amiodarone/NN toxicity/NN lung/NN
amiodarone/NN toxicity/NN
acetaminophen/NN prevent/VB extract/VB proanthocyanidin/VBN induced/VBN nephrotoxicity/NN
AAP/NNP acetaminophen/NN prevent/VB extract/VB proanthocyanidin/VBN induced/VBN nephrotoxicity/NN
doxorubicin/NN toxicity/NN induced/VBN proanthocyanidin/VBN induced/VBN cardiotoxicity/RB
DOX/NNP doxorubicin/NN toxicity/NN induced/VBN proanthocyanidin/VBN induced/VBN cardiotoxicity/RB
amiodarone/NN nephrotoxicity/NN induced/VBN proanthocyanidin/VBN induced/VBN toxicity/NN lung/NN
amiodarone/NN nephrotoxicity/NN induced/VBN proanthocyanidin/VBN induced/VBN toxicity/NN
AMI/NNP nephrotoxicity/NN induced/VBN proanthocyanidin/VBN induced/VBN toxicity/NN lung/NN
AMI/NNP nephrotoxicity/NN induced/VBN proanthocyanidin/VBN induced/VBN toxicity/NN
AAP/NNP induced/VBN drugs/NNS necrosis/VBZ
DOX/NNP AAP/NNP induced/VBN drugs/NNS necrosis/VBZ
AMI/NNP AAP/NNP induced/VBN drugs/NNS necrosis/VBZ
levodopa/NN dyskinesias/NNS
propofol/JJ sedation/NN underwent/VBD dementia/NN delirium/NN
amikacin/NN nephrotoxicity/NN
amikacin/NN associated/VBN nephrotoxicity/RB
amikacin/NN efficacy/NN increase/NN means/NNS nephrotoxicity/JJ
amphetamine/NN diagnosis/NN service/NN patients/NNS relationship/NN catecholamines/NNS symptoms/NNS psychotic/JJ
amphetamine/NN diagnosis/NN service/NN patients/NNS relationship/NN catecholamines/NNS symptoms/NNS
amphetamine/NN diagnosis/NN service/NN patients/NNS relationship/NN examine/VB interviewed/VBN psychosis/NNS
cocaine/NN relationship/NN catecholamines/NNS symptoms/NNS psychotic/JJ
cocaine/NN relationship/NN catecholamines/NNS symptoms/NNS
cocaine/NN relationship/NN examine/VB interviewed/VBN psychosis/NNS
Methamphetamine/JJ levels/NNS related/VBN scores/NNS rating/NN hyperkinesia/NN
amphetamine/JJ Methamphetamine/JJ levels/NNS related/VBN scores/NNS rating/NN hyperkinesia/NN
Valproic/JJ acid/NN induced/VBN encephalopathy/RB
acid/NN induced/VBN encephalopathy/RB
VPA/NNP associated/VBN effect/NN acid/NN induced/VBN encephalopathy/RB
VPA/NNP suppression/NN induced/VBN encephalopathy/RB
VPA/NNP hepatotoxicity/NN induced/VBN suppression/NN induced/VBN encephalopathy/RB
VPA/NNP suppression/NN induced/VBN hepatotoxicity/NN
VPA/NNP hepatotoxicity/NN
VPA/NNP suppression/NN bone/NN
VPA/NNP suppression/NN marrow/NN
VPA/NNP suppression/NN
VPA/NNP hepatotoxicity/NN induced/VBN suppression/NN bone/NN
VPA/NNP hepatotoxicity/NN induced/VBN suppression/NN marrow/NN
VPA/NNP hepatotoxicity/NN induced/VBN suppression/NN
VPA/NNP suppression/NN pancreatitis/NNS
VPA/NNP hepatotoxicity/NN induced/VBN suppression/NN pancreatitis/NNS
VPA/NNP induced/VBN encephalopathy/RB
VPA/NNP signs/NNS consciousness/NN impaired/VBN
VPA/NNP signs/NNS consciousness/NN
VPA/NNP effect/NN proof/NN is/VBZ patients/NNS encephalopathy/NN
VPA/NNP patients/NNS associated/JJ encephalopathy/RB
cimetidine/NN taking/VBG impotence/VBP
cimetidine/NN replaced/VBN disappeared/VBD developed/VBD impotence/VBP
hydroxychloroquine/NN chloroquine/NN used/VBD found/VBD case/NN drugs/NNS attributable/JJ chorioretinopathy/RB
nicotine/NN mechanisms/NNS induced/VBN hyperactivity/NN locomotor/NN
nicotine/NN mechanisms/NNS induced/VBN hyperactivity/NN
nicotine/NN hyperactivity/NN locomotor/NN
nicotine/NN hyperactivity/NN
nicotine/NN treated/VBD develop/VB hyperactivity/NN locomotor/NN
nicotine/NN treated/VBD develop/VB hyperactivity/NN
nicotine/VB develop/VB hyperactivity/NN locomotor/NN
nicotine/VB develop/VB hyperactivity/NN
Prostaglandin/NNP D/NNP had/VBD action/NN hyperalgesic/JJ
D/NNP had/VBD action/NN hyperalgesic/JJ
2/CD had/VBD action/NN hyperalgesic/JJ
prostaglandin/NN D/NNP that/DT lasted/VBD showed/VBD effect/NN hyperalgesic/JJ
D/NNP that/DT lasted/VBD showed/VBD effect/NN hyperalgesic/JJ
2/CD D/NNP that/DT lasted/VBD showed/VBD effect/NN hyperalgesic/JJ
Prostaglandin/NNP E/NNP showed/VBD effect/NN hyperalgesic/JJ
E/NNP showed/VBD effect/NN hyperalgesic/JJ
2/CD E/NNP showed/VBD effect/NN hyperalgesic/JJ
prostaglandin/NN D/NNP effect/NN hyperalgesic/JJ
D/NNP effect/NN hyperalgesic/JJ
2/CD D/NNP effect/NN hyperalgesic/JJ
prostaglandin/NN induced/VBD blocked/VBN hyperalgesia/NN
E/CD 2/CD prostaglandin/NN induced/VBD blocked/VBN hyperalgesia/NN
2/CD prostaglandin/NN induced/VBD blocked/VBN hyperalgesia/NN
prostaglandin/NN D/VBZ hyperalgesia/NN
D/VBZ hyperalgesia/NN
2/CD hyperalgesia/NN
prostaglandin/CD 2/CD hyperalgesia/NN
E/NNP hyperalgesia/NN
2/CD hyperalgesia/NN
Valproic/JJ I/NN course/NN biomarkers/NNS toxicity/NN liver/NN
Valproic/JJ I/NN course/NN biomarkers/NNS toxicity/NN
acid/JJ I/NN course/NN biomarkers/NNS toxicity/NN liver/NN
acid/JJ I/NN course/NN biomarkers/NNS toxicity/NN
valproic/JJ levels/NNS biomarkers/NNS toxicity/NN liver/NN
valproic/JJ levels/NNS biomarkers/NNS toxicity/NN
acid/JJ levels/NNS biomarkers/NNS toxicity/NN liver/NN
acid/JJ levels/NNS biomarkers/NNS toxicity/NN
VPA/NNP relationship/NN was/VBD determine/VB stress/NN hepatotoxicity/NN
VPA/NNP treated/VBN Sprague/NN stress/NN hepatotoxicity/NN
VPA/NNP results/NNS steatosis/VBZ
VPA/NNP results/NNS measured/VBN IsoP/NNP precedes/VBZ onset/NN necrosis/NNS
indomethacin/NN due/JJ anemia/NN aplastic/JJ
indomethacin/NN due/JJ anemia/NN
indomethacin/NN implicated/VBN cause/NN anemia/NN aplastic/JJ
indomethacin/NN implicated/VBN cause/NN anemia/NN
indomethacin/NN allopurinol/NN other/JJ given/VBN described/VBN case/NN anemia/NN aplastic/JJ
indomethacin/NN allopurinol/NN other/JJ given/VBN described/VBN case/NN anemia/NN
indomethacin/NN test/NN substantiates/VBZ role/NN drug/NN causing/VBG anemia/NN aplastic/JJ
indomethacin/NN test/NN substantiates/VBZ role/NN drug/NN causing/VBG anemia/NN
midazolam/NN arrest/NN cardiorespiratory/JJ
midazolam/NN arrest/NN
midazolam/NN administration/NN associated/VBN arrest/NN cardiorespiratory/JJ
midazolam/NN administration/NN associated/VBN arrest/NN
reserpine/NN induced/VBN dyskinesia/NN
reserpine/NN role/NN dyskinesia/NN
alfentanil/NNS induced/VBN rigidity/NN muscle/NN
alfentanil/NNS induced/VBN rigidity/NN
alfentanil/NN acting/VBG attenuated/VBD produced/VBD rigidity/NN muscle/NN
alfentanil/NN acting/VBG attenuated/VBD produced/VBD rigidity/NN
alfentanil/NN produced/VBN rigidity/NN
alfentanil/NN followed/VBN ketanserin/NN received/VBD animals/NNS motionless/JJ absence/NN rigidity/NN
alfentanil/NN receiving/VBG animals/NNS motionless/JJ absence/NN rigidity/NN
epinephrine/NN induced/VBN ischemia/NN myocardial/JJ
epinephrine/NN induced/VBN ischemia/NN
epinephrine/NN eliciting/VBG ischemia/NN myocardial/JJ
epinephrine/NN eliciting/VBG ischemia/NN
epinephrine/NN produced/VBD ischemia/NN myocardial/JJ
epinephrine/NN produced/VBD ischemia/NN
epinephrine/NN induced/VBN ischemia/NN myocardial/JJ
epinephrine/NN induced/VBN ischemia/NN
epinephrine/NN volume/NN product/NN rate/NN Exercise/NNP marked/VBN ischemia/NN myocardial/JJ
epinephrine/NN volume/NN product/NN rate/NN Exercise/NNP marked/VBN ischemia/NN
Nimodipine/NNP Trial/NNP BACKGROUND/NNP reduction/NN
Nimodipine/NNP Trial/NNP BACKGROUND/NNP reduction/NN pressure/NN in/IN
Nimodipine/NNP Trial/NNP BACKGROUND/NNP reduction/NN pressure/NN blood/NN
Nimodipine/NNP Trial/NNP BACKGROUND/NNP reduction/NN pressure/NN
nimodipine/NN correlation/NN found/VBN Trial/NNP BACKGROUND/NNP reduction/NN
nimodipine/NN correlation/NN found/VBN Trial/NNP BACKGROUND/NNP reduction/NN pressure/NN in/IN
nimodipine/NN correlation/NN found/VBN Trial/NNP BACKGROUND/NNP reduction/NN pressure/NN blood/NN
nimodipine/NN correlation/NN found/VBN Trial/NNP BACKGROUND/NNP reduction/NN pressure/NN
Nimodipine/JJ treatment/NN resulted/VBD reduction/NN
Nimodipine/JJ treatment/NN resulted/VBD reduction/NN BP/NNS in/IN
Nimodipine/JJ treatment/NN resulted/VBD reduction/NN BP/NNS systolic/JJ
Nimodipine/JJ treatment/NN resulted/VBD reduction/NN BP/NNS
phenylpropanolamine/NN associated/VBN hemorrhage/NN Cerebral/JJ
phenylpropanolamine/NN associated/VBN hemorrhage/NN
caffeine/NN associated/VBN hemorrhage/NN Cerebral/JJ
caffeine/NN associated/VBN hemorrhage/NN
Phenylpropanolamine/NNP drug/NN associated/VBN effects/NNS stroke/NN
PPA/NNP Phenylpropanolamine/NNP drug/NN associated/VBN effects/NNS stroke/NN
PPA/NNP caffeine/NNP lead/VB stroke/NN
caffeine/NNP lead/VB stroke/NN normotensive/NN rats/NNS hypertensive/NN
PPA/NNP caffeine/NNP lead/VB stroke/NN normotensive/NN rats/NNS hypertensive/NN
caffeine/NN administration/NN lead/VBP hypertension/NN
caffeine/NN administration/NN lead/VBP hypertension/NN normotensive/JJ animals/NNS hypertensive/JJ
PPA/NNP administration/NN lead/VBP hypertension/NN
PPA/NNP administration/NN lead/VBP hypertension/NN normotensive/JJ animals/NNS hypertensive/JJ
PPA/NNP caffeine/NNP lead/VB hemorrhage/NN cerebral/JJ
PPA/NNP caffeine/NNP lead/VB hemorrhage/NN
caffeine/NNP lead/VB hemorrhage/NN cerebral/JJ
caffeine/NNP lead/VB hemorrhage/NN
caffeine/NNP lead/VB hemorrhage/NN animals/NNS hypertensive/JJ
PPA/NNP caffeine/NNP lead/VB hemorrhage/NN animals/NNS hypertensive/JJ
amoxicillin/NNP patient/NN case/NN hepatitis/NNP
clavulanic/JJ acid/NN case/NN hepatitis/NNP
acid/NN case/NN hepatitis/NNP
amoxicillin/NNP patient/NN case/NN hepatitis/NNP granulomas/NNS
clavulanic/JJ acid/NN case/NN hepatitis/NNP granulomas/NNS
acid/NN case/NN hepatitis/NNP granulomas/NNS
cimetidine/NN patients/NNS studies/NNS confusion/NN
cimetidine/NN cases/NNS reported/VBN confusion/NN
DNR/NNP failure/NN heart/NN
DNR/NNP failure/NN
5/CD infusion/NN confusion/NN
fluorouracil/NN confusion/NN
folinic/JJ acid/NN fluorouracil/NN confusion/NN
acid/NN fluorouracil/NN confusion/NN
5/CD lasting/VBG coma/NN
fluorouracil/JJ infusion/NN lasting/VBG coma/NN
5/CD lasting/VBG coma/NN lapsed/VBN developed/VBD symptoms/NNS confusion/NN
fluorouracil/JJ infusion/NN lasting/VBG coma/NN lapsed/VBN developed/VBD symptoms/NNS confusion/NN
5/CD lasting/VBG coma/NN lapsed/VBN developed/VBD symptoms/NNS confusion/NN disorientation/NN
fluorouracil/JJ infusion/NN lasting/VBG coma/NN lapsed/VBN developed/VBD symptoms/NNS confusion/NN disorientation/NN
folinic/JJ fluorouracil/JJ infusion/NN lasting/VBG coma/NN
acid/JJ infusion/NN lasting/VBG coma/NN
folinic/JJ fluorouracil/JJ infusion/NN lasting/VBG coma/NN lapsed/VBN developed/VBD symptoms/NNS confusion/NN
acid/JJ infusion/NN lasting/VBG coma/NN lapsed/VBN developed/VBD symptoms/NNS confusion/NN
folinic/JJ fluorouracil/JJ infusion/NN lasting/VBG coma/NN lapsed/VBN developed/VBD symptoms/NNS confusion/NN disorientation/NN
acid/JJ infusion/NN lasting/VBG coma/NN lapsed/VBN developed/VBD symptoms/NNS confusion/NN disorientation/NN
scopolamine/NN prevention/NN rats/NNS sublethal/VB short/JJ amnesia/NN
scopolamine/NN prevention/NN rats/NNS sublethal/VB exposed/VBN rats/NNS response/NN protection/NN amnesia/NN
Fluconazole/NNP induced/VBN pointes/NNS torsade/JJ
Fluconazole/NNP induced/VBN pointes/NNS de/NNP
Fluconazole/NNP induced/VBN pointes/NNS
fluconazole/NN case/NN torsade/NN
fluconazole/NN case/NN torsade/NN pointes/NNS de/IN
fluconazole/NN case/NN torsade/NN pointes/NNS
fluconazole/NN case/NN torsade/NN pointes/NNS TDP/NNP
fluconazole/NN case/NN present/VB discuss/VB causing/VBG TDP/NNP
fluconazole/NN role/NN discuss/VB present/VB case/NN torsade/NN
fluconazole/NN role/NN discuss/VB present/VB case/NN torsade/NN pointes/NNS de/IN
fluconazole/NN role/NN discuss/VB present/VB case/NN torsade/NN pointes/NNS
fluconazole/NN role/NN discuss/VB present/VB case/NN torsade/NN pointes/NNS TDP/NNP
fluconazole/NN role/NN discuss/VB causing/VBG TDP/NNP
fluconazole/NN commencing/VBG days/NNS developed/VBN TDP/NNP
fluconazole/NN had/VBD TDP/NNP
fluconazole/NN commencing/VBG days/NNS developed/VBN abscess/NNS isolated/VBN glabrata/NNP woman/NN abnormalities/NNS was/VBD association/NN initiation/NN fluconazole/NNP TDP/NNP
fluconazole/NNP initiation/NN association/NN was/VBD abnormalities/NNS woman/NN glabrata/NNP isolated/VBN abscess/NNS developed/VBN TDP/NNP
fluconazole/NNP initiation/NN association/NN was/VBD abnormalities/NNS woman/NN glabrata/NNP isolated/VBN abscess/NNS developed/VBN days/NNS commencing/VBG fluconazole/NN had/VBD TDP/NNP
fluconazole/NNP TDP/NNP
fluconazole/NN discontinued/VBN resolved/VBD TDP/NNP
fluconazole/NN discontinued/VBN resolved/VBD indicates/VBZ relationship/NN use/NN development/NN TDP/NNP
fluconazole/NN use/NN relationship/NN indicates/VBZ resolved/VBD TDP/NNP
fluconazole/NN use/NN development/NN TDP/NNP
fluconazole/JJ suggests/VBZ was/VBD etiology/NN explain/VB TDP/VB
fluconazole/NN cause/VB leading/VBG TDP/NNP
olanzapine/NN induced/VBN syndrome/NN Hypomania/NNP
olanzapine/JJ treatment/NN introduction/NN developed/VBD hypomania/NN
lindane/JJ convulsions/NNS
lindane/JJ convulsions/NNS incidence/NN produce/VB pretreatment/VB increased/VBD incidence/NN convulsions/NNS
lindane/JJ convulsions/NNS incidence/NN increased/VBD pretreatment/VB produce/VB incidence/NN convulsions/NNS
lindane/JJ convulsions/NNS
lindane/NN blocked/VBN incidence/NN convulsions/NNS
lindane/NN treated/VBN animals/NNS increased/VBN P/NNP metabolism/NN lindane/NN blocked/VBN incidence/NN convulsions/NNS
lindane/NN se/FW indicating/VBG lindane/NN treated/VBN animals/NNS increased/VBN P/NNP metabolism/NN lindane/NN blocked/VBN incidence/NN convulsions/NNS
PTU/NNP associated/VBN vasculitis/NNS
propylthiouracil/NN vasculitis/NNS
PTU/NNP propylthiouracil/NN vasculitis/NNS
PTU/NNP withdrawal/NN symptoms/NNS resolution/NN observation/NN made/VBN diagnosis/NN propylthiouracil/NN vasculitis/NNS
lidocaine/NN cocaine/NN kindled/VBN seizures/NNS
cocaine/NN kindled/VBN seizures/NNS
lidocaine/JJ seizures/NNS
lidocaine/JJ seizures/NNS development/NN inhibited/VBD had/VBD effect/NN seizures/NNS
cocaine/JJ lidocaine/JJ seizures/NNS
cocaine/JJ lidocaine/JJ seizures/NNS development/NN inhibited/VBD had/VBD effect/NN seizures/NNS
cocaine/NN mortality/NN incidence/NN seizure/NN
lidocaine/NN induced/VBN seizures/NNS
cocaine/NN kindled/NNP lidocaine/NN induced/VBN seizures/NNS
lidocaine/JJ seizures/NNS
cocaine/JJ lidocaine/JJ seizures/NNS
cocaine/NN induced/VBN seizures/NNS
cocaine/NN injection/NN induced/VBN seizures/NNS
cocaine/NN influences/NNS seizures/NNS
heparin/NN patients/NNS thrombosis/NNS
heparin/NN patients/NNS thrombosis/NNS thrombocytopenia/NN
heparin/NN two/CD antigen/NNP thrombosis/NNS
heparin/NN concentration/NN characteristics/NNS two/CD antigen/NNP thrombosis/NNS
heparin/NN two/CD antigen/NNP thrombocytopenia/NNP
heparin/NN two/CD antigen/NNP HIT/NNP
heparin/NN concentration/NN characteristics/NNS two/CD antigen/NNP thrombocytopenia/NNP
heparin/NN concentration/NN characteristics/NNS two/CD antigen/NNP HIT/NNP
heparin/NN exposure/NN decrease/NN count/NN thrombocytopenia/NN
heparin/NN -RSB-/NNS concentration/NN inhibition/NN antigen/NN two/CD had/VBD heparin/NN exposure/NN decrease/NN count/NN thrombocytopenia/NN
captopril/NN treatment/NN function/NN deterioration/NN sudden/JJ
captopril/NN treatment/NN function/NN deterioration/NN
captopril/NN treatment/NN function/NN of/IN
captopril/NN treatment/NN function/NN renal/JJ
captopril/NN treatment/NN function/NN
Levodopa/NNP induced/VBN dyskinesias/NNS
levodopa/NN dyskinesias/NNS
levodopa/NN pathophysiology/NN systems/NNS preclinical/JJ induced/NNP dyskinesias/NNS
streptozotocin/NN rats/NNS membrane/NN associated/VBN Reduction/NN induced/VBN nephropathy/NN diabetic/JJ
streptozotocin/NN rats/NNS membrane/NN associated/VBN Reduction/NN induced/VBN nephropathy/NN
carbimazole/NN therapy/NN bupropion/NN Acute/VB
carbimazole/NN therapy/NN bupropion/NN Acute/VB failure/NN liver/NN
carbimazole/NN therapy/NN bupropion/NN Acute/VB failure/NN
bupropion/NN Acute/VB
bupropion/NN Acute/VB failure/NN liver/NN
bupropion/NN Acute/VB failure/NN
bupropion/NN induced/VBN hepatotoxicity/RB
carbimazole/NN treatment/NN receiving/VBG resulted/VBN case/NN is/VBZ increasing/VBG evidence/NN hepatotoxicity/NN
carbimazole/NN treatment/NN receiving/VBG resulted/VBN failure/NN acute/JJ
carbimazole/NN treatment/NN receiving/VBG resulted/VBN failure/NN liver/NN
carbimazole/NN treatment/NN receiving/VBG resulted/VBN failure/NN
bupropion/NN induced/VBN hepatotoxicity/NN
bupropion/NN while/NN receiving/VBG resulted/VBN case/NN is/VBZ increasing/VBG evidence/NN hepatotoxicity/NN
bupropion/NN induced/VBN hepatotoxicity/NN evidence/NN increasing/VBG is/VBZ case/NN resulted/VBN failure/NN acute/JJ
bupropion/NN induced/VBN hepatotoxicity/NN evidence/NN increasing/VBG is/VBZ case/NN resulted/VBN failure/NN liver/NN
bupropion/NN induced/VBN hepatotoxicity/NN evidence/NN increasing/VBG is/VBZ case/NN resulted/VBN failure/NN
bupropion/NN while/NN receiving/VBG resulted/VBN failure/NN acute/JJ
bupropion/NN while/NN receiving/VBG resulted/VBN failure/NN liver/NN
bupropion/NN while/NN receiving/VBG resulted/VBN failure/NN
bupropion/NN given/VBN drugs/NNS hepatotoxic/JJ
bupropion/NN induced/VBN insult/NN acute/JJ
bupropion/NN induced/VBN insult/NN liver/NN
bupropion/NN induced/VBN insult/NN
azelastine/NN placebo/NN significantly/RB group/NN increased/VBN Drowsiness/NNS perception/NN altered/JJ
azelastine/NN placebo/NN significantly/RB group/NN increased/VBN Drowsiness/NNS perception/NN taste/NN
azelastine/NN placebo/NN significantly/RB group/NN increased/VBN Drowsiness/NNS perception/NN
azelastine/NN placebo/NN significantly/RB group/NN increased/VBN Drowsiness/NNS
cyclophosphamide/VB granulomatosis/NNS cancer/NN Urinary/JJ
cyclophosphamide/VB granulomatosis/NNS cancer/NN bladder/NN
cyclophosphamide/VB granulomatosis/NNS cancer/NN
cyclophosphamide/NN relation/NN cancer/NN bladder/NN
cyclophosphamide/NN relation/NN cancer/NN
cyclophosphamide/NN bladder/NN
cyclophosphamide/NN cancer/NN
cyclophosphamide/JJ =/NN doubled/VBD risk/NN cancer/NN bladder/NN
cyclophosphamide/JJ =/NN doubled/VBD risk/NN cancer/NN
cyclophosphamide/NN relationship/NN dose/NN risk/NN cancer/NN bladder/NN
cyclophosphamide/NN relationship/NN dose/NN risk/NN cancer/NN
morphine/NN treated/VBN Hyperalgesia/NNS myoclonus/NNS
morphine/NN treated/VBN Hyperalgesia/NNS
morphine/NN doses/NNS treated/VBN disease/NN stages/NNS patients/NNS developed/VBD hyperalgesia/NN
morphine/NN doses/NNS relationship/NN myoclonus/NNS
morphine/NN plays/VBZ indicates/VBZ available/JJ descriptions/NNS relationship/NN myoclonus/NNS
morphine/NN doses/NNS relationship/NN myoclonus/NNS hyperalgesia/JJ
morphine/NN plays/VBZ indicates/VBZ available/JJ descriptions/NNS relationship/NN myoclonus/NNS hyperalgesia/JJ
chlorthalidone/JJ administration/NN loss/NN hypokalaemia/NN
lidocaine/NN system/NN role/NN convulsion/NN
lidocaine/NN convulsions/NNS
lidocaine/NN convulsions/NNS
lidocaine/NN incidence/NN increased/VBN treatment/NN L/NNP induced/VBZ convulsions/NNS
lidocaine/NN mediator/NN convulsions/NNS
tamoxifen/NN women/NNS events/NNS vascular/NN
tamoxifen/NN women/NNS events/NNS
tamoxifen/NN women/NNS events/NNS hypertriglyceridaemia/NN
L/NNP patients/NNS overactivation/NN dose/NN dyskinesia/NN
dopa/NN overactivation/NN dose/NN dyskinesia/NN
L/NNP patients/NNS groups/NNS supplementary/NN task/NN execution/NN dopa/NN dyskinesia/NN
dopa/NN medication/NN execution/NN dopa/NN dyskinesia/NN
L/NNP patients/NNS groups/NNS supplementary/NN task/NN execution/NN other/JJ dyskinesia/NN
dopa/NN medication/NN execution/NN other/JJ dyskinesia/NN
L/NNP one/NN medication/NN execution/NN dopa/NN dyskinesia/NN
dopa/NN dyskinesia/NN
L/NNP one/NN medication/NN execution/NN other/JJ dyskinesia/NN
dopa/NN execution/NN other/JJ dyskinesia/NN
L/NNP movement/NN abnormal/JJ
L/NNP movement/NN involuntary/JJ
L/NNP movement/NN
dopa/NNP L/NNP movement/NN abnormal/JJ
dopa/NNP L/NNP movement/NN involuntary/JJ
dopa/NNP L/NNP movement/NN
L/NNP induced/VBN dyskinesia/NN
dopa/NNP L/NNP induced/VBN dyskinesia/NN
cinacalcet/NN reported/VBN nausea/NN headache/NN
cinacalcet/NN desipramine/NN treated/VBN patients/NNS reported/VBN nausea/NN headache/NN
desipramine/NN treatment/NN alone/JJ receiving/VBG cinacalcet/NN reported/VBN nausea/NN
desipramine/NN receiving/VBG cinacalcet/NN reported/VBN nausea/NN
desipramine/NN treated/VBN patients/NNS reported/VBN nausea/NN
cinacalcet/NN reported/VBN nausea/NN
cinacalcet/NN desipramine/NN treated/VBN patients/NNS reported/VBN nausea/NN
desipramine/NN treatment/NN alone/JJ receiving/VBG cinacalcet/NN reported/VBN nausea/NN headache/NN
desipramine/NN receiving/VBG cinacalcet/NN reported/VBN nausea/NN headache/NN
desipramine/NN treated/VBN patients/NNS reported/VBN nausea/NN headache/NN
cisplatin/NN injection/NN induced/VBN injury/NN acute/JJ
cisplatin/NN injection/NN induced/VBN injury/NN renal/JJ
cisplatin/NN injection/NN induced/VBN injury/NN
paracetamol/NNP developed/VBN bladder/NN epithelium/NN Papillomas/NNS bore/VBD carcinomas/NNS bladder/NN
paracetamol/NNP developed/VBN bladder/NN epithelium/NN Papillomas/NNS bore/VBD carcinomas/NNS
paracetamol/NNP %/NN treated/VBD developed/VBD hyperplasia/NN
paracetamol/NNP livers/NNS study/NN treated/VBD revealed/VBD hepatocytes/NNS resemble/VBP those/DT result/VBP variety/NN hepatocarcinogens/NNS
paclitaxel/NN received/VBD suffered/VBD edema/NN moderate/JJ brain/NN
paclitaxel/NN received/VBD suffered/VBD edema/NN
paclitaxel/NN total/NN received/VBD edema/NN moderate/JJ brain/NN
paclitaxel/NN total/NN received/VBD edema/NN
capsaicin/NN administration/NN induced/VBN hyperalgesia/NN
haloperidol/NN induced/VBN hyperprolactinemia/NN
haloperidol/NN induced/VBN hyperprolactinemia/NN
HAL/NNP haloperidol/NN induced/VBN hyperprolactinemia/NN
tranylcypromine/JJ interaction/NN syndrome/NN Serotonin/NN
tranylcypromine/JJ interaction/NN syndrome/NN
venlafaxine/NN syndrome/NN Serotonin/NN
venlafaxine/NN syndrome/NN
tranylcypromine/NN taking/VBG male/NN y/NN venlafaxine/NN interaction/NNP resulted/VBD syndrome/NN serotonin/NN
tranylcypromine/NN taking/VBG male/NN y/NN venlafaxine/NN interaction/NNP resulted/VBD syndrome/NN
venlafaxine/NN interaction/NNP resulted/VBD syndrome/NN serotonin/NN
venlafaxine/NN interaction/NNP resulted/VBD syndrome/NN
Ciprofloxacin/NNP induced/VBN nephritis/NNS interstitial/JJ
Ciprofloxacin/NNP induced/VBN nephritis/NNS
Ciprofloxacin/NNP associated/VBN effects/NNS nephritis/NNS anemia/NN hemolytic/JJ
Ciprofloxacin/NNP associated/VBN effects/NNS nephritis/NNS anemia/NN
Ciprofloxacin/NNP associated/VBN effects/NNS nephritis/NNS interstitial/JJ
Ciprofloxacin/NNP associated/VBN effects/NNS nephritis/NNS
ciprofloxacin/NN case/NN nephritis/NNS interstitial/JJ
ciprofloxacin/NN case/NN nephritis/NNS
puromycin/NN aminonucleoside/NN induced/VBN Plasma/NNP lipids/NNS development/NN syndrome/NN nephrotic/JJ
puromycin/NN aminonucleoside/NN induced/VBN Plasma/NNP lipids/NNS development/NN syndrome/NN
aminonucleoside/NN induced/VBN Plasma/NNP lipids/NNS development/NN syndrome/NN nephrotic/JJ
aminonucleoside/NN induced/VBN Plasma/NNP lipids/NNS development/NN syndrome/NN
puromycin/NN aminonucleoside/NN induced/VBN syndrome/NN nephrotic/JJ
puromycin/NN aminonucleoside/NN induced/VBN syndrome/NN
aminonucleoside/NN induced/VBN syndrome/NN nephrotic/JJ
aminonucleoside/NN induced/VBN syndrome/NN
puromycin/NN aminonucleoside/NN induced/VBN syndrome/NN found/VBN lipoproteins/NNS alterations/NNS due/JJ syndrome/NN nephrotic/JJ
puromycin/NN aminonucleoside/NN induced/VBN syndrome/NN found/VBN lipoproteins/NNS alterations/NNS due/JJ syndrome/NN
aminonucleoside/NN induced/VBN syndrome/NN found/VBN lipoproteins/NNS alterations/NNS due/JJ syndrome/NN nephrotic/JJ
aminonucleoside/NN induced/VBN syndrome/NN found/VBN lipoproteins/NNS alterations/NNS due/JJ syndrome/NN
aminonucleoside/NN or/CC syndrome/NN due/JJ alterations/NNS lipoproteins/NNS found/VBN syndrome/NN nephrotic/JJ
aminonucleoside/NN or/CC syndrome/NN due/JJ alterations/NNS lipoproteins/NNS found/VBN syndrome/NN
aminonucleoside/NN or/CC syndrome/NN nephrotic/JJ
aminonucleoside/NN or/CC syndrome/NN
puromycin/NN aminonucleoside/NN administration/NN development/NN syndrome/NN nephrotic/JJ
puromycin/NN aminonucleoside/NN administration/NN development/NN syndrome/NN
aminonucleoside/NN administration/NN development/NN syndrome/NN nephrotic/JJ
aminonucleoside/NN administration/NN development/NN syndrome/NN
oral/JJ therapy/NN complications/NNS pretreatment/VB levels/NNS factors/NNS blood/NN
oral/JJ therapy/NN complications/NNS pretreatment/VB levels/NNS factors/NNS coagulation/NN
contraceptive/JJ therapy/NN complications/NNS pretreatment/VB levels/NNS factors/NNS blood/NN
contraceptive/JJ therapy/NN complications/NNS pretreatment/VB levels/NNS factors/NNS coagulation/NN
diltiazem/NN interaction/NN cisapride/VB related/VBD Prolongation/NNP
diltiazem/NN interaction/NN cisapride/VB related/VBD Prolongation/NNP interval/NN of/IN
diltiazem/NN interaction/NN cisapride/VB related/VBD Prolongation/NNP interval/NN the/DT
diltiazem/NN interaction/NN cisapride/VB related/VBD Prolongation/NNP interval/NN QT/NNP
diltiazem/NN interaction/NN cisapride/VB related/VBD Prolongation/NNP interval/NN
cisapride/VB related/VBD Prolongation/NNP
cisapride/VB related/VBD Prolongation/NNP interval/NN of/IN
cisapride/VB related/VBD Prolongation/NNP interval/NN the/DT
cisapride/VB related/VBD Prolongation/NNP interval/NN QT/NNP
cisapride/VB related/VBD Prolongation/NNP interval/NN
azole/JJ erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP death/NN sudden/JJ
azole/JJ erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP death/NN cardiac/JJ
azole/JJ erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP death/NN
azole/JJ erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP pointes/NNS torsades/JJ
azole/JJ erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP pointes/NNS de/NNP
azole/JJ erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP pointes/NNS
erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP pointes/NNS torsades/JJ
erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP pointes/NNS de/NNP
erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP pointes/NNS
azole/JJ erythromycin/NN agents/NNS reported/VBN Prolongation/NNP
azole/JJ erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP of/IN
azole/JJ erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP QT/NNP
azole/JJ erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP
erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP death/NN sudden/JJ
erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP death/NN cardiac/JJ
erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP death/NN
erythromycin/NN agents/NNS reported/VBN Prolongation/NNP
erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP of/IN
erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP QT/NNP
erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP
MMC/NN m/NN developed/VBD failure/NN cardiac/JJ
MMC/NN m/NN developed/VBD failure/NN
doxorubicin/NN m/NN developed/VBD failure/NN cardiac/JJ
doxorubicin/NN m/NN developed/VBD failure/NN
lithium/NN treatment/NN hypothyroidism/VB
lithium/NN taking/VBG developed/VBD Hypothyroidism/NNP
gentamicin/VB resistance/NN responsible/JJ suggested/VBN failure/NN acute/JJ
gentamicin/VB resistance/NN responsible/JJ suggested/VBN failure/NN renal/JJ
gentamicin/VB resistance/NN responsible/JJ suggested/VBN failure/NN
gentamicin/VB resistance/NN responsible/JJ suggested/VBN failure/NN ARF/NNP
streptozotocin/NN mellitus/NNS diabetes/NN
streptozotocin/NN mellitus/NNS
streptozotocin/NN DM/NNP
gentamicin/NN ARF/NNP
ethambutol/NN due/JJ neuropathy/NN Bilateral/JJ
ethambutol/NN due/JJ neuropathy/NN optic/JJ
ethambutol/NN due/JJ neuropathy/NN
isoniazid/JJ treatment/NN ethambutol/NN due/JJ neuropathy/NN Bilateral/JJ
isoniazid/JJ treatment/NN ethambutol/NN due/JJ neuropathy/NN optic/JJ
isoniazid/JJ treatment/NN ethambutol/NN due/JJ neuropathy/NN
doxorubicin/NN kinase/JJ inducible/NN induced/VBN syndrome/NN nephrotic/JJ
doxorubicin/NN kinase/JJ inducible/NN induced/VBN syndrome/NN
Doxorubicin/NN treatment/NN resulted/VBD 44/CD mice/NNS leading/VBG ascites/NN
Doxorubicin/NN treatment/NN resulted/VBD proteinuria/NN
Doxorubicin/NN treatment/NN resulted/VBD 44/CD mice/NNS leading/VBG ascites/NN hypoalbuminemia/NN
Doxorubicin/NN treatment/NN resulted/VBD 44/CD mice/NNS leading/VBG syndrome/NN nephrotic/JJ
Doxorubicin/NN treatment/NN resulted/VBD 44/CD mice/NNS leading/VBG syndrome/NN
Doxorubicin/NN treatment/NN resulted/VBD 44/CD mice/NNS leading/VBG ascites/NN lipidemia/NN
atazanavir/NN simvastatin/NN use/NN secondary/JJ failure/NN rhabdomyolysis/JJ
atazanavir/NN simvastatin/NN use/NN secondary/JJ failure/NN rhabdomyolysis/JJ acute/JJ
atazanavir/NN simvastatin/NN use/NN secondary/JJ failure/NN renal/JJ
atazanavir/NN simvastatin/NN use/NN secondary/JJ failure/NN
amiodarone/NN simvastatin/NN use/NN secondary/JJ failure/NN rhabdomyolysis/JJ
simvastatin/NN use/NN secondary/JJ failure/NN rhabdomyolysis/JJ acute/JJ
simvastatin/NN use/NN secondary/JJ failure/NN renal/JJ
simvastatin/NN use/NN secondary/JJ failure/NN
simvastatin/NN use/NN secondary/JJ failure/NN rhabdomyolysis/JJ
amiodarone/NN simvastatin/NN use/NN secondary/JJ failure/NN rhabdomyolysis/JJ acute/JJ
amiodarone/NN simvastatin/NN use/NN secondary/JJ failure/NN renal/JJ
amiodarone/NN simvastatin/NN use/NN secondary/JJ failure/NN
atazanavir/NN simvastatin/NN resulting/VBG failure/NN rhabdomyolysis/JJ
atazanavir/NN simvastatin/NN resulting/VBG failure/NN rhabdomyolysis/JJ acute/JJ
atazanavir/NN simvastatin/NN resulting/VBG failure/NN renal/JJ
atazanavir/NN simvastatin/NN resulting/VBG failure/NN
amiodarone/NN simvastatin/NN resulting/VBG failure/NN rhabdomyolysis/JJ
simvastatin/NN resulting/VBG failure/NN rhabdomyolysis/JJ acute/JJ
simvastatin/NN resulting/VBG failure/NN renal/JJ
simvastatin/NN resulting/VBG failure/NN
simvastatin/NN resulting/VBG failure/NN rhabdomyolysis/JJ
amiodarone/NN simvastatin/NN resulting/VBG failure/NN rhabdomyolysis/JJ acute/JJ
amiodarone/NN simvastatin/NN resulting/VBG failure/NN renal/JJ
amiodarone/NN simvastatin/NN resulting/VBG failure/NN
simvastatin/NN metabolism/NN inhibit/VBP presence/NN increased/VBN risk/NN rhabdomyolysis/NNS
coniine/NN failed/VBN produce/VB arthrogryposis/NNS
nicotine/NN sulfate/NN occurred/VBD hemorrhage/NN cranial/JJ
nicotine/NN sulfate/NN occurred/VBD hemorrhage/NN
coniine/NN model/NN arthrogryposis/NNS
N/NNP aspirin/NN administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS forestomach/JJ
N/NNP aspirin/NN administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS
-LSB-/NNP administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS forestomach/JJ
-LSB-/NNP administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS
4/CD -LSB-/NNP administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS forestomach/JJ
4/CD -LSB-/NNP administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS
5/CD -LSB-/NNP administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS forestomach/JJ
5/CD -LSB-/NNP administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS
nitro/NN 5/CD -LSB-/NNP administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS forestomach/JJ
nitro/NN 5/CD -LSB-/NNP administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS
2/CD nitro/NN 5/CD -LSB-/NNP administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS forestomach/JJ
2/CD nitro/NN 5/CD -LSB-/NNP administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS
furyl/NN 2/CD nitro/NN 5/CD -LSB-/NNP administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS forestomach/JJ
furyl/NN 2/CD nitro/NN 5/CD -LSB-/NNP administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS
2/CD administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS forestomach/JJ
2/CD administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS
thiazolyl/JJ -RSB-/NNS 2/CD administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS forestomach/JJ
thiazolyl/JJ -RSB-/NNS 2/CD administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS
-RSB-/NNS 2/CD administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS forestomach/JJ
-RSB-/NNS 2/CD administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS
formamide/NN administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS forestomach/JJ
formamide/NN administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS
FANFT/NNP formamide/NN administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS forestomach/JJ
FANFT/NNP formamide/NN administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS
FANFT/NNP incidence/NN resulted/VBN administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS forestomach/JJ
FANFT/NNP incidence/NN resulted/VBN administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS
N/NNP aspirin/NN administration/NN co/NN carcinomas/NNS bladder/NN
N/NNP aspirin/NN administration/NN co/NN carcinomas/NNS
-LSB-/NNP administration/NN co/NN carcinomas/NNS bladder/NN
-LSB-/NNP administration/NN co/NN carcinomas/NNS
4/CD -LSB-/NNP administration/NN co/NN carcinomas/NNS bladder/NN
4/CD -LSB-/NNP administration/NN co/NN carcinomas/NNS
5/CD -LSB-/NNP administration/NN co/NN carcinomas/NNS bladder/NN
5/CD -LSB-/NNP administration/NN co/NN carcinomas/NNS
nitro/NN 5/CD -LSB-/NNP administration/NN co/NN carcinomas/NNS bladder/NN
nitro/NN 5/CD -LSB-/NNP administration/NN co/NN carcinomas/NNS
2/CD nitro/NN 5/CD -LSB-/NNP administration/NN co/NN carcinomas/NNS bladder/NN
2/CD nitro/NN 5/CD -LSB-/NNP administration/NN co/NN carcinomas/NNS
furyl/NN 2/CD nitro/NN 5/CD -LSB-/NNP administration/NN co/NN carcinomas/NNS bladder/NN
furyl/NN 2/CD nitro/NN 5/CD -LSB-/NNP administration/NN co/NN carcinomas/NNS
2/CD administration/NN co/NN carcinomas/NNS bladder/NN
2/CD administration/NN co/NN carcinomas/NNS
thiazolyl/JJ -RSB-/NNS 2/CD administration/NN co/NN carcinomas/NNS bladder/NN
thiazolyl/JJ -RSB-/NNS 2/CD administration/NN co/NN carcinomas/NNS
-RSB-/NNS 2/CD administration/NN co/NN carcinomas/NNS bladder/NN
-RSB-/NNS 2/CD administration/NN co/NN carcinomas/NNS
formamide/NN administration/NN co/NN carcinomas/NNS bladder/NN
formamide/NN administration/NN co/NN carcinomas/NNS
FANFT/NNP formamide/NN administration/NN co/NN carcinomas/NNS bladder/NN
FANFT/NNP formamide/NN administration/NN co/NN carcinomas/NNS
FANFT/NNP incidence/NN resulted/VBN administration/NN co/NN carcinomas/NNS bladder/NN
FANFT/NNP incidence/NN resulted/VBN administration/NN co/NN carcinomas/NNS
amphotericin/NN nephrotoxicity/NN
B/NN nephrotoxicity/NN
amphotericin/NNP B/NNP potential/NN nephrotoxic/JJ
B/NNP potential/NN nephrotoxic/JJ
sulphasalazine/JJ treatment/NN restarting/VBG developed/VBD eyes/NNS effusion/NN pleural/JJ
sulphasalazine/JJ treatment/NN restarting/VBG developed/VBD eyes/NNS effusion/NN
sulphasalazine/JJ treatment/NN cessation/NN resulted/VBD fever/NN effusions/NNS pleural/JJ
sulphasalazine/JJ treatment/NN cessation/NN resulted/VBD fever/NN effusions/NNS
sulphasalazine/JJ treatment/NN cessation/NN resulted/VBD initiated/VBD remained/VBD effusion/NN pleural/JJ
sulphasalazine/JJ treatment/NN cessation/NN resulted/VBD initiated/VBD remained/VBD effusion/NN
sulphasalazine/JJ treatment/NN cessation/NN resulted/VBD fever/NN
Methylphenidate/NNP induced/VBN obsessive/JJ
Methylphenidate/NNP induced/VBN obsessive/JJ symptoms/NNS compulsive/JJ
Methylphenidate/NNP induced/VBN obsessive/JJ symptoms/NNS
methylphenidate/NN replaced/VBN diminished/VBN ensued/VBD obsessive/NN
methylphenidate/NN replaced/VBN diminished/VBN ensued/VBD behavior/NN compulsive/JJ
methylphenidate/NN replaced/VBN diminished/VBN ensued/VBD behavior/NN
nicotine/CD mg/NN caused/VBN locomotor/NN significantly/RB lesions/VBZ operated/VBD induced/VBN hyperactivity/RB
nicotine/NN enhanced/VBD operated/VBD induced/VBN hyperactivity/RB
morphine/VBP antinociception/NN constipation/NN
morphine/JJ combination/NN effects/NNS constipating/VBG
morphine/NN inhibited/VBD suggesting/VBG develop/VB effects/NNS constipating/VBG
morphine/NN produced/VBD constipation/NN
morphine/NN potentiate/VB suggesting/VBG produced/VBD constipation/NN
adriamycin/NN -LSB-/NNS induced/VBN proteinuria/NN
adriamycin/NN elicited/VBD proteinuria/NN
adriamycin/NN correlated/VBD rise/NN proteinuria/NN
LiCl/NNP administration/NN 2/CD mice/NNS led/VBN polyuria/NN
pravastatin/NN use/NN associated/VBN myopathy/NN inflammatory/JJ
pravastatin/NN use/NN associated/VBN myopathy/NN
Clonidine/NNP bradycardia/JJ
1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN liver/NN
1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN
chloro/NNP -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN liver/NN
chloro/NNP -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN
-/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN liver/NN
-/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN
1/CD -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN liver/NN
1/CD -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN
2/CD -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN liver/NN
2/CD -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN
2/CD -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN liver/NN
2/CD -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN
2/CD -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN liver/NN
2/CD -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN
tetrafluoroethane/NN -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN liver/NN
tetrafluoroethane/NN -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN
HCFC/NNP tetrafluoroethane/NN -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN liver/NN
HCFC/NNP tetrafluoroethane/NN -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN
124/CD HCFC/NNP tetrafluoroethane/NN -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN liver/NN
124/CD HCFC/NNP tetrafluoroethane/NN -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN
1/CD mixture/NN exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN liver/NN
1/CD mixture/NN exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN
1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN liver/NN
1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN
dichloro/NNP -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN liver/NN
dichloro/NNP -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN
-/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN liver/NN
-/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN
2/CD -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN liver/NN
2/CD -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN
2/CD -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN liver/NN
2/CD -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN
2/CD -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN liver/NN
2/CD -/NNP 1/CD exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN
trifluoroethane/NN exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN liver/NN
trifluoroethane/NN exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN
HCFC/CD 123/CD trifluoroethane/NN exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN liver/NN
HCFC/CD 123/CD trifluoroethane/NN exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN
123/CD trifluoroethane/NN exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN liver/NN
123/CD trifluoroethane/NN exposure/NN had/VBN workers/NNS investigated/VBD epidemic/NN disease/NN
scopolamine/NN cholinesterase/NN 247/VBN Effects/NNPS induced/VBN amnesia/NN
NIK/NNP Effects/NNPS induced/VBN amnesia/NN
247/VBN Effects/NNPS induced/VBN amnesia/NN
scopolamine/RB 247/VBN induced/VBN examined/VBN amnesia/NN
tacrine/NN 247/VBN induced/VBN examined/VBN amnesia/NN
E/NN tacrine/NN 247/VBN induced/VBN examined/VBN amnesia/NN
2020/VBZ effects/NNS 247/VBN induced/VBN examined/VBN amnesia/NN
NIK/NNP effects/NNS 247/VBN induced/VBN examined/VBN amnesia/NN
247/VBN induced/VBN examined/VBN amnesia/NN
scopolamine/NN induced/VBN amnesia/NN
scopolamine/NN induced/VBN amnesia/NN
NIK/NNP 247/NNP improves/VBZ scopolamine/NN induced/VBN amnesia/NN
-/NNP 247/NNP improves/VBZ scopolamine/NN induced/VBN amnesia/NN
247/NNP improves/VBZ scopolamine/NN induced/VBN amnesia/NN
levodopa/NN administration/NN caused/VBD epilepsy/NN
//CD administration/NN caused/VBD epilepsy/NN
carbidopa/NN administration/NN caused/VBD epilepsy/NN
dexamethasone/JJ treatment/NN years/NNS age/NN dysfunction/NN neurological/JJ
dexamethasone/JJ treatment/NN years/NNS age/NN dysfunction/NN
dexamethasone/JJ therapy/NN assess/VB dysfunction/NN neurological/JJ
dexamethasone/JJ therapy/NN assess/VB dysfunction/NN
dexamethasone/JJ treatment/NN showed/VBD rate/NN dysfunctions/NNS neurological/JJ
dexamethasone/JJ treatment/NN showed/VBD rate/NN dysfunctions/NNS
sodium/NN anticoagulant/NN resulting/VBG hypocalcemia/NN
citrate/NN anticoagulant/NN resulting/VBG hypocalcemia/NN
citrate/VB due/JJ prevent/VB help/VB recommended/VBN screening/NN medications/NNS conditions/NNS predisposing/VBG hypocalcemia/NN
2/CD injection/NN chloroprocaine/JJ CE/NNP limb/NN paralysis/NN
chloroprocaine/JJ CE/NNP limb/NN paralysis/NN
CE/NNP limb/NN paralysis/NN
2/CD received/VBD animals/NNS cords/NNS showed/VBD necrosis/NNS subpial/JJ
2/CD received/VBD animals/NNS cords/NNS showed/VBD necrosis/NNS
chloroprocaine/RB showed/VBD necrosis/NNS subpial/JJ
chloroprocaine/RB showed/VBD necrosis/NNS
CE/RB showed/VBD necrosis/NNS subpial/JJ
CE/RB showed/VBD necrosis/NNS
methotrexate/NN accident/NN leukoencephalopathy/JJ
methotrexate/NN treated/VBN patients/NNS identified/VBD reports/NNS leukoencephalopathy/NN
5/CD methotrexate/NN treated/VBN patients/NNS identified/VBD reports/NNS leukoencephalopathy/NN
fluorouracil/NN 5/CD methotrexate/NN treated/VBN patients/NNS identified/VBD reports/NNS leukoencephalopathy/NN
carmofur/NN fluorouracil/NN 5/CD methotrexate/NN treated/VBN patients/NNS identified/VBD reports/NNS leukoencephalopathy/NN
capecitabine/NN methotrexate/NN treated/VBN patients/NNS identified/VBD reports/NNS leukoencephalopathy/NN
scopolamine/NN MEASURES/NNP impairment/NN
scopolamine/NN MEASURES/NNP impairment/NN recall/NN in/IN
scopolamine/NN MEASURES/NNP impairment/NN recall/NN word/NN
scopolamine/NN MEASURES/NNP impairment/NN recall/NN
scopolamine/NN induced/VBN impairment/NN
scopolamine/NN induced/VBN impairment/NN recall/NN in/IN
scopolamine/NN induced/VBN impairment/NN recall/NN word/NN
scopolamine/NN induced/VBN impairment/NN recall/NN
amiodarone/JJ treatment/NN occurring/VBG block/VBP presented/VBN intra/NN
amiodarone/JJ treatment/NN occurring/VBG block/VBP Hisian/NNP
amiodarone/JJ treatment/NN occurring/VBG block/VBP
cocaine/NN users/NNS sleepiness/NNS daytime/JJ
cocaine/NN users/NNS sleepiness/NNS
cocaine/NN users/NNS decreases/VBZ sleepiness/NNS daytime/JJ
cocaine/NN users/NNS decreases/VBZ sleepiness/NNS
cocaine/NN use/NN related/VBN incidence/NN increasing/VBG indicate/VBP exceeds/VBZ that/DT infarction/NN cerebral/JJ
cocaine/NN use/NN related/VBN incidence/NN increasing/VBG indicate/VBP exceeds/VBZ that/DT infarction/NN
cocaine/NN -/VBD indicate/VBP exceeds/VBZ that/DT infarction/NN cerebral/JJ
cocaine/NN -/VBD indicate/VBP exceeds/VBZ that/DT infarction/NN
cocaine/NN administration/NN route/NN follow/VB indicate/VBP exceeds/VBZ that/DT infarction/NN cerebral/JJ
cocaine/NN administration/NN route/NN follow/VB indicate/VBP exceeds/VBZ that/DT infarction/NN
cocaine/NN use/NN associated/VBN indicate/VBP exceeds/VBZ that/DT infarction/NN cerebral/JJ
cocaine/NN use/NN associated/VBN indicate/VBP exceeds/VBZ that/DT infarction/NN
cocaine/NN 5/CD stroke/NN exceeds/VBZ that/DT infarction/NN cerebral/JJ
cocaine/NN 5/CD stroke/NN exceeds/VBZ that/DT infarction/NN
isoproterenol/NN detection/NN mTc/NN induced/VBN infarction/NN myocardial/JJ
isoproterenol/NN detection/NN mTc/NN induced/VBN infarction/NN
isoproterenol/NN rats/NNS study/VB used/VBN easy/JJ mTc/NN induced/VBN infarction/NN myocardial/JJ
isoproterenol/NN rats/NNS study/VB used/VBN easy/JJ mTc/NN induced/VBN infarction/NN
estrogen/NN microscopic/NN prolactinomas/NNS
estrogen/NN applied/VBN clarify/VB cells/NNS prolactinoma/NN
estrogen/NN applied/VBN induced/VBN h/NN cells/NNS prolactinoma/NN
Calcium/JJ toxicity/NN milk/NN
Calcium/JJ toxicity/NN alkali/VBZ
Calcium/JJ toxicity/NN alkali/VBZ syndrome/NN
carbonate/NN toxicity/NN milk/NN
carbonate/NN toxicity/NN alkali/VBZ
carbonate/NN toxicity/NN alkali/VBZ syndrome/NN
calcium/NN carbonate/NN describe/VB induced/VBN insights/NNS hypercalcemia/NN
carbonate/NN describe/VB induced/VBN insights/NNS hypercalcemia/NN
calcium/NN carbonate/NN describe/VB induced/VBN cause/NN milk/NN
calcium/NN carbonate/NN describe/VB alkali/VBG
calcium/NN carbonate/NN describe/VB alkali/VBG syndrome/NN
carbonate/NN describe/VB induced/VBN cause/NN milk/NN
carbonate/NN describe/VB alkali/VBG
carbonate/NN describe/VB alkali/VBG syndrome/NN
pamidronate/JJ intravenously/NN caused/VBD hypocalcemia/NN
calcium/NN carbonate/NN amounts/NNS precipitated/VBN cause/NN CONCLUSION/NNP Milk/NN
calcium/NN carbonate/NN amounts/NNS precipitated/VBN cause/NN syndrome/NN alkali/NN
calcium/NN carbonate/NN amounts/NNS precipitated/VBN cause/NN syndrome/NN
carbonate/NN amounts/NNS precipitated/VBN cause/NN CONCLUSION/NNP Milk/NN
carbonate/NN amounts/NNS precipitated/VBN cause/NN syndrome/NN alkali/NN
carbonate/NN amounts/NNS precipitated/VBN cause/NN syndrome/NN
calcium/NN carbonate/NN amounts/NNS precipitated/VBN cause/NN hypercalcemia/NN
carbonate/NN amounts/NNS precipitated/VBN cause/NN hypercalcemia/NN
Pamidronate/JJ treatment/NN associated/VBN risk/NN hypocalcemia/NN
sirolimus/NNS administration/NN association/NN syndrome/NN capillary/JJ
sirolimus/NNS administration/NN association/NN syndrome/NN leak/NN
sirolimus/NNS administration/NN association/NN syndrome/NN
rapamycin/NN sirolimus/NNS administration/NN association/NN syndrome/NN capillary/JJ
rapamycin/NN sirolimus/NNS administration/NN association/NN syndrome/NN leak/NN
rapamycin/NN sirolimus/NNS administration/NN association/NN syndrome/NN
sirolimus/NNS treatment/NN syndrome/NN capillary/JJ
sirolimus/NNS treatment/NN syndrome/NN leak/NN
sirolimus/NNS treatment/NN syndrome/NN
sirolimus/NNS specimen/NN OBSERVATIONS/NNP induced/VBN leak/NN capillary/JJ
sirolimus/NNS specimen/NN OBSERVATIONS/NNP induced/VBN leak/NN
sirolimus/NNS specimen/NN OBSERVATIONS/NNP induced/VBN leak/NN syndrome/NN
sirolimus/NNS fold/VB 3/CD syndrome/NN leak/NN capillary/JJ
sirolimus/NNS fold/VB 3/CD syndrome/NN leak/NN
sirolimus/NNS fold/VB 3/CD syndrome/NN
sirolimus/NNS effects/NNS include/VBP fever/NN syndrome/NN capillary/JJ
sirolimus/NNS effects/NNS include/VBP fever/NN syndrome/NN leak/NN
sirolimus/NNS effects/NNS include/VBP fever/NN syndrome/NN
diazepam/NN complications/NNS Venous/JJ
diazepam/NN complications/NNS
midazolam/NN complications/NNS Venous/JJ
midazolam/NN complications/NNS
diazepam/NN associated/VBN venous/NNS
diazepam/NN associated/VBN complications/NNS
midazolam/NN associated/VBN venous/NNS
midazolam/NN associated/VBN complications/NNS
diazepam/NN injection/NN evaluated/VBN incidence/NN complications/NNS venous/JJ
diazepam/NN injection/NN evaluated/VBN incidence/NN complications/NNS
midazolam/NN diazepam/NN injection/NN evaluated/VBN incidence/NN complications/NNS venous/JJ
midazolam/NN diazepam/NN injection/NN evaluated/VBN incidence/NN complications/NNS
diazepam/NN frequent/JJ complications/NNS venous/NNS
diazepam/NN frequent/JJ complications/NNS
midazolam/NN frequent/JJ complications/NNS venous/NNS
midazolam/NN frequent/JJ complications/NNS
streptozotocin/NN role/NN nephropathy/NN diabetic/JJ
streptozotocin/NN role/NN nephropathy/NN
streptozotocin/NN tissues/NNS using/VBG nephropathy/NN diabetic/JJ
streptozotocin/NN tissues/NNS using/VBG nephropathy/NN
streptozotocin/NN tissues/NNS patients/NNS diabetic/JJ
streptozotocin/NN tissues/NNS patients/NNS nephropathy/NN
streptozotocin/NN tissues/NNS model/NN diabetic/JJ
streptozotocin/NN tissues/NNS model/NN nephropathy/NN
prednisolone/NN administration/NN occurred/VBD enlargement/NN wastage/NN muscle/NN
prednisolone/NN administration/NN occurred/VBD enlargement/NN wastage/NN
prednisolone/NN administration/NN occurred/VBD enlargement/NN Liver/JJ
prednisolone/NN administration/NN occurred/VBD enlargement/NN
streptozocin/NN crocin/NN L/NNP constituents/NNS Effects/NNPS model/NN disease/NN Alzheimer/NNP
streptozocin/NN crocin/NN L/NNP constituents/NNS Effects/NNPS model/NN disease/NN Alzheimer/NNP '/POS
streptozocin/NN crocin/NN L/NNP constituents/NNS Effects/NNPS model/NN disease/NN s/JJ
streptozocin/NN crocin/NN L/NNP constituents/NNS Effects/NNPS model/NN disease/NN
streptozocin/NN induced/VBN disease/NN Alzheimer/NNP
streptozocin/NN induced/VBN disease/NN Alzheimer/NNP '/POS
streptozocin/NN induced/VBN disease/NN s/JJ
streptozocin/NN induced/VBN disease/NN
STZ/NNP streptozocin/NN induced/VBN disease/NN Alzheimer/NNP
STZ/NNP streptozocin/NN induced/VBN disease/NN Alzheimer/NNP '/POS
STZ/NNP streptozocin/NN induced/VBN disease/NN s/JJ
STZ/NNP streptozocin/NN induced/VBN disease/NN
STZ/NNP injected/VBN groups/NNS Alzheimer/NNP
STZ/NNP injected/VBN groups/NNS Alzheimer/NNP '/POS
STZ/NNP injected/VBN groups/NNS s/JJ
STZ/NNP injected/VBN groups/NNS disease/NN
STZ/NN repeated/VBN injected/VBN groups/NNS Alzheimer/NNP
STZ/NN repeated/VBN injected/VBN groups/NNS Alzheimer/NNP '/POS
STZ/NN repeated/VBN injected/VBN groups/NNS s/JJ
STZ/NN repeated/VBN injected/VBN groups/NNS disease/NN
STZ/NNP caused/VBN deficits/NNS cognitive/JJ
STZ/NNP caused/VBN deficits/NNS
STZ/NNP caused/VBN deficits/NNS antagonizing/VBG demonstrate/VBP disease/NN potential/NN treatment/NN diseases/NNS Alzheimer/NNP
STZ/NNP caused/VBN deficits/NNS antagonizing/VBG demonstrate/VBP disease/NN potential/NN treatment/NN diseases/NNS Alzheimer/NNP '/POS
STZ/NNP caused/VBN deficits/NNS antagonizing/VBG demonstrate/VBP disease/NN s/VBZ
STZ/NNP caused/VBN deficits/NNS antagonizing/VBG demonstrate/VBP disease/NN
aminophylline/NN threshold/NN initiating/VBG fibrillation/NN ventricular/NN
aminophylline/NN threshold/NN initiating/VBG fibrillation/NN
aminophylline/NN threshold/NN ventricular/NN
aminophylline/NN threshold/NN fibrillation/NN
aminophylline/NN infusion/NN reduced/VBN threshold/NN ventricular/NN
aminophylline/NN infusion/NN reduced/VBN threshold/NN fibrillation/NN
aminophylline/NN infusion/NN resulted/VBD decrease/NN threshold/NN ventricular/NN
aminophylline/NN infusion/NN resulted/VBD decrease/NN threshold/NN fibrillation/NN
octreotide/NN analog/NN function/NN formation/NN gallstone/NN
octreotide/NN treatment/NN had/VBD gallstones/NNS
octreotide/NN treatment/NN had/VBD developed/VBD cholecystitis/NNS acute/JJ
octreotide/NN treatment/NN had/VBD developed/VBD cholecystitis/NNS
octreotide/NN patients/NNS gallstones/NNS
octreotide/JJ therapy/NN cholecystitis/NNS sludge/NN gallstones/NNS
timolol/JJ 0/CD treated/CD %/NN h/NN diagnosed/VBD suffering/NN depression/NN
timolol/JJ treatment/NN patients/NNS presented/VBD values/NNS depression/NN
timolol/NN inducer/JJ less/JJR depression/NN
ACTH/NNP stimulation/NN dystonia/JJ
MSH/NNP ACTH/NNP stimulation/NN dystonia/JJ
suxamethonium/NN doses/NNS Comparison/NNP bradycardia/NN
suxamethonium/NN doses/NNS arrhythmia/NN bradycardia/NN
corticosteroid/JJ therapy/NN resolved/VBN pressure/NN elevated/JJ
corticosteroid/JJ therapy/NN resolved/VBN pressure/NN intraocular/JJ
corticosteroid/JJ therapy/NN resolved/VBN pressure/NN
amphotericin/VB related/VBN dilated/VBD
amphotericin/VB related/VBN cardiomyopathy/RB
B/NNP therapy/NN amphotericin/VB related/VBN dilated/VBD
B/NNP therapy/NN amphotericin/VB related/VBN cardiomyopathy/RB
amphotericin/NNP B/NNP developed/VBD cardiomyopathy/NN failure/NN heart/NN
amphotericin/NNP B/NNP developed/VBD cardiomyopathy/NN failure/NN
B/NNP developed/VBD cardiomyopathy/NN failure/NN heart/NN
B/NNP developed/VBD cardiomyopathy/NN failure/NN
AmB/NNP B/NNP developed/VBD cardiomyopathy/NN failure/NN heart/NN
AmB/NNP B/NNP developed/VBD cardiomyopathy/NN failure/NN
amphotericin/NNP B/NNP developed/VBD cardiomyopathy/NN dilated/JJ
amphotericin/NNP B/NNP developed/VBD cardiomyopathy/NN
B/NNP developed/VBD cardiomyopathy/NN dilated/JJ
B/NNP developed/VBD cardiomyopathy/NN
AmB/NNP B/NNP developed/VBD cardiomyopathy/NN dilated/JJ
AmB/NNP B/NNP developed/VBD cardiomyopathy/NN
AmB/NNP substituted/VBN abnormalities/NN failure/NN heart/NN
AmB/NNP substituted/VBN abnormalities/NN failure/NN
cidofovir/NN Use/NN associated/VBN failure/NN progressive/JJ
cidofovir/NN Use/NN associated/VBN failure/NN renal/JJ
cidofovir/NN Use/NN associated/VBN failure/NN
cidofovir/NN Use/NN associated/VBN failure/NN neutropenia/NN
Cocaine/NNP induced/VBN infarction/NN myocardial/JJ
Cocaine/NNP induced/VBN infarction/NN
cocaine/NN result/VB infarction/NN acute/JJ
cocaine/NN result/VB infarction/NN myocardial/JJ
cocaine/NN result/VB infarction/NN
cocaine/NN associated/VBN demand/NN result/VB infarction/NN acute/JJ
cocaine/NN associated/VBN demand/NN result/VB infarction/NN myocardial/JJ
cocaine/NN associated/VBN demand/NN result/VB infarction/NN
Verapamil/NNP induced/VBN neurotoxicity/RB
carbamazepine/JJ induced/VBN neurotoxicity/RB
verapamil/NN treatment/NN neurotoxicity/NN
carbamazepine/JJ neurotoxicity/NN
methylphenidate/NN intake/NN vasculitis/NNS Cerebral/JJ
methylphenidate/NN intake/NN vasculitis/NNS
methylphenidate/JJ intake/NN reported/VBN documented/VBN vasculitis/NNS Cerebral/JJ
methylphenidate/JJ intake/NN reported/VBN documented/VBN vasculitis/NNS
sulphasalazine/NN course/NN day/NN developed/VBD constellation/NN dermatitis/NN hepatitis/NN
sulphasalazine/NN course/NN day/NN developed/VBD constellation/NN dermatitis/NN lymphadenopathy/NN
sulphasalazine/NN course/NN day/NN developed/VBD constellation/NN dermatitis/NN
sulphasalazine/NN course/NN day/NN developed/VBD constellation/NN dermatitis/NN fever/NN
levodopa/NN dyskinesias/NNS
fenoldopam/NN induced/VBN hypotension/NN
fenoldopam/NN used/VBN induce/VB hypotension/NN
fenoldopam/NN induced/VBN +/NNS hypotension/JJ
fenoldopam/NN increased/VBN flow/NN hypotension/NN
nitroprusside/NN cent/NN 8/CD flow/NN increased/VBN fenoldopam/NN induced/VBN +/NNS hypotension/JJ
nitroprusside/NN cent/NN 8/CD flow/NN hypotension/NN
nitroprusside/NNP non/NN arteriolar/NN produce/VB kidney/NN hypotension/NN
riboflavin/NN thiamine/NN deficiency/NN common/JJ neuropathy/VBD Peripheral/NNP
riboflavin/NN thiamine/NN deficiency/NN common/JJ neuropathy/VBD
riboflavin/NN thiamine/NN deficiency/NN common/JJ neuropathy/VBD presented/VBD neuropathy/NN sensory/NN sensori/JJ
riboflavin/NN thiamine/NN deficiency/NN common/JJ neuropathy/VBD presented/VBD neuropathy/NN motor/NN
riboflavin/NN thiamine/NN deficiency/NN common/JJ neuropathy/VBD presented/VBD neuropathy/NN
thiamine/NN deficiency/NN common/JJ neuropathy/VBD Peripheral/NNP
thiamine/NN deficiency/NN common/JJ neuropathy/VBD
thiamine/NN deficiency/NN common/JJ neuropathy/VBD presented/VBD neuropathy/NN sensory/NN sensori/JJ
thiamine/NN deficiency/NN common/JJ neuropathy/VBD presented/VBD neuropathy/NN motor/NN
thiamine/NN deficiency/NN common/JJ neuropathy/VBD presented/VBD neuropathy/NN
vitamin/NN doses/NNS D/NNP 5/CD x/SYM associated/VBN hypercalcemia/NN hyperphosphatemia/NN
D/NNP 5/CD x/SYM associated/VBN hypercalcemia/NN hyperphosphatemia/NN
3/CD D/NNP 5/CD x/SYM associated/VBN hypercalcemia/NN hyperphosphatemia/NN
vitamin/NNP D/NNP 10/CD associated/VBN hypercalcemia/NN hyperphosphatemia/NN
D/NNP 10/CD associated/VBN hypercalcemia/NN hyperphosphatemia/NN
3/CD D/NNP 10/CD associated/VBN hypercalcemia/NN hyperphosphatemia/NN
vitamin/NNP 3/NNP increases/NNS hypercalcemia/NN hyperphosphatemia/NN
D/NNP 3/NNP increases/NNS hypercalcemia/NN hyperphosphatemia/NN
3/NNP increases/NNS hypercalcemia/NN hyperphosphatemia/NN
vitamin/NN doses/NNS D/NNP 5/CD x/SYM associated/VBN hypercalcemia/NN
D/NNP 5/CD x/SYM associated/VBN hypercalcemia/NN
3/CD D/NNP 5/CD x/SYM associated/VBN hypercalcemia/NN
vitamin/NNP D/NNP 10/CD associated/VBN hypercalcemia/NN
D/NNP 10/CD associated/VBN hypercalcemia/NN
3/CD D/NNP 10/CD associated/VBN hypercalcemia/NN
vitamin/NNP 3/NNP increases/NNS hypercalcemia/NN
D/NNP 3/NNP increases/NNS hypercalcemia/NN
3/NNP increases/NNS hypercalcemia/NN
adriamycin/NN cardiotoxicity/NN
adriamycin/NN effects/NNS cardiotoxic/JJ
cyclooxygenase/JJ inhibitors/NNS treatment/NN failure/NN infarction/NN stroke/NN
inhibitors/NNS treatment/NN failure/NN infarction/NN stroke/NN
cyclooxygenase/JJ inhibitors/NNS treatment/NN failure/NN myocardial/JJ
cyclooxygenase/JJ inhibitors/NNS treatment/NN failure/NN infarction/NN
inhibitors/NNS treatment/NN failure/NN myocardial/JJ
inhibitors/NNS treatment/NN failure/NN infarction/NN
cyclooxygenase/JJ inhibitors/NNS treatment/NN failure/NN infarction/NN hypertension/NN
inhibitors/NNS treatment/NN failure/NN infarction/NN hypertension/NN
cyclooxygenase/JJ inhibitors/NNS treatment/NN failure/NN infarction/NN heart/NN
cyclooxygenase/JJ inhibitors/NNS treatment/NN failure/NN
inhibitors/NNS treatment/NN failure/NN infarction/NN heart/NN
inhibitors/NNS treatment/NN failure/NN
pilocarpine/NN neurons/NNS containing/VBG induced/VBN seizures/NNS
pilocarpine/NN injected/VBN studied/VBN 1/CD seizures/NNS
pilocarpine/NN intervals/NNS 1/CD seizures/NNS
phenylephrine/NN labeled/VBN quantitated/VBN induced/VBN hypertension/NN
Nitroglycerin/NNP shown/VBN reduce/VB ST/NNP induced/VBN hypotension/NN
nitroglycerin/NN reverse/VB agents/NNS potentiated/VBN elevation/NN ST/NNP induced/VBN hypotension/NN
levodopa/JJ dyskinesias/NNS
mannitol/JJ lower/JJR elevated/VBD
mannitol/JJ lower/JJR elevated/VBD ICP/NNP
zidovudine/NN suppression/NN bone/NN
zidovudine/NN suppression/NN marrow/NN
zidovudine/NN suppression/NN
ZDV/NNP zidovudine/NN suppression/NN bone/NN
ZDV/NNP zidovudine/NN suppression/NN marrow/NN
ZDV/NNP zidovudine/NN suppression/NN
ZDV/NNP therapy/NN supplementation/NN 12/CD seem/VB B/NNP induced/VBN myelotoxicity/RB
ZDV/NNP induced/VBN myelotoxicity/RB
phenytoin/NN patients/NNS cerebellum/NN volumetry/NN overdosages/VBZ
phenytoin/NN overdosage/NN
phenytoin/NN medication/NN cause/NN unlikely/JJ conclude/VBP result/VB overdosage/NN
sirolimus/NNS switch/NN proteinuria/NN
sirolmus/NNS lacks/VBZ reported/VBN proteinuria/NN
Srl/NNP sirolmus/NNS lacks/VBZ reported/VBN proteinuria/NN
Srl/NNP associated/VBN proteinuria/NN
Srl/NNP associated/VBN proteinuria/NN
Srl/NNP develop/VB proteinuria/NN
Srl/NNP used/VBN monitored/VBD proteinuria/NN
haloperidol/NN induced/VBN catalepsy/RB
haloperidol/NN induced/VBN catalepsy/NN
Haloperidol/NNP challenged/VBN catalepsy/RB
haloperidol/NN injections/NNS previous/JJ attenuated/VBD catalepsy/NN
haloperidol/NN mechanisms/NNS glutamate/NN induced/VBN catalepsy/RB
Acetazolamide/NNP induced/VBN syndrome/NN Gerstmann/JJ
Acetazolamide/NNP induced/VBN syndrome/NN
acetazolamide/NN case/NN report/VBP induced/VBN syndrome/NN Gerstmann/JJ
acetazolamide/NN case/NN report/VBP induced/VBN syndrome/NN
oral/JJ contraception/NN associated/VBN Chorea/NNP
contraception/NN associated/VBN Chorea/NNP
oral/JJ contraceptives/NNS receiving/VBG developed/VBD chorea/NN
contraceptives/NNS receiving/VBG developed/VBD chorea/NN
amphetamine/NN induced/VBN chorea/NN
oral/JJ contraception/NN induced/VBN chorea/NN
contraception/NN induced/VBN chorea/NN
co/NN exams/NNS formation/NN cases/NNS patients/NNS developed/VBD cholestasis/NNS intrahepatic/JJ
co/NN exams/NNS formation/NN cases/NNS patients/NNS developed/VBD cholestasis/NNS
trimoxazole/JJ treatment/NN formation/NN cases/NNS patients/NNS developed/VBD cholestasis/NNS intrahepatic/JJ
trimoxazole/JJ treatment/NN formation/NN cases/NNS patients/NNS developed/VBD cholestasis/NNS
haloperidol/NN induced/VBN rigidity/NN Muscle/JJ
haloperidol/NN induced/VBN rigidity/NN
haloperidol/NN rigidity/NN muscle/NN
haloperidol/NN rigidity/NN
CLZ/NNP ingestion/NN accompanying/VBG flush/NN nausea/NN
CLZ/NNP ingestion/NN accompanying/VBG duration/NN headache/NN
CLZ/NNP ingestion/NN accompanying/VBG flush/NN facial/JJ
CLZ/NNP ingestion/NN accompanying/VBG flush/NN
clonidine/NN induces/VBZ withdrawal/NN bradycardia/NN
clonidine/NNP effects/NNS hypothesized/VBN exhibits/VBZ given/VBN induces/VBZ withdrawal/NN bradycardia/NN
clonidine/NN rate/NN induced/VBN bradycardia/NN
ribavirin/NNP has/VBZ managed/VBN anemia/NN
iohexol/NN study/NN comparing/VBG effects/NNS nephrotoxic/JJ
neostigmine/NN nicotine/NN induced/VBN endpoints/NNS convulsion/NN
carbachol/NN nicotine/NN induced/VBN endpoints/NNS convulsion/NN
nicotine/NN induced/VBN endpoints/NNS convulsion/NN
fluocinolone/JJ implant/NN treated/VBN uveitis/NNS patients/NNS report/VB incidence/NN pressure/NN elevated/JJ
fluocinolone/JJ implant/NN treated/VBN uveitis/NNS patients/NNS report/VB incidence/NN pressure/NN intraocular/JJ
fluocinolone/JJ implant/NN treated/VBN uveitis/NNS patients/NNS report/VB incidence/NN pressure/NN
acetonide/NN implant/NN treated/VBN uveitis/NNS patients/NNS report/VB incidence/NN pressure/NN elevated/JJ
acetonide/NN implant/NN treated/VBN uveitis/NNS patients/NNS report/VB incidence/NN pressure/NN intraocular/JJ
acetonide/NN implant/NN treated/VBN uveitis/NNS patients/NNS report/VB incidence/NN pressure/NN
FA/NNP implant/NN treated/VBN uveitis/NNS patients/NNS report/VB incidence/NN pressure/NN elevated/JJ
FA/NNP implant/NN treated/VBN uveitis/NNS patients/NNS report/VB incidence/NN pressure/NN intraocular/JJ
FA/NNP implant/NN treated/VBN uveitis/NNS patients/NNS report/VB incidence/NN pressure/NN
haloperidol/NN antagonist/NN beta/NN induced/VBN catalepsy/RB
haloperidol/NN induced/VBN catalepsy/RB
haloperidol/NN induced/VBN catalepsy/RB
DFP/NNP TOTP/NNP given/VBN chickens/NNS exacerbated/VBD induced/VBN neuropathy/JJ
TOTP/NNP effects/NNS had/VBN corticosterone/NN concentrations/NNS induced/VBN neuropathy/JJ
TOTP/NNP given/VBN chickens/NNS exacerbated/VBD induced/VBN neuropathy/JJ
DFP/NNP TOTP/NNP evident/JJ fibers/NNS Degenerating/VBG
DFP/NNP TOTP/NNP evident/JJ fibers/NNS myelinated/JJ
DFP/NNP TOTP/NNP evident/JJ fibers/NNS
TOTP/NNP evident/JJ fibers/NNS Degenerating/VBG
TOTP/NNP evident/JJ fibers/NNS myelinated/JJ
TOTP/NNP evident/JJ fibers/NNS
carbon/NN tetrachloride/NN effects/NNS hepatotoxic/JJ
tetrachloride/NN effects/NNS hepatotoxic/JJ
CCl/NNP tetrachloride/NN effects/NNS hepatotoxic/JJ
4/CD CCl/NNP tetrachloride/NN effects/NNS hepatotoxic/JJ
acetaminophen/CD CHCl/NNP CCl/NNP effects/NNS hepatotoxic/JJ
CCl/NNP effects/NNS hepatotoxic/JJ
4/CD CCl/NNP effects/NNS hepatotoxic/JJ
CHCl/NNP CCl/NNP effects/NNS hepatotoxic/JJ
3/CD CHCl/NNP CCl/NNP effects/NNS hepatotoxic/JJ
galactosamine/NN CCl/NNP effects/NNS hepatotoxic/JJ
adriamycin/NN administration/NN effect/NN cardiotoxic/JJ
galactosamine/JJ hepatotoxicity/NN
streptomycin/NN edaravone/NN effect/NN vestibulotoxicity/NN
streptomycin/NN induced/VBN vestibulotoxicity/RB
streptomycin/NN induced/VBN vestibulotoxicity/RB
indomethacin/NN misoprostol/NN effect/NN induced/VBN dysfunction/NN renal/JJ
indomethacin/NN misoprostol/NN effect/NN induced/VBN dysfunction/NN
indomethacin/NN dysfunction/NN renal/JJ
indomethacin/NN dysfunction/NN
paclitaxel/NN neurotoxicity/NN peripheral/JJ
paclitaxel/NN neurotoxicity/NN
paclitaxel/NN chemotherapy/NN factor/NN neuropathy/NN peripheral/JJ
paclitaxel/NN chemotherapy/NN factor/NN neuropathy/NN
PAC/NNP paclitaxel/NN chemotherapy/NN factor/NN neuropathy/NN peripheral/JJ
PAC/NNP paclitaxel/NN chemotherapy/NN factor/NN neuropathy/NN
PAC/NNP ameliorate/VB claimed/VBN factor/NN neuropathy/NN peripheral/JJ
PAC/NNP ameliorate/VB claimed/VBN factor/NN neuropathy/NN
PAC/NNP preventing/VBG evaluate/VB aimed/VBN induced/VBN neuropathy/NN peripheral/JJ
PAC/NNP preventing/VBG evaluate/VB aimed/VBN induced/VBN neuropathy/NN
PAC/NNP neurotoxicity/NN peripheral/JJ
PAC/NNP neurotoxicity/NN
cyclosporine/NN nephrotoxicity/NN
cyclosporine/NN role/NN role/NN' combination/NN chemotherapeutics/NNS development/NN toxicity/NN renal/JJ
cyclosporine/NN role/NN role/NN' combination/NN chemotherapeutics/NNS development/NN toxicity/NN
CSA/NNP cyclosporine/NN role/NN role/NN' combination/NN chemotherapeutics/NNS development/NN toxicity/NN renal/JJ
CSA/NNP cyclosporine/NN role/NN role/NN' combination/NN chemotherapeutics/NNS development/NN toxicity/NN
CSA/NNP administration/NN potential/NN nephrotoxic/JJ
CSA/NNP toxicity/NN aggravate/VB administration/NN potential/NN nephrotoxic/JJ
CSA/NNP increased/VBD nephrotoxicity/RB
CSA/NNP induced/VBN nephrotoxicity/NN
smoking/VBG influence/NN estimated/VBN associated/VBN loss/NN hearing/NN
smoking/VBG influence/NN estimated/VBN associated/VBN loss/NN
smoking/NN associated/VBN loss/NN hearing/NN
smoking/NN associated/VBN loss/NN
haloperidol/NN doses/NNS higher/JJR incidence/NN parkinsonism/NN
CaCl/NNP induced/VBN aneurysm/NN thoracic/JJ
CaCl/NNP induced/VBN aneurysm/NN aortic/JJ
CaCl/NNP induced/VBN aneurysm/NN
2/CD CaCl/NNP induced/VBN aneurysm/NN thoracic/JJ
2/CD CaCl/NNP induced/VBN aneurysm/NN aortic/JJ
2/CD CaCl/NNP induced/VBN aneurysm/NN
calcium/NN chloride/NN establish/VB model/NN aneurysm/NN thoracic/JJ
calcium/NN chloride/NN establish/VB model/NN aneurysm/NN aortic/JJ
calcium/NN chloride/NN establish/VB model/NN aneurysm/NN
chloride/NN establish/VB model/NN aneurysm/NN thoracic/JJ
chloride/NN establish/VB model/NN aneurysm/NN aortic/JJ
chloride/NN establish/VB model/NN aneurysm/NN
calcium/NN chloride/NN establish/VB model/NN aneurysm/NN TAA/NNP
chloride/NN establish/VB model/NN aneurysm/NN TAA/NNP
calcium/NN chloride/NN establish/VB designed/VBN explore/VB formation/NN TAA/NNP
chloride/NN establish/VB designed/VBN explore/VB formation/NN TAA/NNP
CaCl/NNP chloride/NN establish/VB model/NN aneurysm/NN thoracic/JJ
CaCl/NNP chloride/NN establish/VB model/NN aneurysm/NN aortic/JJ
CaCl/NNP chloride/NN establish/VB model/NN aneurysm/NN
2/CD NNS chloride/NN establish/VB model/NN aneurysm/NN thoracic/JJ
2/CD NNS chloride/NN establish/VB model/NN aneurysm/NN aortic/JJ
2/CD NNS chloride/NN establish/VB model/NN aneurysm/NN
CaCl/NNP chloride/NN establish/VB model/NN aneurysm/NN TAA/NNP
2/CD NNS chloride/NN establish/VB model/NN aneurysm/NN TAA/NNP
CaCl/NNP chloride/NN establish/VB designed/VBN explore/VB formation/NN TAA/NNP
2/CD NNS chloride/NN establish/VB designed/VBN explore/VB formation/NN TAA/NNP
CaCl/NNP establishes/VBZ model/NN TAA/NNP
2/LS exposure/NN CaCl/NNP establishes/VBZ model/NN TAA/NNP
suprofen/NN epidemiology/NN syndrome/NN flank/NN
suprofen/NN epidemiology/NN syndrome/NN pain/NN
CGS/NNP agonist/NN manner/NN induced/VBN responses/NNS cataleptic/JJ
21680/CD CGS/NNP agonist/NN manner/NN induced/VBN responses/NNS cataleptic/JJ
reserpine/NN induced/VBN' induced/VBN catalepsy/NN
haloperidol/NN induced/VBN catalepsy/NN
capsaicin/NN components/NNS memory/NN pain/NN
capsaicin/NN doses/NNS injections/NNS received/VBD address/VB long/JJ memory/NN pain/NN
capsaicin/NN doses/NNS able/JJ magnitude/NN pain/NN
penicillamine/JJ therapy/NN caused/VBD gravis/NNS Myasthenia/NNP
penicillamine/JJ therapy/NN caused/VBD gravis/NNS
chloroquine/JJ penicillamine/JJ therapy/NN caused/VBD gravis/NNS Myasthenia/NNP
chloroquine/JJ penicillamine/JJ therapy/NN caused/VBD gravis/NNS
penicillamine/JJ therapy/NN had/VBD gravis/NNS myasthenia/NN
penicillamine/JJ therapy/NN had/VBD gravis/NNS
chloroquine/JJ penicillamine/JJ therapy/NN had/VBD gravis/NNS myasthenia/NN
chloroquine/JJ penicillamine/JJ therapy/NN had/VBD gravis/NNS
ketamine/NN induced/VBN tachycardia/NN
sulpiride/NN induced/VBN catalepsy/RB
fluphenazine/NN sulpiride/NN induced/VBN catalepsy/RB
SCH/NNP 23390/NNS fluphenazine/NN sulpiride/NN induced/VBN catalepsy/RB
23390/NNS fluphenazine/NN sulpiride/NN induced/VBN catalepsy/RB
sulpiride/NN Combination/NNP induce/VB potentiation/NN catalepsy/JJ
SCH/NNP Combination/NNP induce/VB potentiation/NN catalepsy/JJ
23390/CD SCH/NNP Combination/NNP induce/VB potentiation/NN catalepsy/JJ
sulpiride/NN fluphenazine/NN induced/VBN catalepsy/NN
fluphenazine/NN induced/VBN catalepsy/NN
SCH/NNP fluphenazine/NN induced/VBN catalepsy/NN
23390/CD SCH/NNP fluphenazine/NN induced/VBN catalepsy/NN
delta/NN induced/VBN involvement/NN catalepsy/NN
9/CD delta/NN induced/VBN involvement/NN catalepsy/NN
tetrahydrocannabinol/NN delta/NN induced/VBN involvement/NN catalepsy/NN
haloperidol/NN induced/VBN catalepsy/NN important/JJ have/VBP role/NN manifestation/NN catalepsy/NN
haloperidol/NN induced/VBN catalepsy/NN
THC/NNP induced/VBN catalepsy/NN
THC/NNP induced/VBN catalepsy/NN manifestation/NN role/NN have/VBP important/JJ catalepsy/NN
Lithium/NNP seems/VBZ polyuria/NNP
dobutamine/NN glucagon/NN induced/VBN ischemia/NN myocardial/JJ
dobutamine/NN glucagon/NN induced/VBN ischemia/NN
dobutamine/JJ testing/NN attenuates/VBZ evidence/NN ischemia/NN myocardial/JJ
dobutamine/JJ testing/NN attenuates/VBZ evidence/NN ischemia/NN
oral/JJ contraceptives/NNS use/NN thromboembolism/NN venous/JJ
oral/JJ contraceptives/NNS use/NN thromboembolism/NN
contraceptives/NNS use/NN thromboembolism/NN venous/JJ
contraceptives/NNS use/NN thromboembolism/NN
oral/JJ contraceptives/NNS associated/VBN thromboembolism/NN venous/JJ
oral/JJ contraceptives/NNS associated/VBN thromboembolism/NN
contraceptives/NNS associated/VBN thromboembolism/NN venous/JJ
contraceptives/NNS associated/VBN thromboembolism/NN
oral/JJ contraceptives/NNS associated/VBN thromboembolism/NN VTE/NNP
contraceptives/NNS associated/VBN thromboembolism/NN VTE/NNP
OC/NNP contraceptives/NNS associated/VBN thromboembolism/NN venous/JJ
OC/NNP contraceptives/NNS associated/VBN thromboembolism/NN
OC/NNP contraceptives/NNS associated/VBN thromboembolism/NN VTE/NNP
OC/NNP use/NN patterns/NNS distinguish/VB risk/NN thromboembolism/NN venous/JJ
OC/NNP use/NN patterns/NNS distinguish/VB risk/NN thromboembolism/NN
OC/NNP use/NN patterns/NNS distinguish/VB risk/NN thromboembolism/NN VTE/NNP
OC/NN users/NNS VTE/NNP
mepivacaine/VB seen/VBN addition/NN damage/NN muscle/NN
mepivacaine/VB seen/VBN addition/NN damage/NN
lidocaine/VB mepivacaine/VB seen/VBN addition/NN damage/NN muscle/NN
lidocaine/VB mepivacaine/VB seen/VBN addition/NN damage/NN
amphetamine/NN Protection/NNP induced/VBN neurotoxicity/RB
amphetamine/JJ compounds/NNS effect/NN neurotoxic/JJ
cyclophosphamide/NN responses/NNS characterization/NN cystitis/NNS
cyclophosphamide/NN cystitis/NNS
aspirin/NN users/NNS users/NNS higher/JJR risk/NN Thrombotic/JJ
aspirin/NN nonusers/NNS higher/JJR risk/NN Thrombotic/JJ
Capsaicin/NNP injected/VBN induce/VB pain/NN
nitric/JJ oxide/NN levels/NNS gene/NN headache/NN
oxide/NN levels/NNS gene/NN headache/NN
nitric/JJ oxide/NN induced/VBN headache/NN
oxide/NN induced/VBN headache/NN
NO/RB oxide/NN induced/VBN headache/NN
glyceryl/JJ trinitrate/NN induced/VBN headache/NN
trinitrate/NN induced/VBN headache/NN
GTN/NNP trinitrate/NN induced/VBN headache/NN
NO/DT donor/NN glyceryl/JJ trinitrate/NN induced/VBN headache/NN
GTN/NNP headache/NN
GTN/NNP day/NN developed/VBD headache/NN
GTN/NNP day/NN developed/VBD pronounced/JJ headache/NN
NO/DT headache/NN
Levodopa/NNP induced/VBN dystonia/NN
phenylpropanolamine/NN infarction/NN Cerebral/JJ
phenylpropanolamine/NN infarction/NN
PPA/NNP dose/NN taking/VBG suffered/VBD infarction/NN cerebral/JJ
PPA/NNP dose/NN taking/VBG suffered/VBD infarction/NN
sodium/NN Contribution/NNP valproate/VBP syndrome/NN
sodium/NN Contribution/NNP valproate/VBP syndrome/NN secretion/NN of/IN
sodium/NN Contribution/NNP valproate/VBP syndrome/NN secretion/NN inappropriate/JJ
sodium/NN Contribution/NNP valproate/VBP syndrome/NN secretion/NN
sodium/NN Contribution/NNP valproate/VBP syndrome/NN secretion/NN hormone/NN of/IN
sodium/NN Contribution/NNP valproate/VBP syndrome/NN secretion/NN hormone/NN antidiuretic/JJ
sodium/NN Contribution/NNP valproate/VBP syndrome/NN secretion/NN hormone/NN
valproate/VBP syndrome/NN
valproate/VBP syndrome/NN secretion/NN of/IN
valproate/VBP syndrome/NN secretion/NN inappropriate/JJ
valproate/VBP syndrome/NN secretion/NN
valproate/VBP syndrome/NN secretion/NN hormone/NN of/IN
valproate/VBP syndrome/NN secretion/NN hormone/NN antidiuretic/JJ
valproate/VBP syndrome/NN secretion/NN hormone/NN
sodium/NN valproate/NN administered/VBN developed/VBD syndrome/NN
sodium/NN valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN of/IN
sodium/NN valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN inappropriate/JJ
sodium/NN valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN
sodium/NN valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN of/IN
sodium/NN valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN antidiuretic/JJ
sodium/NN valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN
valproate/NN administered/VBN developed/VBD syndrome/NN
valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN of/IN
valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN inappropriate/JJ
valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN
valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN of/IN
valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN antidiuretic/JJ
valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN
sodium/NN valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN SIADH/NNP
valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN SIADH/NNP
VPA/NNP valproate/NN administered/VBN developed/VBD syndrome/NN
VPA/NNP valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN of/IN
VPA/NNP valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN inappropriate/JJ
VPA/NNP valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN
VPA/NNP valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN of/IN
VPA/NNP valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN antidiuretic/JJ
VPA/NNP valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN
VPA/NNP valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN SIADH/NNP
VPA/NNP administration/NN consider/VBP episode/NN SIADH/NNP
furosemide/NN pretreated/VBD function/NN Renal/JJ
furosemide/NN pretreated/VBD function/NN
furosemide/NN pretreated/VBD function/NN deteriorated/VBN significantly/RB
furosemide/NN pretreated/VBD function/NN deteriorated/VBN
valproate/VBP features/NNS encephalopathy/NN
sodium/NN application/NN valproate/VBP revealed/VBD valproate/VB encephalopathy/RB
valproate/VBP revealed/VBD valproate/VB encephalopathy/RB
valproate/VB encephalopathy/RB
valproate/JJ encephalopathy/NN
levodopa/NN exhibit/VB primed/VBN induced/VBN dyskinesias/NNS
levodopa/NN exhibit/VB primed/VBN induced/VBN evaluate/VB locomotor/NN effects/NNS dyskinetic/JJ
levodopa/NNP induced/VBN MPTP/NNP alleviating/VBG efficacious/JJ induced/VBN dyskinesias/NNS
levodopa/NN reproduce/VB likely/JJ efficacious/JJ induced/VBN dyskinesias/NNS
levodopa/NN challenge/NN 171555/CD 86929/CD efficacious/JJ induced/VBN dyskinesias/NNS
MPTP/NNP induced/VBN parkinsonism/NN
fluoxetine/JJ prenatally/NN increases/VBZ prevalence/NN syndrome/NN pulmonary/JJ
fluoxetine/JJ prenatally/NN increases/VBZ prevalence/NN syndrome/NN hypertension/NN
fluoxetine/JJ prenatally/NN increases/VBZ prevalence/NN syndrome/NN
fluoxetine/NN effect/NN pulmonary/JJ
fluoxetine/NN effect/NN hypertension/NN
fluoxetine/JJ exposure/NN induces/VBZ hypertension/NN pulmonary/JJ
fluoxetine/JJ exposure/NN induces/VBZ hypertension/NN
sulpiride/NN induced/VBN hyperprolactinemia/NN
molindone/JJ administration/NN rhabdomyolysis/NNS
molindone/JJ administration/NN failure/NN acute/JJ
molindone/JJ administration/NN failure/NN renal/JJ
molindone/JJ administration/NN failure/NN
molindone/JJ administration/NN failure/NN rhabdomyolysis/NNS
epinephrine/NN developed/VBN stunning/NNS myocardial/JJ
epinephrine/NN developed/VBN stunning/NNS
lidocaine/NN sevoflurane/NN effects/NNS convulsions/NNS
lidocaine/NN influence/NN studied/VBN convulsions/NNS
lidocaine/NN //NNS was/VBD threshold/NN convulsive/JJ
lidocaine/JJ toxicity/NN effect/NN convulsive/JJ
salbutamol/NN triggered/VBN tachyarrhythmia/NN atrial/JJ
salbutamol/NN triggered/VBN tachyarrhythmia/NN
Salbutamol/NNP presented/VBN trigger/NN SIAT/NNP
alcohol/NN impairment/NN growth/NN
alcohol/NN impairment/NN
alcohol/NN recognition/NN resulted/VBD growth/NN reduced/JJ
alcohol/NN recognition/NN resulted/VBD growth/NN cerebellar/NN
alcohol/NN recognition/NN resulted/VBD growth/NN
alcohol/NN recognition/NN resulted/VBD growth/NN cranial/NN decreased/VBN
alcohol/NN recognition/NN resulted/VBD growth/NN cranial/NN
alcohol/NN recognition/NN resulted/VBD growth/NN cranial/NN growth/NN to/TO
alcohol/NN recognition/NN resulted/VBD growth/NN cranial/NN growth/NN body/NN
alcohol/NN recognition/NN resulted/VBD growth/NN cranial/NN growth/NN
imipenem/JJ cilastatin/NN doses/NNS receiving/VBG developed/VBD seizures/NNS
//JJ cilastatin/NN doses/NNS receiving/VBG developed/VBD seizures/NNS
cilastatin/NN doses/NNS receiving/VBG developed/VBD seizures/NNS
oral/JJ contraceptives/NNS associated/VBN factors/NNS pathogenesis/NNS tumors/NNS liver/NN
oral/JJ contraceptives/NNS associated/VBN factors/NNS pathogenesis/NNS tumors/NNS
contraceptives/NNS associated/VBN factors/NNS pathogenesis/NNS tumors/NNS liver/NN
contraceptives/NNS associated/VBN factors/NNS pathogenesis/NNS tumors/NNS
oral/JJ steroids/NNS using/VBG seen/VBN tumors/NNS liver/NN
oral/JJ steroids/NNS using/VBG seen/VBN tumors/NNS
contraceptive/JJ steroids/NNS using/VBG seen/VBN tumors/NNS liver/NN
contraceptive/JJ steroids/NNS using/VBG seen/VBN tumors/NNS
Oral/NNP Contraceptives/NNP Associated/NNP Liver/NNP
Oral/NNP Contraceptives/NNP Associated/NNP Tumors/NNPS
Contraceptives/NNP Associated/NNP Liver/NNP
Contraceptives/NNP Associated/NNP Tumors/NNPS
digoxin/NN administration/NN assessment/NN dysfunction/NN sexual/JJ
digoxin/NN administration/NN assessment/NN dysfunction/NN
lithium/NN therapy/NN secondary/JJ block/VBP atrioventricular/NN
lithium/NN therapy/NN secondary/JJ block/VBP
lithium/NN effects/NNS reported/VBN dysfunction/NN Sinus/JJ
lithium/NN effects/NNS reported/VBN dysfunction/NN node/NN
lithium/NN effects/NNS reported/VBN dysfunction/NN
lithium/NN therapy/NN secondary/JJ developed/VBN attacks/NNS block/VBP atrioventricular/NN
lithium/NN therapy/NN secondary/JJ developed/VBN attacks/NNS block/VBP atrioventricular/NN AV/NNP
lithium/NN therapy/NN secondary/JJ developed/VBN attacks/NNS block/VBP
diazepam/NN greater/JJR impaired/VBN
diazepam/NN greater/JJR impaired/VBN recall/NN immediate/JJ
diazepam/NN greater/JJR impaired/VBN recall/NN free/JJ
diazepam/NN greater/JJR impaired/VBN recall/NN
propranolol/NN greater/JJR impaired/VBN
propranolol/NN greater/JJR impaired/VBN recall/NN immediate/JJ
propranolol/NN greater/JJR impaired/VBN recall/NN free/JJ
propranolol/NN greater/JJR impaired/VBN recall/NN
6/CD caused/VBN disease/NN veno/NN Hepatic/JJ
6/CD caused/VBN disease/NN veno/NN
6/CD caused/VBN disease/NN occlusive/JJ
6/CD caused/VBN disease/NN
thioguanine/VBP veno/NN Hepatic/JJ
thioguanine/VBP veno/NN
thioguanine/VBP veno/NN disease/NN occlusive/JJ
thioguanine/VBP veno/NN disease/NN
6/CD man/NN year/NN developed/VBN liver/NN disease/NN veno/NN
6/CD man/NN year/NN developed/VBN liver/NN disease/NN occlusive/JJ
6/CD man/NN year/NN developed/VBN liver/NN disease/NN
6/CD man/NN year/NN developed/VBN liver/NN of/IN
6/CD man/NN year/NN developed/VBN liver/NN the/DT
6/CD man/NN year/NN developed/VBN liver/NN
thioguanine/VBN year/NN developed/VBN liver/NN disease/NN veno/NN
thioguanine/VBN year/NN developed/VBN liver/NN disease/NN occlusive/JJ
thioguanine/VBN year/NN developed/VBN liver/NN disease/NN
thioguanine/VBN year/NN developed/VBN liver/NN of/IN
thioguanine/VBN year/NN developed/VBN liver/NN the/DT
thioguanine/VBN year/NN developed/VBN liver/NN
6/CD related/VBN occlusive/NN case/NN presented/VBD observe/VB features/NNS veno/NN hepatic/JJ
6/CD related/VBN occlusive/NN case/NN presented/VBD observe/VB features/NNS veno/NN
6/CD related/VBN occlusive/NN case/NN presented/VBD observe/VB features/NNS veno/NN disease/NN occlusive/JJ
6/CD related/VBN occlusive/NN case/NN presented/VBD observe/VB features/NNS veno/NN disease/NN
thioguanine/JJ case/NN presented/VBD observe/VB features/NNS veno/NN hepatic/JJ
thioguanine/JJ case/NN presented/VBD observe/VB features/NNS veno/NN
thioguanine/JJ case/NN presented/VBD observe/VB features/NNS veno/NN disease/NN occlusive/JJ
thioguanine/JJ case/NN presented/VBD observe/VB features/NNS veno/NN disease/NN
Heparin/NNP induced/VBN thrombocytopenia/NN
Heparin/NNP thrombocytopenia/NN
Heparin/NNP thrombocytopenia/NN HIT/NNP
heparin/NN reaction/NN Heparin/NNP thrombocytopenia/NN
heparin/NN reaction/NN Heparin/NNP thrombocytopenia/NN HIT/NNP
heparin/NN transplantation/NN HIT/NNP
heparin/NN antibody/NN antibody/NN HIT/NNP
UFH/NNP developed/VBD related/VBD HIT/NNP
alpha/NN mg/CD methyldopa/NN effect/NN hypotensive/JJ
methyldopa/NN effect/NN hypotensive/JJ
hepatitis/NN reactivation/NN hepatitis/NNP
hepatitis/NN reactivation/NN B/NNP
B/NNP antigen/NN Lamivudine/NNP prevention/NN reactivation/NN hepatitis/NNP
B/NNP antigen/NN Lamivudine/NNP prevention/NN reactivation/NN B/NNP
surface/NN antigen/NN Lamivudine/NNP prevention/NN reactivation/NN hepatitis/NNP
surface/NN antigen/NN Lamivudine/NNP prevention/NN reactivation/NN B/NNP
antigen/NN Lamivudine/NNP prevention/NN reactivation/NN hepatitis/NNP
antigen/NN Lamivudine/NNP prevention/NN reactivation/NN B/NNP
HBSAG/NNP antigen/NN Lamivudine/NNP prevention/NN reactivation/NN hepatitis/NNP
HBSAG/NNP antigen/NN Lamivudine/NNP prevention/NN reactivation/NN B/NNP
butylated/JJ hydroxyanisole/NN induced/VBN rats/NNS carcinogenesis/NNS forestomach/JJ
butylated/JJ hydroxyanisole/NN induced/VBN rats/NNS carcinogenesis/NNS
hydroxyanisole/NN induced/VBN rats/NNS carcinogenesis/NNS forestomach/JJ
hydroxyanisole/NN induced/VBN rats/NNS carcinogenesis/NNS
butylated/JJ hydroxyanisole/NN tumorigenesis/NNS forestomach/NN
butylated/JJ hydroxyanisole/NN tumorigenesis/NNS
hydroxyanisole/NN tumorigenesis/NNS forestomach/NN
hydroxyanisole/NN tumorigenesis/NNS
BHA/NNP hydroxyanisole/NN tumorigenesis/NNS forestomach/NN
BHA/NNP hydroxyanisole/NN tumorigenesis/NNS
BHA/NNP given/VBN groups/NNS increased/VBD incidence/NN tumors/NNS forestomach/JJ
BHA/NNP given/VBN groups/NNS increased/VBD incidence/NN tumors/NNS
BHA/NNP carcinogen/NN forestomach/VBP
BHA/NNP carcinogen/NN forestomach/VBP carcinogenesis/NNS
cocaine/NN marker/NN oscillation/NN pupillary/JJ
cocaine/NN marker/NN oscillation/NN
cocaine/NN marker/NN oscillation/NN measure/NN paranoia/NN
Cocaine/NNP induced/VBN remains/VBZ paranoia/NN
Cocaine/NNP induced/VBN remains/VBZ paranoia/NN CIP/NNP
Cocaine/NNP induced/VBN remains/VBZ drug/NN model/NN paranoia/NN
Propylthiouracil/NNP induced/VBN staining/VBG pericarditis/NNS
propylthiouracil/NN case/NN describe/VB induced/VBN vasculitis/NNS manifesting/VBG pericarditis/NNS
propylthiouracil/NN developed/VBD syndrome/NN pericarditis/NNS fever/NN
propylthiouracil/NN developed/VBD syndrome/NN pericarditis/NNS
propylthiouracil/NN developed/VBD syndrome/NN pericarditis/NNS glomerulonephritis/NNS
propylthio/NN associated/VBN vasculitis/NNS pANCA/NNP uracil/VBP revealed/VBD reports/NNS pericarditis/NNS
uracil/VBP revealed/VBD reports/NNS pericarditis/NNS
propylthio/NN attributable/JJ induced/VBN manifestation/NN Pericarditis/NNP
uracil/JJ therapy/NN manifestation/NN Pericarditis/NNP
Adriamycin/NNP induced/VBN plays/VBZ role/NN model/NN failure/NN heart/NN
Adriamycin/NNP induced/VBN plays/VBZ role/NN model/NN failure/NN
adriamycin/NN induced/VBN failure/NN heart/NN
adriamycin/NN induced/VBN failure/NN
adriamycin/NN induced/VBN failure/NN heart/NN
adriamycin/NN induced/VBN failure/NN
adriamycin/NN induced/VBN failure/NN progression/NN involved/VBN develop/VB failure/NN heart/NN
adriamycin/NN induced/VBN failure/NN progression/NN involved/VBN develop/VB failure/NN
adriamycin/NN induced/VBN rats/NNS model/NN heart/NN
adriamycin/NN induced/VBN rats/NNS model/NN failure/NN
adriamycin/NN induced/VBN rats/NNS plays/VBZ role/NN pathogenesis/NNS failure/NN heart/NN
adriamycin/NN induced/VBN rats/NNS plays/VBZ role/NN pathogenesis/NNS failure/NN
adriamycin/NN caused/VBN failure/NN heart/NN
adriamycin/NN caused/VBN failure/NN
ADR/NNP induced/VBN alterations/NNS cardiac/JJ
ADR/NNP induced/VBN alterations/NNS morphological/JJ
ADR/NNP induced/VBN alterations/NNS
Cocaine/JJ pain/NN chest/NN
Cocaine/JJ pain/NN
cocaine/NN produce/VB pain/NN chest/NN
cocaine/NN produce/VB pain/NN
cocaine/NN tendency/NN ought/MD mind/NN faced/VBN victim/NN pain/NN chest/NN
cocaine/NN tendency/NN ought/MD mind/NN faced/VBN victim/NN pain/NN
cocaine/NN use/NN related/VBN pain/NN chest/NN
cocaine/NN use/NN related/VBN pain/NN
aspirin/NN ingestion/NN salicylates/NNS association/NN lack/NN disappearing/VBG syndrome/NN Reye/JJ
aspirin/NN ingestion/NN salicylates/NNS association/NN lack/NN disappearing/VBG syndrome/NN
nitroglycerin/NN caused/VBN impairment/NN hypotension/NN
nitroglycerin/NN caused/VBN impairment/NN memory/NN
nitroglycerin/NN caused/VBN impairment/NN
nitroglycerin/NN onset/NN administered/VBN tested/VBD preserve/VB hypotension/NN
NTG/NNP nitroglycerin/NN onset/NN administered/VBN tested/VBD preserve/VB hypotension/NN
NTG/NNP NIMO/NNP saline/NN injected/VBN those/DT showed/VBD Mice/NNS subjected/VBN hypotensive/VB
NTG/NNP delayed/VBN injected/VBN those/DT showed/VBD Mice/NNS subjected/VBN hypotensive/VB
NTG/NNP injection/NN produced/VBD impairment/NN memory/NN mice/NNS had/VBD hypotension/NN
NTG/NNP caused/VBD improve/VB absence/NN hypotension/NN
Ammonia/NNP higher/JJR patients/NNS complained/VBD drowsiness/NNS
NH/CD 3/CD Ammonia/NNP higher/JJR patients/NNS complained/VBD drowsiness/NNS
3/CD Ammonia/NNP higher/JJR patients/NNS complained/VBD drowsiness/NNS
VPA/NNP levels/NNS similar/JJ higher/JJR patients/NNS complained/VBD drowsiness/NNS
lithium/NN therapy/NN years/NNS hypothyroidism/NN
lithium/NN therapy/NN onset/NN years/NNS hypothyroidism/NN
lithium/NN therapy/NN factor/NN hypothyroidism/NN
epinephrine/NN bolus/NNS provoked/VBD crisis/NN hypertensive/JJ
Doxorubicin/NN cardiomyopathy/NN
DOX/NNP cardiomyopathy/NN
DOX/NNP cardiomyopathy/NN development/NN elucidate/VB studied/VBD B/NNP induced/VBN cardiomyopathy/RB
DOX/NNP induction/NN investigating/VBG mice/NNS B/NNP studied/VBD elucidate/VB development/NN cardiomyopathy/NN
DOX/NNP induction/NN investigating/VBG mice/NNS B/NNP induced/VBN cardiomyopathy/RB
DOX/NNP cardiomyopathy/NN
DOX/NNP treatment/NN antagonists/NNS utilizing/VBG cardiomyopathy/RB
Diazepam/VB served/VBD amnesia/NNP
scopolamine/JJ amnesia/NNP
diazepam/NN scopolamine/NN induced/VBN amnesia/NN
scopolamine/NN induced/VBN amnesia/NN
indomethacin/NN therapy/NN pulmonale/NN patient/JJ cirrhosis/NNS ascites/NNS
indomethacin/NN therapy/NN pulmonale/NN reported/VBN hyperkalemia/NN
indomethacin/NN therapy/NN pulmonale/NN patient/JJ cirrhosis/NNS cor/NN
indomethacin/NN therapy/NN pulmonale/NN
indomethacin/NN therapy/NN pulmonale/NN patient/JJ cirrhosis/NNS
indomethacin/NN dose/NN exposure/NN caused/VBD recurrence/NN oliguria/NN
pilocarpine/NN injection/NN rats/NNS Similar/JJ causes/VBZ epilepticus/NNS status/NN
pilocarpine/NN injection/NN rats/NNS Similar/JJ causes/VBZ epilepticus/NNS
pilocarpine/NN injection/NN rats/NNS Similar/JJ causes/VBZ epilepticus/NNS SE/NNP
pilocarpine/NN injection/NN rats/NNS Similar/JJ causes/VBZ epilepticus/NNS development/NN seizures/NNS
pilocarpine/VBD treated/VBN mice/NNS experience/VB SE/NNP
levodopa/NN hypotension/NN disorders/NNS gastrointestinal/JJ
levodopa/NN hypotension/NN disorders/NNS
levodopa/NN hypotension/NN orthostatic/JJ
levodopa/NN hypotension/NN
levodopa/NN psychosis/NNS parasomnias/NNS
Pilocarpine/JJ age/NN impairment/NN
Pilocarpine/JJ age/NN impairment/NN discrimination/NN in/IN
Pilocarpine/JJ age/NN impairment/NN discrimination/NN auditory/JJ
Pilocarpine/JJ age/NN impairment/NN discrimination/NN location/NN
Pilocarpine/JJ age/NN impairment/NN discrimination/NN
Pilocarpine/NNP induced/VBN epilepticus/NNS status/NN
Pilocarpine/NNP induced/VBN epilepticus/NNS
Pilocarpine/NNP induced/VBN resulted/VBD epilepticus/NNS status/NN
Pilocarpine/NNP induced/VBN resulted/VBD epilepticus/NNS
muscimol/NN drugs/NNS jerks/NNS myoclonic/JJ
muscimol/NN drugs/NNS jerks/NNS
muscimol/NN produced/VBD jerks/NNS myoclonic/JJ
muscimol/NN produced/VBD jerks/NNS
muscimol/NN myoclonus/NNS
muscimol/NN myoclonus/NNS management/NN beneficial/JJ found/VBN seems/VBZ myoclonus/NNS
nitroglycerin/NN Provocation/NNP hypotension/NN
phenytoin/NN administration/NN developed/VBD bradycardia/NN
haloperidol/NN potentiation/NN induced/VBN catalepsy/NN
apomorphine/NN prevention/NN catalepsy/NN induced/VBN potentiation/NN induced/VBN hyperactivity/RB
pilocarpine/JJ acid/NN seizures/NNS
kainic/JJ pilocarpine/JJ acid/NN seizures/NNS
acid/NN seizures/NNS
pilocarpine/JJ acid/NN seizures/NNS epilepticus/NNS status/NN
pilocarpine/JJ acid/NN seizures/NNS epilepticus/NNS
kainic/JJ pilocarpine/JJ acid/NN seizures/NNS epilepticus/NNS status/NN
kainic/JJ pilocarpine/JJ acid/NN seizures/NNS epilepticus/NNS
acid/NN seizures/NNS epilepticus/NNS status/NN
acid/NN seizures/NNS epilepticus/NNS
pilocarpine/NN activity/NN evaluated/VBN beta/NN metabolites/NNS seizures/NNS
kainic/JJ acid/NN beta/NN metabolites/NNS seizures/NNS
acid/NN beta/NN metabolites/NNS seizures/NNS
pilocarpine/NN protecting/VBG effective/JJ Steroids/NNS induced/VBZ seizures/NNS
pilocarpine/NN protecting/VBG effective/JJ Steroids/NNS induced/VBZ seizures/NNS epilepticus/NNS status/NN
pilocarpine/NN protecting/VBG effective/JJ Steroids/NNS induced/VBZ seizures/NNS epilepticus/NNS
pilocarpine/JJ seizures/NNS
pilocarpine/JJ seizures/NNS protecting/VBG potent/JJ had/VBD values/NNS TD/NNP divided/VBN protection/NN seizure/NN
kainic/JJ acid/NN induced/VBN seizures/NNS
acid/NN induced/VBN seizures/NNS
kainic/JJ acid/NN induced/VBN seizures/NNS onset/NN produced/VBD protect/VB seizures/NNS
acid/NN induced/VBN seizures/NNS onset/NN produced/VBD protect/VB seizures/NNS
kainic/JJ acid/NN administered/VBN However/RB obtained/VBN seizures/NNS
acid/NN administered/VBN However/RB obtained/VBN seizures/NNS
kainic/JJ acid/NN administered/VBN However/RB obtained/VBN seizures/NNS epilepticus/NNS status/NN
kainic/JJ acid/NN administered/VBN However/RB obtained/VBN seizures/NNS epilepticus/NNS
acid/NN administered/VBN However/RB obtained/VBN seizures/NNS epilepticus/NNS status/NN
acid/NN administered/VBN However/RB obtained/VBN seizures/NNS epilepticus/NNS
pilocarpine/JJ acid/NN seizures/NNS
kainic/JJ pilocarpine/JJ acid/NN seizures/NNS
acid/NN seizures/NNS
pilocarpine/JJ acid/NN seizures/NNS epilepticus/NNS status/NN
pilocarpine/JJ acid/NN seizures/NNS epilepticus/NNS
pilocarpine/JJ acid/NN protecting/VBG effective/JJ utility/NN treatment/NN forms/NNS epilepticus/NNS status/NN
pilocarpine/JJ acid/NN protecting/VBG effective/JJ utility/NN treatment/NN forms/NNS epilepticus/NNS
kainic/JJ pilocarpine/JJ acid/NN seizures/NNS epilepticus/NNS status/NN
kainic/JJ pilocarpine/JJ acid/NN seizures/NNS epilepticus/NNS
acid/NN seizures/NNS epilepticus/NNS status/NN
acid/NN seizures/NNS epilepticus/NNS
kainic/JJ pilocarpine/JJ acid/NN protecting/VBG effective/JJ utility/NN treatment/NN forms/NNS epilepticus/NNS status/NN
kainic/JJ pilocarpine/JJ acid/NN protecting/VBG effective/JJ utility/NN treatment/NN forms/NNS epilepticus/NNS
acid/NN protecting/VBG effective/JJ utility/NN treatment/NN forms/NNS epilepticus/NNS status/NN
acid/NN protecting/VBG effective/JJ utility/NN treatment/NN forms/NNS epilepticus/NNS
morphine/VB analgesia/NN hypothermia/NN
morphine/VB analgesia/NN catalepsy/NN
morphine/JJ bradycardia/NN
morphine/JJ induced/VBN bradycardia/NN
morphine/JJ bradycardia/NN induced/VBN hypotension/NN
morphine/JJ induced/VBN hypotension/NN
methylprednisolone/NN Hypotension/NN
methylprednisolone/NN Hypotension/NN bradycardia/NN
methylprednisolone/NN Hypotension/NN asystole/NN
methylprednisolone/NN year/NN administration/NN hypotension/NN
methylprednisolone/NN year/NN administration/NN hypotension/NN bradycardia/NN
methylprednisolone/NN year/NN administration/NN hypotension/NN asystole/NN
Mipafox/NNP dosages/NNS produced/VBD degree/NN damage/NN cord/NN
Mipafox/NNP dosages/NNS produced/VBD degree/NN damage/NN
amiodarone/NN Hepatotoxicity/NNP
amiodarone/JJ treatment/NN due/JJ hepatitis/NN presented/VBN given/VBN review/NN hepatotoxicity/NN
amiodarone/NN hepatotoxicity/NN
amiodarone/JJ treatment/NN due/JJ injury/NN exists/VBZ concluded/VBN alterations/VBZ hepatitis/NN hepatitis/NN cirrhosis/NNS
amiodarone/JJ treatment/NN due/JJ injury/NN exists/VBZ concluded/VBN alterations/VBZ hepatitis/NN hepatitis/NN liver/NN of/IN
amiodarone/JJ treatment/NN due/JJ injury/NN exists/VBZ concluded/VBN alterations/VBZ hepatitis/NN hepatitis/NN liver/NN the/DT
amiodarone/JJ treatment/NN due/JJ injury/NN exists/VBZ concluded/VBN alterations/VBZ hepatitis/NN hepatitis/NN liver/NN
amiodarone/JJ treatment/NN due/JJ injury/NN steatosis/NNS
amiodarone/JJ treatment/NN due/JJ injury/NN hepatic/JJ
amiodarone/JJ treatment/NN due/JJ injury/NN
isoflurane/NN metabolism/NNS flow/NN induced/VBN hypotension/NN
isoflurane/NN hypotension/NN
isoflurane/NN dose/NN increasing/VBG induced/VBN MAP/NN hypotension/NN
Spironolactone/NNP induced/VBN insufficiency/NN renal/JJ
Spironolactone/NNP induced/VBN insufficiency/NN
Spironolactone/NNP induced/VBN insufficiency/NN hyperkalemia/NN
spironolactone/NN use/NN evaluating/VBG patients/NNS reported/VBN risk/NN hyperkalemia/NN insufficiency/NN renal/JJ
spironolactone/NN use/NN evaluating/VBG patients/NNS reported/VBN risk/NN hyperkalemia/NN insufficiency/NN
spironolactone/NN use/NN evaluating/VBG patients/NNS reported/VBN risk/NN hyperkalemia/NN
spironolactone/NN treated/VBN patients/NNS determine/VB prevalence/NN associations/NNS insufficiency/NN hyperkalemia/NN renal/JJ
spironolactone/NN treated/VBN patients/NNS determine/VB prevalence/NN associations/NNS insufficiency/NN
spironolactone/NN treated/VBN patients/NNS determine/VB prevalence/NN associations/NNS insufficiency/NN hyperkalemia/NN
spironolactone/NN failure/NN renal/JJ
spironolactone/NN failure/NN
spironolactone/NN hyperkalemia/NN
Spironolactone/NNP CONCLUSIONS/NNS common/JJ hyperkalemia/NN insufficiency/NN renal/JJ
Spironolactone/NNP CONCLUSIONS/NNS common/JJ hyperkalemia/NN insufficiency/NN
Spironolactone/NNP CONCLUSIONS/NNS common/JJ hyperkalemia/NN
MDMA/NNP users/NNS show/VBP process/NN impairments/NNS coupled/VBN processes/NNS social/JJ impaired/JJ
MDMA/NNP users/NNS show/VBP process/NN impairments/NNS coupled/VBN processes/NNS social/JJ
MDMA/NNP users/NNS show/VBP process/NN impairments/NNS coupled/VBN processes/NNS social/JJ and/CC
MDMA/NNP users/NNS show/VBP process/NN impairments/NNS coupled/VBN processes/NNS social/JJ emotional/JJ
MDMA/NNP users/NNS show/VBP process/NN impairments/NNS coupled/VBN processes/NNS judgement/NN
MDMA/NNP users/NNS show/VBP process/NN impairments/NNS coupled/VBN processes/NNS
melatonin/NN effects/NNS narcosis/NNS
Melatonin/NNP affects/VBZ clear/JJ influence/VB drug/NN narcosis/NNS
Melatonin/NNP pre/NNP affected/VBD narcosis/NNS
melatonin/NN dose/NN caused/VBD produced/VBD reduction/NN duration/NN narcosis/NNS
ketamine/JJ narcosis/NNS
diazepam/JJ ketamine/JJ narcosis/NNS
Melatonin/RB 0/CD 5/CD kg/NN influenced/VBN duration/NN latency/NN narcosis/NNS
melatonin/NN narcosis/NNS
diclofenac/NN induced/NNS recorded/VBN abnormalities/NNS
diclofenac/NN induced/NNS recorded/VBN abnormalities/NNS function/NN of/IN
diclofenac/NN induced/NNS recorded/VBN abnormalities/NNS function/NN liver/NN
diclofenac/NN induced/NNS recorded/VBN abnormalities/NNS function/NN
diclofenac/NN induced/NNS hepatitis/NN
MDMA/NNP users/NNS observed/VBN evidence/NN impairment/NN memory/NN
MDMA/NNP users/NNS observed/VBN evidence/NN impairment/NN
MDMA/NNP use/NN associated/VBN functioning/NN impaired/VBN
MDMA/NNP use/NN associated/VBN functioning/NN memory/NN
MDMA/NNP use/NN associated/VBN functioning/NN
MDMA/NNP use/NN associated/VBN lead/VB impairments/NNS memory/NN
MDMA/NNP use/NN associated/VBN lead/VB impairments/NNS
MDMA/NNP use/NN use/NN lead/VB associated/VBN functioning/NN impaired/VBN
MDMA/NNP use/NN use/NN lead/VB associated/VBN functioning/NN memory/NN
MDMA/NNP use/NN use/NN lead/VB associated/VBN functioning/NN
MDMA/NNP use/NN use/NN lead/VB impairments/NNS memory/NN
MDMA/NNP use/NN use/NN lead/VB impairments/NNS
haloperidol/NN Effects/NNPS catalepsy/NN parkinsonian/NN
haloperidol/NN Effects/NNPS catalepsy/NN
haloperidol/JJ pallidus/NNS infusions/NNS RESULTS/NNS catalepsy/NN parkinsonian/NN
haloperidol/JJ pallidus/NNS infusions/NNS RESULTS/NNS catalepsy/NN
testosterone/NN implanted/VBN rats/NNS developed/VBD incidence/NN cancer/NN prostate/NN
testosterone/NN implanted/VBN rats/NNS developed/VBD incidence/NN cancer/NN
testosterone/NN developed/VBD cancer/NN prostate/NN
testosterone/NN developed/VBD cancer/NN
testosterone/JJ prostatitis/NNS
citalopram/NN adolescent/NN twitching/VBG Palpebral/NNP
citalopram/NN adolescent/NN twitching/VBG
citalopram/NNP boy/NN treatment/NN report/VBP depression/NN exhibited/VBD twitching/NN palpebral/JJ
citalopram/NNP boy/NN treatment/NN report/VBP depression/NN exhibited/VBD twitching/NN
Quinidine/NNP hepatitis/NNP
quinidine/NN had/VBD hepatotoxicity/RB
scopolamine/NN produced/VBN Amnesia/NNP
cycloheximide/NN scopolamine/NN produced/VBN Amnesia/NNP
scopolamine/NN reversed/VBN cycloheximide/NN induced/VBN amnesia/NN
scopolamine/NN pre/NN failed/VBD reverse/VB amnesia/NN
scopolamine/JJ cycloheximide/NN induced/VBN amnesia/NN
scopolamine/JJ cycloheximide/NN reversed/VBN scopolamine/NN pre/NN failed/VBD reverse/VB amnesia/NN
cycloheximide/NN induced/VBN amnesia/NN
cycloheximide/NN reversed/VBN scopolamine/NN pre/NN failed/VBD reverse/VB amnesia/NN
cycloheximide/NN amnesia/NN reverse/VB failed/VBD pre/NN scopolamine/NN reversed/VBN cycloheximide/NN induced/VBN amnesia/NN
cycloheximide/NN amnesia/NN
penicillamine/JJ therapy/NN complications/NNS recorded/VBN rashes/NNS polymyositis/NNS
penicillamine/JJ therapy/NN complications/NNS recorded/VBN rashes/NNS erythematosus/NNS systemic/JJ
penicillamine/JJ therapy/NN complications/NNS recorded/VBN rashes/NNS erythematosus/NNS lupus/NNS
penicillamine/JJ therapy/NN complications/NNS recorded/VBN rashes/NNS erythematosus/NNS
penicillamine/JJ therapy/NN complications/NNS recorded/VBN rashes/NNS Skin/NN
penicillamine/JJ therapy/NN complications/NNS recorded/VBN rashes/NNS
penicillamine/JJ therapy/NN complications/NNS recorded/VBN rashes/NNS proteinuria/NN
penicillamine/JJ therapy/NN complications/NNS recorded/VBN rashes/NNS gravis/NNS myasthenia/NN
penicillamine/JJ therapy/NN complications/NNS recorded/VBN rashes/NNS gravis/NNS
morphine/JJ group/NN incidence/NN tachyarrhythmias/NNS beats/NNS ventricular/JJ
morphine/JJ group/NN incidence/NN tachyarrhythmias/NNS beats/NNS ectopic/JJ
morphine/JJ group/NN incidence/NN tachyarrhythmias/NNS beats/NNS
choline/NN diet/NN fed/VBN rats/NNS developed/VBD nodules/NNS carcinomas/NNS hepatocellular/NN
choline/NN diet/NN fed/VBN rats/NNS developed/VBD nodules/NNS carcinomas/NNS
choline/NN diet/NN fed/VBN developed/VBD nodule/NN carcinoma/NN hepatocellular/NN
choline/NN diet/NN fed/VBN developed/VBD nodule/NN carcinoma/NN
choline/NN fed/VBN rats/NNS %/NN carcinomas/NNS incidence/NN hepatocellular/NN
choline/NN fed/VBN rats/NNS %/NN carcinomas/NNS
choline/NN containing/VBG diet/NN fed/VBN rats/NNS fed/VBN rats/NNS %/NN carcinomas/NNS incidence/NN hepatocellular/NN
choline/NN containing/VBG diet/NN fed/VBN rats/NNS fed/VBN rats/NNS %/NN carcinomas/NNS
ketamine/JJ catatonia/NN
ketamine/NN idolamines/NNS catatonia/NN
ketamine/NN increased/VBD duration/NN catatonia/NN
dopamine/NN pretreatment/NN increased/VBD duration/NN catatonia/NN
ketamine/JJ catatonia/NN
dopamine/NN appeared/VBD act/VB induction/NN catatonia/NN
vigabatrin/NN carbamazepine/NN administration/NN epilepsy/NN absence/NN
vigabatrin/NN carbamazepine/NN administration/NN epilepsy/NN
carbamazepine/NN administration/NN epilepsy/NN absence/NN
carbamazepine/NN administration/NN epilepsy/NN
sodium/NN nitroprusside/NN anesthesia/NN pressure/NN maintenance/NN system/NN hypotension/NN
nitroprusside/NN anesthesia/NN pressure/NN maintenance/NN system/NN hypotension/NN
SNP/NNP anesthesia/NN pressure/NN maintenance/NN system/NN hypotension/NN
halothane/JJ anesthesia/NN pressure/NN maintenance/NN system/NN hypotension/NN
SNP/NNP halothane/NNP effects/NNS hypotensive/JJ
halothane/NNP effects/NNS hypotensive/JJ
Amphetamine/NNP similar/JJ locomotor/NN
Amphetamine/NNP similar/JJ hyperactivity/RB
heparin/NN injection/NN duration/NN effect/NN study/NN bruising/NN pain/NN
heparin/NN injection/NN duration/NN effect/NN study/NN bruising/NN
heparin/NN injection/NN administration/NN bruising/NN pain/NN
heparin/NN injection/NN administration/NN bruising/NN
heparin/NN injection/NN pain/NN
heparin/NN injection/NN pain/NN bruising/VBG prevent/VB methods/NNS studied/VBN documented/VBN effect/NN duration/NN occurrence/NN bruising/NN pain/NN
heparin/NN injection/NN pain/NN bruising/VBG
heparin/NN injection/NN pain/NN bruising/VBG prevent/VB methods/NNS studied/VBN documented/VBN effect/NN duration/NN occurrence/NN bruising/NN
heparin/NN bruising/JJ
heparin/NN administration/NN had/VBD effect/NN bruising/NN pain/NN
heparin/NN administration/NN had/VBD effect/NN bruising/NN
iopamidol/JJ patients/NNS administration/NN different/JJ nephropathy/NN
iodixanol/JJ high/JJ iopamidol/JJ patients/NNS administration/NN different/JJ nephropathy/NN
Cyclophosphamide/JJ cancer/NN bladder/NN
Cyclophosphamide/JJ cancer/NN
cyclophosphamide/NN associated/VBN cancer/NN bladder/NN
cyclophosphamide/NN associated/VBN cancer/NN
Cyclophosphamide/NNP associated/VBN disease/NN tumor/NN bladder/NN
Cyclophosphamide/NNP associated/VBN disease/NN tumor/NN
Amisulpride/VB tic/NN
Amisulpride/VB symptoms/NNS like/IN
Amisulpride/VB symptoms/NNS
amisulpride/NN dose/NN reduced/VBD resolved/VBN symptoms/NNS tic/NN
amisulpride/NN dose/NN reduced/VBD resolved/VBN symptoms/NNS like/JJ
amisulpride/NN dose/NN reduced/VBD resolved/VBN symptoms/NNS
amisulpride/JJ quetiapine/JJ occur/VB suggests/VBZ tic/NN
amisulpride/JJ quetiapine/JJ occur/VB symptoms/NNS like/JJ
amisulpride/JJ quetiapine/JJ occur/VB symptoms/NNS
5/CD infusion/NN occurred/VBN reaction/NN consisting/VBG edema/NN angioneurotic/JJ
5/CD infusion/NN occurred/VBN reaction/NN consisting/VBG edema/NN
fluorouracil/RB occurred/VBN reaction/NN consisting/VBG edema/NN angioneurotic/JJ
fluorouracil/RB occurred/VBN reaction/NN consisting/VBG edema/NN
ouabain/NN rat/NN induced/VBN designed/VBN models/NNS arrhythmia/NN
aconitine/NN using/VBG designed/VBN models/NNS arrhythmia/NN
ouabain/NN aconitine/NN induced/VBN rat/NN arrhythmic/JJ
aconitine/NN induced/VBN rat/NN arrhythmic/JJ
Prazosin/NNP induced/VBN incontinence/NN stress/NN
Prazosin/NNP induced/VBN incontinence/NN
prazosin/NN due/JJ incontinence/NN stress/NN
prazosin/NN due/JJ incontinence/NN
prazosin/NN taking/VBG change/VB incontinence/VBP Patients/NNS present/VBP stress/NN
prazosin/NN taking/VBG change/VB incontinence/VBP
warfarin/NN model/NN hemorrhage/VB associated/JJ hemorrhage/NN intracerebral/JJ
warfarin/NN model/NN hemorrhage/VB associated/JJ hemorrhage/NN
Warfarin/NNP associated/VBN type/NN hemorrhage/NN intracerebral/JJ
Warfarin/NNP associated/VBN type/NN hemorrhage/NN
Warfarin/NNP associated/VBN type/NN hemorrhage/NN W/NNP ICH/NNP
Desipramine/NNP induced/VBN delirium/NN
Desipramine/NN treated/VBN patient/NN developed/VBD delirium/NN
Rizatriptan/NNP superior/JJ ergotamine/VB proportions/NNS patients/NNS nausea/NN
rizatriptan/NN caffeine/NN events/NNS dizziness/NN 6/CD nausea/NN
rizatriptan/NN caffeine/NN events/NNS dizziness/NN
rifampin/NN therapy/NN associated/VBN glomerulonephritis/NNS
rifampin/NN treated/VBN patient/NN glomerulonephritis/NNS
rifampin/NN regimen/NN 10/CD underwent/VBD discovered/VBN developed/VBN signs/NNS failure/NN renal/JJ
rifampin/NN regimen/NN 10/CD underwent/VBD discovered/VBN developed/VBN signs/NNS failure/NN
rifampin/NN treated/VBN patient/NN documents/VBZ occurrence/NN glomerulonephritis/NNS
rifampin/NN treated/VBN patient/NN documents/VBZ occurrence/NN glomerulonephritis/NNS crescents/NNS glomerulonephritis/NNS
haloperidol/NN induced/VBN catalepsy/RB
haloperidol/NN duration/NN induced/VBN catalepsy/RB
phenylephrine/NN indicate/VBP instituted/VBD hypertension/NN
suxamethonium/NN dose/NN spasm/NN masseter/NN
suxamethonium/NN dose/NN spasm/NN
piroxicam/NN dose/NN treated/VBN rats/NNS found/VBN toxicity/NNP retardation/NN intrauterine/JJ
piroxicam/NN dose/NN treated/VBN rats/NNS found/VBN toxicity/NNP retardation/NN growth/NN
piroxicam/NN dose/NN treated/VBN rats/NNS found/VBN toxicity/NNP retardation/NN
piroxicam/NN dose/NN treated/VBN rats/NNS found/VBN toxicity/NNP increase/NN
piroxicam/NN dose/NN treated/VBN rats/NNS found/VBN toxicity/NNP increase/NN variations/NNS of/IN
piroxicam/NN dose/NN treated/VBN rats/NNS found/VBN toxicity/NNP increase/NN variations/NNS external/JJ
piroxicam/NN dose/NN treated/VBN rats/NNS found/VBN toxicity/NNP increase/NN variations/NNS external/JJ and/CC
piroxicam/NN dose/NN treated/VBN rats/NNS found/VBN toxicity/NNP increase/NN variations/NNS external/JJ skeletal/JJ
piroxicam/NN dose/NN treated/VBN rats/NNS found/VBN toxicity/NNP increase/NN variations/NNS
gentamicin/NN therapy/NN sodium/NN combination/NN receiving/VBG necrosis/NNS acute/JJ
gentamicin/NN therapy/NN sodium/NN combination/NN receiving/VBG necrosis/NNS tubular/JJ
gentamicin/NN therapy/NN sodium/NN combination/NN receiving/VBG necrosis/NNS
sulfate/NN therapy/NN sodium/NN combination/NN receiving/VBG necrosis/NNS acute/JJ
sulfate/NN therapy/NN sodium/NN combination/NN receiving/VBG necrosis/NNS tubular/JJ
sulfate/NN therapy/NN sodium/NN combination/NN receiving/VBG necrosis/NNS
cephalothin/JJ sodium/NN combination/NN receiving/VBG necrosis/NNS acute/JJ
cephalothin/JJ sodium/NN combination/NN receiving/VBG necrosis/NNS tubular/JJ
cephalothin/JJ sodium/NN combination/NN receiving/VBG necrosis/NNS
sodium/NN combination/NN receiving/VBG necrosis/NNS acute/JJ
sodium/NN combination/NN receiving/VBG necrosis/NNS tubular/JJ
sodium/NN combination/NN receiving/VBG necrosis/NNS
morphine/NN cord/NN changes/NNS 801/CD MK/NNP induced/VBN paraparesis/NNS spastic/JJ
morphine/NN cord/NN changes/NNS 801/CD MK/NNP induced/VBN paraparesis/NNS
morphine/NN reduced/VBD paraparesis/NNS spastic/JJ
morphine/NN reduced/VBD paraparesis/NNS
morphine/RB induces/VBZ paraparesis/NNS spastic/JJ
morphine/RB induces/VBZ paraparesis/NNS
propofol/JJ pain/NN
propofol/JJ pain/NN
propofol/JJ pain/NN
amantadine/NN Readministration/NNP increased/VBD occurred/VBD suppression/NN
amantadine/NN Readministration/NNP increased/VBD occurred/VBD suppression/NN motility/NN of/IN
amantadine/NN Readministration/NNP increased/VBD occurred/VBD suppression/NN motility/NN
amantadine/JJ mice/NNS caused/VBN depression/NN behavioral/JJ
amantadine/JJ mice/NNS caused/VBN depression/NN
epinephrine/NN overflow/NN stimulus/NN induced/VBN mediated/VBN rats/NNS hypertensive/JJ
morphine/NN produced/VBN rigidity/NN muscular/JJ
morphine/NN produced/VBN rigidity/NN
morphine/NN produced/VBN rigidity/NN muscular/JJ
morphine/NN produced/VBN rigidity/NN
morphine/NN dose/NN given/VBN controls/NNS Saline/NNP showed/VBD rigidity/NN
morphine/NN days/NNS treated/VBN showed/VBD differences/NNS half/PDT animals/NNS showed/VBD rigidity/NN
morphine/NN dose/NN showed/VBD rigidity/NN
morphine/NN days/NNS treated/VBN showed/VBD differences/NNS half/PDT animals/NNS showed/VBD akinetic/JJ
morphine/NN dose/NN showed/VBD akinetic/JJ
haloperidol/JJ mg/NN used/VBN block/VB estimate/VB rigidity/NN
Haloperidol/NNP enhanced/VBD rigidity/NN
morphine/NN action/NN due/JJ assumed/VBN rigidity/NN
Amphotericin/NNP B/NNP induced/VBN seizures/NNS
B/NNP induced/VBN seizures/NNS
amphotericin/JJ infusion/NN patent/NN report/VB case/NN episodes/NNS activity/NN seizure/NN
B/NN infusion/NN patent/NN report/VB case/NN episodes/NNS activity/NN seizure/NN
amphotericin/NNP B/NNP infusion/NN experienced/VBD stopped/VBN seizures/NNS
B/NNP infusion/NN experienced/VBD stopped/VBN seizures/NNS
amphotercin/JJ administration/NN occurred/VBD persisted/VBD seizures/NNS
B/NN administration/NN occurred/VBD persisted/VBD seizures/NNS
amphotericin/NNP B/NNP cause/NN seizures/NNS
B/NNP cause/NN seizures/NNS
Amphotericin/NNP B/NNP seems/VBZ cause/NN seizures/NNS
B/NNP seems/VBZ cause/NN seizures/NNS
amphotericin/NNP B/NNP associated/VBN seizures/NNS
B/NNP associated/VBN seizures/NNS
scopolamine/NN amnesia/NN
scopolamine/NN ritanserin/NN effect/NN amnesia/NN
scopolamine/NN amnesia/NN
scopolamine/NN induced/VBN impairment/NN memory/NN
scopolamine/NN induced/VBN impairment/NN
scopolamine/NN induced/VBN attention/NN impairment/NN
scopolamine/NN induced/VBN attention/NN of/IN
scopolamine/NN induced/VBN attention/NN
scopolamine/NN induced/VBN attention/NN and/CC
scopolamine/NN induced/VBN attention/NN memory/NN
amoxicillin/NNP allergic/VBD
amoxicillin/NNP allergic/VBD reactions/NNS
amoxicillin/NNP responses/NNS had/VBD allergic/VBP
amoxicillin/NNP responses/NNS allergic/JJ
AX/NNP amoxicillin/NNP responses/NNS had/VBD allergic/VBP
AX/NNP amoxicillin/NNP responses/NNS allergic/JJ
AX/NNP allergy/NN
AX/NNP tests/NNS performed/VBN establish/VB diagnosis/NN reaction/NN allergic/JJ
AX/NNP tests/NNS performed/VBN establish/VB diagnosis/NN reaction/NN
AX/NNP establish/VB diagnosis/NN reaction/NN allergic/JJ
AX/NNP establish/VB diagnosis/NN reaction/NN
AX/NNP test/NN negative/JJ performed/VBN establish/VB diagnosis/NN reaction/NN allergic/JJ
AX/NNP test/NN negative/JJ performed/VBN establish/VB diagnosis/NN reaction/NN
AX/NNP group/NN patients/NNS allergic/JJ
alkylating/VBG agents/NNS treated/VBN Patients/NNS have/VBP risk/NN development/NN leukemia/NN acute/JJ
alkylating/VBG agents/NNS treated/VBN Patients/NNS have/VBP risk/NN development/NN leukemia/NN nonlymphocytic/JJ
alkylating/VBG agents/NNS treated/VBN Patients/NNS have/VBP risk/NN development/NN leukemia/NN
agents/NNS treated/VBN Patients/NNS have/VBP risk/NN development/NN leukemia/NN acute/JJ
agents/NNS treated/VBN Patients/NNS have/VBP risk/NN development/NN leukemia/NN nonlymphocytic/JJ
agents/NNS treated/VBN Patients/NNS have/VBP risk/NN development/NN leukemia/NN
alkylating/JJ agents/NNS associated/VBN have/VBP risk/NN development/NN leukemia/NN acute/JJ
alkylating/JJ agents/NNS associated/VBN have/VBP risk/NN development/NN leukemia/NN nonlymphocytic/JJ
alkylating/JJ agents/NNS associated/VBN have/VBP risk/NN development/NN leukemia/NN
agents/NNS associated/VBN have/VBP risk/NN development/NN leukemia/NN acute/JJ
agents/NNS associated/VBN have/VBP risk/NN development/NN leukemia/NN nonlymphocytic/JJ
agents/NNS associated/VBN have/VBP risk/NN development/NN leukemia/NN
alkylating/VBG agents/NNS treated/VBN Patients/NNS have/VBP associated/VBN development/NN non/NN
alkylating/VBG agents/NNS treated/VBN Patients/NNS have/VBP lymphoma/JJ Hodgkin/NNP
alkylating/VBG agents/NNS treated/VBN Patients/NNS have/VBP lymphoma/JJ Hodgkin/NNP '/POS
alkylating/VBG agents/NNS treated/VBN Patients/NNS have/VBP lymphoma/JJ s/VBZ
alkylating/VBG agents/NNS treated/VBN Patients/NNS have/VBP lymphoma/JJ
agents/NNS treated/VBN Patients/NNS have/VBP associated/VBN development/NN non/NN
agents/NNS treated/VBN Patients/NNS have/VBP lymphoma/JJ Hodgkin/NNP
agents/NNS treated/VBN Patients/NNS have/VBP lymphoma/JJ Hodgkin/NNP '/POS
agents/NNS treated/VBN Patients/NNS have/VBP lymphoma/JJ s/VBZ
agents/NNS treated/VBN Patients/NNS have/VBP lymphoma/JJ
alkylating/JJ agents/NNS associated/VBN development/NN non/NN
alkylating/JJ agents/NNS associated/VBN have/VBP lymphoma/JJ Hodgkin/NNP
alkylating/JJ agents/NNS associated/VBN have/VBP lymphoma/JJ Hodgkin/NNP '/POS
alkylating/JJ agents/NNS associated/VBN have/VBP lymphoma/JJ s/VBZ
alkylating/JJ agents/NNS associated/VBN have/VBP lymphoma/JJ
agents/NNS associated/VBN development/NN non/NN
agents/NNS associated/VBN have/VBP lymphoma/JJ Hodgkin/NNP
agents/NNS associated/VBN have/VBP lymphoma/JJ Hodgkin/NNP '/POS
agents/NNS associated/VBN have/VBP lymphoma/JJ s/VBZ
agents/NNS associated/VBN have/VBP lymphoma/JJ
azathioprine/NN agents/NNS associated/VBN development/NN non/NN
azathioprine/NN agents/NNS associated/VBN have/VBP lymphoma/JJ Hodgkin/NNP
azathioprine/NN agents/NNS associated/VBN have/VBP lymphoma/JJ Hodgkin/NNP '/POS
azathioprine/NN agents/NNS associated/VBN have/VBP lymphoma/JJ s/VBZ
azathioprine/NN agents/NNS associated/VBN have/VBP lymphoma/JJ
Ethambutol/NNP associated/VBN neuropathy/NN optic/JJ
Ethambutol/NNP associated/VBN neuropathy/NN
Ethambutol/NNP used/VBN treatment/NN prevalent/JJ associated/VBN loss/NN visual/JJ
Ethambutol/NNP used/VBN treatment/NN prevalent/JJ associated/VBN loss/NN
ethambutol/NN patients/NNS PICTURE/NNP associated/VBN neuropathy/NN optic/JJ
ethambutol/NN patients/NNS PICTURE/NNP associated/VBN neuropathy/NN
Ethambutol/NNP usage/NN associated/VBN loss/NN visual/JJ
Ethambutol/NNP usage/NN associated/VBN loss/NN
Ifosfamide/JJ encephalopathy/NN
ifosfamide/NN infusion/NN developed/VBD myoclonus/NNS
ifosfamide/JJ findings/NNS infusion/NN asterixis/NNS presence/NN suggest/VBP associated/VBN myoclonus/NNS
IFX/NNP use/NN associated/VBN myoclonus/NNS
MPTP/NNP mediator/NN receptor/NN Cardona/NNP neurodegeneration/NN
MPTP/NNP METH/NNP caused/VBN damage/NN CNS/NNP
MPTP/NNP METH/NNP caused/VBN damage/NN
METH/NNP caused/VBN damage/NN CNS/NNP
METH/NNP caused/VBN damage/NN
METH/NNP role/NN plays/VBZ hypothesized/VBZ selective/JJ damage/NN CNS/NNP
METH/NNP role/NN plays/VBZ hypothesized/VBZ selective/JJ damage/NN
lidocaine/NN incidence/NN symptoms/NNS Transient/JJ
lidocaine/NN incidence/NN symptoms/NNS neurologic/JJ
lidocaine/NN incidence/NN symptoms/NNS
prilocaine/NN incidence/NN symptoms/NNS Transient/JJ
prilocaine/NN incidence/NN symptoms/NNS neurologic/JJ
prilocaine/NN incidence/NN symptoms/NNS
lidocaine/JJ anesthesia/NN follow/VBP symptoms/NNS transient/JJ
lidocaine/JJ anesthesia/NN follow/VBP symptoms/NNS neurologic/JJ
lidocaine/JJ anesthesia/NN follow/VBP symptoms/NNS
lidocaine/JJ anesthesia/NN follow/VBP symptoms/NNS TNSs/NNP
lidocaine/NN prilocaine/JJ compares/VBZ duration/NN risk/NN TNSs/NNP
prilocaine/JJ compares/VBZ duration/NN risk/NN TNSs/NNP
lidocaine/JJ TNSs/NNS
lidocaine/JJ TNSs/NNS receiving/VBG patients/NNS Nine/CD RESULTS/NNS had/VBD TNSs/NNS
prilocaine/NN had/VBD receiving/VBG patients/NNS 1/CD Nine/CD patients/NNS receiving/VBG TNSs/NNS
prilocaine/NN had/VBD receiving/VBG patients/NNS 1/CD Nine/CD RESULTS/NNS had/VBD TNSs/NNS
lidocaine/VB preferable/JJ has/VBZ duration/NN incidence/NN TNSs/NNP
Prilocaine/NNP preferable/JJ has/VBZ duration/NN incidence/NN TNSs/NNP
propofol/NN Assessment/NNP onset/NN amnesia/NN
amphetamine/NN reflects/VBZ rotation/NN contralateral/JJ
amphetamine/NN reflects/VBZ rotation/NN
amphetamine/NN examined/VBD clarify/VB nature/NN rotation/NN contralateral/JJ
amphetamine/NN examined/VBD clarify/VB nature/NN rotation/NN
amphetamine/NN induced/VBN behavior/NN rotational/JJ
amphetamine/NN induced/VBN behavior/NN
amphetamine/NN administered/VBN days/NNS lesioning/VBG involvement/NN cells/NNS rotation/NN contralateral/JJ
amphetamine/NN administered/VBN days/NNS lesioning/VBG involvement/NN cells/NNS rotation/NN
amphetamine/JJ dose/NN volume/NN recovery/NN duration/NN regardless/RB tended/VBD rotation/NN
amphetamine/RB duration/NN regardless/RB tended/VBD rotation/NN
amphetamine/NN injections/NNS circled/VBD tended/VBD rotation/NN
amphetamine/NN has/VBZ suggest/VBP pool/VBP contributing/VBG rotation/NN contralateral/JJ
amphetamine/NN has/VBZ suggest/VBP pool/VBP contributing/VBG rotation/NN
Clarithromycin/NNP induced/VBN tachycardia/NN ventricular/NN
Clarithromycin/NNP induced/VBN tachycardia/NN
erythromycin/NN profile/NN established/VBN gastroenteritis/NNS
Phenobarbital/NNP dyskinesia/NN
phenobarbital/JJ therapy/NN starting/VBG soon/RB dyskinesia/NN
phenobarbital/NN challenge/NN recurred/VBD dyskinesia/NN
salbutamol/NN effects/NNS Tremor/JJ
salbutamol/NN effects/NNS tremor/NN
salbutamol/NN doses/NNS administration/NN assessed/VBD tremor/NN
Salbutamol/NNP increased/VBD severity/NN tremor/NN
pilocarpine/NN latency/NN indicated/VBN increased/VBN seizures/NNS
pilocarpine/NN latency/NN indicated/VBN increased/VBN seizures/NNS
carbamazepine/VB presenting/VBG reaction/NN erythroderma/NN
carbamazepine/VB presenting/VBG reaction/NN leukemoid/JJ
carbamazepine/VB presenting/VBG reaction/NN
carbamazepine/VB Hypersensitivity/VB
carbamazepine/VB presenting/VBG reaction/NN failure/NN renal/JJ
carbamazepine/VB presenting/VBG reaction/NN failure/NN
carbamazepine/VB presented/VBN erythroderma/NN
carbamazepine/VB presented/VBN erythroderma/NN reaction/NN leukemoid/JJ
carbamazepine/VB presented/VBN erythroderma/NN reaction/NN
carbamazepine/VB hypersensitivity/RB
carbamazepine/VB presented/VBN erythroderma/NN failure/NN renal/JJ
carbamazepine/VB presented/VBN erythroderma/NN failure/NN
carbamazepine/VB presented/VBN erythroderma/NN hyponatremia/NN
amphetamine/NN ie/NN challenge/NN models/NNS hyperactivity/NN
MK/NN ie/NN challenge/NN models/NNS hyperactivity/NN
801/CD ie/NN challenge/NN models/NNS hyperactivity/NN
MK/NNP antagonist/NN hyperactivity/NN
801/CD hyperactivity/NN
MK/NNP antagonist/NN hyperactivity/NN 801/CD hyperactivity/NN
801/CD hyperactivity/NN
amphetamine/NN induced/VBN hyperactivity/RB
Valproate/NNP induced/VBN encephalopathy/RB
Valproate/NNP syndrome/NN encephalopathy/RB
valproate/NN induced/VBN encephalopathy/RB
cimetidine/NN infusion/NN arrest/NN Sinus/JJ
cimetidine/NN infusion/NN arrest/NN
cimetidine/NN infusions/NNS administration/NN associated/VBN development/NN bradyarrhythmias/NNS
cimetidine/NN mg/JJ continuous/JJ hour/NN receiving/VBG developed/VBD episodes/NNS arrest/NN sinus/NNS
cimetidine/NN mg/JJ continuous/JJ hour/NN receiving/VBG developed/VBD episodes/NNS arrest/NN
cimetidine/VBP case/NN arrest/NN sinus/JJ
cimetidine/VBP case/NN arrest/NN
methyl/NN dopa/NN occurring/VBG depressions/NNP
dopa/NN occurring/VBG depressions/NNP
haloperidol/NN induced/VBN catalepsy/RB
haloperidol/JJ induced/NNS reverse/VB catalepsy/RB
gemfibrozil/NN cyclosporin/NN treated/VBN patients/NNS lovastatin/NN reported/VBN Myopathy/RB
lovastatin/NN reported/VBN associated/VBN myoglobinuria/NN
lovastatin/NN reported/VBN associated/VBN failure/NN renal/JJ
lovastatin/NN reported/VBN associated/VBN failure/NN
niacin/NN cyclosporin/NN treated/VBN patients/NNS lovastatin/NN reported/VBN Myopathy/RB
cyclosporin/NN treated/VBN patients/NNS lovastatin/NN reported/VBN Myopathy/RB
adriamycin/NN activity/NN Detection/NNP induced/VBN cardiomyopathy/RB
adriamycin/NN induced/VBN cardiomyopathy/RB
adriamycin/NN model/NN Using/VBG tested/VBD hypothesis/NNS appear/VB exacerbated/VBN cardiomyopathy/NN
adriamycin/NN cardiomyopathy/NN exacerbated/VBN appear/VB hypothesis/NNS tested/VBD Using/VBG model/NN adriamycin/NN induced/VBN cardiomyopathy/RB
adriamycin/NN cardiomyopathy/NN
adriamycin/NN detection/NN method/NN indicates/VBZ appearance/NN presence/NN impairment/NN myocardial/JJ
adriamycin/NN detection/NN method/NN indicates/VBZ appearance/NN presence/NN impairment/NN
adriamycin/NN induced/VBN cardiomyopathy/RB
sodium/NN nitroprusside/NN than/IN greater/JJR induced/VBN hypotension/NN
nitroprusside/NN than/IN greater/JJR induced/VBN hypotension/NN
SNP/NNP group/NN that/DT lower/JJR hypotension/NN
SNP/NNP group/NN Hg/NNP //NNS Hg/NNP mm/VBP was/VBD SPV/NNP hypotension/NN
SNP/NNP HEM/NNP groups/NNS Hg/NNP 20/NNP hypotension/NN
bendrofluazide/JJ treatment/NN impotence/NN
bendrofluazide/JJ treatment/NN association/NN show/VBP occurred/VBD impotence/NN
propranolol/NN taking/VBG patients/NNS occurred/VBD show/VBP association/NN treatment/NN impotence/NN
propranolol/NN taking/VBG patients/NNS occurred/VBD impotence/NN
propranolol/JJ taking/VBG phenomenon/NN Raynaud/NNP
propranolol/JJ taking/VBG phenomenon/NN Raynaud/NNP '/POS
propranolol/JJ taking/VBG phenomenon/NN s/VBZ
propranolol/JJ taking/VBG phenomenon/NN
bendrofluazide/JJ treatment/NN associated/VBN men/NNS gout/NN
bendrofluazide/JJ treatment/NN associated/VBN men/NNS gout/NN tolerance/NN impaired/VBN
bendrofluazide/JJ treatment/NN associated/VBN men/NNS gout/NN tolerance/NN glucose/NN
bendrofluazide/JJ treatment/NN associated/VBN men/NNS gout/NN tolerance/NN
propranolol/JJ taking/VBG phenomenon/NN dyspnoea/NN
scopolamine/NN impaired/VBN memory/NN
scopolamine/NN impaired/VBN
scopolamine/NN impaired/VBN memory/NN improve/VB showed/VBD associative/VBD s/PRP relieved/VBD deficit/NN
scopolamine/NN impaired/VBN memory/NN improve/VB showed/VBD associative/VBD s/PRP relieved/VBD deficit/NN memory/NN of/IN
scopolamine/NN impaired/VBN memory/NN improve/VB showed/VBD associative/VBD s/PRP relieved/VBD deficit/NN memory/NN associative/JJ
scopolamine/NN impaired/VBN memory/NN improve/VB showed/VBD associative/VBD s/PRP relieved/VBD deficit/NN memory/NN
lidocaine/NN buffered/VBD Reduction/NN pain/NN
lidocaine/NN injection/NN associated/VBN pain/NN
lidocaine/NN pH/NN adjust/VB solution/NN addition/NN reduce/VB pain/NN
lidocaine/NN receiving/VBG quantify/VB severity/NN pain/NN
lidocaine/NN area/NN receiving/VBG quantify/VB severity/NN pain/NN
lidocaine/NN score/NN pain/NN
lidocaine/NN score/NN lower/JJR score/NN pain/NN
lidocaine/NN adjustment/NN accomplished/VBN reduction/NN pain/NN
cyclosporine/JJ levels/NNS reduction/NN led/VBD relief/NN pain/NN
tacrolimus/JJ cyclosporine/JJ levels/NNS reduction/NN led/VBD relief/NN pain/NN
cyclosporine/NN effect/NN Syndrome/NNP Pain/NNP
tacrolimus/NNS cyclosporine/NN effect/NN Syndrome/NNP Pain/NNP
warfarin/NN discontinued/VBN available/JJ patients/NNS lesions/NNS LV/NNP
warfarin/NN discontinued/VBN available/JJ patients/NNS lesions/NNS Cutaneous/NNP
warfarin/NN discontinued/VBN available/JJ patients/NNS lesions/NNS
tranexamic/JJ thrombin/JJ acid/NN injection/NN fibrinolysis/NNS coagulation/NN intravascular/NN
tranexamic/JJ thrombin/JJ acid/NN injection/NN fibrinolysis/NNS coagulation/NN
acid/NN injection/NN fibrinolysis/NNS coagulation/NN intravascular/NN
acid/NN injection/NN fibrinolysis/NNS coagulation/NN
AMCA/NNP acid/NN injection/NN fibrinolysis/NNS coagulation/NN intravascular/NN
AMCA/NNP acid/NN injection/NN fibrinolysis/NNS coagulation/NN
Sulfonamides/NNS associated/VBN anencephaly/NN
Sulfonamides/NNS associated/VBN anencephaly/NN adjusted/VBN AOR/NNP syndrome/NN CI/NNP atresia/NN AOR/NNP 0/CD %/NN =/NN transverse/JJ
Sulfonamides/NNS associated/VBN anencephaly/NN adjusted/VBN AOR/NNP syndrome/NN CI/NNP atresia/NN AOR/NNP 0/CD %/NN =/NN limb/NN
Sulfonamides/NNS associated/VBN anencephaly/NN adjusted/VBN AOR/NNP syndrome/NN CI/NNP atresia/NN AOR/NNP 0/CD %/NN =/NN deficiency/NN
Sulfonamides/NNS associated/VBN anencephaly/NN adjusted/VBN AOR/NNP syndrome/NN hernia/NN diaphragmatic/JJ
Sulfonamides/NNS associated/VBN anencephaly/NN adjusted/VBN AOR/NNP syndrome/NN hernia/NN
Sulfonamides/NNS associated/VBN anencephaly/NN adjusted/VBN AOR/NNP syndrome/NN CI/NNP coarctation/NN
Sulfonamides/NNS associated/VBN anencephaly/NN adjusted/VBN AOR/NNP syndrome/NN CI/NNP coarctation/NN aorta/NN of/IN
Sulfonamides/NNS associated/VBN anencephaly/NN adjusted/VBN AOR/NNP syndrome/NN CI/NNP coarctation/NN aorta/NN the/DT
Sulfonamides/NNS associated/VBN anencephaly/NN adjusted/VBN AOR/NNP syndrome/NN CI/NNP coarctation/NN aorta/NN
Sulfonamides/NNS associated/VBN anencephaly/NN adjusted/VBN AOR/NNP syndrome/NN CI/NNP atresia/NN choanal/JJ
Sulfonamides/NNS associated/VBN anencephaly/NN adjusted/VBN AOR/NNP syndrome/NN CI/NNP atresia/NN
Sulfonamides/NNS associated/VBN anencephaly/NN adjusted/VBN AOR/NNP syndrome/NN hypoplastic/JJ
Sulfonamides/NNS associated/VBN anencephaly/NN adjusted/VBN AOR/NNP syndrome/NN left/JJ
Sulfonamides/NNS associated/VBN anencephaly/NN adjusted/VBN AOR/NNP syndrome/NN heart/NN
Sulfonamides/NNS associated/VBN anencephaly/NN adjusted/VBN AOR/NNP syndrome/NN
Nitrofurantoins/NNS associated/VBN anophthalmia/NN microphthalmos/NNS
Nitrofurantoins/NNS associated/VBN anophthalmia/NN microphthalmos/NNS lip/NN cleft/JJ
Nitrofurantoins/NNS associated/VBN anophthalmia/NN microphthalmos/NNS lip/NN
Nitrofurantoins/NNS associated/VBN anophthalmia/NN
Nitrofurantoins/NNS associated/VBN anophthalmia/NN microphthalmos/NNS CI/NNP syndrome/NN hypoplastic/JJ
Nitrofurantoins/NNS associated/VBN anophthalmia/NN microphthalmos/NNS CI/NNP syndrome/NN left/JJ
Nitrofurantoins/NNS associated/VBN anophthalmia/NN microphthalmos/NNS CI/NNP syndrome/NN heart/NN
Nitrofurantoins/NNS associated/VBN anophthalmia/NN microphthalmos/NNS CI/NNP syndrome/NN
Nitrofurantoins/NNS associated/VBN anophthalmia/NN microphthalmos/NNS CI/NNP syndrome/NN AOR/NNP 2/CD %/NN defects/NNS atrial/JJ
Nitrofurantoins/NNS associated/VBN anophthalmia/NN microphthalmos/NNS CI/NNP syndrome/NN AOR/NNP 2/CD %/NN defects/NNS septal/JJ
Nitrofurantoins/NNS associated/VBN anophthalmia/NN microphthalmos/NNS CI/NNP syndrome/NN AOR/NNP 2/CD %/NN defects/NNS
Nitrofurantoins/NNS associated/VBN anophthalmia/NN microphthalmos/NNS lip/NN =/NN cleft/NN
Nitrofurantoins/NNS associated/VBN anophthalmia/NN microphthalmos/NNS lip/NN =/NN palate/CD
nitrofurantoins/NNS Sulfonamides/NNS associated/VBN defects/NNS birth/NN
nitrofurantoins/NNS Sulfonamides/NNS associated/VBN defects/NNS
Sulfonamides/NNS associated/VBN defects/NNS birth/NN
Sulfonamides/NNS associated/VBN defects/NNS
estrogens/NNS treatment/NN implicated/VBN development/NN cancer/NN endometrial/JJ
estrogens/NNS treatment/NN implicated/VBN development/NN cancer/NN
estrogens/NNS women/NNS have/VB risk/NN carcinoma/NN endometrial/JJ
estrogens/NNS women/NNS have/VB risk/NN carcinoma/NN
haloperidol/NN induced/VBN Catalepsy/NNP
thioperamide/JJ methylhistamine/JJ R/NN cause/VB catalepsy/RB
THP/NNP thioperamide/JJ methylhistamine/JJ R/NN cause/VB catalepsy/RB
THP/NNP Administration/NNP increase/NN times/NNS catalepsy/JJ
haloperidol/NN mg/CD THP/NNP Administration/NNP increase/NN times/NNS catalepsy/JJ
amphetamine/NN induced/VBN hyperactivity/RB
THP/NNP exhibited/VBD antipsychotic/NN like/VB induced/VBN catalepsy/RB
amphetamine/NN reducing/VBG like/VB induced/VBN hyperactivity/RB
haloperidol/NN potentiating/VBG like/VB induced/VBN catalepsy/RB
tranexamic/JJ Acid/NN associated/VBN seizures/NNS
Acid/NN associated/VBN seizures/NNS
TXA/NNP usage/NN seizures/NNS
TXA/NNP doses/NNS received/VBD patients/NNS seizures/NNS
TXA/NNP high/JJ surgery/NN use/NN associated/VBN seizures/NNS
paracetamol/NNP overdose/NN due/JJ ALF/NNP
paracetamol/NNP overdose/NNP due/JJ defect/NN ALF/NNP
LiCl/NNP pre/NNP administered/VBN Tacrine/NNP induces/VBZ seizures/NNS
LiCl/NNP pre/NNP administered/VBN Tacrine/NNP induces/VBZ seizures/NNS damage/NN hippocampal/JJ
LiCl/NNP pre/NNP administered/VBN Tacrine/NNP induces/VBZ seizures/NNS damage/NN
Tacrine/NNP induces/VBZ seizures/NNS damage/NN hippocampal/JJ
Tacrine/NNP induces/VBZ seizures/NNS damage/NN
Tacrine/NNP induces/VBZ seizures/NNS
tacrine/NN administration/NN induced/VBN damage/NN
tacrine/NN administration/NN induced/VBN damage/NN cells/NNS of/IN
tacrine/NN administration/NN induced/VBN damage/NN cells/NNS neuronal/JJ
tacrine/NN administration/NN induced/VBN damage/NN cells/NNS
tacrine/NN solution/NN treated/VBD tacrine/NN administration/NN induced/VBN damage/NN
tacrine/NN solution/NN treated/VBD tacrine/NN administration/NN induced/VBN damage/NN cells/NNS of/IN
tacrine/NN solution/NN treated/VBD tacrine/NN administration/NN induced/VBN damage/NN cells/NNS neuronal/JJ
tacrine/NN solution/NN treated/VBD tacrine/NN administration/NN induced/VBN damage/NN cells/NNS
Nicotine/NNP induced/VBN correlates/NNS nystagmus/JJ
nicotine/NN pathomechanism/NN nystagmus/NNS
nicotine/NN pathomechanism/NN nystagmus/NNS NIN/NNP
hexafluorodiethyl/JJ ether/NN induced/VBN Seizures/NNS
ether/NN induced/VBN Seizures/NNS
hexafluorodiethyl/JJ ether/NN induced/VBN Seizures/NNS found/VBN seizures/NNS
ether/NN induced/VBN Seizures/NNS found/VBN seizures/NNS
HFDE/NNP Seizures/NNS
HFDE/NNP Seizures/NNS found/VBN seizures/NNS
HFDE/NNP protective/JJ induced/VBN seizures/NNS
amphetamine/NN antagonism/NN localization/NN induced/VBN hyperactivity/RB
ritonavir/NN treatment/NN increases/VBZ formation/NN atherosclerotic/JJ
ritonavir/NN treatment/NN increases/VBZ formation/NN lesion/NN
pilocarpine/JJ model/NN status/NN
pilocarpine/JJ model/NN epilepticus/NNS
pilocarpine/NN model/NN evaluated/VBN effect/NN PDTC/NNP epilepticus/NNS status/NN
pilocarpine/NN model/NN evaluated/VBN effect/NN PDTC/NNP epilepticus/NNS
Amiodarone/NNP agent/NN effects/NNS pneumonitis/NNS
isoproterenol/NN tea/NN Effect/NN induced/VBN infarction/NN myocardial/JJ
isoproterenol/NN tea/NN Effect/NN induced/VBN infarction/NN
isoproterenol/NN ATPases/NNS infarction/NN myocardial/JJ
isoproterenol/NN ATPases/NNS infarction/NN
ISO/NNP isoproterenol/NN ATPases/NNS infarction/NN myocardial/JJ
ISO/NNP isoproterenol/NN ATPases/NNS infarction/NN
ISO/NNP induced/VBN infarction/NN myocardial/JJ
ISO/NNP induced/VBN infarction/NN
furosemide/NN Tetany/JJ
furosemide/NN Tetany/JJ rhabdomyolysis/JJ
ribavirin/NNP strategies/NNS anemia/NN hemolytic/JJ
ribavirin/NNP strategies/NNS anemia/NN
ribavirin/NNP anemia/NN hemolytic/JJ
ribavirin/NNP anemia/NN
ribavirin/NNP anemia/NN RIHA/NNP
ribavirin/NNP dosage/NN reduction/NN standard/NN care/NN management/NN RIHA/NNP
ribavirin/NNP dose/NN incidence/NN RIHA/NNP
cyclophosphamide/NN high/JJ regimen/NN failure/NN congestive/JJ
cyclophosphamide/NN high/JJ regimen/NN failure/NN heart/NN
cyclophosphamide/NN high/JJ regimen/NN failure/NN
cyclophosphamide/NN high/JJ regimen/NN failure/NN CHF/NNP
cyclophosphamide/NN CHF/NNP
cyclophosphamide/NN monitoring/VBG EKG/NNP predict/VB development/NN CHF/NNP
Octreotide/NNP induced/VBN hypertension/NN hypoxemia/NN pulmonary/JJ
Octreotide/NNP induced/VBN hypertension/NN
octreotide/RB developed/VBD hypertension/NN Pulmonary/JJ
octreotide/RB developed/VBD hypertension/NN
DEN/NNP given/VBN reduced/VBN number/NN size/NN foci/NNS preneoplastic/JJ
DEN/NNP given/VBN reduced/VBN number/NN size/NN foci/NNS
androgen/NN administration/NN sleep/VBP Induction/NNP obstructive/NN
androgen/NN administration/NN sleep/VBP
androgen/NN administration/NN sleep/VBP syndrome/NN apnea/NN
androgen/NN administration/NN sleep/VBP syndrome/NN
androgens/NNS exogenous/VBZ developed/VBN changes/NNS syndrome/NN
androgens/NNS exogenous/VBZ developed/VBN changes/NNS syndrome/NN apnea/NN of/IN
androgens/NNS exogenous/VBZ developed/VBN changes/NNS syndrome/NN apnea/NN obstructive/JJ
androgens/NNS exogenous/VBZ developed/VBN changes/NNS syndrome/NN apnea/NN sleep/NN
androgens/NNS exogenous/VBZ developed/VBN changes/NNS syndrome/NN apnea/NN
androgen/NN rechallenge/NN produced/VBD symptoms/NNS apnea/NN obstructive/JJ
androgen/NN rechallenge/NN produced/VBD symptoms/NNS apnea/NN sleep/NN
androgen/NN rechallenge/NN produced/VBD symptoms/NNS apnea/NN
androgen/NN therapy/NN effect/NN considered/VBN Development/NNP syndrome/NN obstructive/JJ
androgen/NN therapy/NN effect/NN considered/VBN Development/NNP syndrome/NN sleep/NN
androgen/NN therapy/NN effect/NN considered/VBN Development/NNP syndrome/NN apnea/NN
androgen/NN therapy/NN effect/NN considered/VBN Development/NNP syndrome/NN
labetalol/NN comparison/NN hypotension/NN
nitroprusside/NN labetalol/NN comparison/NN hypotension/NN
labetalol/JJ hypotension/NNS hypotension/NN
labetalol/JJ hypotension/NNS
nitroprusside/NN hypotension/NN
nitroprusside/NN hypotension/NN hypotension/NNS
nitroprusside/NN discontinuation/NN observed/VBN associated/VBN increase/NN
nitroprusside/NN discontinuation/NN observed/VBN associated/VBN increase/NN rate/NN in/IN
nitroprusside/NN discontinuation/NN observed/VBN associated/VBN increase/NN rate/NN heart/NN
nitroprusside/NN discontinuation/NN observed/VBN associated/VBN increase/NN rate/NN
nitroprusside/NN discontinuation/NN observed/VBN associated/VBN increase/NN rate/NN and/CC
nitroprusside/NN discontinuation/NN observed/VBN associated/VBN increase/NN rate/NN output/NN cardiac/JJ
nitroprusside/NN discontinuation/NN observed/VBN associated/VBN increase/NN rate/NN output/NN
cyproterone/JJ acetate/NN prescribed/VBN women/NNS thromboembolism/NN venous/JJ
cyproterone/JJ acetate/NN prescribed/VBN women/NNS thromboembolism/NN
acetate/NN prescribed/VBN women/NNS thromboembolism/NN venous/JJ
acetate/NN prescribed/VBN women/NNS thromboembolism/NN
ethinyl/JJ estradiol/NN prescribed/VBN women/NNS thromboembolism/NN venous/JJ
ethinyl/JJ estradiol/NN prescribed/VBN women/NNS thromboembolism/NN
estradiol/NN prescribed/VBN women/NNS thromboembolism/NN venous/JJ
estradiol/NN prescribed/VBN women/NNS thromboembolism/NN
CPA/NNP EE/NNP associated/VBN thromboembolism/NN venous/JJ
CPA/NNP EE/NNP associated/VBN thromboembolism/NN
CPA/NNP EE/NNP associated/VBN thromboembolism/NN VTE/NNP
EE/NNP associated/VBN thromboembolism/NN venous/JJ
EE/NNP associated/VBN thromboembolism/NN
EE/NNP associated/VBN thromboembolism/NN VTE/NNP
CPA/NNP EE/NNP associated/VBN VTE/NNP
EE/NNP associated/VBN VTE/NNP
CPA/NNP EE/NNP use/NN associated/VBN VTE/NNP
EE/NNP use/NN associated/VBN VTE/NNP
5/CD patients/NNS supervision/NN discontinued/VBN observed/JJ pain/NN chest/NN
5/CD patients/NNS supervision/NN discontinued/VBN observed/JJ pain/NN
FU/NNP treatment/NN supervision/NN discontinued/VBN observed/JJ pain/NN chest/NN
FU/NNP treatment/NN supervision/NN discontinued/VBN observed/JJ pain/NN
levodopa/NN patients/NNS selected/VBN dyskinesias/NNS
fentanyl/NN infusion/NN result/NN urine/NN retention/NN
fentanyl/NN infusion/NN result/NN urine/NN of/IN
fentanyl/NN infusion/NN result/NN urine/NN
fentanyl/JJ administration/NN effects/NNS include/VBP rigidity/NN hypotension/NN
fentanyl/JJ administration/NN effects/NNS include/VBP rigidity/NN depression/NN respiratory/JJ
fentanyl/JJ administration/NN effects/NNS include/VBP rigidity/NN depression/NN
fentanyl/JJ administration/NN effects/NNS include/VBP rigidity/NN bradycardia/NN
fentanyl/NN infusion/NN result/NN mimicking/VBG leading/VBG retention/NN urinary/JJ
fentanyl/NN infusion/NN result/NN mimicking/VBG leading/VBG retention/NN bladder/NN
fentanyl/NN infusion/NN result/NN mimicking/VBG leading/VBG retention/NN
clomipramine/NN effects/NNS sexual/JJ
clomipramine/NN effects/NNS side/NN
clomipramine/NN effects/NNS
ifosfamide/JJ toxicity/NN renal/JJ
ifosfamide/JJ toxicity/NN
epsilon/NN induce/VB myopathy/RB
aminocaproic/JJ acid/NN epsilon/NN induce/VB myopathy/RB
acid/NN epsilon/NN induce/VB myopathy/RB
EACA/NNP epsilon/NN induce/VB myopathy/RB
Valproate/NNP induced/VBN chorea/NN encephalopathy/NN
Valproate/NNP induced/VBN chorea/NN
valproate/JJ therapy/NN initiation/NN have/VB hyperglycinemia/NN presentation/NN encephalopathy/NN
valproate/JJ therapy/NN initiation/NN have/VB hyperglycinemia/NN presentation/NN encephalopathy/NN chorea/NN
carboplatin/NN chemotherapy/NN Acute/VB
carboplatin/NN chemotherapy/NN Acute/VB failure/NN renal/JJ
carboplatin/NN chemotherapy/NN Acute/VB failure/NN
Carboplatin/NNP reported/VBN cause/VB failure/NN acute/JJ
Carboplatin/NNP reported/VBN cause/VB failure/NN renal/JJ
Carboplatin/NNP reported/VBN cause/VB failure/NN
amphotericin/NNP B/NNP prevention/NN drug/NN it/PRP hypokalemia/NN
B/NNP prevention/NN drug/NN it/PRP hypokalemia/NN
AmB/NNP treatment/NN patients/NNS prevent/VB hypokalemia/NN
AmB/NNP treatment/NN patients/NNS reducing/VBG prevent/VB hypokalemia/NN
methyldopa/NN induced/VBN Patterns/NNS injury/NN hepatic/JJ
methyldopa/NN induced/VBN Patterns/NNS injury/NN
methyldopa/NN episode/NN recommenced/VBN hepatitis/NN
methyldopa/NN dysfunction/NN relationship/NN proved/VBN recurrence/NN hepatitis/NN
sulfasalazine/NN associated/VBN Hepatotoxicity/NNP
sulfasalazine/NN hepatotoxicity/NN
sulfasalazine/NN hepatotoxicity/NN
sulfasalazine/NN hepatotoxicity/NN
sulfasalazine/NN associated/VBN hepatotoxicity/NN
noradrenaline/NN infusion/NN caused/VBD hypertension/NN
noradrenaline/NN infusion/NN hypertension/NN
noradrenaline/NN circulating/VBG levels/NNS produced/VBN hypertension/NN
caffeine/NN administration/NN onset/NN convulsions/NNS
caffeine/NN administration/NN interval/NN increased/VBN acetaminophen/NN pretreatment/NN pretreatment/NN acetaminophen/NN reduced/VBN incidence/NN seizures/NNS
caffeine/NN presence/NN produced/VBN incidence/NN reduced/VBN acetaminophen/NN pretreatment/NN pretreatment/NN acetaminophen/NN increased/VBN interval/NN administration/NN onset/NN convulsions/NNS
caffeine/NN presence/NN produced/VBN incidence/NN seizures/NNS
caffeine/NN 5/CD seizures/NNS
pentylenetetrezol/NN dose/NN alter/VB modify/VB seizures/NNS
caffeine/NN absence/NN modify/VB seizures/NNS
PTZ/NNP suppressed/VBD increased/VBD amplitude/NN startle/NN
PTZ/NNP suppressed/VBD increased/VBD suppressed/VBD startle/NN
PTZ/NNP suppressed/VBD startle/NN
yohimbine/NN increased/VBD amplitude/NN startle/NN
yohimbine/NN increased/VBD suppressed/VBD startle/NN
yohimbine/NN increased/VBD suppressed/VBD startle/NN
mCPP/NN suppressed/VBD increased/VBD amplitude/NN startle/NN
mCPP/NN suppressed/VBD startle/NN
mCPP/NN suppressed/VBD increased/VBD suppressed/VBD startle/NN
sodium/NN powders/NNS ate/VBD reported/VBN case/NN two/CD nephrolithiasis/NNS
bicarbonate/NN powders/NNS ate/VBD reported/VBN case/NN two/CD nephrolithiasis/NNS
calcium/NN carbon/NN amounts/NNS consumed/VBN patients/NNS reported/VBN case/NN hypercalcaemia/NN
carbon/NN amounts/NNS consumed/VBN patients/NNS reported/VBN case/NN hypercalcaemia/NN
ate/VBD reported/VBN case/NN hypercalcaemia/NN
calcium/NN carbon/NN amounts/NNS consumed/VBN patients/NNS reported/VBN case/NN two/CD nephrolithiasis/NNS
carbon/NN amounts/NNS consumed/VBN patients/NNS reported/VBN case/NN two/CD nephrolithiasis/NNS
ate/VBD reported/VBN case/NN two/CD nephrolithiasis/NNS
sodium/NN powders/NNS ate/VBD reported/VBN case/NN hypercalcaemia/NN
bicarbonate/NN powders/NNS ate/VBD reported/VBN case/NN hypercalcaemia/NN
terbutaline/NN relationship/NN induced/VBN hypokalemia/NN
terbutaline/NN concentrations/NNS spite/NN antagonized/VBN hypokalemia/NN
isoniazid/JJ therapy/NN due/JJ convulsions/NNS
isoniazid/JJ mg/NN infant/NN day/NN 17/CD kg/VBP admitted/VBN days/NNS fits/NNS clonic/JJ
isoniazid/JJ mg/NN infant/NN day/NN 17/CD kg/VBP admitted/VBN days/NNS fits/NNS
isoniazid/JJ medication/NN suggesting/VBG ceased/VBD fits/NNS
warfarin/NN juice/NN haemopericardium/NN haemorrhage/NN gastrointestinal/NN
warfarin/NN juice/NN haemopericardium/NN haemorrhage/NN
vancomycin/NN course/NN receiving/VBG Acute/VB
vancomycin/NN course/NN receiving/VBG Acute/VB failure/NN renal/JJ
vancomycin/NN course/NN receiving/VBG Acute/VB failure/NN
clomiphene/JJ citrate/NN associated/VBN infarction/NN Myocardial/JJ
clomiphene/JJ citrate/NN associated/VBN infarction/NN
citrate/NN associated/VBN infarction/NN Myocardial/JJ
citrate/NN associated/VBN infarction/NN
CC/NNP reported/VBN complication/NN rare/JJ Thromboembolism/NNP
CC/NNP infarction/NN myocardial/JJ
CC/NNP infarction/NN
Mellaril/NNP appeared/VBD responsible/JJ cases/NNS tachycardia/NN ventricular/NN
Mellaril/NNP appeared/VBD responsible/JJ cases/NNS tachycardia/NN
thioridazine/NN Mellaril/NNP appeared/VBD responsible/JJ cases/NNS tachycardia/NN ventricular/NN
thioridazine/NN Mellaril/NNP appeared/VBD responsible/JJ cases/NNS tachycardia/NN
Aventyl/NNP produced/VBD block/NN left/JJ
Aventyl/NNP produced/VBD block/NN bundle/NN
Aventyl/NNP produced/VBD block/NN branch/NN
Aventyl/NNP produced/VBD block/NN
nortriptyline/NN Aventyl/NNP produced/VBD block/NN left/JJ
nortriptyline/NN Aventyl/NNP produced/VBD block/NN bundle/NN
nortriptyline/NN Aventyl/NNP produced/VBD block/NN branch/NN
nortriptyline/NN Aventyl/NNP produced/VBD block/NN
Elavil/NNP Aventyl/NNP produced/VBD block/NN left/JJ
Elavil/NNP Aventyl/NNP produced/VBD block/NN bundle/NN
Elavil/NNP Aventyl/NNP produced/VBD block/NN branch/NN
Elavil/NNP Aventyl/NNP produced/VBD block/NN
amitriptyline/NNP Elavil/NNP Aventyl/NNP produced/VBD block/NN left/JJ
amitriptyline/NNP Elavil/NNP Aventyl/NNP produced/VBD block/NN bundle/NN
amitriptyline/NNP Elavil/NNP Aventyl/NNP produced/VBD block/NN branch/NN
amitriptyline/NNP Elavil/NNP Aventyl/NNP produced/VBD block/NN
cocaine/NN abusers/NNS Eleven/CD had/VBD evidence/NN injury/NN defined/VBN infarction/NN block/NN bundle/NN
cocaine/NN abusers/NNS Eleven/CD had/VBD evidence/NN injury/NN defined/VBN infarction/NN block/NN branch/NN
cocaine/NN abusers/NNS Eleven/CD had/VBD evidence/NN injury/NN defined/VBN infarction/NN block/NN
cocaine/NN abusers/NNS Eleven/CD had/VBD evidence/NN injury/NN defined/VBN infarction/NN myocardial/JJ
cocaine/NN abusers/NNS Eleven/CD had/VBD evidence/NN injury/NN defined/VBN infarction/NN
doxorubicin/NN heart/NN derivative/JJ induced/VBN cardiomyopathy/RB
doxorubicin/NN courses/NNS received/VBD Animals/NNS demonstrated/VBD changes/NNS decrease/NN cardiomyopathy/NN
doxorubicin/NN cardiomyopathy/NN
terbutaline/NN metoprolol/NN antagonism/NN hypokalemia/NN
diphenylhydantoin/NN toxicity/NN manifestation/NN hemiparesis/NNS
diphenylhydantoin/NNP overdose/NN effects/NNS encountered/VBD those/DT dysfunction/NN cerebellar/NN
diphenylhydantoin/NNP overdose/NN effects/NNS encountered/VBD those/DT dysfunction/NN
DPH/NNP overdose/NN effects/NNS encountered/VBD those/DT dysfunction/NN cerebellar/NN
DPH/NNP overdose/NN effects/NNS encountered/VBD those/DT dysfunction/NN
diphenylhydantoin/NNP overdose/NN
DPH/NNP overdose/NN
DPH/NNP overdose/NN
DPH/NNP overdose/NN due/JJ hemiparesis/NNS
dexamethasone/NN programs/NNS injury/NN hypertension/NN
dexamethasone/NN programs/NNS injury/NN hypertension/NN renal/JJ
dexamethasone/NN programs/NNS injury/NN
dexamethasone/NN programmed/VBN increase/NN
dexamethasone/NN programmed/VBN pressure/NN in/IN
dexamethasone/NN programmed/VBN pressure/NN blood/NN
dexamethasone/NN programmed/VBN pressure/NN
dexamethasone/NN programmed/VBN pressure/NN injury/NN renal/JJ
dexamethasone/NN programmed/VBN pressure/NN injury/NN
dexamethasone/JJ gestation/NN administered/VBN rats/NNS Offspring/NN had/VBD reduction/NN
dexamethasone/JJ gestation/NN administered/VBN rats/NNS Offspring/NN had/VBD reduction/NN number/NN in/IN
dexamethasone/JJ gestation/NN administered/VBN rats/NNS Offspring/NN had/VBD reduction/NN number/NN glomerular/NN
dexamethasone/JJ gestation/NN administered/VBN rats/NNS Offspring/NN had/VBD reduction/NN number/NN
dexamethasone/NN received/VBD rats/NNS had/VBD pressures/NNS elevated/JJ
dexamethasone/NN received/VBD rats/NNS had/VBD pressures/NNS blood/NN
dexamethasone/NN received/VBD rats/NNS had/VBD pressures/NNS
dexamethasone/NN received/VBD rats/NNS had/VBD have/VB reduction/NN
dexamethasone/NN received/VBD rats/NNS had/VBD have/VB reduction/NN number/NN in/IN
dexamethasone/NN received/VBD rats/NNS had/VBD have/VB reduction/NN number/NN glomerular/NN
dexamethasone/NN received/VBD rats/NNS had/VBD have/VB reduction/NN number/NN
dexamethasone/NN shows/VBZ results/NNS reduction/NN number/NN hypertension/NN
dexamethasone/NN shows/VBZ results/NNS reduction/NN
dexamethasone/NN shows/VBZ results/NNS reduction/NN number/NN in/IN
dexamethasone/NN shows/VBZ results/NNS reduction/NN number/NN glomerular/NN
dexamethasone/NN shows/VBZ results/NNS reduction/NN number/NN
gentamicin/NN induced/VBN failure/NN acute/JJ
gentamicin/NN induced/VBN failure/NN renal/JJ
gentamicin/NN induced/VBN failure/NN
Heparin/NNP induced/VBN thrombocytopenia/NN hemorrhage/NN
Heparin/NNP induced/VBN thrombocytopenia/NN
heparin/NN patients/NNS Sixty/CD induced/VBD reported/VBN thrombocytopenia/NN
heparin/NN receiving/VBG hemorrhage/JJ
heparin/NN receiving/VBG hemorrhage/JJ events/NNS thromboembolic/JJ
carbamazepine/JJ phenobarbitone/JJ rats/NNS dysfunction/NN cognitive/JJ
carbamazepine/JJ phenobarbitone/JJ rats/NNS dysfunction/NN
phenobarbitone/JJ rats/NNS dysfunction/NN cognitive/JJ
phenobarbitone/JJ rats/NNS dysfunction/NN
carbamazepine/NN drugs/NNS known/VBN cause/VB impairment/NN cognitive/JJ
carbamazepine/NN drugs/NNS known/VBN cause/VB impairment/NN
phenobarbitone/NN drugs/NNS known/VBN cause/VB impairment/NN cognitive/JJ
phenobarbitone/NN drugs/NNS known/VBN cause/VB impairment/NN
carbamazepine/JJ phenobarbitone/JJ impairment/NN cognitive/JJ
carbamazepine/JJ phenobarbitone/JJ impairment/NN
phenobarbitone/JJ impairment/NN cognitive/JJ
phenobarbitone/JJ impairment/NN
carbamazepine/NN phenobarbitone/NN administration/NN caused/VBD impairment/NN
carbamazepine/NN phenobarbitone/NN administration/NN caused/VBD impairment/NN learning/NN of/IN
carbamazepine/NN phenobarbitone/NN administration/NN caused/VBD impairment/NN learning/NN
carbamazepine/NN phenobarbitone/NN administration/NN caused/VBD impairment/NN learning/NN and/CC
carbamazepine/NN phenobarbitone/NN administration/NN caused/VBD impairment/NN learning/NN memory/NN
phenobarbitone/NN administration/NN caused/VBD impairment/NN
phenobarbitone/NN administration/NN caused/VBD impairment/NN learning/NN of/IN
phenobarbitone/NN administration/NN caused/VBD impairment/NN learning/NN
phenobarbitone/NN administration/NN caused/VBD impairment/NN learning/NN and/CC
phenobarbitone/NN administration/NN caused/VBD impairment/NN learning/NN memory/NN
carbamazepine/NN phenobarbitone/NN treated/VBN rats/NNS mitigating/VBG deterioration/NN
carbamazepine/NN phenobarbitone/NN treated/VBN rats/NNS mitigating/VBG deterioration/NN functions/NNS of/IN
carbamazepine/NN phenobarbitone/NN treated/VBN rats/NNS mitigating/VBG deterioration/NN functions/NNS cognitive/JJ
carbamazepine/NN phenobarbitone/NN treated/VBN rats/NNS mitigating/VBG deterioration/NN functions/NNS
phenobarbitone/NN treated/VBN rats/NNS mitigating/VBG deterioration/NN
phenobarbitone/NN treated/VBN rats/NNS mitigating/VBG deterioration/NN functions/NNS of/IN
phenobarbitone/NN treated/VBN rats/NNS mitigating/VBG deterioration/NN functions/NNS cognitive/JJ
phenobarbitone/NN treated/VBN rats/NNS mitigating/VBG deterioration/NN functions/NNS
carbamazepine/VB phenobarbitone/VB preventing/VBG impairment/NN cognitive/JJ
carbamazepine/VB phenobarbitone/VB preventing/VBG impairment/NN
phenobarbitone/VB preventing/VBG impairment/NN cognitive/JJ
phenobarbitone/VB preventing/VBG impairment/NN
carbachol/NN produced/VBD mydriasis/NNS
carbachol/NN produced/VBD mydriasis/NNS tremor/NN
eserine/NN carbachol/NN produced/VBD mydriasis/NNS clonic/NNS
eserine/NN carbachol/NN produced/VBD convulsions/NNS tonic/NN
eserine/NN carbachol/NN produced/VBD convulsions/NNS
eserine/NN carbachol/NN produced/VBD mydriasis/NNS
carbachol/NN produced/VBD mydriasis/NNS clonic/NNS
carbachol/NN produced/VBD convulsions/NNS tonic/NN
carbachol/NN produced/VBD convulsions/NNS
eserine/NN carbachol/NN produced/VBD mydriasis/NNS tremor/NN
carbachol/NN evoked/VBN convulsions/NNS changed/VBN hand/NN mydriasis/NNS
carbachol/NN evoked/VBN convulsions/NNS changed/VBN hand/NN tremor/NN
eserine/NN carbachol/NN evoked/VBN convulsions/NNS changed/VBN hand/NN clonic/NN
eserine/NN carbachol/NN evoked/VBN convulsions/NNS tonic/NN
eserine/NN carbachol/NN evoked/VBN convulsions/NNS
eserine/NN carbachol/NN evoked/VBN convulsions/NNS changed/VBN hand/NN mydriasis/NNS
carbachol/NN evoked/VBN convulsions/NNS changed/VBN hand/NN clonic/NN
carbachol/NN evoked/VBN convulsions/NNS tonic/NN
carbachol/NN evoked/VBN convulsions/NNS
eserine/NN carbachol/NN evoked/VBN convulsions/NNS changed/VBN hand/NN tremor/NN
carbachol/NN caused/VBN convulsions/NNS phenomena/NNS mydriasis/NNS
carbachol/NN caused/VBN convulsions/NNS phenomena/NNS mydriasis/NNS tremor/NN
eserine/NN carbachol/NN caused/VBN convulsions/NNS phenomena/NNS mydriasis/NNS clonic/NN
eserine/NN carbachol/NN caused/VBN convulsions/NNS tonic/NN
eserine/NN carbachol/NN caused/VBN convulsions/NNS
eserine/NN carbachol/NN caused/VBN convulsions/NNS phenomena/NNS mydriasis/NNS
carbachol/NN caused/VBN convulsions/NNS phenomena/NNS mydriasis/NNS clonic/NN
carbachol/NN caused/VBN convulsions/NNS tonic/NN
carbachol/NN caused/VBN convulsions/NNS
eserine/NN carbachol/NN caused/VBN convulsions/NNS phenomena/NNS mydriasis/NNS tremor/NN
dextromethorphan/NN abuse/NN deterioration/NN Cognitive/JJ
dextromethorphan/NN abuse/NN deterioration/NN
DM/NNP use/NN resulting/VBG deterioration/NN cognitive/JJ
DM/NNP use/NN resulting/VBG deterioration/NN
ritodrine/JJ therapy/NN section/NN tachyarrhythmias/NNS Ventricular/JJ
ritodrine/JJ therapy/NN section/NN tachyarrhythmias/NNS
scopolamine/NN depletion/NN induced/VBN deficits/NNS memory/NN
scopolamine/NN depletion/NN induced/VBN deficits/NNS
pilocarpine/NN SE/NNP
lithium/NN subjected/VBN rats/NNS estradiol/JJ effects/NNS pilocarpine/NN SE/NNP
Clomipramine/NNP induced/VBN disturbance/NN sleep/NN
Clomipramine/NNP induced/VBN disturbance/NN
clomipramine/JJ administration/NN induced/VBN disturbance/NN sleep/NN
clomipramine/JJ administration/NN induced/VBN disturbance/NN
tobramycin/NN sulfate/NN sulfate/NN day/NN followed/VBN failure/NN renal/JJ
tobramycin/NN sulfate/NN sulfate/NN day/NN followed/VBN failure/NN
sulfate/NN sulfate/NN day/NN followed/VBN failure/NN renal/JJ
sulfate/NN sulfate/NN day/NN followed/VBN failure/NN
gentamicin/NN sulfate/NN day/NN followed/VBN failure/NN renal/JJ
gentamicin/NN sulfate/NN day/NN followed/VBN failure/NN
sulfate/NN day/NN followed/VBN failure/NN renal/JJ
sulfate/NN day/NN followed/VBN failure/NN
tobramycin/NN 33/CD Five/CD treated/VBD had/VBD failure/NN renal/JJ
tobramycin/NN 33/CD Five/CD treated/VBD had/VBD failure/NN
gentamicin/NN 29/CD 16/CD patients/NNS treated/VBN Five/CD treated/VBD had/VBD failure/NN renal/JJ
gentamicin/NN 29/CD 16/CD patients/NNS treated/VBN Five/CD treated/VBD had/VBD failure/NN
tobramycin/VBN times/NNS failure/NN renal/JJ
tobramycin/VBN times/NNS failure/NN
gentamicin/NN associated/VBN failure/NN renal/JJ
gentamicin/NN associated/VBN failure/NN
PTZ/NNP pentylenetrazol/NN decrease/VB threshold/NN seizure/NN
PTZ/NNP pentylenetrazol/NN h/NN seizures/NNS
PTZ/NNP threshold/NN h/NN pentylenetrazol/NN decrease/VB threshold/NN seizure/NN
PTZ/NNP threshold/NN h/NN seizures/NNS
methyl/NNP acid/NN 3/CD due/JJ activity/NN different/JJ decreased/VBN activity/NN Seizure/JJ
6/CD methyl/NNP acid/NN 3/CD due/JJ activity/NN different/JJ decreased/VBN activity/NN Seizure/JJ
7/CD methyl/NNP acid/NN 3/CD due/JJ activity/NN different/JJ decreased/VBN activity/NN Seizure/JJ
dimethoxy/NN 3/CD due/JJ activity/NN different/JJ decreased/VBN activity/NN Seizure/JJ
4/CD 3/CD due/JJ activity/NN different/JJ decreased/VBN activity/NN Seizure/JJ
ethyl/NN 3/CD due/JJ activity/NN different/JJ decreased/VBN activity/NN Seizure/JJ
B/NNP 3/CD due/JJ activity/NN different/JJ decreased/VBN activity/NN Seizure/JJ
carboline/NN 3/CD due/JJ activity/NN different/JJ decreased/VBN activity/NN Seizure/JJ
3/CD 3/CD due/JJ activity/NN different/JJ decreased/VBN activity/NN Seizure/JJ
carboxylate/NN 3/CD due/JJ activity/NN different/JJ decreased/VBN activity/NN Seizure/JJ
methyl/NNP acid/NN 3/CD due/JJ activity/NN seizure/NN
6/CD methyl/NNP acid/NN 3/CD due/JJ activity/NN seizure/NN
7/CD methyl/NNP acid/NN 3/CD due/JJ activity/NN seizure/NN
dimethoxy/NN 3/CD due/JJ activity/NN seizure/NN
4/CD 3/CD due/JJ activity/NN seizure/NN
ethyl/NN 3/CD due/JJ activity/NN seizure/NN
B/NNP 3/CD due/JJ activity/NN seizure/NN
carboline/NN 3/CD due/JJ activity/NN seizure/NN
3/CD 3/CD due/JJ activity/NN seizure/NN
carboxylate/NN 3/CD due/JJ activity/NN seizure/NN
DMCM/NNP carboxylate/NN 3/CD due/JJ activity/NN different/JJ decreased/VBN activity/NN Seizure/JJ
DMCM/NNP carboxylate/NN 3/CD due/JJ activity/NN seizure/NN
strychnine/NN 3/CD due/JJ activity/NN different/JJ decreased/VBN activity/NN Seizure/JJ
strychnine/NN 3/CD due/JJ activity/NN seizure/NN
STR/NNP activity/NN different/JJ decreased/VBN activity/NN Seizure/JJ
STR/NNP activity/NN seizure/NN
picrotoxin/NN activity/NN Seizure/JJ
picrotoxin/NN activity/NN decreased/VBN different/JJ activity/NN seizure/NN
PTX/NNP picrotoxin/NN activity/NN Seizure/JJ
PTX/NNP picrotoxin/NN activity/NN decreased/VBN different/JJ activity/NN seizure/NN
PTZ/NNP due/JJ activity/NN Seizure/JJ
PTZ/NNP due/JJ activity/NN decreased/VBN different/JJ activity/NN seizure/NN
3/CD due/JJ activity/NN different/JJ decreased/VBN activity/NN Seizure/JJ
mercaptopropionic/JJ acid/NN 3/CD due/JJ activity/NN different/JJ decreased/VBN activity/NN Seizure/JJ
acid/NN 3/CD due/JJ activity/NN different/JJ decreased/VBN activity/NN Seizure/JJ
3/CD due/JJ activity/NN seizure/NN
mercaptopropionic/JJ acid/NN 3/CD due/JJ activity/NN seizure/NN
acid/NN 3/CD due/JJ activity/NN seizure/NN
MPA/NNP acid/NN 3/CD due/JJ activity/NN different/JJ decreased/VBN activity/NN Seizure/JJ
MPA/NNP acid/NN 3/CD due/JJ activity/NN seizure/NN
bicuculline/NN acid/NN 3/CD due/JJ activity/NN different/JJ decreased/VBN activity/NN Seizure/JJ
bicuculline/NN acid/NN 3/CD due/JJ activity/NN seizure/NN
BCC/NNP bicuculline/NN acid/NN 3/CD due/JJ activity/NN different/JJ decreased/VBN activity/NN Seizure/JJ
BCC/NNP bicuculline/NN acid/NN 3/CD due/JJ activity/NN seizure/NN
PTX/VB occur/VB activity/NN seizure/NN
PTX/VB occur/VB suggest/VBP decreased/VBN HCH/NNP response/NN seizure/NNS
PTZ/NNP induced/VBN activity/NN seizure/NN
PTZ/NNP induced/VBN activity/NN occur/VB suggest/VBP decreased/VBN HCH/NNP response/NN seizure/NNS
gentamicin/NN failure/NN acute/JJ
gentamicin/NN failure/NN renal/JJ
gentamicin/NN failure/NN
ifosfamide/NN Treatment/NNP toxicity/NN urothelial/JJ
ifosfamide/NN Treatment/NNP toxicity/NN
ifosfamide/NN induced/VBN toxicity/NN urothelial/JJ
ifosfamide/NN induced/VBN toxicity/NN
IF/NNP effect/NN sodium/NN sulphonate/JJ toxicity/NN urothelial/JJ
IF/NNP effect/NN sodium/NN sulphonate/JJ toxicity/NN
IF/NNP treatment/NN tested/VBN effect/NN sodium/NN sulphonate/JJ toxicity/NN urothelial/JJ
IF/NNP treatment/NN tested/VBN effect/NN sodium/NN sulphonate/JJ toxicity/NN
cisplatin/JJ paclitaxel/JJ drugs/NNS neurons/NNS cultures/NNS exposing/VBG mimic/VBP neuropathy/NN peripheral/JJ
cisplatin/JJ paclitaxel/JJ drugs/NNS neurons/NNS cultures/NNS exposing/VBG mimic/VBP neuropathy/NN
paclitaxel/JJ drugs/NNS neurons/NNS cultures/NNS exposing/VBG mimic/VBP neuropathy/NN peripheral/JJ
paclitaxel/JJ drugs/NNS neurons/NNS cultures/NNS exposing/VBG mimic/VBP neuropathy/NN
prostaglandin/NN E/NNP effects/NNS hypotension/NN
E/NNP effects/NNS hypotension/NN
1/CD E/NNP effects/NNS hypotension/NN
prostaglandin/NN E/NN hypotension/NN
E/NN hypotension/NN
1/CD E/NN hypotension/NN
PGE/NNP 1/CD E/NN hypotension/NN
1/CD PGE/NNP 1/CD E/NN hypotension/NN
PGE/NNP induced/VBN hypotension/NN
1/CD PGE/NNP induced/VBN hypotension/NN
PGE/NNP min/NN combination/NN cause/VB impairment/NN
PGE/NNP min/NN combination/NN cause/VB impairment/NN function/NN of/IN
PGE/NNP min/NN combination/NN cause/VB impairment/NN function/NN hepatic/JJ
PGE/NNP min/NN combination/NN cause/VB impairment/NN function/NN
1/CD PGE/NNP min/NN combination/NN cause/VB impairment/NN
1/CD PGE/NNP min/NN combination/NN cause/VB impairment/NN function/NN of/IN
1/CD PGE/NNP min/NN combination/NN cause/VB impairment/NN function/NN hepatic/JJ
1/CD PGE/NNP min/NN combination/NN cause/VB impairment/NN function/NN
PGE/NNP min/NN hypotension/NN
1/CD PGE/NNP min/NN hypotension/NN
tamoxifen/NN use/NN associated/VBN tumor/NN Granulosa/NNP
tamoxifen/NN use/NN associated/VBN tumor/NN cell/NN
tamoxifen/NN use/NN associated/VBN tumor/NN
tamoxifen/NN use/NN associated/VBN tumor/NN ovary/NN of/IN
tamoxifen/NN use/NN associated/VBN tumor/NN ovary/NN the/DT
tamoxifen/NN use/NN associated/VBN tumor/NN ovary/NN
tamoxifen/NN Patients/NNS CONCLUSION/NNP induced/VBD risk/NN dysfunction/NN liver/NN
tamoxifen/NN Patients/NNS CONCLUSION/NNP induced/VBD risk/NN dysfunction/NN
tamoxifen/NN metabolism/NN alterations/NNS tumors/NNS risk/NN dysfunction/NN liver/NN
tamoxifen/NN metabolism/NN alterations/NNS tumors/NNS risk/NN dysfunction/NN
Li/NNP events/NNS DVP/NNP EPS/NNP
Li/NNP DVP/NNP different/JJ DVP/NNP EPS/NNP
haloperidol/NN treated/VBN events/NNS related/VBN EPS/NNP
haloperidol/NN treated/VBN experienced/VBD events/NNS related/VBN EPS/NNP
lithium/NN treated/VBN patients/NNS 26/NNP experienced/VBD treated/VBN events/NNS related/VBN EPS/NNP
lithium/NN treated/VBN patients/NNS 26/NNP experienced/VBD events/NNS related/VBN EPS/NNP
Lithium/NNP associated/VBN incidence/NN tremor/NN
Lithium/NNP associated/VBN contributed/VBN tremor/NN
Lithium/NNP associated/VBN contributed/VBN rate/NN tremor/NN
lithium/NN effect/NN tremor/NN contributed/VBN associated/VBN incidence/NN tremor/NN
lithium/NN effect/NN tremor/NN
lithium/NN effect/NN tremor/NN contributed/VBN rate/NN tremor/NN
lithium/NN therapy/NN receiving/VBG patients/NNS contributed/VBN associated/VBN incidence/NN tremor/NN
lithium/NN therapy/NN receiving/VBG patients/NNS contributed/VBN tremor/NN
lithium/NN therapy/NN receiving/VBG patients/NNS contributed/VBN rate/NN tremor/NN
Haloperidol/NNP induced/VBN incidence/NN akathisia/NN syndrome/NN extrapyramidal/JJ
Haloperidol/NNP induced/VBN incidence/NN akathisia/NN syndrome/NN
Haloperidol/NNP induced/VBN incidence/NN akathisia/NN tremor/NN
Haloperidol/NNP induced/VBN incidence/NN akathisia/NN
haloperidol/NN indicated/VBD developed/VBD moderate/JJ signs/NNS extrapyramidal/JJ
haloperidol/NN indicated/VBD developed/VBD moderate/JJ signs/NNS
adriamycin/NN injection/NN induced/VBN syndrome/NN nephrotic/JJ
adriamycin/NN injection/NN induced/VBN syndrome/NN
ADR/NNP adriamycin/NN injection/NN induced/VBN syndrome/NN nephrotic/JJ
ADR/NNP adriamycin/NN injection/NN induced/VBN syndrome/NN
Dexatrim/NNP cause/NN infarction/NN myocardial/JJ
Dexatrim/NNP cause/NN infarction/NN
Phenylpropanolamine/NNP Dexatrim/NNP cause/NN infarction/NN myocardial/JJ
Phenylpropanolamine/NNP Dexatrim/NNP cause/NN infarction/NN
scopolamine/NN non/NN induced/VBN amnesia/NN
S/NNP non/NN induced/VBN amnesia/NN
-/NNP non/NN induced/VBN amnesia/NN
ET/NNP non/NN induced/VBN amnesia/NN
126/CD non/NN induced/VBN amnesia/NN
mexiletine/JJ group/NN frequent/JJ effects/NNS tremor/NN problems/NNS gastrointestinal/JJ
mexiletine/JJ group/NN frequent/JJ effects/NNS tremor/NN problems/NNS
mexiletine/JJ group/NN frequent/JJ effects/NNS tremor/NN
terodiline/JJ terfenadine/JJ g/JJ market/NN led/VBN effect/NN side/NN TDP/NNP
terfenadine/JJ g/JJ market/NN led/VBN effect/NN side/NN TDP/NNP
terodiline/NN terfenadine/NN compounds/NNS known/VBN increase/VB cause/VB investigated/VBN TDP/NNP
cisapride/NN terfenadine/NN compounds/NNS known/VBN increase/VB cause/VB investigated/VBN TDP/NNP
terfenadine/NN compounds/NNS known/VBN increase/VB cause/VB investigated/VBN TDP/NNP
terodiline/NN cisapride/NN clinic/NN TDP/NNP
cisapride/NN clinic/NN TDP/NNP
terfenadine/NN cisapride/NN clinic/NN TDP/NNP
doxorubicin/NN development/NN failure/NN heart/NN
doxorubicin/NN development/NN failure/NN
cefazedone/JJ beagle/JJ cefonicid/JJ dogs/NNS administration/NN caused/VBD dose/NN incidence/NN anemia/NN neutropenia/NN
cefonicid/JJ dogs/NNS administration/NN caused/VBD dose/NN incidence/NN anemia/NN neutropenia/NN
cefazedone/JJ beagle/JJ cefonicid/JJ dogs/NNS administration/NN caused/VBD dose/NN incidence/NN anemia/NN thrombocytopenia/NN
cefonicid/JJ dogs/NNS administration/NN caused/VBD dose/NN incidence/NN anemia/NN
cefazedone/JJ beagle/JJ cefonicid/JJ dogs/NNS administration/NN caused/VBD dose/NN incidence/NN anemia/NN
cefonicid/JJ dogs/NNS administration/NN caused/VBD dose/NN incidence/NN anemia/NN thrombocytopenia/NN
cefonicid/NN mg/NN receiving/VBG dogs/NNS %/NN occurred/VBD compromising/NN anemia/NN
cefazedone/JJ kg/VBN mg/NN receiving/VBG dogs/NNS %/NN occurred/VBD compromising/NN anemia/NN
isoproterenol/NN Crataegus/NNP tincture/NN effect/NN infarction/NN myocardial/JJ
isoproterenol/NN Crataegus/NNP tincture/NN effect/NN infarction/NN
ethinyl/JJ treatment/NN used/VBD models/NNS cholestasis/NNS intrahepatic/JJ
ethinyl/JJ treatment/NN used/VBD models/NNS cholestasis/NNS
estradiol/JJ treatment/NN used/VBD models/NNS cholestasis/NNS intrahepatic/JJ
estradiol/JJ treatment/NN used/VBD models/NNS cholestasis/NNS
EE/NNP treatment/NN used/VBD models/NNS cholestasis/NNS intrahepatic/JJ
EE/NNP treatment/NN used/VBD models/NNS cholestasis/NNS
isoniazid/NN unmasked/VBN disorder/NN behavioral/JJ
isoniazid/NN unmasked/VBN disorder/NN
isoniazid/NN administration/NN difficulties/NNS hyperkinesis/NNS had/VBD deterioration/NN behavioral/JJ
isoniazid/NN administration/NN difficulties/NNS hyperkinesis/NNS had/VBD deterioration/NN
isoniazid/NN administration/NN difficulties/NNS hyperkinesis/NNS
fentanyl/JJ administration/NN rigidity/NN
fentanyl/NN dose/NN received/VBD period/NN case/NN rigidity/NN
oxytocin/NN administration/NN associated/VBN intoxication/NNP Water/NNP
oxytocin/NN administration/NN associated/VBN intoxication/NNP
oxytocin/NN administration/NN intoxication/VBN cases/NNS water/NN
oxytocin/NN administration/NN intoxication/VBN
Oxytocin/NN administration/NN advocated/VBN carried/VBN aware/JJ symptoms/NNS intoxication/NN water/NN
Oxytocin/NN administration/NN advocated/VBN carried/VBN aware/JJ symptoms/NNS intoxication/NN
clioquinol/NN dose/NN ingestion/NN related/VBN encephalopathy/NN
tiazofurin/NN usage/NN associated/VBN lesions/NNS cerebral/JJ
tiazofurin/NN usage/NN associated/VBN lesions/NNS
octreotide/NN associated/VBN stones/NNS gall/NN
octreotide/NN associated/VBN stones/NNS bladder/NN
octreotide/NN associated/VBN stones/NNS
Octreotide/NNP induces/VBZ stones/NNS gall/NN
Octreotide/NNP induces/VBZ stones/NNS bladder/NN
Octreotide/NNP induces/VBZ stones/NNS
octreotide/NN treated/VBN stones/NNS gall/NN
octreotide/NN treated/VBN stones/NNS
octreotide/JJ stones/NNS gall/NN
octreotide/JJ stones/NNS
octreotide/JJ stones/NNS small/JJ have/VB common/JJ disease/NN gall/NN
octreotide/JJ stones/NNS small/JJ have/VB common/JJ disease/NN stone/NN
octreotide/JJ stones/NNS small/JJ have/VB common/JJ disease/NN
octreotide/JJ stones/NNS small/JJ have/VB duct/NN stones/NNS gall/NN
octreotide/JJ stones/NNS small/JJ have/VB duct/NN stones/NNS
metoclopramide/NN caused/VBD case/NN dyskinesia/NN tardive/JJ
metoclopramide/NN caused/VBD case/NN dyskinesia/NN
metoclopramide/NN took/VBD patient/NN appeared/VBD movements/NNS Abnormal/JJ
metoclopramide/NN took/VBD patient/NN appeared/VBD movements/NNS involuntary/JJ
metoclopramide/NN took/VBD patient/NN appeared/VBD movements/NNS
metoclopramide/JJ administration/NN discontinued/VBN improved/VBD movements/NNS abnormal/JJ
metoclopramide/JJ administration/NN discontinued/VBN improved/VBD movements/NNS
ammonium/NN Pretreatment/NNP doubled/VBD increased/VBD incoordination/NN
acetate/NN approximately/RB doubled/VBD increased/VBD incoordination/NN
NH/CD 4/CD Ac/NNS acetate/NN approximately/RB doubled/VBD increased/VBD incoordination/NN
4/CD Ac/NNS acetate/NN approximately/RB doubled/VBD increased/VBD incoordination/NN
Ac/NNS acetate/NN approximately/RB doubled/VBD increased/VBD incoordination/NN
NH/CD 4/CD treatment/NN had/VBD doubled/VBD increased/VBD incoordination/NN
4/CD treatment/NN had/VBD doubled/VBD increased/VBD incoordination/NN
Ac/NN treatment/NN had/VBD doubled/VBD increased/VBD incoordination/NN
diazepam/NN increased/VBD incoordination/NN
NH/CD 4/CD activity/NN analgesia/JJ diazepam/JJ incoordination/NN
4/CD activity/NN analgesia/JJ diazepam/JJ incoordination/NN
Ac/JJ activity/NN analgesia/JJ diazepam/JJ incoordination/NN
NH/JJ verapamil/JJ mg/NN activity/NN analgesia/JJ diazepam/JJ incoordination/NN
4/CD Ac/JJ verapamil/NN mg/NN activity/NN analgesia/JJ diazepam/JJ incoordination/NN
Ac/JJ verapamil/NN mg/NN activity/NN analgesia/JJ diazepam/JJ incoordination/NN
diazepam/JJ incoordination/NN
Hydrocortisone/NNP hypertension/NN
hydrocortisone/NN rise/NN
hydrocortisone/NN rise/NN pressure/NN in/IN
hydrocortisone/NN rise/NN pressure/NN resting/JJ
hydrocortisone/NN rise/NN pressure/NN blood/NN
hydrocortisone/NN rise/NN pressure/NN
lead/NN course/NN expression/NN hypertension/NN
lead/NN rats/NNS increased/VBN reduced/VBN hypertension/NN
lead/NN NOx/NN hypertension/NN
lead/NN hypertension/NN
lead/NN inactivation/NN actions/NNS stress/NN associated/VBN hypertension/NN
Procainamide/NNP induced/VBN tachycardia/NN ventricular/NN
Procainamide/NNP induced/VBN tachycardia/NN
procainamide/NN cases/NNS polymorphous/NNS presented/VBN tachycardia/NN ventricular/NN
procainamide/NN cases/NNS polymorphous/NNS presented/VBN tachycardia/NN
procainamide/NN mg/NN administration/NN appeared/VBD tachycardia/NN ventricular/NN
procainamide/NN mg/NN administration/NN appeared/VBD tachycardia/NN
procainamide/NN mg/NN administration/NN appeared/VBD treatment/NN tachycardia/NN ventricular/NN
procainamide/NN mg/NN administration/NN appeared/VBD treatment/NN tachycardia/NN
procainamide/JJ therapy/NN continuation/NN inserted/VBN polymorphous/VBZ reoccur/VB tachycardia/NN ventricular/NN
procainamide/JJ therapy/NN continuation/NN inserted/VBN polymorphous/VBZ reoccur/VB tachycardia/NN
procainamide/NN produce/VB Q/NN syndrome/NN tachycardia/NN ventricular/NN
procainamide/NN produce/VB Q/NN syndrome/NN tachycardia/NN
Apomorphine/NNP selected/VBN effects/NNS ability/NN induce/VB hypothermia/NN
apomorphine/NN induced/VBN hyperactivity/RB
apomorphine/NN drug/NN hypothermia/NN
dexamethasone/NN induced/VBN hypertension/NN
dexamethasone/NN assess/VB hypertension/NN
dex/NN dexamethasone/NN assess/VB hypertension/NN
dex/NN hypertension/NN
dex/NN 392/CD +/JJ superoxide/NN hypertension/NN
dex/NNPS </NNP 0001/CD 392/CD +/JJ superoxide/NN hypertension/NN
dexamethasone/NN induced/VBN hypertension/NN
Glyceryl/JJ trinitrate/NN induces/VBZ attacks/NNS migraine/NN
Glyceryl/JJ trinitrate/NN induces/VBZ aura/NN without/IN
Glyceryl/JJ trinitrate/NN induces/VBZ aura/NN
trinitrate/NN induces/VBZ attacks/NNS migraine/NN
trinitrate/NN induces/VBZ aura/NN without/IN
trinitrate/NN induces/VBZ aura/NN
nitric/JJ oxide/NN involved/VBN mechanisms/NNS migraine/NN
nitric/JJ oxide/NN involved/VBN aura/NN without/IN
nitric/JJ oxide/NN involved/VBN aura/NN
oxide/NN involved/VBN mechanisms/NNS migraine/NN
oxide/NN involved/VBN aura/NN without/IN
oxide/NN involved/VBN aura/NN
NO/RB oxide/NN involved/VBN mechanisms/NNS migraine/NN
NO/RB oxide/NN involved/VBN aura/NN without/IN
NO/RB oxide/NN involved/VBN aura/NN
bendrofluazide/NN Amelioration/NNP hypokalemia/NN
bendrofluazide/NN treatment/NN hypokalemia/NN
alpha/NN induced/VBN mice/NNS Changes/NNS liver/NN hepatoma/NN
benzene/VBP Changes/NNS liver/NN hepatoma/NN
hexachloride/JJ benzene/VBP Changes/NNS liver/NN hepatoma/NN
alpha/NNS induced/VBN Peroxisomes/NNS lesions/NNS hepatomas/JJ
benzene/JJ hexachloride/NN examined/VBN induced/VBN Peroxisomes/NNS lesions/NNS hepatomas/JJ
hexachloride/NN examined/VBN induced/VBN Peroxisomes/NNS lesions/NNS hepatomas/JJ
succinylcholine/NN apnea/NN
succinylcholine/NN action/NN duration/NN patients/NNS eleven/NNS had/VBD indicating/VBG reason/NN period/NN apnea/NN
prostaglandin/NN E/NN inhibition/NN dose/NN induced/VBN hyperalgesia/NN
E/NN inhibition/NN dose/NN induced/VBN hyperalgesia/NN
2/CD E/NN inhibition/NN dose/NN induced/VBN hyperalgesia/NN
8/CD induced/VBN hyperalgesia/NN
bromo/JJ monophosphate/NN hyperalgesia/NN
cyclic/JJ monophosphate/NN hyperalgesia/NN
adenosine/NN monophosphate/NN hyperalgesia/NN
monophosphate/NN hyperalgesia/NN
haloperidol/NN sensitization/NN impairment/NN cognitive/JJ
haloperidol/NN sensitization/NN impairment/NN
haloperidol/NN administration/NN observed/VBN Impairment/NNP
haloperidol/NN administration/NN observed/VBN Impairment/NNP function/NN of/IN
haloperidol/NN administration/NN observed/VBN Impairment/NNP function/NN cognitive/JJ
haloperidol/NN administration/NN observed/VBN Impairment/NNP function/NN
Haloperidol/NNP produced/VBD profile/NN impairment/NN cognitive/JJ
Haloperidol/NNP produced/VBD profile/NN impairment/NN
methadone/VB associated/VBN movements/NNS Choreoathetoid/JJ
methadone/VB associated/VBN movements/NNS
methadone/VBP report/NN movements/NNS euphoria/NN choreoathetoid/NN
methadone/VBP report/NN movements/NNS
cocaine/NN heroine/NN abusing/VBG methadone/VBP report/NN movements/NNS euphoria/NN choreoathetoid/NN
cocaine/NN heroine/NN abusing/VBG methadone/VBP report/NN movements/NNS
metoclopramide/NN induced/VBN pointes/VBZ de/NNP Torsade/NNP
metoclopramide/NN induced/VBN pointes/VBZ de/NNP
metoclopramide/NN induced/VBN pointes/VBZ
metoclopramide/NN administration/NN developed/VBD pointes/NNS torsade/JJ
metoclopramide/NN administration/NN developed/VBD pointes/NNS de/NNP
metoclopramide/NN administration/NN developed/VBD pointes/NNS
erythromycin/NN cisapride/NN given/VBN pointes/VBZ de/NNP torsade/NNP
erythromycin/NN cisapride/NN given/VBN pointes/VBZ de/NNP
erythromycin/NN cisapride/NN given/VBN pointes/VBZ
cisapride/NN given/VBN pointes/VBZ de/NNP torsade/NNP
cisapride/NN given/VBN pointes/VBZ de/NNP
cisapride/NN given/VBN pointes/VBZ
metoclopramide/JJ provokes/NNS torsade/VBP
metoclopramide/JJ provokes/NNS torsade/VBP clinically/NNS de/IN
metoclopramide/JJ provokes/NNS torsade/VBP clinically/NNS pointes/NN
Metoclopramide/NNP used/VBN patients/NNS risk/NN pointes/NNS torsade/JJ
Metoclopramide/NNP used/VBN patients/NNS risk/NN pointes/NNS de/NNP
Metoclopramide/NNP used/VBN patients/NNS risk/NN pointes/NNS
benzoylecgonine/NN induced/VBN Seizures/NNS
cocaine/NN benzoylecgonine/NN induced/VBN Seizures/NNS
cocaine/NN life/NN short/JJ occur/VB some/DT seizures/NNS
benzoylecgonine/NN cocaine/NN metabolite/NN potential/NN evaluated/VBN cause/VB seizures/NNS
BE/NNP benzoylecgonine/NN cocaine/NN metabolite/NN potential/NN evaluated/VBN cause/VB seizures/NNS
cocaine/NN metabolite/NN potential/NN evaluated/VBN cause/VB seizures/NNS
BE/NNP occurred/VBD seizures/NNS
cocaine/NN amounts/NNS induced/VBN those/DT latencies/NNS had/VBD occurred/VBD seizures/NNS
BE/NNP induced/VBN those/DT prolonged/JJ characterized/VBN cocaine/NN seizures/NNS
cocaine/NN seizures/NNS
BE/NNP rats/NNS have/VB had/VBD seizures/NNS
BE/NNP injected/VBD seizures/NNS
cocaine/NN had/VBD seizures/NNS
cocaine/NN had/VBD have/VB rats/NNS BE/NNP injected/VBD seizures/NNS
BE/JJ cocaine/JJ seizures/NNS
BE/JJ cocaine/JJ seizures/NNS differ/VBP finding/NN suggests/VBZ mechanism/NN seizures/NNS
BE/NNP metabolite/NN importance/NN emphasizes/VBZ suggests/VBZ finding/NN differ/VBP seizures/NNS
BE/NNP metabolite/NN importance/NN emphasizes/VBZ suggests/VBZ mechanism/NN seizures/NNS
cocaine/JJ seizures/NNS
cocaine/JJ seizures/NNS differ/VBP finding/NN suggests/VBZ mechanism/NN seizures/NNS
cocaine/NN mechanism/NN suggests/VBZ finding/NN differ/VBP seizures/NNS
cocaine/NN mechanism/NN seizures/NNS
cocaine/NN metabolite/NN importance/NN emphasizes/VBZ suggests/VBZ finding/NN differ/VBP seizures/NNS
cocaine/NN metabolite/NN importance/NN emphasizes/VBZ suggests/VBZ mechanism/NN seizures/NNS
mazindol/JJ effects/NNS included/VBD appetite/NN symptoms/NNS gastrointestinal/JJ
mazindol/JJ effects/NNS included/VBD appetite/NN symptoms/NNS
mazindol/JJ dosage/NN reduced/VBN included/VBD appetite/NN symptoms/NNS gastrointestinal/JJ
mazindol/JJ dosage/NN reduced/VBN included/VBD appetite/NN symptoms/NNS
mazindol/JJ effects/NNS included/VBD appetite/NN decreased/VBN
mazindol/JJ effects/NNS included/VBD appetite/NN
mazindol/JJ dosage/NN reduced/VBN included/VBD appetite/NN decreased/VBN
mazindol/JJ dosage/NN reduced/VBN included/VBD appetite/NN
mazindol/JJ effects/NNS included/VBD appetite/NN mouth/NN dry/JJ
mazindol/JJ effects/NNS included/VBD appetite/NN mouth/NN
mazindol/JJ dosage/NN reduced/VBN included/VBD appetite/NN mouth/NN dry/JJ
mazindol/JJ dosage/NN reduced/VBN included/VBD appetite/NN mouth/NN
ifosfamide/VBP function/NN impaired/VBN
ifosfamide/VBP function/NN renal/JJ
ifosfamide/VBP function/NN
ifosfamide/VBP anuria/NNP
ifosfamide/JJ sixty/NN developed/VBD anuria/NN
Ifosfamide/NNP drug/NN nephrotoxic/JJ
Ifosfamide/NNP drug/NN tubulopathies/NNS
ifosfamide/VB due/JJ anuria/NN
ifosfamide/NN use/NN recommend/VBP patients/NNS pretreated/VBN chemotherapy/NN nephrotoxic/JJ
lithium/NN Attenuation/NNP diabetes/NNP
lithium/NN Attenuation/NNP diabetes/NNP insipidus/NNS
lithium/NN Attenuation/NNP syndrome/NN like/JJ
lithium/NN Attenuation/NNP syndrome/NN
lithium/NN attenuation/NN diabetes/NNP
lithium/NN attenuation/NN insipidus/NNS
lithium/NN attenuation/NN syndrome/NN like/IN
lithium/NN attenuation/NN syndrome/NN
lithium/NN concentration/NN ratio/NN reduction/NN accompanied/VBN attenuation/NN diabetes/NNP
lithium/NN concentration/NN ratio/NN reduction/NN accompanied/VBN attenuation/NN insipidus/NNS
lithium/NN concentration/NN ratio/NN reduction/NN accompanied/VBN attenuation/NN syndrome/NN like/IN
lithium/NN concentration/NN ratio/NN reduction/NN accompanied/VBN attenuation/NN syndrome/NN
edrophonium/NN min/NN stability/NN provided/VBD kg/NN induced/VBN bradycardias/NNS
edrophonium/NN induced/VBN bradycardias/NNS
pilocarpine/NN neurotransmitters/NNS urea/NNS effects/NNS seizure/NN
pilocarpine/NN rats/NNS seizure/NN
pilocarpine/NN protect/VB finding/NN seizure/NN
pilocarpine/NN reduce/VB finding/NN induced/VBN seizure/NN
pilocarpine/NN observed/VBD partly/RB account/VB induced/VBN finding/NN induced/VBN seizure/NN
desipramine/JJ toxicity/NN tachycardia/NN ventricular/NN
desipramine/JJ toxicity/NN tachycardia/NN
desipramine/JJ toxicity/NN induced/VBN tachycardia/NN ventricular/NN
desipramine/JJ toxicity/NN induced/VBN tachycardia/NN
quinine/NN containing/VBG products/NNS produce/VB complications/NNS confusion/NN
quinine/NN containing/VBG products/NNS produce/VB complications/NNS confusion/NN seizures/NNS
quinine/NN containing/VBG products/NNS produce/VB complications/NNS confusion/NN coma/NN
desipramine/NN IP/VBP produce/VB hypotension/NN
desipramine/NN IP/VBP produce/VB hypotension/NN bradycardia/NN
CaCl/NNP group/NN incidence/NN arrhythmias/NNS ventricular/NN
CaCl/NNP group/NN incidence/NN arrhythmias/NNS
2/CD group/NN incidence/NN arrhythmias/NNS ventricular/NN
2/CD group/NN incidence/NN arrhythmias/NNS
lithium/NN case/NN pathology/NN insipidus/NNS diabetes/NN
lithium/NN case/NN pathology/NN insipidus/NNS
lithium/NN case/NN reported/VBN insipidus/NNS diabetes/NN
lithium/NN case/NN reported/VBN insipidus/NNS
ouabain/NN administration/NN falls/VBZ conclude/VBP disease/NN failure/NN left/VBN
ouabain/NN administration/NN falls/VBZ conclude/VBP disease/NN failure/NN left/VBN end/NN ventricular/NN
ouabain/NN administration/NN falls/VBZ conclude/VBP disease/NN failure/NN left/VBN end/NN
ouabain/NN administration/NN falls/VBZ volume/NN diastolic/JJ
ouabain/NN administration/NN falls/VBZ volume/NN
ouabain/NN administration/NN falls/VBZ
statin/NN therapy/NN associated/VBN myopathy/NN
Statins/NNS cause/VB myopathy/NN
statins/NNS induce/VB myopathy/NN
statins/NNS initiate/VB immune/JJ myopathy/NN
statins/NNS involve/VB uncertain/JJ mechanism/NN myopathy/NN
propofol/JJ controlled/VBN Reduction/NN pain/NN
propofol/NN injection/NN Pain/NNP
propofol/JJ pain/NN
propofol/JJ infusion/NN starting/VBG infusing/VBG prevented/VBN pain/NN
propofol/NN caused/VBN pain/NN
propofol/JJ infusion/NN scale/NN four/CD using/VBG evaluated/VBN pain/NN
propofol/NN TCI/NNP anaesthesia/NN induction/NN achieved/VBN reduction/NN pain/NN
propofol/JJ pain/NN
cyclophosphamide/NN used/VBN damage/NN heart/NN
cyclophosphamide/NN used/VBN damage/NN
mitoxantrone/NN cyclophosphamide/NN used/VBN damage/NN heart/NN
mitoxantrone/NN cyclophosphamide/NN used/VBN damage/NN
warfarin/NN induced/VBN haemorrhage/NN Cerebral/JJ
warfarin/NN induced/VBN haemorrhage/NN
warfarin/NN frequency/NN evaluate/VB induced/VBN due/JJ haemorrhages/NNS cerebral/CD
warfarin/NN frequency/NN evaluate/VB induced/VBN due/JJ haemorrhages/NNS
warfarin/NN due/JJ haemorrhages/NNS cerebral/CD
warfarin/NN due/JJ haemorrhages/NNS
warfarin/NN warfarin/NN due/JJ haemorrhages/NNS cerebral/CD
warfarin/NN warfarin/NN due/JJ haemorrhages/NNS
warfarin/NN evaluate/VB studied/VBN caused/VBN haemorrhage/NN cerebral/JJ
warfarin/NN evaluate/VB studied/VBN caused/VBN haemorrhage/NN
warfarin/NN warfarin/NN evaluate/VB studied/VBN caused/VBN haemorrhage/NN cerebral/JJ
warfarin/NN warfarin/NN evaluate/VB studied/VBN caused/VBN haemorrhage/NN
warfarin/NN related/VBN treatment/NN assessed/VBN patients/NNS haemorrhage/NN cerebral/JJ
warfarin/NN related/VBN treatment/NN assessed/VBN patients/NNS haemorrhage/NN
Warfarin/NNP CONCLUSIONS/NNS problem/NN haemorrhages/NNS cerebral/JJ
Warfarin/NNP CONCLUSIONS/NNS problem/NN haemorrhages/NNS
warfarin/NN proportion/NN prevented/VBN haemorrhages/NNS cerebral/JJ
warfarin/NN proportion/NN prevented/VBN haemorrhages/NNS
warfarin/NN interact/VB known/VBN taken/VBN prevented/VBN haemorrhages/NNS cerebral/JJ
warfarin/NN interact/VB known/VBN taken/VBN prevented/VBN haemorrhages/NNS
scopolamine/JJ induced/VBN amnesia/NN
scopolamine/JJ amnesia/JJ
cocaine/NN microinjected/VBD HT/NNP hyperactivity/NN locomotor/NN
cocaine/NN microinjected/VBD HT/NNP hyperactivity/NN
cocaine/NN induced/VBN locomotor/NN
cocaine/NN induced/VBN hyperactivity/RB
cocaine/NN prior/RB induced/VBN hyperactivity/NN locomotor/NN
cocaine/NN prior/RB induced/VBN hyperactivity/NN
CP/NNP antagonist/NN effects/NNS consisting/VBG modification/NN core/NN shell/NN microinjected/VBD indicate/VBP modified/VBN hyperlocomotion/NN
93129/CD CP/NNP antagonist/NN effects/NNS consisting/VBG modification/NN core/NN shell/NN microinjected/VBD indicate/VBP modified/VBN hyperlocomotion/NN
cocaine/NN hyperlocomotion/NN
ampicillin/NN caused/VBD multiforme/NN myocarditis/NNS hypersensitivity/NN
ampicillin/NN caused/VBD multiforme/NN myocarditis/NNS
ampicillin/NN caused/VBD multiforme/NN Erythema/NNP
ampicillin/NN caused/VBD multiforme/NN
ampicillin/NN caused/VBN multiforme/NN myocarditis/NNS hypersensitivity/NN
ampicillin/NN caused/VBN multiforme/NN myocarditis/NNS
ampicillin/NN caused/VBN multiforme/NN erythema/JJ
ampicillin/NN caused/VBN multiforme/NN
caffeine/NN pretreatment/NN related/VBN case/NN tachycardia/NN ventricular/NN
caffeine/NN pretreatment/NN related/VBN case/NN tachycardia/NN
caffeine/NN used/VBN improve/VB duration/NN seizure/NN
caffeine/NN used/VBN tolerated/VBN reports/NNS ectopy/NN ventricular/NN
caffeine/NN used/VBN tolerated/VBN reports/NNS ectopy/NN
caffeine/NN administration/NN developed/VBD bigeminy/NN runs/NNS tachycardia/NN ventricular/NN
caffeine/NN administration/NN developed/VBD bigeminy/NN runs/NNS tachycardia/NN
heparin/NN therapy/NN receiving/VBG patients/NNS thromboembolism/NN induced/VBN thrombocytopenia/NN
heparin/NN associated/VBN complication/NN thromboembolism/NN induced/VBN thrombocytopenia/NN
heparin/NN therapy/NN initiation/NN days/NNS occurring/VBG ischemia/NN thrombi/NNS occlusion/NN arterial/JJ
heparin/NN therapy/NN initiation/NN days/NNS occurring/VBG ischemia/NN thrombi/NNS occlusion/NN
heparin/NN therapy/NN initiation/NN days/NNS preceded/VBN thrombocytopenia/NN
heparin/NN factor/NN relating/VBG thromboembolism/NN thrombocytopenia/NN
Prostaglandin/NNP E/NNP hyperactivity/NN bladder/NN
Prostaglandin/NNP E/NNP hyperactivity/NN
E/NNP hyperactivity/NN bladder/NN
E/NNP hyperactivity/NN
2/CD E/NNP hyperactivity/NN bladder/NN
2/CD E/NNP hyperactivity/NN
azithromycin/NN induced/VBN nephritis/NNS interstitial/JJ
azithromycin/NN induced/VBN nephritis/NNS
azithromycin/NN recurrent/NN reported/VBN nephritis/NNS interstitial/JJ
azithromycin/NN recurrent/NN reported/VBN nephritis/NNS
L/NNP model/NN analysis/NN DOPA/NNP dyskinesia/NN
DOPA/NNP dyskinesia/NN
L/NNP complications/NNS dyskinesia/NN
DOPA/NNP L/NNP complications/NNS dyskinesia/NN
L/NNP complications/NNS dyskinesia/NN LID/NNP
DOPA/NNP L/NNP complications/NNS dyskinesia/NN LID/NNP
L/NNP treatment/NN arise/VBP complications/NNS dyskinesia/NN
DOPA/NNP arise/VBP complications/NNS dyskinesia/NN
L/NNP treatment/NN arise/VBP complications/NNS dyskinesia/NN LID/NNP
DOPA/NNP arise/VBP complications/NNS dyskinesia/NN LID/NNP
L/NNP treated/VBN allocated/VBN groups/NNS based/VBN presence/NN LID/NNP
DOPA/NNP allocated/VBN groups/NNS based/VBN presence/NN LID/NNP
clozapine/NN threshold/NN agranulocytosis/NNS
clozapine/VB agranulocytosis/NNS
MA/NN induced/VBN hyperthermia/NN
MA/NNP ameliorate/VBP induced/VBN damage/NN neuronal/JJ
MA/NNP ameliorate/VBP induced/VBN damage/NN
haloperidol/NN catalepsy/NN
clonidine/NN treated/VBN subjects/NNS bradycardia/NN
clonidine/NN treated/VBN those/DT treated/VBN subjects/NNS bradycardia/NN
clonidine/NN monitor/VB bradycardia/NN
methotrexate/NN taking/NN co/NN associated/VBN found/VBN common/JJ Impotence/NNP
Chloroquine/JJ block/NN blindness/NN
chloroquine/NN ingestion/NN presented/VBN deterioration/NN dizziness/NN
chloroquine/NN ingestion/NN presented/VBN deterioration/NN fatiguability/JJ
chloroquine/NN ingestion/NN presented/VBN deterioration/NN dizziness/NN progressing/VBG attacks/NNS syncopal/JJ
chloroquine/NN ingestion/NN presented/VBN deterioration/NN dizziness/NN progressing/VBG attacks/NNS
chloroquine/NN ingestion/NN presented/VBN deterioration/NN dyspnoea/NN
chloroquine/JJ retinopathy/NN features/NNS revealed/VBD revealed/VBD features/NNS failure/NN heart/NN
chloroquine/JJ retinopathy/NN features/NNS revealed/VBD revealed/VBD features/NNS failure/NN
chloroquine/JJ retinopathy/NN features/NNS revealed/VBD revealed/VBD pattern/NN right/JJ
chloroquine/JJ retinopathy/NN features/NNS revealed/VBD revealed/VBD pattern/NN bundle/NN
chloroquine/JJ retinopathy/NN features/NNS revealed/VBD revealed/VBD pattern/NN branch/NN
chloroquine/JJ retinopathy/NN features/NNS revealed/VBD revealed/VBD pattern/NN block/NN
chloroquine/JJ retinopathy/NN
chloroquine/JJ discontinuation/NN resolved/VBN failure/NN heart/NN
chloroquine/JJ discontinuation/NN resolved/VBN failure/NN
Oral/VB contraceptives/NNS risk/NN infarction/NN myocardial/JJ
Oral/VB contraceptives/NNS risk/NN infarction/NN
contraceptives/NNS risk/NN infarction/NN myocardial/JJ
contraceptives/NNS risk/NN infarction/NN
oral/JJ contraceptives/NNS use/NN risk/NN infarction/NN myocardial/JJ
oral/JJ contraceptives/NNS use/NN risk/NN infarction/NN
contraceptives/NNS use/NN risk/NN infarction/NN myocardial/JJ
contraceptives/NNS use/NN risk/NN infarction/NN
oral/JJ contraceptives/NNS levonorgestrel/VB dose/NN presence/NN identified/VBD years/NNS had/VBN infarction/NN myocardial/JJ
oral/JJ contraceptives/NNS levonorgestrel/VB dose/NN presence/NN identified/VBD years/NNS had/VBN infarction/NN
contraceptives/NNS levonorgestrel/VB dose/NN presence/NN identified/VBD years/NNS had/VBN infarction/NN myocardial/JJ
contraceptives/NNS levonorgestrel/VB dose/NN presence/NN identified/VBD years/NNS had/VBN infarction/NN
oral/JJ contraceptives/NNS levonorgestrel/VB 925/VB women/NNS had/VBN infarction/NN myocardial/JJ
oral/JJ contraceptives/NNS levonorgestrel/VB 925/VB women/NNS had/VBN infarction/NN
contraceptives/NNS levonorgestrel/VB 925/VB women/NNS had/VBN infarction/NN myocardial/JJ
contraceptives/NNS levonorgestrel/VB 925/VB women/NNS had/VBN infarction/NN
oral/JJ contraceptive/NN type/NN used/VBD women/NNS infarction/NN myocardial/JJ
oral/JJ contraceptive/NN type/NN used/VBD women/NNS infarction/NN
contraceptive/NN type/NN used/VBD women/NNS infarction/NN myocardial/JJ
contraceptive/NN type/NN used/VBD women/NNS infarction/NN
oral/JJ contraceptives/NNS generation/NN women/NNS increased/VBN risk/NN infarction/NN myocardial/JJ
oral/JJ contraceptives/NNS generation/NN women/NNS increased/VBN risk/NN infarction/NN
contraceptives/NNS generation/NN women/NNS increased/VBN risk/NN infarction/NN myocardial/JJ
contraceptives/NNS generation/NN women/NNS increased/VBN risk/NN infarction/NN
oral/JJ contraceptives/NNS used/VBD women/NNS similar/JJ risk/NN infarction/NN myocardial/JJ
oral/JJ contraceptives/NNS used/VBD women/NNS similar/JJ risk/NN infarction/NN
contraceptives/NNS used/VBD women/NNS similar/JJ risk/NN infarction/NN myocardial/JJ
contraceptives/NNS used/VBD women/NNS similar/JJ risk/NN infarction/NN
hepatitis/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN screening/NN B/NNP hepatitis/NNP
hepatitis/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN screening/NN B/NNP
B/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN screening/NN B/NNP hepatitis/NNP
B/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN screening/NN B/NNP
surface/NN antigen/NN born/VBN infants/NNS done/VBN following/NN screening/NN B/NNP hepatitis/NNP
surface/NN antigen/NN born/VBN infants/NNS done/VBN following/NN screening/NN B/NNP
antigen/NN born/VBN infants/NNS done/VBN following/NN screening/NN B/NNP hepatitis/NNP
antigen/NN born/VBN infants/NNS done/VBN following/NN screening/NN B/NNP
hepatitis/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN dose/NN hepatitis/NNP
hepatitis/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN dose/NN B/NNP
B/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN dose/NN hepatitis/NNP
B/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN dose/NN B/NNP
surface/NN antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN dose/NN hepatitis/NNP
surface/NN antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN dose/NN B/NNP
antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN dose/NN hepatitis/NNP
antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN dose/NN B/NNP
hepatitis/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN globulin/NN hepatitis/NNP
hepatitis/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN globulin/NN B/NNP
B/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN globulin/NN hepatitis/NNP
B/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN globulin/NN B/NNP
surface/NN antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN globulin/NN hepatitis/NNP
surface/NN antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN globulin/NN B/NNP
antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN globulin/NN hepatitis/NNP
antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN globulin/NN B/NNP
hepatitis/NNP antigen/NN born/VBN infants/NNS received/VBD globulin/NN hepatitis/NNP
hepatitis/NNP antigen/NN born/VBN infants/NNS received/VBD globulin/NN B/NNP
B/NNP antigen/NN born/VBN infants/NNS received/VBD globulin/NN hepatitis/NNP
B/NNP antigen/NN born/VBN infants/NNS received/VBD globulin/NN B/NNP
surface/NN antigen/NN born/VBN infants/NNS received/VBD globulin/NN hepatitis/NNP
surface/NN antigen/NN born/VBN infants/NNS received/VBD globulin/NN B/NNP
antigen/NN born/VBN infants/NNS received/VBD globulin/NN hepatitis/NNP
antigen/NN born/VBN infants/NNS received/VBD globulin/NN B/NNP
atracurium/NN use/NN Persistent/VB paralysis/NN
vecuronium/NN bromide/NN NMBAs/NNS aminosteroid/JJ involved/VBN Reports/NNS paralysis/NN
bromide/NN NMBAs/NNS aminosteroid/JJ involved/VBN Reports/NNS paralysis/NN
Atracurium/JJ besylate/NN associated/VBN paralysis/NN
besylate/NN associated/VBN paralysis/NN
atracurium/NN case/NN paralysis/NN
enflurane/JJ anesthetics/NNS associated/VBN allergic/NN injury/NN hepatic/JJ
enflurane/JJ anesthetics/NNS associated/VBN allergic/NN injury/NN
halothane/NN exposure/NN both/DT injury/NN hepatic/JJ
halothane/NN exposure/NN both/DT injury/NN
isoflurane/JJ enflurane/JJ anesthetics/NNS associated/VBN allergic/NN injury/NN hepatic/JJ
isoflurane/JJ enflurane/JJ anesthetics/NNS associated/VBN allergic/NN injury/NN
Halothane/NNP hepatitis/NNP
halothane/JJ patients/NNS hepatitis/NN
enflurane/NN produce/VB similar/JJ that/DT hepatitis/NN
halothane/JJ hepatitis/NN
halothane/JJ administration/NN subsequent/JJ produce/VB similar/JJ that/DT hepatitis/NN
isoflurane/NN //NN enflurane/NN produce/VB similar/JJ that/DT hepatitis/NN
Myocet/NNP improves/VBZ index/NN doxorubicin/NN reducing/VBG neutropenia/NN
doxorubicin/NN reducing/VBG neutropenia/NN
cyclophosphamide/NN used/VBN provides/VBZ improves/VBZ index/NN doxorubicin/NN reducing/VBG neutropenia/NN
puromycin/NN aminonucleoside/NN antithrombin/NN effects/NNS nephrosis/VBZ
aminonucleoside/NN antithrombin/NN effects/NNS nephrosis/VBZ
puromycin/NN aminonucleoside/NN rats/NNS nephrosis/NNS
aminonucleoside/NN rats/NNS nephrosis/NNS
apomorphine/VBN had/VBN induced/VBN erection/JJ penile/JJ
apomorphine/VBN had/VBN induced/VBN erection/JJ
epinephrine/NN use/NN associated/VBN bleeding/NN intracranial/JJ
epinephrine/NN use/NN associated/VBN bleeding/NN
Epinephrine/NNP has/VBZ role/NN arrest/NN cardiac/JJ
Epinephrine/NNP has/VBZ role/NN arrest/NN
oral/JJ contraceptives/NNS taking/VBG woman/NN reported/VBN syndrome/NN uremic/JJ hemolytic/JJ
oral/JJ contraceptives/NNS taking/VBG woman/NN reported/VBN syndrome/NN uremic/JJ
oral/JJ contraceptives/NNS taking/VBG woman/NN reported/VBN syndrome/NN
contraceptives/NNS taking/VBG woman/NN reported/VBN syndrome/NN uremic/JJ hemolytic/JJ
contraceptives/NNS taking/VBG woman/NN reported/VBN syndrome/NN uremic/JJ
contraceptives/NNS taking/VBG woman/NN reported/VBN syndrome/NN
oral/JJ contraceptives/NNS taking/VBG woman/NN reported/VBN syndrome/NN HUS/NNP
contraceptives/NNS taking/VBG woman/NN reported/VBN syndrome/NN HUS/NNP
verapamil/NN fibrillation/NN atrial/JJ
verapamil/NN fibrillation/NN
verapamil/JJ administered/VBZ evaluate/VB mechanisms/NNS promotion/NN AF/NNP
Verapamil/NNP caused/VBD promotion/NN AF/NNP
Verapamil/NNP caused/VBD increasing/VBG mean/VB duration/NN induced/NNP AF/NNP
verapamil/JJ shortened/NNS mean/VBP decreased/VBD AF/NNP
verapamil/NN caused/VBN that/DT similar/JJ produced/VBD affect/VB ERP/NNP length/NN AF/NNP
verapamil/NN caused/VBN that/DT similar/JJ produced/VBD affect/VB ERP/NNP duration/NNP AF/NNP
verapamil/NN failed/VBD promote/VB AF/NNP
verapamil/NN promoted/VBN AF/NNP
Verapamil/NNP AF/NNP
amphotericin/NN Recurrent/VB failure/NN acute/JJ
amphotericin/NN Recurrent/VB failure/NN renal/JJ
amphotericin/NN Recurrent/VB failure/NN
amphotericin/NNP B/NNP administration/NN developed/VBD failure/NN acute/JJ
amphotericin/NNP B/NNP administration/NN developed/VBD failure/NN renal/JJ
amphotericin/NNP B/NNP administration/NN developed/VBD failure/NN
B/NNP administration/NN developed/VBD failure/NN acute/JJ
B/NNP administration/NN developed/VBD failure/NN renal/JJ
B/NNP administration/NN developed/VBD failure/NN
amphotericin/NN activate/VB contributing/VBG failure/NN acute/JJ
amphotericin/NN activate/VB contributing/VBG failure/NN renal/JJ
amphotericin/NN activate/VB contributing/VBG failure/NN
pilocarpine/VB reported/VBN seizures/NNS model/NN epilepsy/NN temporal/JJ
pilocarpine/VB reported/VBN seizures/NNS model/NN epilepsy/NN lobe/NN
pilocarpine/VB reported/VBN seizures/NNS model/NN epilepsy/NN
cis/NN predicted/VBN included/VBD hypercalcemia/NN
RA/NNP levels/NNS cis/NN predicted/VBN included/VBD hypercalcemia/NN
lithium/NN Ebstein/NNP
lithium/NN Ebstein/NNP '/POS
lithium/NN anomaly/NN s/JJ
lithium/NN anomaly/NN
cocaine/NN nephritis/NNS Henoch/NNP related/VBN failure/NN acute/JJ
cocaine/NN nephritis/NNS Henoch/NNP related/VBN failure/NN renal/JJ
cocaine/NN nephritis/NNS Henoch/NNP related/VBN failure/NN
cocaine/NN expression/NN critical/JJ induced/VBN anxiety/NN
cocaine/NN effects/NNS studied/VBN paid/VBN states/NNS anxiety/NN
cocaine/NN induced/VBN states/NNS anxiety/NN
cocaine/NN examine/VB lack/VBP mice/NNS performance/NN induced/VBN anxiety/NN
cocaine/NN dose/NN anxiety/NN
Cocaine/NNP induced/VBN attenuated/VBN anxiety/NN
cocaine/NN antagonist/NN anxiety/NN
cocaine/NN required/VBN indicate/VB induced/VBN anxiety/NN
echothiophate/JJ drops/NNS use/NN developed/VBD presented/VBD weakness/NN muscle/NN
echothiophate/JJ drops/NNS use/NN developed/VBD presented/VBD weakness/NN
iodide/JJ drops/NNS use/NN developed/VBD presented/VBD weakness/NN muscle/NN
iodide/JJ drops/NNS use/NN developed/VBD presented/VBD weakness/NN
capsaicin/NN induced/VBN effects/NNS ketamine/NN lidocaine/NN hyperalgesia/NN
capsaicin/NN induced/VBN administration/NN hyperalgesia/NN ketamine/JJ lidocaine/JJ brush/NN pain/NN
capsaicin/NN induced/VBN administration/NN hyperalgesia/NN
levodopa/JJ pallidotomy/JJ dyskinesias/NNS
levodopa/JJ pallidotomy/JJ dyskinesias/NNS LID/NNP
levodopa/NN responsiveness/NNS found/VBD was/VBD correlation/NN improvement/NN LID/NNP
levodopa/NN responsiveness/NNS responsiveness/NNS found/VBD was/VBD correlation/NN improvement/NN LID/NNP
levodopa/NN responsiveness/NNS outcome/NN signs/NNS LID/NNP
levodopa/NN responsiveness/NNS outcome/NN correlations/NNS volume/NN dyskinesias/NNS
levodopa/NN responsiveness/NNS value/NN indicate/VBP dyskinesias/VBZ
vigabatrin/NN patients/NNS electroretinography/NN oculography/NN Electro/NNP attributed/VBD constriction/NN visual/JJ
vigabatrin/NN patients/NNS electroretinography/NN oculography/NN Electro/NNP attributed/VBD constriction/NN field/NN
vigabatrin/NN patients/NNS electroretinography/NN oculography/NN Electro/NNP attributed/VBD constriction/NN
vigabatrin/NN associated/VBN thought/VBN constriction/NN visual/JJ
vigabatrin/NN associated/VBN thought/VBN constriction/NN field/NN
vigabatrin/NN associated/VBN thought/VBN constriction/NN
vigabatrin/NN patients/NNS fields/NNS attributed/VBD loss/NN visual/JJ
vigabatrin/NN patients/NNS fields/NNS attributed/VBD loss/NN field/NN
vigabatrin/NN patients/NNS fields/NNS attributed/VBD loss/NN
vigabatrin/NN therapy/NN associated/VBN appears/VBZ constriction/NN visual/JJ
vigabatrin/NN therapy/NN associated/VBN appears/VBZ constriction/NN field/NN
vigabatrin/NN therapy/NN associated/VBN appears/VBZ constriction/NN
D/NNP caused/VBD syndrome/NN nephrotic/JJ
D/NNP caused/VBD syndrome/NN
Penicillamine/NNP caused/VBD syndrome/NN nephrotic/JJ
Penicillamine/NNP caused/VBD syndrome/NN
D/NNP caused/VBD proteinuria/NN
Penicillamine/NNP caused/VBD proteinuria/NN
fluoxetine/JJ hydrochloride/NN induced/VBN hyperprolactinemia/NN
hydrochloride/NN induced/VBN hyperprolactinemia/NN
fluoxetine/JJ hydrochloride/NN induced/VBN hyperprolactinemia/NN effects/NNS model/NN adenomyosis/NNS
hydrochloride/NN induced/VBN hyperprolactinemia/NN effects/NNS model/NN adenomyosis/NNS
fluoxetine/JJ hydrochloride/NN induced/VBN induction/NN adenomyosis/JJ
hydrochloride/NN induced/VBN induction/NN adenomyosis/JJ
fluoxetine/NN caused/VBD hyperprolactinemia/NN
fluoxetine/NN caused/VBD adenomyosis/NNS
Fluoxetine/NNP given/VBN produce/VB hyperprolactinemia/NN
fluoxetine/NN receiving/VBG group/NN revealed/VBD cases/NNS adenomyosis/NNS
azidothymidine/NN mice/NNS anemia/NN
Azidothymidine/NNP anemia/NN
AZT/NNP Azidothymidine/NNP anemia/NN
dipivalyl/NN thrombosis/NNS vein/NN
dipivalyl/NN thrombosis/NNS
epinephrine/VBP thrombosis/NNS vein/NN
epinephrine/VBP thrombosis/NNS
dipivalyl/JJ epinephrine/NN started/VBN day/NN seeing/VBG acquired/VBD thrombosis/NNS vein/NN
dipivalyl/JJ epinephrine/NN started/VBN day/NN seeing/VBG acquired/VBD thrombosis/NNS
epinephrine/NN started/VBN day/NN seeing/VBG acquired/VBD thrombosis/NNS vein/NN
epinephrine/NN started/VBN day/NN seeing/VBG acquired/VBD thrombosis/NNS
verapamil/NN therapy/NN hypotension/NN bradycardia/NN
verapamil/NN therapy/NN hypotension/NN adrenergic/JJ failure/NN cardiac/JJ
verapamil/NN therapy/NN hypotension/NN adrenergic/JJ failure/NN
beta/NN verapamil/NN therapy/NN hypotension/NN bradycardia/NN
adrenergic/JJ hypotension/NN bradycardia/NN
blocking/VBG developed/VBD failure/NN adrenergic/JJ hypotension/NN bradycardia/NN
drugs/NNS blocking/VBG developed/VBD failure/NN adrenergic/JJ hypotension/NN bradycardia/NN
verapamil/NN therapy/NN hypotension/NN
beta/NN verapamil/NN therapy/NN hypotension/NN
adrenergic/JJ hypotension/NN
blocking/VBG developed/VBD failure/NN adrenergic/JJ hypotension/NN
drugs/NNS blocking/VBG developed/VBD failure/NN adrenergic/JJ hypotension/NN
beta/NN verapamil/NN therapy/NN hypotension/NN adrenergic/JJ failure/NN cardiac/JJ
beta/NN verapamil/NN therapy/NN hypotension/NN adrenergic/JJ failure/NN
adrenergic/JJ failure/NN cardiac/JJ
adrenergic/JJ failure/NN
blocking/VBG developed/VBD failure/NN cardiac/JJ
blocking/VBG developed/VBD failure/NN
drugs/NNS blocking/VBG developed/VBD failure/NN cardiac/JJ
drugs/NNS blocking/VBG developed/VBD failure/NN
prazosin/NN blockade/NN 2/CD occurs/VBZ hypotension/NN Orthostatic/JJ
prazosin/NN blockade/NN 2/CD occurs/VBZ hypotension/NN
prazosin/NN treated/VBN hypotension/NN orthostatic/JJ
prazosin/NN treated/VBN hypotension/NN
prazosin/NN dosing/NN performed/VBD produce/VB hypotension/NN orthostatic/JJ
prazosin/NN dosing/NN performed/VBD produce/VB hypotension/NN
Abbott/NNP responses/NNS bradycardia/NN
53693/CD Abbott/NNP responses/NNS bradycardia/NN
noradrenaline/NN i/NNS micrograms/NNS responses/NNS bradycardia/NN
cirazoline/NN responses/NNS bradycardia/NN
cirazoline/NN effects/NNS bradycardia/NN
Abbott/NNP effects/NNS similar/JJ greater/JJR bradycardia/NN
53693/CD Abbott/NNP effects/NNS similar/JJ greater/JJR bradycardia/NN
noradrenaline/NN accompanied/VBD bradycardia/NN
iron/NN dextran/NN infusion/NN associated/VBN syndrome/NN Value/NNP methylprednisolone/NN prevention/NN arthralgia/NN
dextran/NN infusion/NN associated/VBN syndrome/NN Value/NNP methylprednisolone/NN prevention/NN arthralgia/NN
amphetamine/JJ use/NN setting/NN woman/NN syndrome/NN left/VBD
amphetamine/JJ use/NN setting/NN woman/NN syndrome/NN ventricular/JJ
amphetamine/JJ use/NN setting/NN woman/NN syndrome/NN apical/NN
amphetamine/JJ use/NN setting/NN woman/NN syndrome/NN ballooning/VBG
amphetamine/JJ use/NN setting/NN woman/NN syndrome/NN
amphetamine/JJ use/NN setting/NN woman/NN syndrome/NN cardiomyopathy/NN Takotsubo/JJ
amphetamine/JJ use/NN setting/NN woman/NN syndrome/NN cardiomyopathy/NN
amphetamine/JJ use/NN occurring/VBG syndrome/NN apical/NN
amphetamine/JJ use/NN occurring/VBG syndrome/NN ballooning/VBG
amphetamine/JJ use/NN occurring/VBG syndrome/NN
flumazenil/JJ administration/NN Seizure/VB
flumazenil/NN administration/NN patient/NN seizure/NN occurrence/NN tonic/NN
flumazenil/NN administration/NN patient/NN seizure/NN clonic/JJ
flumazenil/NN administration/NN patient/NN seizure/NN
nitrendipine/VBP nephrosclerosis/NNS
nitrendipine/NN treatment/NN effect/NN angiotensin/NN converting/VBG pressure/NN albuminuria/NN
nitrendipine/NN treated/VBN albuminuria/NN
thiopentone/RB 4/CD mg/NN that/DT Somewhat/VB slower/JJR i/FW found/VBN lasted/VBD occurred/VBD apnoea/NN
midazolam/NNP mg/NN effect/NN inducing/VBG sleep/NN kg/VBP found/VBN lasted/VBD occurred/VBD apnoea/NN
midazolam/NN group/NN found/VBN lasted/VBD occurred/VBD apnoea/NN
midazolam/NN group/NN occurred/VBD apnoea/NN
amikacin/NN receiving/VBG patients/NNS associated/VBN outcome/NN nephrotoxicity/JJ
amikacin/NN treated/VBN patients/NNS Data/NNP analyzed/VBN factors/NNS associated/VBN nephrotoxicity/NN
Perhexiline/VB maleate/NN neuropathy/NN peripheral/JJ
Perhexiline/VB maleate/NN neuropathy/NN
maleate/NN neuropathy/NN peripheral/JJ
maleate/NN neuropathy/NN
perhexiline/JJ maleate/NN noted/VBN neuropathy/NNP Peripheral/NNP
perhexiline/JJ maleate/NN noted/VBN neuropathy/NNP
maleate/NN noted/VBN neuropathy/NNP Peripheral/NNP
maleate/NN noted/VBN neuropathy/NNP
malondialdehyde/NN dependence/NN oxypurines/VBZ nucleosides/VBZ ischemia/NN cerebral/JJ
malondialdehyde/NN dependence/NN oxypurines/VBZ nucleosides/VBZ ischemia/NN
levodopa/NN Improvement/NNP dyskinesia/NN
levodopa/NN improve/VB induced/VBN dyskinesia/NN
nifedipine/NN induced/VBN telangiectasia/NN
nifedipine/NN starting/VBG months/NNS developed/VBD telangiectasia/NN
Adalat/NNP nifedipine/NN starting/VBG months/NNS developed/VBD telangiectasia/NN
amlodipine/NN commenced/VBD recurrence/NN telangiectasia/NN
nondepolarizing/VBG blocking/VBG implicated/VBN cause/NN weakness/NN muscle/NN
nondepolarizing/VBG blocking/VBG implicated/VBN cause/NN weakness/NN
neuromuscular/NN nondepolarizing/VBG blocking/VBG implicated/VBN cause/NN weakness/NN muscle/NN
neuromuscular/NN nondepolarizing/VBG blocking/VBG implicated/VBN cause/NN weakness/NN
blocking/VBG implicated/VBN cause/NN weakness/NN muscle/NN
blocking/VBG implicated/VBN cause/NN weakness/NN
agents/NNS implicated/VBN cause/NN weakness/NN muscle/NN
agents/NNS implicated/VBN cause/NN weakness/NN
ND/NNP agents/NNS implicated/VBN cause/NN weakness/NN muscle/NN
ND/NNP agents/NNS implicated/VBN cause/NN weakness/NN
NMBA/NNP ND/NNP agents/NNS implicated/VBN cause/NN weakness/NN muscle/NN
NMBA/NNP ND/NNP agents/NNS implicated/VBN cause/NN weakness/NN
ND/NNP discontinuation/NN weakness/NN
NMBAs/VBZ patients/NNS insufficiency/NN developed/VBD weakness/NN
ND/NNP likely/JJ junction/NN pathology/VB due/JJ weakness/NN
NMBA/NNP ND/NNP likely/JJ junction/NN pathology/VB due/JJ weakness/NN
ND/NNP likely/JJ junction/NN pathology/VB
ND/NNP likely/JJ junction/NN at/IN
ND/NNP likely/JJ junction/NN both/PDT
ND/NNP likely/JJ junction/NN the/DT
ND/NNP likely/JJ junction/NN neuromuscular/NN
ND/NNP likely/JJ junction/NN
NMBA/NNP ND/NNP likely/JJ junction/NN pathology/VB
NMBA/NNP ND/NNP likely/JJ junction/NN at/IN
NMBA/NNP ND/NNP likely/JJ junction/NN both/PDT
NMBA/NNP ND/NNP likely/JJ junction/NN the/DT
NMBA/NNP ND/NNP likely/JJ junction/NN neuromuscular/NN
NMBA/NNP ND/NNP likely/JJ junction/NN
doxorubicin/NN cycle/NN fibrillation/NN atrial/JJ
doxorubicin/NN cycle/NN fibrillation/NN
scopolamine/NN improve/VB decline/NN cognitive/JJ
scopolamine/NN improve/VB decline/NN
scopolamine/NNP overdosage/NN
hyoscine/NN overdosage/NN
ouabain/NN injection/NN intermittent/VBG induced/VBN arrhythmia/NN
adrenaline/JJ infusion/NN induced/VBN arrhythmia/NN Adrenaline/JJ
adrenaline/JJ infusion/NN induced/VBN arrhythmia/NN
adrenaline/JJ digitalis/JJ cibenzoline/VBP arrhythmias/NNS
adrenaline/JJ digitalis/JJ arrhythmias/NNS
adrenaline/NN suppress/VB needed/VBN dose/NN -/NNP cibenzoline/NN suppressed/VBN induced/VBN v/JJ arrhythmia/NN
adrenaline/NN arrhythmias/NNS
adrenaline/JJ digitalis/JJ arrhythmia/NNP
thiopental/NN produced/VBD involvement/NN reversal/NN paralysis/NN respiratory/JJ
thiopental/NN produced/VBD involvement/NN reversal/NN paralysis/NN
thiopental/NN induced/VBN paralysis/NN respiratory/JJ
thiopental/NN induced/VBN paralysis/NN
thiopental/NN produced/VBN paralysis/NN respiratory/JJ
thiopental/NN produced/VBN paralysis/NN
nitrazepam/NN overdose/NN
nitrazepam/NN overdose/NN
chlormethiazole/JJ intoxication/NN those/DT two/CD patient/NN conformed/VBD coma/NN
nitrazepam/NN overdose/NN patient/NN conformed/VBD coma/NN
morphine/NN modulators/NNS Effect/NN increase/NN
morphine/NN modulators/NNS Effect/NN increase/NN activity/NN in/IN
morphine/NN modulators/NNS Effect/NN increase/NN activity/NN locomotor/NN
morphine/NN modulators/NNS Effect/NN increase/NN activity/NN
morphine/NN modulators/NNS increase/NN
morphine/NN modulators/NNS increase/NN activity/NN in/IN
morphine/NN modulators/NNS increase/NN activity/NN locomotor/NN
morphine/NN modulators/NNS increase/NN activity/NN
morphine/NN kg/VBN administration/NN produced/VBD increase/NN
morphine/NN kg/VBN administration/NN produced/VBD activity/NN in/IN
morphine/NN kg/VBN administration/NN produced/VBD activity/NN locomotor/NN
morphine/NN kg/VBN administration/NN produced/VBD activity/NN
morphine/NN potentiated/VBN hyperactivity/RB
scopolamine/NN potentiated/VBN hyperactivity/RB
morphine/NN produced/VBN hyperactivity/NN
chondroitin/JJ sulfate/JJ derivative/NN elicit/VB response/NN hypotensive/JJ
sulfate/JJ derivative/NN elicit/VB response/NN hypotensive/JJ
zonisamide/NN associated/VBN hallucinations/NNS Visual/JJ
zonisamide/NN associated/VBN hallucinations/NNS
zonisamide/JJ treatment/NN begun/VBN experienced/VBD patients/NNS describe/VBP reported/VBN hallucinations/NNS visual/JJ
zonisamide/JJ treatment/NN begun/VBN experienced/VBD patients/NNS describe/VBP reported/VBN hallucinations/NNS
zonisamide/JJ treatment/NN begun/VBN experienced/VBD hallucinations/NNS visual/JJ
zonisamide/JJ treatment/NN begun/VBN experienced/VBD hallucinations/NNS
Topiramate/NNP induced/VBN nephrolithiasis/NNS
topiramate/NN cases/NNS nephrolithiasis/NNS
Phenobarbitone/NNP enlargement/NN
Phenobarbitone/NNP enlargement/NN liver/NN of/IN
Phenobarbitone/NNP enlargement/NN liver/NN the/DT
Phenobarbitone/NNP enlargement/NN liver/NN
carbon/NN tetrachloride/NN yield/NN cirrhosis/NNS
carbon/NN tetrachloride/NN yield/NN cirrhosis/NNS liver/NN of/IN
carbon/NN tetrachloride/NN yield/NN cirrhosis/NNS liver/NN the/DT
carbon/NN tetrachloride/NN yield/NN cirrhosis/NNS liver/NN
tetrachloride/NN yield/NN cirrhosis/NNS
tetrachloride/NN yield/NN cirrhosis/NNS liver/NN of/IN
tetrachloride/NN yield/NN cirrhosis/NNS liver/NN the/DT
tetrachloride/NN yield/NN cirrhosis/NNS liver/NN
carbon/NN tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS
carbon/NN tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS liver/NN of/IN
carbon/NN tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS liver/NN the/DT
carbon/NN tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS liver/NN
tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS
tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS liver/NN of/IN
tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS liver/NN the/DT
tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS liver/NN
phenobarbitone/NN given/VBN induced/VBN enlargement/NN
phenobarbitone/NN given/VBN induced/VBN enlargement/NN liver/NN of/IN
phenobarbitone/NN given/VBN induced/VBN enlargement/NN liver/NN the/DT
phenobarbitone/NN given/VBN induced/VBN enlargement/NN liver/NN
phenobarbitone/NN peak/NN giving/VBG increased/VBN primed/VBN given/VBN induced/VBN enlargement/NN
phenobarbitone/NN peak/NN giving/VBG increased/VBN primed/VBN given/VBN induced/VBN enlargement/NN liver/NN of/IN
phenobarbitone/NN peak/NN giving/VBG increased/VBN primed/VBN given/VBN induced/VBN enlargement/NN liver/NN the/DT
phenobarbitone/NN peak/NN giving/VBG increased/VBN primed/VBN given/VBN induced/VBN enlargement/NN liver/NN
phenobarbitone/NN given/VBN yield/NN cirrhosis/NNS
phenobarbitone/NN given/VBN yield/NN cirrhosis/NNS liver/NN of/IN
phenobarbitone/NN given/VBN yield/NN cirrhosis/NNS liver/NN the/DT
phenobarbitone/NN given/VBN yield/NN cirrhosis/NNS liver/NN
phenobarbitone/NN peak/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS
phenobarbitone/NN peak/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS liver/NN of/IN
phenobarbitone/NN peak/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS liver/NN the/DT
phenobarbitone/NN peak/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS liver/NN
ceftriaxone/NN induced/VBN hepatitis/NNP
ceftriaxone/NN induced/VBN hepatitis/NNP anemia/NN autoimmune/JJ
ceftriaxone/NN induced/VBN hepatitis/NNP anemia/NN hemolytic/JJ
ceftriaxone/NN induced/VBN hepatitis/NNP anemia/NN
ceftriaxone/NN ingesting/VBG developed/VBN hepatitis/NN
ouabain/NN arrhythmia/NN
levofloxacin/NN associated/VBN Seizures/NNS
levofloxacin/NN drug/NN initiating/VBG developed/VBD seizures/NNS
levofloxacin/NN drug/NN levofloxacin/NN induced/VBN seizures/NNS
levofloxacin/NN drug/NN initiating/VBG developed/VBD seizures/NNS
levofloxacin/NN induced/VBN seizures/NNS
levofloxacin/NN cases/NNS RESULTS/NNS induced/VBD reported/VBN seizures/NNS
ethinyl/JJ estradiol/NN acid/NN hydroxylation/NN sulfation/NN cholestasis/NNS
estradiol/NN acid/NN hydroxylation/NN sulfation/NN cholestasis/NNS
chlorthalidone/JJ phase/NN associated/VBN frequency/NN beats/NNS ventricular/JJ
chlorthalidone/JJ phase/NN associated/VBN frequency/NN beats/NNS ectopic/JJ
chlorthalidone/JJ phase/NN associated/VBN frequency/NN beats/NNS
amiodarone/JJ pneumonitis/NNS
amiodarone/NN withdrawal/NN need/NN diagnosis/NN pneumonitis/NNS
bupivacaine/NN develop/VB loss/NN hearing/NN
bupivacaine/NN develop/VB loss/NN
prilocaine/JJ given/VBN Patients/NNS likely/JJ develop/VB loss/NN hearing/NN
prilocaine/JJ given/VBN Patients/NNS likely/JJ develop/VB loss/NN
bupivacaine/NN dB/VBN loss/NN hearing/NN
bupivacaine/NN dB/VBN loss/NN
prilocaine/NN dB/VBN loss/NN hearing/NN
prilocaine/NN dB/VBN loss/NN
risperidone/NN treated/VBN subjects/NNS observed/VBN Drug/NNP
risperidone/NN treated/VBN subjects/NNS observed/VBN parkinsonism/NNP induced/NNP
risperidone/NN treated/VBN subjects/NNS observed/VBN parkinsonism/NNP
haloperidol/NN risperidone/NN treated/VBN subjects/NNS observed/VBN Drug/NNP
haloperidol/NN risperidone/NN treated/VBN subjects/NNS observed/VBN parkinsonism/NNP induced/NNP
haloperidol/NN risperidone/NN treated/VBN subjects/NNS observed/VBN parkinsonism/NNP
tacrolimus/NNS cyclosporine/NN known/VBN nephrotoxic/JJ
cyclosporine/NN known/VBN nephrotoxic/JJ
pilocarpine/JJ model/NN epilepsy/NN temporal/JJ
pilocarpine/JJ model/NN epilepsy/NN lobe/NN
pilocarpine/JJ model/NN epilepsy/NN
quinine/NN ingestion/NN associated/VBN syndrome/NN Hemolytic/NNP
quinine/NN ingestion/NN associated/VBN syndrome/NN uremic/JJ
quinine/NN ingestion/NN associated/VBN syndrome/NN
quinine/JJ ingestion/NN syndrome/NN Hemolytic/NNP
quinine/JJ ingestion/NN syndrome/NN uremic/JJ
quinine/JJ ingestion/NN syndrome/NN
Quinine/RB occurs/VBZ associated/VBN hemolytic/JJ
Quinine/RB occurs/VBZ syndrome/NN uremic/JJ
Quinine/RB occurs/VBZ syndrome/NN
isoflurane/NN function/NN hypotension/NN
isoflurane/NN effect/NN hypotension/NN
isoflurane/JJ inspired/JJ concentration/NN increasing/VBG min/JJ //NNS 236/NNP induced/VBN Hypotension/NNP
isoflurane/NN induced/VBN hypotension/NN
labetalol/NN induced/VBN Effects/NNPS hypotension/NN
isoflurane/NN induced/VBN Effects/NNPS hypotension/NN
labetalol/NN induced/VBN hypotension/NN
labetalol/NN induced/VBN isoflurane/NN group/NN hypotensive/JJ
isoflurane/NN induced/VBN hypotension/NN
isoflurane/NN group/NN hypotensive/JJ
labetalol/NN induced/VBN hypotension/NN
isoflurane/NN induced/VBN hypotension/NN
phenacetin/NN comparison/NN use/NN acetaminophen/NN factor/NN failure/NN chronic/JJ
phenacetin/NN comparison/NN use/NN acetaminophen/NN factor/NN failure/NN renal/JJ
phenacetin/NN comparison/NN use/NN acetaminophen/NN factor/NN failure/NN
phenacetin/NN use/NN associated/VBN development/NN failure/NN chronic/JJ
phenacetin/NN use/NN associated/VBN development/NN failure/NN renal/JJ
phenacetin/NN use/NN associated/VBN development/NN failure/NN
phenacetin/NN use/NN associated/VBN development/NN failure/NN end/NN
phenacetin/NN use/NN associated/VBN development/NN failure/NN disease/NN stage/NN
phenacetin/NN use/NN associated/VBN development/NN failure/NN disease/NN renal/JJ
phenacetin/NN use/NN associated/VBN development/NN failure/NN disease/NN
phenacetin/NN use/NN associated/VBN development/NN failure/NN disease/NN ESRD/NNP
phenacetin/NN contribute/VB burden/NN ESRD/NNP
terbutaline/NN treatment/NN abnormalities/NNS implications/NNS autism/NN
Terbutaline/RB associated/VBN concordance/NN autism/NN
ketoconazole/NN treatment/NN complication/NN hypertension/NN
ketoconazole/NN treated/VBN syndrome/NN patients/NNS Two/CD developed/VBD hypertension/NN
ketoconazole/JJ therapy/NN achieved/VBN demonstrated/VBD hypertension/NN
ketoconazole/NN doses/NNS treatment/NN induce/VB blockade/NN leading/VBG mineralocorticoid/VB hypertension/NN
ribavirin/NN treatment/NN interferon/NN Development/NNP myasthenia/NN ocular/NN
ribavirin/NN treatment/NN interferon/NN Development/NNP myasthenia/NN
pegylated/JJ interferon/NN Development/NNP myasthenia/NN ocular/NN
pegylated/JJ interferon/NN Development/NNP myasthenia/NN
interferon/NN Development/NNP myasthenia/NN ocular/NN
interferon/NN Development/NNP myasthenia/NN
ribavirin/NNP alpha/NNP therapy/NN associated/VBN myasthenia/NN ocular/NN
ribavirin/NNP alpha/NNP therapy/NN associated/VBN myasthenia/NN
pegylated/JJ alpha/NNP therapy/NN associated/VBN myasthenia/NN ocular/NN
pegylated/JJ alpha/NNP therapy/NN associated/VBN myasthenia/NN
IFN/NNP alpha/NNP therapy/NN associated/VBN myasthenia/NN ocular/NN
IFN/NNP alpha/NNP therapy/NN associated/VBN myasthenia/NN
alpha/NNP therapy/NN associated/VBN myasthenia/NN ocular/NN
alpha/NNP therapy/NN associated/VBN myasthenia/NN
2/CD alpha/NNP therapy/NN associated/VBN myasthenia/NN ocular/NN
2/CD alpha/NNP therapy/NN associated/VBN myasthenia/NN
b/SYM alpha/NNP therapy/NN associated/VBN myasthenia/NN ocular/NN
b/SYM alpha/NNP therapy/NN associated/VBN myasthenia/NN
IFN/NNP therapy/NN complications/NNS review/NN present/VBP reported/VBN myasthenia/NN ocular/NN
IFN/NNP therapy/NN complications/NNS review/NN present/VBP reported/VBN myasthenia/NN
asenapine/NN %/NN %/NN occurred/VBD reported/VBD symptoms/NNS Extrapyramidal/JJ
asenapine/NN %/NN %/NN occurred/VBD reported/VBD symptoms/NNS
haloperidol/NNP asenapine/NN %/NN %/NN occurred/VBD reported/VBD symptoms/NNS Extrapyramidal/JJ
haloperidol/NNP asenapine/NN %/NN %/NN occurred/VBD reported/VBD symptoms/NNS
asenapine/NN similar/JJ indicated/VBD seen/VBN AEs/NNP symptoms/NNS extrapyramidal/JJ
asenapine/NN similar/JJ indicated/VBD seen/VBN AEs/NNP symptoms/NNS
haloperidol/NN asenapine/NN similar/JJ indicated/VBD seen/VBN AEs/NNP symptoms/NNS extrapyramidal/JJ
haloperidol/NN asenapine/NN similar/JJ indicated/VBD seen/VBN AEs/NNP symptoms/NNS
amphetamine/NN induced/VBN hyperactivity/RB
fluvoxamine/NN treatment/NN potentiated/VBD amphetamine/NN induced/VBN hyperactivity/RB
nomifensine/NN induced/VBN hyperactivity/NN
fluvoxamine/NN remained/VBD hyperactivity/NN
clonidine/NN undergoing/VBG arrest/VB Cardiac/NNP
clonidine/NN undergoing/VBG arrest/VB
clonidine/NN reports/NNS arrest/NN cardiac/JJ
clonidine/NN reports/NNS arrest/NN
heparin/NN Delayed/JJ induced/VBN thrombocytopenia/NN
Heparin/NNP BACKGROUND/NNP presents/VBZ thrombocytopenia/NNP
heparin/NN exposure/NN presents/VBZ thrombocytopenia/NNP
heparin/NN recognition/NN contribute/VBP thrombocytopenia/NNP
heparin/NN manifestations/NNS thrombocytopenia/NN
heparin/NN thrombocytopenia/NN
heparin/NN exposure/NN included/VBN thrombocytopenia/NN
heparin/NN thrombocytopenia/NNS
heparin/NN thrombocytopenia/NN
heparin/JJ returns/NNS initiated/VBN thrombocytopenia/NN
Verapamil/JJ withdrawal/NN cause/NN infarction/NN myocardial/JJ
Verapamil/JJ withdrawal/NN cause/NN infarction/NN
verapamil/NN withdrawal/NN introduction/NN coincided/VBD infarction/NN myocardial/JJ
verapamil/NN withdrawal/NN introduction/NN coincided/VBD infarction/NN
Nitroprusside/NNP induced/VBN ACTH/VB evokes/NNS hypotension/NN
nitroprusside/VB secretion/NN Suppression/NN induced/VBN observed/JJ hypotension/NN
isoniazid/JJ neuropathy/NN
isoniazid/NN dose/NN caused/VBN neuropathy/NN
pilocarpine/NN treated/VBN analyze/VBP occurrence/NN seizures/NNS
pilocarpine/NN induced/VBN result/NN seizures/NNS
KA/VB //VBZ pilocarpine/NN induced/VBN result/NN seizures/NNS
alendronate/VBD proteinuria/NN
alendronate/VBD proteinuria/NN failure/NN acute/JJ
alendronate/VBD proteinuria/NN failure/NN renal/JJ
alendronate/VBD proteinuria/NN failure/NN
alendronate/JJ sodium/NN administration/NN days/NNS increased/VBD g/NN failure/NN acute/JJ
alendronate/JJ sodium/NN administration/NN days/NNS increased/VBD g/NN failure/NN renal/JJ
alendronate/JJ sodium/NN administration/NN days/NNS increased/VBD g/NN failure/NN
sodium/NN administration/NN days/NNS increased/VBD g/NN failure/NN acute/JJ
sodium/NN administration/NN days/NNS increased/VBD g/NN failure/NN renal/JJ
sodium/NN administration/NN days/NNS increased/VBD g/NN failure/NN
dobutamine/NN detection/NN performance/NN index/NN Assessment/NNP induced/NNP ischemia/NN myocardial/JJ
dobutamine/NN detection/NN performance/NN index/NN Assessment/NNP induced/NNP ischemia/NN
dobutamine/NN detecting/VBG ischemia/NN myocardial/JJ
dobutamine/NN detecting/VBG ischemia/NN
dobutamine/NN detecting/VBG ECG/NNP lead/VB assess/VB induced/VBN ischemia/NN myocardial/JJ
dobutamine/NN detecting/VBG ECG/NNP lead/VB assess/VB induced/VBN ischemia/NN
Tiopronin/NNP due/JJ nephritis/NNS dermatitis/NNS
Tiopronin/NNP due/JJ due/JJ' dermatitis/NNS
gold/JJ thiosulphate/NN due/JJ dermatitis/NNS due/JJ' due/JJ nephritis/NNS dermatitis/NNS
gold/JJ thiosulphate/NN due/JJ dermatitis/NNS
Tiopronin/NNP due/JJ nephritis/NNS
Tiopronin/NNP group/NN nephritis/NNS
puromycin/NN aminonucleoside/NN barrier/NN proteins/NNS distribution/NN changes/NNS nephrosis/VBZ
aminonucleoside/NN barrier/NN proteins/NNS distribution/NN changes/NNS nephrosis/VBZ
puromycin/NN rats/NNS nephrosis/NN
aminonucleoside/NN rats/NNS nephrosis/NN
tolazamide/NN Wernicke/NNP
tolazamide/NN abnormality/NN encephalopathy/JJ s/VBZ
tolazamide/NN abnormality/NN encephalopathy/JJ
tolazamide/NN treated/VBN encephalopathy/JJ Wernicke/NNP
tolazamide/NN treated/VBN encephalopathy/JJ Wernicke/NNP '/POS
tolazamide/NN treated/VBN encephalopathy/JJ s/VBZ
tolazamide/NN treated/VBN encephalopathy/JJ
tolazamide/NN patient/NN syndrome/NN similarity/NN encephalopathy/NN Wernicke/NNP
tolazamide/NN patient/NN syndrome/NN similarity/NN encephalopathy/NN Wernicke/NNP '/POS
tolazamide/NN patient/NN syndrome/NN similarity/NN encephalopathy/NN s/JJ
tolazamide/NN patient/NN syndrome/NN similarity/NN encephalopathy/NN
methyldopa/NN effect/NN hypotensive/JJ
methyldopa/JJ neurons/NNS microinjection/NN elicits/VBZ response/NN hypotensive/JJ
methyldopa/NN microinjection/NN caused/VBD hypotension/NN
methyldopa/NN mediate/VB hypotension/NN
methyldopa/NN mediate/VB cells/NNS contribute/VBP action/NN hypotensive/JJ
methyldopa/NN action/NN contribute/VBP cells/NNS mediate/VB hypotension/NN
methyldopa/NN action/NN hypotensive/JJ
isoproterenol/NN severity/NN infarction/NN myocardial/JJ
isoproterenol/NN severity/NN infarction/NN
Ximelagatran/NNP found/VBN efficient/JJ antagonist/VBP withdrawn/VBN tests/NNS abnormal/JJ
Ximelagatran/NNP found/VBN efficient/JJ antagonist/VBP withdrawn/VBN tests/NNS liver/NN
Ximelagatran/NNP found/VBN efficient/JJ antagonist/VBP withdrawn/VBN tests/NNS function/NN
Lamotrigine/NNP associated/VBN myoclonus/NNS
lamotrigine/JJ exacerbation/NN appearance/NN jerks/NNS myoclonic/JJ
lamotrigine/JJ exacerbation/NN appearance/NN jerks/NNS
lamotrigine/JJ exacerbation/NN appearance/NN jerks/NNS MJ/NNP
LTG/NNP exacerbation/NN appearance/NN jerks/NNS myoclonic/JJ
LTG/NNP exacerbation/NN appearance/NN jerks/NNS
LTG/NNP exacerbation/NN appearance/NN jerks/NNS MJ/NNP
LTG/NNP exacerbated/VBD MJ/NNP
LTG/NNP dose/NNP decreased/VBN disappeared/VBD MJ/NNP
LTG/NNP exacerbated/VBD MJ/NNP
LTG/NNP exacerbated/VBD status/NN myoclonic/JJ
LTG/NNP exacerbated/VBD status/NN
LTG/NNP withdrawal/NN ceased/VBD status/NN exacerbated/VBD MJ/NNP
LTG/NNP withdrawal/NN ceased/VBD status/NN myoclonic/JJ
LTG/NNP withdrawal/NN ceased/VBD status/NN
tizanidine/NN initiation/NN Hypotension/NNP
lisinopril/NN treated/VBN chronically/NNS angiotensin/NN converting/VBG control/VB hypertension/NN developed/VBD hypotension/NN
tizanidine/NN addition/NN hypotension/NN
FK/NNP Mechanisms/NNPS hypertension/NN
506/CD FK/NNP Mechanisms/NNPS hypertension/NN
FK/NNP utility/NN complicated/VBN hypertension/NN
506/CD FK/NNP utility/NN complicated/VBN hypertension/NN
FK/NNP mechanisms/NNS clarify/VB hypertension/NN
506/CD FK/NNP mechanisms/NNS clarify/VB hypertension/NN
FK/NNP effects/NNS studied/VBD hypertension/NN
506/CD FK/NNP effects/NNS studied/VBD hypertension/NN
FK/NNP FR/NNP antagonist/VBP studied/VBN hypertension/NN
506/CD FK/NNP FR/NNP antagonist/VBP studied/VBN hypertension/NN
FK/NNP induced/VBN hypertension/NN
506/CD FK/NNP induced/VBN hypertension/NN
carrageenan/NN licking/NNP models/NNS induced/VBN hyperalgesia/NN thermal/JJ
carrageenan/NN licking/NNP models/NNS induced/VBN hyperalgesia/NN
carrageenan/NN licking/NNP models/NNS induced/VBN hyperalgesia/NN mechanical/JJ
carrageenan/NN licking/NNP models/NNS induced/VBN hyperalgesia/NN
capsaicin/NN hyperalgesia/NN thermal/JJ
capsaicin/NN hyperalgesia/NN
capsaicin/NN hyperalgesia/NN induced/VBN models/NNS induced/VBN hyperalgesia/NN mechanical/JJ
capsaicin/NN hyperalgesia/NN induced/VBN models/NNS induced/VBN hyperalgesia/NN
reserpine/JJ hypothermia/NN
d/SYM induced/VBN hyperactivity/RB
amphetamine/NN d/SYM induced/VBN hyperactivity/RB
quinpirole/NN amphetamine/NN d/SYM induced/VBN hyperactivity/RB
TRI/NNP increases/VBZ locomotor/NN induced/VBN hyperactivity/RB
heparin/NN enhanced/VBN volume/NN hematoma/NN
isoproterenol/NN Development/NNP hypertrophy/NN cardiac/JJ
isoproterenol/NN Development/NNP hypertrophy/NN
isoproterenol/NN injections/NNS rats/NNS studied/VBN development/NN hypertrophy/NN cardiac/JJ
isoproterenol/NN injections/NNS rats/NNS studied/VBN development/NN hypertrophy/NN
ISO/NNP isoproterenol/NN injections/NNS rats/NNS studied/VBN development/NN hypertrophy/NN cardiac/JJ
ISO/NNP isoproterenol/NN injections/NNS rats/NNS studied/VBN development/NN hypertrophy/NN
FK/NNP 506/NNP consisted/VBD vacuolization/NN glomerulosclerosis/NNS focal/JJ
FK/NNP 506/NNP consisted/VBD vacuolization/NN glomerulosclerosis/NNS segmental/JJ
FK/NNP 506/NNP consisted/VBD vacuolization/NN glomerulosclerosis/NNS
506/NNP consisted/VBD vacuolization/NN glomerulosclerosis/NNS focal/JJ
506/NNP consisted/VBD vacuolization/NN glomerulosclerosis/NNS segmental/JJ
506/NNP consisted/VBD vacuolization/NN glomerulosclerosis/NNS
Calcitriol/NNP therapy/NN suppresses/VBZ has/VBZ hypercalcemia/NN
Calcitriol/NNP therapy/NN suppresses/VBZ has/VBZ hypercalcemia/NN suppression/NN
Calcitriol/NNP therapy/NN suppresses/VBZ has/VBZ hypercalcemia/NN suppression/NN turnover/NN of/IN
Calcitriol/NNP therapy/NN suppresses/VBZ has/VBZ hypercalcemia/NN suppression/NN turnover/NN bone/NN
Calcitriol/NNP therapy/NN suppresses/VBZ has/VBZ hypercalcemia/NN suppression/NN turnover/NN
Calcitriol/NNP therapy/NN suppresses/VBZ has/VBZ hypercalcemia/NN suppression/NN turnover/NN lead/VB disease/NN adynamic/JJ
Calcitriol/NNP therapy/NN suppresses/VBZ has/VBZ hypercalcemia/NN suppression/NN turnover/NN lead/VB disease/NN bone/NN
Calcitriol/NNP therapy/NN suppresses/VBZ has/VBZ hypercalcemia/NN suppression/NN turnover/NN lead/VB disease/NN
OCT/NNP prevent/VB occurrence/NN hypercalcemia/NN
trihexyphenidyl/JJ challenge/NN allele/VBP slowing/NN mental/JJ
trihexyphenidyl/JJ challenge/NN allele/VBP slowing/NN
trihexyphenidyl/NN dose/NN resulted/VBD ratings/NNS slowness/NNS mental/JJ
trihexyphenidyl/NN dose/NN resulted/VBD ratings/NNS slowness/NNS
trihexyphenidyl/JJ mg/NN ratings/NNS slowness/NNS mental/JJ
trihexyphenidyl/JJ mg/NN ratings/NNS slowness/NNS
trihexyphenidyl/JJ challenge/NN associated/VBN slowing/NN mental/JJ
trihexyphenidyl/JJ challenge/NN associated/VBN slowing/NN
sulindac/JJ therapy/NN associated/VBN Hyperkalemia/NNP
indomethacin/NN agents/NNS complication/NN recognized/VBN Hyperkalemia/NNP
sulindac/JJ administration/NN days/NNS developed/VBN hyperkalemia/NN
sulindac/NN hyperkalemia/NN
Sulfasalazine/NNP induced/VBN erythematosus/NNS lupus/JJ
Sulfasalazine/NNP induced/VBN erythematosus/NNS
sulfasalazine/NN therapy/NN autoantibodies/NNS effusions/NNS Pneumonitis/NNS
sulfasalazine/NN therapy/NN autoantibodies/NNS effusions/NNS evidence/NN tamponade/NN cardiac/JJ
sulfasalazine/NN therapy/NN autoantibodies/NNS effusions/NNS evidence/NN tamponade/NN
sulfasalazine/NN therapy/NN autoantibodies/NNS effusions/NNS pleural/JJ
sulfasalazine/NN therapy/NN autoantibodies/NNS effusions/NNS
sulfasalazine/NN lupus/NNS
sulfasalazine/JJ use/VBP Physicians/NNP aware/JJ lupus/VBZ
sulfasalazine/JJ use/VBP Physicians/NNP aware/JJ lupus/VBZ syndrome/NN
sulfasalazine/NN signs/NNS aware/JJ lupus/VBZ
sulfasalazine/NN signs/NNS aware/JJ lupus/VBZ syndrome/NN
metronidazole/NN treatment/NN syndrome/NN Haemolytic/NNP
metronidazole/NN treatment/NN syndrome/NN uraemic/JJ
metronidazole/NN treatment/NN syndrome/NN
metronidazole/NN developed/VBD syndrome/NN haemolytic/NN
metronidazole/NN developed/VBD syndrome/NN uraemic/JJ
metronidazole/NN developed/VBD syndrome/NN
metronidazole/NN aetiology/NN syndrome/NN haemolytic/JJ
metronidazole/NN aetiology/NN syndrome/NN uraemic/NN
metronidazole/NN aetiology/NN syndrome/NN
metronidazole/NN involvement/NN established/VBN suggest/VBP action/NN drug/NN evidence/NN syndrome/NN haemolytic/JJ
metronidazole/NN involvement/NN established/VBN suggest/VBP action/NN drug/NN evidence/NN syndrome/NN uraemic/NN
metronidazole/NN involvement/NN established/VBN suggest/VBP action/NN drug/NN evidence/NN syndrome/NN
metronidazole/NN involvement/NN established/VBN suggest/VBP link/NN cases/NNS syndrome/NN haemolytic/JJ
metronidazole/NN involvement/NN established/VBN suggest/VBP link/NN cases/NNS syndrome/NN uraemic/NN
metronidazole/NN involvement/NN established/VBN suggest/VBP link/NN cases/NNS syndrome/NN
metronidazole/JJ treatment/NN link/NN suggest/VBP established/VBN involvement/NN metronidazole/NN aetiology/NN syndrome/NN haemolytic/JJ
metronidazole/JJ treatment/NN link/NN suggest/VBP established/VBN involvement/NN metronidazole/NN aetiology/NN syndrome/NN uraemic/NN
metronidazole/JJ treatment/NN link/NN suggest/VBP established/VBN involvement/NN metronidazole/NN aetiology/NN syndrome/NN
metronidazole/JJ treatment/NN link/NN suggest/VBP action/NN drug/NN evidence/NN syndrome/NN haemolytic/JJ
metronidazole/JJ treatment/NN link/NN suggest/VBP action/NN drug/NN evidence/NN syndrome/NN uraemic/NN
metronidazole/JJ treatment/NN link/NN suggest/VBP action/NN drug/NN evidence/NN syndrome/NN
metronidazole/JJ treatment/NN link/NN cases/NNS syndrome/NN haemolytic/JJ
metronidazole/JJ treatment/NN link/NN cases/NNS syndrome/NN uraemic/NN
metronidazole/JJ treatment/NN link/NN cases/NNS syndrome/NN
clomiphene/NN associated/VBN occlusion/NN retinal/JJ
clomiphene/NN associated/VBN occlusion/NN vein/NN
clomiphene/NN associated/VBN occlusion/NN
clomiphene/JJ citrate/NN associated/VBN occlusion/NN retinal/JJ
clomiphene/JJ citrate/NN associated/VBN occlusion/NN vein/NN
clomiphene/JJ citrate/NN associated/VBN occlusion/NN
citrate/NN associated/VBN occlusion/NN retinal/JJ
citrate/NN associated/VBN occlusion/NN vein/NN
citrate/NN associated/VBN occlusion/NN
CC/NNP citrate/NN associated/VBN occlusion/NN retinal/JJ
CC/NNP citrate/NN associated/VBN occlusion/NN vein/NN
CC/NNP citrate/NN associated/VBN occlusion/NN
CC/NNP occlusion/VBN vein/NN retinal/JJ
CC/NNP occlusion/VBN vein/NN
CC/NNP occlusion/VBN
CC/NNP courses/NNS developed/VBN occlusion/NNS retinal/JJ
CC/NNP courses/NNS developed/VBN occlusion/NNS vein/NN
CC/NNP courses/NNS developed/VBN occlusion/NNS
CC/NNP complications/NNS literature/NN search/NN include/VB uncommon/JJ disturbance/NN visual/JJ
CC/NNP complications/NNS literature/NN search/NN include/VB uncommon/JJ disturbance/NN
CC/NNP intake/NN disturbance/NN visual/JJ
CC/NNP intake/NN disturbance/NN
CC/NNP occlusion/VBN vein/NN retinal/JJ
CC/NNP occlusion/VBN vein/NN
CC/NNP occlusion/VBN
pemoline/JJ overdose/NN
lithium/NN therapy/NN insipidus/NNS nephrogenic/JJ
lithium/NN therapy/NN insipidus/NNS diabetes/NN
lithium/NN therapy/NN insipidus/NNS
lithium/NN induced/VBN insipidus/NNS nephrogenic/JJ
lithium/NN induced/VBN insipidus/NNS diabetes/NN
lithium/NN induced/VBN insipidus/NNS
lithium/NN therapy/NN discontinued/VBN diagnosed/VBN have/VB lithium/NN induced/VBN insipidus/NNS nephrogenic/JJ
lithium/NN therapy/NN discontinued/VBN diagnosed/VBN have/VB lithium/NN induced/VBN insipidus/NNS diabetes/NN
lithium/NN therapy/NN discontinued/VBN diagnosed/VBN have/VB lithium/NN induced/VBN insipidus/NNS
lithium/NN cessation/NN remained/VBD thirsty/JJ polyuric/JJ
lithium/NN cessation/NN remained/VBD showed/VBD evidence/NN insipidus/NNS nephrogenic/JJ
lithium/NN cessation/NN remained/VBD showed/VBD evidence/NN insipidus/NNS diabetes/NN
lithium/NN cessation/NN remained/VBD showed/VBD evidence/NN insipidus/NNS
Lithium/RB considered/VBN persisted/VBD polyuria/NN
lithium/NN stopped/VBN persisted/VBD polyuria/NN
Lithium/RB considered/VBN insipidus/NNS nephrogenic/JJ
Lithium/RB considered/VBN insipidus/NNS diabetes/NN
Lithium/RB considered/VBN insipidus/NNS
lithium/NN stopped/VBN persisted/VBD considered/VBN insipidus/NNS nephrogenic/JJ
lithium/NN stopped/VBN persisted/VBD considered/VBN insipidus/NNS diabetes/NN
lithium/NN stopped/VBN persisted/VBD considered/VBN insipidus/NNS
lithium/NN patients/NNS management/NN implications/NNS mechanisms/NNS insipidus/NNS nephrogenic/JJ
lithium/NN patients/NNS management/NN implications/NNS mechanisms/NNS insipidus/NNS diabetes/NN
lithium/NN patients/NNS management/NN implications/NNS mechanisms/NNS insipidus/NNS
Dapsone/NNP associated/VBN anemia/NN hemolytic/JJ
Dapsone/NNP associated/VBN anemia/NN
dapsone/NN dose/NN taking/VBG developed/VBD anemia/NN hemolytic/NN
dapsone/NN dose/NN taking/VBG developed/VBD anemia/NN
dapsone/NN cause/VB anemia/NN hemolytic/JJ
dapsone/NN cause/VB anemia/NN
rifampin/NN proteinuria/NN
rifampin/NN treated/VBN patients/NNS 9/CD found/VBN proteinuria/NN
Sirolimus/NNS proteinuria/NN
Sirolimus/NNS proteinuria/NN dysfunction/NN renal/JJ
Sirolimus/NNS proteinuria/NN dysfunction/NN
Sirolimus/NNS represents/VBZ advance/NN prevention/NN rejection/NN nephropathy/NN
sirolimus/NNS share/VB designated/VBN non/NN drug/NN nephrotoxic/JJ
sirolimus/NNS associated/VBN dysfunction/NN proteinuria/JJ
sirolimus/NNS mechanisms/NNS multifactorial/JJ proteinuria/NN
sirolimus/NNS effects/NNS knowledge/NN minimised/VBN close/VB monitoring/NN function/NN proteinuria/NN
sirolimus/NNS effects/NNS knowledge/NN minimised/VBN use/VB occurs/VBZ proteinuria/NN
sirolimus/NNS use/NN kidney/NN sirolimus/NNS effects/NNS knowledge/NN minimised/VBN close/VB monitoring/NN function/NN proteinuria/NN
sirolimus/NNS use/NN kidney/NN sirolimus/NNS effects/NNS knowledge/NN minimised/VBN use/VB occurs/VBZ proteinuria/NN
Clomipramine/JJ exposure/NN hoarding/NN
Clomipramine/JJ exposure/NN include/VBP anxiety/NN
Clomipramine/JJ exposure/NN include/VBP anxiety/NN impairment/NN memory/NN
Clomipramine/JJ exposure/NN include/VBP anxiety/NN impairment/NN
hydralazine/NN induced/VBN hypotension/NN
nitroglycerin/NN hydralazine/NN induced/VBN hypotension/NN
Glyburide/NNP induced/VBN hepatitis/NN
glyburide/NN exist/VBP sulfonylurea/NN reports/NNS hepatotoxicity/NN
glyburide/JJ therapy/NN initiation/NN developed/VBD syndrome/NN acute/JJ
glyburide/JJ therapy/NN initiation/NN developed/VBD syndrome/NN hepatitis/NN
glyburide/JJ therapy/NN initiation/NN developed/VBD syndrome/NN like/JJ
glyburide/JJ therapy/NN initiation/NN developed/VBD syndrome/NN
Glyburide/NNP produce/VB hepatitis/NN acute/JJ
Glyburide/NNP produce/VB hepatitis/NN
Glyburide/NNP produce/VB illness/NN like/IN
Glyburide/NNP produce/VB illness/NN
puromycin/NN aminonucleoside/NN subunits/NNS targeting/VBG expression/NN syndrome/NN nephrotic/JJ
puromycin/NN aminonucleoside/NN subunits/NNS targeting/VBG expression/NN syndrome/NN
aminonucleoside/NN subunits/NNS targeting/VBG expression/NN syndrome/NN nephrotic/JJ
aminonucleoside/NN subunits/NNS targeting/VBG expression/NN syndrome/NN
PAN/NNP treatment/NN induced/VBN proteinuria/NN hypoalbuminemia/NN
PAN/NNP treatment/NN induced/VBN proteinuria/NN ascites/NNS
PAN/NNP treatment/NN induced/VBN proteinuria/NN
PAN/NNP associated/VBN syndrome/NN nephrotic/JJ
PAN/NNP associated/VBN syndrome/NN
PGE/NNP NGF/NNP increased/VBN patients/NNS OAB/NNP
2/CD PGE/NNP NGF/NNP increased/VBN patients/NNS OAB/NNP
PGF/NNP NGF/NNP increased/VBN patients/NNS OAB/NNP
2/CD alpha/NN PGF/NNP NGF/NNP increased/VBN patients/NNS OAB/NNP
alpha/NN PGF/NNP NGF/NNP increased/VBN patients/NNS OAB/NNP
PGE/NNP OAB/NNP
2/CD PGE/NNP OAB/NNP
PGF/NNP alpha/NNP correlate/VB parameters/NNS patients/NNS OAB/NNP
2/CD alpha/NNP correlate/VB parameters/NNS patients/NNS OAB/NNP
alpha/NNP correlate/VB parameters/NNS patients/NNS OAB/NNP
iron/NN dextran/NN induced/VBN degeneration/NN
iron/NN dextran/NN induced/VBN degeneration/NN neurons/NNS of/IN
iron/NN dextran/NN induced/VBN degeneration/NN neurons/NNS dopaminergic/JJ
iron/NN dextran/NN induced/VBN degeneration/NN neurons/NNS
dextran/NN induced/VBN degeneration/NN
dextran/NN induced/VBN degeneration/NN neurons/NNS of/IN
dextran/NN induced/VBN degeneration/NN neurons/NNS dopaminergic/JJ
dextran/NN induced/VBN degeneration/NN neurons/NNS
iron/NN animals/NNS content/NN detection/NN study/VB degeneration/NN
iron/NN animals/NNS content/NN detection/NN study/VB degeneration/NN neurons/NNS of/IN
iron/NN animals/NNS content/NN detection/NN study/VB degeneration/NN neurons/NNS dopaminergic/JJ
iron/NN animals/NNS content/NN detection/NN study/VB degeneration/NN neurons/NNS
dextran/NN animals/NNS content/NN detection/NN study/VB degeneration/NN
dextran/NN animals/NNS content/NN detection/NN study/VB degeneration/NN neurons/NNS of/IN
dextran/NN animals/NNS content/NN detection/NN study/VB degeneration/NN neurons/NNS dopaminergic/JJ
dextran/NN animals/NNS content/NN detection/NN study/VB degeneration/NN neurons/NNS
iron/NN dextran/NN increase/VB SN/NNP causes/VBZ degeneration/NN
iron/NN dextran/NN increase/VB SN/NNP causes/VBZ degeneration/NN neurons/NNS of/IN
iron/NN dextran/NN increase/VB SN/NNP causes/VBZ degeneration/NN neurons/NNS dopaminergic/JJ
iron/NN dextran/NN increase/VB SN/NNP causes/VBZ degeneration/NN neurons/NNS
dextran/NN increase/VB SN/NNP causes/VBZ degeneration/NN
dextran/NN increase/VB SN/NNP causes/VBZ degeneration/NN neurons/NNS of/IN
dextran/NN increase/VB SN/NNP causes/VBZ degeneration/NN neurons/NNS dopaminergic/JJ
dextran/NN increase/VB SN/NNP causes/VBZ degeneration/NN neurons/NNS
carbimazole/NN reactivity/NN hepatitis/NN Toxic/JJ
carbimazole/NN reactivity/NN hepatitis/NN
carbimazole/NN hepatitis/NN
carbimazole/NN mixed/JJ cholestatic/JJ
carbimazole/JJ replaced/VBN appeared/VBD hepatitis/NN
alprazolam/NN patients/NNS developed/VBD reactions/NNS depression/NN
alprazolam/NN patients/NNS developed/VBD reactions/NNS memory/NN impaired/VBN
alprazolam/NN patients/NNS developed/VBD reactions/NNS memory/NN
alprazolam/NN patients/NNS developed/VBD reactions/NNS memory/NN ataxia/NN
alprazolam/NN patients/NNS developed/VBD reactions/NNS depression/NN enuresis/NN
alprazolam/NN patients/NNS developed/VBD reactions/NNS memory/NN loss/NN weight/NN
alprazolam/NN patients/NNS developed/VBD reactions/NNS memory/NN loss/NN
everolimus/NNS prophylaxis/NNS Graft/NNP associated/VBN incidence/NN syndrome/NN microangiopathy/NN
tacrolimus/NNS everolimus/NNS prophylaxis/NNS Graft/NNP associated/VBN incidence/NN syndrome/NN sinusoidal/JJ
tacrolimus/NNS everolimus/NNS prophylaxis/NNS Graft/NNP associated/VBN incidence/NN syndrome/NN obstruction/NN
tacrolimus/NNS everolimus/NNS prophylaxis/NNS Graft/NNP associated/VBN incidence/NN syndrome/NN
tacrolimus/NNS everolimus/NNS prophylaxis/NNS Graft/NNP associated/VBN incidence/NN syndrome/NN microangiopathy/NN
everolimus/NNS prophylaxis/NNS Graft/NNP associated/VBN incidence/NN syndrome/NN sinusoidal/JJ
everolimus/NNS prophylaxis/NNS Graft/NNP associated/VBN incidence/NN syndrome/NN obstruction/NN
everolimus/NNS prophylaxis/NNS Graft/NNP associated/VBN incidence/NN syndrome/NN
mepivacaine/JJ 850/CD block/NN performance/NN mg/VBP observed/VBN increase/NN
mepivacaine/JJ 850/CD block/NN performance/NN mg/VBP observed/VBN increase/NN pressure/NN in/IN
mepivacaine/JJ 850/CD block/NN performance/NN mg/VBP observed/VBN increase/NN pressure/NN blood/NN
mepivacaine/JJ 850/CD block/NN performance/NN mg/VBP observed/VBN increase/NN pressure/NN
adrenaline/NN containing/VBG mg/VBP observed/VBN increase/NN
adrenaline/NN containing/VBG mg/VBP observed/VBN increase/NN pressure/NN in/IN
adrenaline/NN containing/VBG mg/VBP observed/VBN increase/NN pressure/NN blood/NN
adrenaline/NN containing/VBG mg/VBP observed/VBN increase/NN pressure/NN
mepivacaine/JJ 850/CD block/NN performance/NN mg/VBP observed/VBN increase/NN accompanied/VBN fibrillation/NN atrial/JJ
mepivacaine/JJ 850/CD block/NN performance/NN mg/VBP observed/VBN increase/NN accompanied/VBN fibrillation/NN
adrenaline/NN containing/VBG mg/VBP observed/VBN increase/NN accompanied/VBN fibrillation/NN atrial/JJ
adrenaline/NN containing/VBG mg/VBP observed/VBN increase/NN accompanied/VBN fibrillation/NN
epinephrine/NN hydrocortisone/JJ dipyridamole/JJ Effects/NNPS induced/VBN injury/NN myocardial/JJ
epinephrine/NN hydrocortisone/JJ dipyridamole/JJ Effects/NNPS induced/VBN injury/NN
epinephrine/JJ infusion/NN injury/NN myocardial/JJ
epinephrine/JJ infusion/NN injury/NN
sumatriptan/NN use/NN sensations/NNS Atypical/JJ
sumatriptan/NN use/NN sensations/NNS
T/NNP had/VBD effect/NN locomotion/NN irritability/NN
T/NNP had/VBD increased/VBD preference/NN aggression/NN
enalapril/NN assigned/VBN Patients/NNS RESULTS/NNS had/VBD likelihood/NN function/NN decreased/VBN
enalapril/NN assigned/VBN Patients/NNS RESULTS/NNS had/VBD likelihood/NN function/NN renal/JJ
enalapril/NN assigned/VBN Patients/NNS RESULTS/NNS had/VBD likelihood/NN function/NN
enalapril/JJ groups/NNS placebo/NN associated/VBN function/NN decreased/VBN
enalapril/JJ groups/NNS placebo/NN associated/VBN function/NN renal/JJ
enalapril/JJ groups/NNS placebo/NN associated/VBN function/NN
diuretic/JJ therapy/NN age/NN associated/VBN function/NN decreased/VBN
diuretic/JJ therapy/NN age/NN associated/VBN function/NN renal/JJ
diuretic/JJ therapy/NN age/NN associated/VBN function/NN
enalapril/JJ group/NN significantly/RB %/NN 32/CD 1/CD 52/CD associated/VBN risk/NN developing/VBG function/NN decreased/VBN
enalapril/JJ group/NN significantly/RB %/NN 32/CD 1/CD 52/CD associated/VBN risk/NN developing/VBG function/NN renal/JJ
enalapril/JJ group/NN significantly/RB %/NN 32/CD 1/CD 52/CD associated/VBN risk/NN developing/VBG function/NN
enalapril/JJ group/NN significantly/RB %/NN 32/CD 1/CD 52/CD associated/VBN risk/NN developing/VBG function/NN decreased/VBN
enalapril/JJ group/NN significantly/RB %/NN 32/CD 1/CD 52/CD associated/VBN risk/NN developing/VBG function/NN renal/JJ
enalapril/JJ group/NN significantly/RB %/NN 32/CD 1/CD 52/CD associated/VBN risk/NN developing/VBG function/NN
enalapril/NN 52/CD associated/VBN risk/NN developing/VBG function/NN decreased/VBN
enalapril/NN 52/CD associated/VBN risk/NN developing/VBG function/NN renal/JJ
enalapril/NN 52/CD associated/VBN risk/NN developing/VBG function/NN
enalapril/JJ group/NN function/NN decreased/VBN
enalapril/JJ group/NN function/NN renal/JJ
enalapril/JJ group/NN function/NN
Diuretic/JJ therapy/NN associated/VBN risk/NN function/NN decreased/VBN
Diuretic/JJ therapy/NN associated/VBN risk/NN function/NN renal/JJ
Diuretic/JJ therapy/NN associated/VBN risk/NN function/NN
Enalapril/JJ use/NN caused/VBN risk/NN function/NN decreased/VBN
Enalapril/JJ use/NN caused/VBN risk/NN function/NN renal/JJ
Enalapril/JJ use/NN caused/VBN risk/NN function/NN
enalapril/JJ group/NN reduced/VBN associated/VBN risk/NN impairment/NN renal/JJ
enalapril/JJ group/NN reduced/VBN associated/VBN risk/NN impairment/NN
capsaicin/NN injection/NN determined/VBN obtained/VBN stimuli/NNS hyperalgesia/NN mechanical/JJ
capsaicin/NN injection/NN determined/VBN obtained/VBN stimuli/NNS hyperalgesia/NN
capsaicin/NN injection/NN determined/VBN obtained/VBN stimuli/NNS hyperalgesia/NN allodynia/NN
capsaicin/NN injection/NN reduced/VBD hyperalgesia/NN mechanical/JJ
capsaicin/NN injection/NN reduced/VBD hyperalgesia/NN
capsaicin/NN injection/NN reduced/VBD hyperalgesia/NN allodynia/NN
losartan/NN administration/NN anuria/NN
losartan/NN administration/NN developed/VBD episodes/NNS anuria/NN
losartan/NN mg/NN dose/NN resulted/VBD anuria/NN
losartan/NN prescribed/VBN developed/VBD episode/NN anuria/NN
omeprazole/NN use/NN associated/VBN anemia/NNP Hemolytic/NNP
omeprazole/NN use/NN associated/VBN anemia/NNP
omeprazole/NN use/NN reaction/NN anemia/NN hemolytic/JJ
omeprazole/NN use/NN reaction/NN anemia/NN
omeprazole/NN starting/VBG days/NNS developed/VBD weakness/NN lethargy/NN
omeprazole/NN starting/VBG days/NNS developed/VBD weakness/NN shortness/NN
omeprazole/NN starting/VBG days/NNS developed/VBD weakness/NN breath/NN of/IN
omeprazole/NN starting/VBG days/NNS developed/VBD weakness/NN breath/NN
omeprazole/NN caused/VBD anemia/NN hemolytic/JJ
omeprazole/NN caused/VBD anemia/NN
beta/NN selected/VBN carboline/NN sensitive/JJ seizures/NNS
carboline/NN sensitive/JJ seizures/NNS
methyl/NN beta/NN injection/NN resistance/NN seizures/NNS
beta/NN injection/NN resistance/NN seizures/NNS
carboline/NN injection/NN resistance/NN seizures/NNS
3/CD carboline/NN injection/NN resistance/NN seizures/NNS
carboxylate/NN injection/NN resistance/NN seizures/NNS
beta/NN carboxylate/NN injection/NN resistance/NN seizures/NNS
CCM/NNP beta/NN carboxylate/NN injection/NN resistance/NN seizures/NNS
picrotoxin/JJ states/NNS recording/VBG induced/VBN plus/NN induced/VBN diazepam/NN induced/VBN seizures/NNS
pentylenetetrazol/JJ picrotoxin/JJ states/NNS recording/VBG induced/VBN plus/NN induced/VBN diazepam/NN induced/VBN seizures/NNS
lopinavir/VB related/VBN dilated/VBD
lopinavir/VB related/VBN cardiomyopathy/RB
ritonavir/NN therapy/NN agent/NN lopinavir/VB related/VBN dilated/VBD
ritonavir/NN therapy/NN agent/NN lopinavir/VB related/VBN cardiomyopathy/RB
lopinavir/VB related/VBN dilated/VBD developed/VBD block/NN heart/NN
lopinavir/VB related/VBN dilated/VBD developed/VBD block/NN
ritonavir/NN therapy/NN agent/NN lopinavir/VB related/VBN dilated/VBD developed/VBD block/NN heart/NN
ritonavir/NN therapy/NN agent/NN lopinavir/VB related/VBN dilated/VBD developed/VBD block/NN
lopinavir/VB agent/NN developed/VBD bradycardia/NN
ritonavir/NN therapy/NN agent/NN developed/VBD bradycardia/NN
nitric/JJ hypertension/NN
oxide/NN hypertension/NN
NO/DT synthesis/NN Inhibition/NNP induces/VBZ hypertension/NN
NO/RB ATPase/NNP response/NN induced/NNS hypertension/NN
NO/RB rats/NNS induced/NNS hypertension/NN
NO/RB Inhibition/NNP synthase/NN induced/VBN hypertension/NN
venlafaxine/JJ overdose/NN
venlafaxine/JJ overdose/NN resulting/VBG Seizure/NNP
venlafaxine/JJ overdose/NN
venlafaxine/NN overdose/NN
venlafaxine/VBP experienced/VBD seizure/NN
venlafaxine/JJ overdose/NN
venlafaxine/JJ overdose/NN case/NN resulted/VBD seizure/NN
venlafaxine/JJ overdose/NN
venlafaxine/JJ overdose/NN patient/NN resulted/VBN episode/NN seizure/NN
theophylline/NN fenoldopam/NN induced/VBN arteritis/NNS
fenoldopam/NN induced/VBN arteritis/NNS
theophylline/NN vasodilators/NNS induced/VBN Arteritis/NNS
fenoldopam/NN vasodilators/NNS induced/VBN Arteritis/NNS
streptozotocin/NN caused/VBN function/NN reverse/VB mellitus/VBZ diabetes/NNP
streptozotocin/NN caused/VBN function/NN reverse/VB mellitus/VBZ
streptozotocin/NN function/VBP investigated/VBN rats/NNS diabetic/JJ
streptozotocin/NN diabetes/NNP
ketoconazole/NN ingestion/NN developed/VBD weakness/NN extremities/NNS tremor/NN
ketoconazole/NN ingestion/NN developed/VBD weakness/NN
ketoconazole/NN ingestion/NN developed/VBD weakness/NN extremities/NNS of/IN
ketoconazole/NN ingestion/NN developed/VBD weakness/NN extremities/NNS
ketoconazole/NN ingestion/NN developed/VBD weakness/NN extremities/NNS paralysis/NN legs/NNS
ketoconazole/NN ingestion/NN developed/VBD weakness/NN extremities/NNS paralysis/NN
ketoconazole/NN ingestion/NN developed/VBD weakness/NN extremities/NNS dysarthria/NN
gentamicin/NN induced/VBN failure/NN acute/JJ
gentamicin/NN induced/VBN failure/NN renal/JJ
gentamicin/NN induced/VBN failure/NN
GM/NNP gentamicin/NN induced/VBN failure/NN acute/JJ
GM/NNP gentamicin/NN induced/VBN failure/NN renal/JJ
GM/NNP gentamicin/NN induced/VBN failure/NN
gum/NN rats/NNS treatment/NN effect/NN assessed/VBD Arabic/NNP failure/NN acute/JJ
gum/NN rats/NNS treatment/NN effect/NN assessed/VBD Arabic/NNP failure/NN renal/JJ
gum/NN rats/NNS treatment/NN effect/NN assessed/VBD Arabic/NNP failure/NN
Arabic/NNP failure/NN acute/JJ
Arabic/NNP failure/NN renal/JJ
Arabic/NNP failure/NN
tacrolimus/NNS Recovery/NNP associated/JJ neuritis/NNS brachial/JJ
tacrolimus/NNS Recovery/NNP associated/JJ neuritis/NNS
cocaine/NN use/NN delirium/JJ
cocaine/NN toxicity/NN mechanisms/NNS provide/VB Fatal/VB use/NN delirium/JJ
cocaine/NN induced/VBN delirium/NN
cocaine/NN induced/VBN delirium/NN EDDs/NNP
cocaine/NN registry/NN compared/VBN EDDs/NNS
cocaine/NN registry/NN compared/VBN delirium/NN
cocaine/NN overdose/NN victims/NNS compared/VBN EDDs/NNS
cocaine/NN overdose/NN victims/NNS compared/VBN delirium/NN
cocaine/NN concentrations/NNS had/VBD EDDs/NNS
cocaine/NN use/NN disrupts/VBZ precipitate/VB agitation/NN death/NN sudden/JJ
cocaine/NN use/NN disrupts/VBZ precipitate/VB agitation/NN death/NN
cocaine/NN use/NN coupled/VBN disrupts/VBZ precipitate/VB agitation/NN death/NN sudden/JJ
cocaine/NN use/NN coupled/VBN disrupts/VBZ precipitate/VB agitation/NN death/NN
cocaine/NN use/NN disrupts/VBZ precipitate/VB agitation/NN rhabdomyolysis/NNS
cocaine/NN use/NN coupled/VBN disrupts/VBZ precipitate/VB agitation/NN rhabdomyolysis/NNS
cocaine/NN use/NN disrupts/VBZ precipitate/VB agitation/NN delirium/NN
cocaine/NN use/NN coupled/VBN disrupts/VBZ precipitate/VB agitation/NN delirium/NN
levofloxacin/NN warfarin/NN interaction/NN result/NN appear/VBP cases/NNS complications/NNS bleeding/NN
warfarin/NN interaction/NN result/NN appear/VBP cases/NNS complications/NNS bleeding/NN
tAMCA/NN retains/VBZ action/NN convulsive/JJ
tAMCA/NN caused/VBN activity/NN associated/VBN behaviours/NNS convulsive/NN
tAMCA/NN concentration/NN increased/VBD degree/NN seizures/NNS
tAMCA/NN evoked/VBD seizures/NNS generalized/JJ
tAMCA/NN evoked/VBD seizures/NNS
tAMCA/NN evoked/VBD mg/NN correlated/VBD potentials/NNS convulsive/JJ
tAMCA/NN concentration/NN evoked/VBD evoked/VBD seizures/NNS generalized/JJ
tAMCA/NN concentration/NN evoked/VBD evoked/VBD seizures/NNS
tAMCA/NN concentration/NN evoked/VBD evoked/VBD mg/NN correlated/VBD potentials/NNS convulsive/JJ
Tranexamic/JJ acid/NN retains/VBZ action/NN convulsive/JJ
acid/NN retains/VBZ action/NN convulsive/JJ
cocaine/NN induce/VB sensitization/VB seizures/NNS
lidocaine/NN appearance/NN induced/VBN convulsions/NNS
lidocaine/NN appearance/NN induced/VBN convulsions/NNS
cocaine/NN that/DT decreased/VBN induced/VBN convulsions/NNS
cocaine/NN that/DT decreased/VBN induced/VBN appearance/NN induced/VBN convulsions/NNS
lidocaine/NN administration/NN reversed/VBD changes/NNS activity/NN convulsive/JJ
lidocaine/NN activity/NN convulsive/JJ
cocaine/NN lidocaine/NN activity/NN convulsive/JJ
lidocaine/JJ convulsions/NNS
lidocaine/JJ seizures/NNS
cocaine/NN administration/NN resulting/VBG kindling/VBG distinct/JJ have/VB sensitization/NN seizures/NNS
Triazolam/NNP induced/VBN episodes/NNS mania/NN
triazolam/NN doses/NNS induced/VBN episodes/NNS mania/NN
triazolam/NN action/NN duration/NN coincident/VBN excitement/NN Manic/NNP
pilocarpine/NN induced/VBN epilepsy/NN
succinylcholine/NN induced/VBN myalgia/NN postoperative/JJ
succinylcholine/NN induced/VBN myalgia/NN
succinylcholine/NN used/VBN proven/VBN agent/NN reduction/NN myalgia/NN postoperative/JJ
succinylcholine/NN used/VBN proven/VBN agent/NN reduction/NN myalgia/NN
NH/IN 4/CD mmol/NN CL/NNP intraperitonealinjection/NN minutes/NNS rats/NNS produced/VBN coma/NNP
4/CD mmol/NN CL/NNP intraperitonealinjection/NN minutes/NNS rats/NNS produced/VBN coma/NNP
CL/NNP intraperitonealinjection/NN minutes/NNS rats/NNS produced/VBN coma/NNP
lignocaine/NN anaesthesia/NN syndrome/NN Cauda/NNP
lignocaine/NN anaesthesia/NN syndrome/NN equina/NN
lignocaine/NN anaesthesia/NN syndrome/NN
lignocaine/NN anaesthesia/NN syndrome/NN review/NN cases/NNS syndrome/NN cauda/NN
lignocaine/NN anaesthesia/NN syndrome/NN review/NN cases/NNS syndrome/NN equina/NN
lignocaine/NN anaesthesia/NN syndrome/NN review/NN cases/NNS syndrome/NN
Sulpiride/NNP induced/VBN dystonia/NN tardive/JJ
Sulpiride/NNP induced/VBN dystonia/NN
sulpiride/JJ therapy/NN starting/VBG developed/VBD dystonia/NN
sulpiride/NN reports/NNS dystonia/NN tardive/NN
sulpiride/NN reports/NNS dystonia/NN
carboplatin/NN dose/NN using/VBG induced/VBN Anemia/NNP
carboplatin/NN application/NN days/NNS administered/VBN rHuEPO/NN prevented/VBN development/NN anemia/NN
Nicotine/JJ potentiation/NN catalepsy/NN
morphine/NN potentiation/NN catalepsy/NN
nicotine/NN catalepsy/NN
morphine/NN induced/VBN catalepsy/NN
nicotine/NNS Morphine/NNS induced/VBN dose/NN catalepsy/JJ
Morphine/NNS induced/VBN dose/NN catalepsy/JJ
nicotine/NN reduced/VBD induced/NNS catalepsy/JJ
morphine/NN combination/NN reduced/VBD induced/NNS catalepsy/JJ
nicotine/NNP morphine/NNP induced/VBN catalepsy/RB
morphine/NNP induced/VBN catalepsy/RB
nicotine/NN induced/VBN morphine/NN potentiation/NN mediated/VBN concluded/VBN elicited/VBN catalepsy/NN
morphine/JJ catalepsy/NN
morphine/NN potentiation/NN mediated/VBN concluded/VBN elicited/VBN catalepsy/NN
N/NNP rats/NNS Production/NN cancer/NN prostate/NN
N/NNP rats/NNS Production/NN cancer/NN
nitroso/NN rats/NNS Production/NN cancer/NN prostate/NN
nitroso/NN rats/NNS Production/NN cancer/NN
N/NNP rats/NNS Production/NN cancer/NN prostate/NN
N/NNP rats/NNS Production/NN cancer/NN
methylurea/NN rats/NNS Production/NN cancer/NN prostate/NN
methylurea/NN rats/NNS Production/NN cancer/NN
N/NNP treatments/NNS adenocarcinomas/NNS prostate/NN
N/NNP treatments/NNS adenocarcinomas/NNS
nitroso/NN treatments/NNS adenocarcinomas/NNS prostate/NN
nitroso/NN treatments/NNS adenocarcinomas/NNS
N/NNP treatments/NNS adenocarcinomas/NNS prostate/NN
N/NNP treatments/NNS adenocarcinomas/NNS
methylurea/NN treatments/NNS adenocarcinomas/NNS prostate/NN
methylurea/NN treatments/NNS adenocarcinomas/NNS
N/NNP treatments/NNS adenocarcinomas/NNS PAs/NNP
nitroso/NN treatments/NNS adenocarcinomas/NNS PAs/NNP
N/NNP treatments/NNS adenocarcinomas/NNS PAs/NNP
methylurea/NN treatments/NNS adenocarcinomas/NNS PAs/NNP
testosterone/NN methylurea/NN treatments/NNS adenocarcinomas/NNS prostate/NN
testosterone/NN methylurea/NN treatments/NNS adenocarcinomas/NNS
propionate/NNP CAS/NNP testosterone/NN methylurea/NN treatments/NNS adenocarcinomas/NNS prostate/NN
propionate/NNP CAS/NNP testosterone/NN methylurea/NN treatments/NNS adenocarcinomas/NNS
testosterone/NN methylurea/NN treatments/NNS adenocarcinomas/NNS PAs/NNP
propionate/NNP CAS/NNP testosterone/NN methylurea/NN treatments/NNS adenocarcinomas/NNS PAs/NNP
TP/NNP CAS/NNP testosterone/NN methylurea/NN treatments/NNS adenocarcinomas/NNS prostate/NN
TP/NNP CAS/NNP testosterone/NN methylurea/NN treatments/NNS adenocarcinomas/NNS
TP/NNP CAS/NNP testosterone/NN methylurea/NN treatments/NNS adenocarcinomas/NNS PAs/NNP
TP/NNP treated/VBN PA/VBP
TP/NNP acted/VBD development/NN cancer/NN prostate/NN
TP/NNP acted/VBD development/NN cancer/NN
alfentanil/JJ anesthesia/NN rigidity/NN muscle/NN
alfentanil/JJ anesthesia/NN rigidity/NN
alfentanil/JJ prevented/VBN MED/NNP D/NNP induced/VBN rigidity/NN muscle/NN
alfentanil/JJ prevented/VBN MED/NNP D/NNP induced/VBN rigidity/NN
valproic/JJ acid/NN reaction/NN Confusion/NN
acid/NN reaction/NN Confusion/NN
valproic/JJ acid/NN observed/VBN reaction/NN Confusion/NN
acid/NN observed/VBN reaction/NN Confusion/NN
valproic/JJ acid/NN reported/VBD cases/NNS confusion/NN
acid/NN reported/VBD cases/NNS confusion/NN
valproic/JJ acid/NN reported/VBN confusion/NN
acid/NN reported/VBN confusion/NN
valproic/JJ exposure/NN weeks/NNS occurred/VBD Confusion/NN
acid/JJ exposure/NN weeks/NNS occurred/VBD Confusion/NN
valproic/JJ acid/NN confusion/NN
acid/NN confusion/NN
D/NNP treatment/NN globulin/NN induced/VBN anemia/NN aplastic/JJ
D/NNP treatment/NN globulin/NN induced/VBN anemia/NN
penicillamine/NN globulin/NN induced/VBN anemia/NN aplastic/JJ
penicillamine/NN globulin/NN induced/VBN anemia/NN
D/NNP due/JJ therapy/NN anemia/NN aplastic/JJ
D/NNP due/JJ therapy/NN anemia/NN
penicillamine/JJ therapy/NN described/VBN patient/NN received/VBD due/JJ therapy/NN anemia/NN aplastic/JJ
penicillamine/JJ therapy/NN described/VBN patient/NN received/VBD due/JJ therapy/NN anemia/NN
D/NNP induced/VBN anemia/NN aplastic/JJ
D/NNP induced/VBN anemia/NN
penicillamine/JJ D/NNP induced/VBN anemia/NN aplastic/JJ
penicillamine/JJ D/NNP induced/VBN anemia/NN
adriamycin/NN nephrosis/NNS
adriamycin/NN dose/NN given/VBN divided/VBN groups/NNS matched/VBN albuminuria/NN
adriamycin/NN nephrosis/NNS
levodopa/NN dyskinesias/NNS
Levodopa/NNP induced/VBN present/VB dyskinesias/NNS
Levodopa/NNP induced/VBN present/VB dyskinesias/NNS LIDs/NNP
MPTP/NNP types/NNS Using/VBG parkinsonism/NN
levodopa/NN therapy/NN duration/NN progression/NN rate/NN involved/VBN development/NN LIDs/NNP
levodopa/NN therapy/NN onset/NN exposure/NN Monkeys/NNS developed/VBD dyskinesia/NN
levodopa/NN administration/NN days/NNS dyskinesia/NN
levodopa/NN therapy/NN duration/NN monkeys/NNS resistant/JJ LIDs/NNS
levodopa/NN therapy/NN duration/NN monkeys/NNS resistant/JJ LIDs/NNS e/NNP developed/VBD dyskinesia/NN
levodopa/NN administration/NN e/NNP LIDs/NNS
levodopa/NN administration/NN e/NNP developed/VBD dyskinesia/NN
levodopa/NN develop/VB LIDs/NNP
levodopa/NN develop/VB demonstrate/VB studying/VBG pathophysiology/NN LIDs/NNP
Etoposide/NNP infarction/NN myocardial/JJ
Etoposide/NNP infarction/NN
etoposide/NN containing/VBG reported/VBN occurrence/NN infarction/NN myocardial/JJ
etoposide/NN containing/VBG reported/VBN occurrence/NN infarction/NN
verapamil/NN induced/VBN bradycardia/NN
dipyridamole/NN administration/NN occurred/VBD Angina/NNP
levodopa/NN effect/NN hypotensive/JJ
levodopa/NN mechanism/NN hypotensive/JJ
tobramycin/NN netilmicin/NN treated/VBN patients/NNS proportion/NN occurred/VBD Nephrotoxicity/NNP
netilmicin/NN treated/VBN patients/NNS proportion/NN occurred/VBD Nephrotoxicity/NNP
piperacillin/NN netilmicin/NN four/CD occurred/VBD Ototoxicity/NNP
piperacillin/NN tobramycin/NN occurred/VBD Ototoxicity/NNP
tobramycin/NN occurred/VBD Ototoxicity/NNP
netilmicin/NN four/CD occurred/VBD Ototoxicity/NNP
tobramycin/NN severe/JJ ototoxicity/RB
netilmicin/NN severe/JJ ototoxicity/RB
Capsaicin/NNP applied/VBD increases/NNS
Capsaicin/NNP applied/VBD flow/NN in/IN
Capsaicin/NNP applied/VBD flow/NN dural/JJ
Capsaicin/NNP applied/VBD flow/NN dural/JJ and/CC
Capsaicin/NNP applied/VBD flow/NN dural/JJ cortical/JJ
Capsaicin/NNP applied/VBD flow/NN blood/NN
Capsaicin/NNP applied/VBD flow/NN
Thyroxine/JJ abuse/NN case/NN thyrotoxicosis/NNS
thyroxine/JJ abuse/NN considered/VBN remains/VBZ cause/NN thyrotoxicosis/NNS
ketoconazole/JJ treatment/NN associated/VBN deaths/NNS two/CD continued/VBN onset/NN symptoms/NNS hepatitis/NN
ketoconazole/JJ treatment/NN associated/VBN deaths/NNS two/CD continued/VBN onset/NN symptoms/NNS jaundice/JJ
ketoconazole/NN treatment/NN advised/VBN monitoring/NN intervals/NNS evidence/NN hepatitis/NN
ketoconazole/NN treatment/NN advised/VBN prevent/VB injury/NN hepatic/JJ
ketoconazole/NN treatment/NN advised/VBN prevent/VB injury/NN
digitalis/NN stage/VB induced/VBN arrhythmias/NNS ventricular/NN
digitalis/NN stage/VB induced/VBN arrhythmias/NNS
digitalis/NN stage/VB induced/VBN two/CD Using/VBG examined/VBN determined/VBN concentration/NN model/NN arrhythmia/NN
adrenaline/VB stage/VB induced/VBN arrhythmias/NNS ventricular/NN
adrenaline/VB stage/VB induced/VBN arrhythmias/NNS
adrenaline/VB stage/VB induced/VBN two/CD Using/VBG examined/VBN determined/VBN concentration/NN model/NN arrhythmia/NN
digitalis/NN ligation/NN concentrations/NNS arrhythmias/NNS
digitalis/NN ligation/NN concentrations/NNS arrhythmias/NNS
adrenaline/NN concentrations/NNS arrhythmias/NNS
adrenaline/NN concentrations/NNS arrhythmias/NNS
adrenaline/NN concentration/NN higher/JJR arrhythmia/NNP
adrenaline/NN concentration/NN higher/JJR those/DT types/NNS arrhythmias/NNS
scopolamine/NN model/NN amnesia/NN
scopolamine/NN amnesia/NN
Ketoconazole/NNP induced/NNP torsades/VBZ
Ketoconazole/NNP induced/NNP torsades/VBZ pointes/NNS de/NNP
Ketoconazole/NNP induced/NNP torsades/VBZ pointes/NNS
ketoconazole/NN taking/VBG developed/VBD torsades/VBZ
ketoconazole/NN taking/VBG developed/VBD pointes/NNS de/IN
ketoconazole/NN taking/VBG developed/VBD pointes/NNS
ketoconazole/NN taking/VBG developed/VBD pointes/NNS TdP/NNP
ketoconazole/NN taking/VBG developed/VBD interval/NN prolonged/JJ
ketoconazole/NN taking/VBG developed/VBD interval/NN QT/NNP
ketoconazole/NN taking/VBG developed/VBD interval/NN
ketoconazole/NN prolong/VB induce/VB TdP/NNP
ketoconazole/NN administered/VBN patients/NNS factors/NNS syndrome/NN long/JJ
ketoconazole/NN administered/VBN patients/NNS factors/NNS syndrome/NN QT/NN
ketoconazole/NN administered/VBN patients/NNS factors/NNS syndrome/NN
cyclosporine/NN showed/VBD decrease/NN therapy/NN secondary/JJ nephrotoxicity/RB
cyclosporine/NN dosages/NNS cause/VB nephrotoxicity/NN
M/NNP %/NN groups/NNS treated/VBN steroid/NN showed/VBD reduction/NN
M/NNP %/NN groups/NNS treated/VBN steroid/NN showed/VBD reduction/NN intake/NN of/IN
M/NNP %/NN groups/NNS treated/VBN steroid/NN showed/VBD reduction/NN intake/NN food/NN
M/NNP %/NN groups/NNS treated/VBN steroid/NN showed/VBD reduction/NN intake/NN
T/NNP M/NNP %/NN groups/NNS treated/VBN steroid/NN showed/VBD reduction/NN
T/NNP M/NNP %/NN groups/NNS treated/VBN steroid/NN showed/VBD reduction/NN intake/NN of/IN
T/NNP M/NNP %/NN groups/NNS treated/VBN steroid/NN showed/VBD reduction/NN intake/NN food/NN
T/NNP M/NNP %/NN groups/NNS treated/VBN steroid/NN showed/VBD reduction/NN intake/NN
T/NNP showed/VBD IIa/NNS atrophy/JJ
T/NNP showed/VBD IIa/NNS atrophy/RB
T/NNP C/NNP rats/NNS performed/VBN study/NN showed/VBD pronounced/JJ atrophy/NN muscle/NN
T/NNP C/NNP rats/NNS performed/VBN study/NN showed/VBD pronounced/JJ atrophy/NN
T/NNP pronounced/JJ atrophy/NN muscle/NN
T/NNP pronounced/JJ atrophy/NN
capsaicin/NN intensity/NN modulation/NN induced/NNP hyperalgesia/NN
capsaicin/NN attention/NN affected/VBN hyperalgesia/NN
capsaicin/NN that/DT similar/JJ magnitude/NN modulation/NN hyperalgesia/NN
capsaicin/JJ treatment/NN interaction/NN suggest/VBP capsaicin/NN induced/VBN hyperalgesia/NN
capsaicin/NN induced/VBN hyperalgesia/NN
scopolamine/JJ test/NN induced/VBN amnesia/NN
dicyclomine/JJ scopolamine/JJ test/NN induced/VBN amnesia/NN
Suxamethonium/JJ infusion/NN fasciculations/VBZ
apraclonidine/NN significant/JJ effects/NNS ocular/NN
apraclonidine/NN significant/JJ effects/NNS hypotensive/NN
apraclonidine/NN administration/NN significant/JJ treated/VBN significant/JJ effects/NNS ocular/NN
apraclonidine/NN administration/NN significant/JJ treated/VBN significant/JJ effects/NNS hypotensive/NN
puromycin/NN aminonucleoside/NN subunit/VBP syndrome/NN nephrotic/JJ
puromycin/NN aminonucleoside/NN subunit/VBP syndrome/NN
aminonucleoside/NN subunit/VBP syndrome/NN nephrotic/JJ
aminonucleoside/NN subunit/VBP syndrome/NN
puromycin/NN aminonucleoside/NN syndrome/NN nephrotic/JJ
puromycin/NN aminonucleoside/NN syndrome/NN
aminonucleoside/NN syndrome/NN nephrotic/JJ
aminonucleoside/NN syndrome/NN
PAN/NNP aminonucleoside/NN syndrome/NN nephrotic/JJ
PAN/NNP aminonucleoside/NN syndrome/NN
PAN/NN dose/NN treated/VBN studied/VBN courses/NNS excretion/NN proteinuria/NN
PAN/NNP model/NN phase/NN syndrome/NN nephrotic/JJ
PAN/NNP model/NN phase/NN syndrome/NN
azithromycin/NN associated/VBN hiccups/NNS
azithromycin/NN therapy/NN associated/VBN hiccups/NNS
azithromycin/NN beginning/VBG presented/VBN hiccups/NNS
azithromycin/NN Discontinuation/NNP resolved/VBD hiccups/NNS
baclofen/NN azithromycin/NN Discontinuation/NNP resolved/VBD hiccups/NNS
azithromycin/NN mediated/VBN mechanism/NN pathogenesis/NNS hiccups/NNS
sirolimus/NNS administration/NN proteinuria/NN
sirolimus/NNS use/NN linked/VBN proteinuria/NN
sirolimus/JJ use/NN associated/VBN proteinuria/NN
sirolimus/JJ therapy/NN proteinuria/NN
sirolimus/JJ therapy/NN commencement/NN association/NN implicated/VBN etiology/NN proteinuria/NN
sirolimus/NNS implicated/VBN association/NN commencement/NN therapy/NN proteinuria/NN
sirolimus/NNS implicated/VBN etiology/NN proteinuria/NN
sirolimus/NNS initiation/NN association/NN proteinuria/NN
sirolimus/JJ therapy/NN correlated/VBD Proteinuria/NNP
sirolimus/NNS discontinuation/NN resulted/VBD decrease/NN proteinuria/NN
Sirolimus/NNP induces/VBZ pre/NN proteinuria/NN
sirolimus/NNS withdrawn/VBN improve/VB Proteinuria/NNP
tacrolimus/NNS receiving/VBG patients/NNS groups/NNS compared/VBN period/NN year/NN group/NN comprising/VBG patients/NNS hypertensive/JJ
tacrolimus/NNS associated/VBN nephrotoxicity/NN reducing/VBG nifedipine/JJ recipients/NNS impact/NN factor/NN selecting/VBG agent/NN treat/VB hypertension/NN
Ketamine/NNP elicited/VBD psychosis/NNS
Fluoxetine/NNP induced/VBN akathisia/NN
fluoxetine/NN receiving/VBG patients/NNS developed/VBD akathisia/NN
fluoxetine/NN purposeless/VBZ indistinguishable/JJ akathisia/JJ
fluoxetine/NN symptoms/NNS identical/JJ reported/VBD akathisia/NN
fluoxetine/NN akathisia/NN
fluoxetine/NN effect/NN appeared/VBD Akathisia/NNP
fluoxetine/NN akathisia/NN
fluoxetine/NN caused/VBN identical/JJ pathophysiology/NN jitteriness/NNS akathisia/NN
fluoxetine/JJ jitteriness/NNS pathophysiology/NN identical/JJ caused/VBN fluoxetine/NN akathisia/NN
fluoxetine/JJ jitteriness/NNS akathisia/NN
verapamil/NN ablation/NN induced/VBN tachycardia/NN atrioventricular/NN
verapamil/NN ablation/NN induced/VBN tachycardia/NN reentrant/NN
verapamil/NN ablation/NN induced/VBN tachycardia/NN
verapamil/JJ block/NN caused/VBN QRS/NNP established/VBD attack/NN AVRT/NN
warfarin/NN trends/NNS hemorrhage/NN
warfarin/NN incidence/NN bleeding/NN
prochlorperazine/NN administration/NN infusion/NN affect/VB incidence/NN akathisia/NN
prochlorperazine/NN administration/NN compare/VB rate/NN akathisia/NN
prochlorperazine/NN administered/VBN reduction/NN incidence/NN akathisia/NN
valsartan/NN %/NN day/NN mg/NN dose/NN higher/JJR incidence/NN drug/NN edema/NN
valsartan/NN %/NN %/NN %/NN day/NN mg/NN dose/NN higher/JJR incidence/NN drug/NN edema/NN
amlodipine/JJ group/NN higher/JJR incidence/NN drug/NN edema/NN
amlodipine/NN %/NN %/NN day/NN mg/NN dose/NN higher/JJR incidence/NN drug/NN edema/NN
amlodipine/NN %/NN %/NN %/NN day/NN mg/NN dose/NN higher/JJR incidence/NN drug/NN edema/NN
amlodipine/NN %/NN %/NN day/NN mg/NN dose/NN higher/JJR incidence/NN drug/NN edema/NN
Ceftriaxone/NNP associated/VBN pseudolithiasis/NNS biliary/JJ
Ceftriaxone/NNP associated/VBN pseudolithiasis/NNS
ceftriaxone/NN leads/VBZ pseudolithiasis/NNS
ceftriaxone/JJ treatment/NN receiving/VBG patients/NNS evaluated/VBN importance/NN pseudolithiasis/NNS
5/CD flourouracil/NN induced/VBN syndrome/NN apical/JJ
5/CD flourouracil/NN induced/VBN syndrome/NN ballooning/VBG
5/CD flourouracil/NN induced/VBN syndrome/NN
flourouracil/NN induced/VBN syndrome/NN apical/JJ
flourouracil/NN induced/VBN syndrome/NN ballooning/VBG
flourouracil/NN induced/VBN syndrome/NN
nitroprusside/NN CPAP/NNP shunt/NN hypotension/NN
nitroprusside/JJ infusion/NN produced/VBD decrease/NN
nitroprusside/JJ infusion/NN produced/VBD pressure/NN in/IN
nitroprusside/JJ infusion/NN produced/VBD pressure/NN arterial/JJ
nitroprusside/JJ infusion/NN produced/VBD pressure/NN blood/NN
nitroprusside/JJ infusion/NN produced/VBD pressure/NN
Nitroprusside/NNP caused/VBD decreases/NNS
Nitroprusside/NNP caused/VBD pressure/NN in/IN
Nitroprusside/NNP caused/VBD pressure/NN arterial/JJ
Nitroprusside/NNP caused/VBD pressure/NN blood/NN
Nitroprusside/NNP caused/VBD pressure/NN
fentanyl/NN neurotransmission/NN Involvement/NNP rigidity/NN muscular/JJ
fentanyl/NN neurotransmission/NN Involvement/NNP rigidity/NN
fentanyl/JJ anesthesia/NN dose/NN effect/NN well/NN rigidity/NN muscular/JJ
fentanyl/JJ anesthesia/NN dose/NN effect/NN well/NN rigidity/NN
fentanyl/NN rigidity/NN muscular/JJ
fentanyl/NN rigidity/NN
Isoproterenol/NNP induces/VBZ loss/NN correlation/NN injury/NN myocardial/JJ
Isoproterenol/NNP induces/VBZ loss/NN correlation/NN injury/NN
isoproterenol/NN demand/NN unknown/JJ damage/NN myocardial/JJ
isoproterenol/NN demand/NN unknown/JJ damage/NN
isoproterenol/NN demand/NN hypotension/NN hyperactivity/NN myocardial/JJ
isoproterenol/NN demand/NN hypotension/NN hyperactivity/NN
isoproterenol/NN induced/VBN injury/NN integrity/NN alterations/NNS explain/VBP changes/NNS related/VBN injury/NN ischaemic/JJ
isoproterenol/NN induced/VBN injury/NN integrity/NN alterations/NNS explain/VBP changes/NNS related/VBN injury/NN
flunitrazepam/NN injection/NN pain/NN
cisplatin/NN nephrotoxicity/NN
pilocarpine/NN evoked/VBN epilepticus/NNS status/NN
pilocarpine/NN evoked/VBN epilepticus/NNS
pilocarpine/NN evoked/VBN Infarcts/NNS
pilocarpine/NN evoked/VBN Infarcts/NNS reticulata/NN in/IN
pilocarpine/NN evoked/VBN Infarcts/NNS reticulata/NN substantia/JJ
pilocarpine/NN evoked/VBN Infarcts/NNS reticulata/NN nigra/NN
pilocarpine/NN evoked/VBN Infarcts/NNS reticulata/NN pars/NNS
pilocarpine/NN evoked/VBN Infarcts/NNS reticulata/NN
creatine/JJ supplementation/NN associated/VBN fibrillation/NN atrial/JJ
creatine/JJ supplementation/NN associated/VBN fibrillation/NN
levodopa/NN Tiapride/NNP movements/NNS involuntary/JJ
levodopa/NN Tiapride/NNP movements/NNS
levodopa/NN Tiapride/NNP induced/VBN movements/NNS involuntary/JJ
levodopa/NN Tiapride/NNP induced/VBN movements/NNS
levodopa/NN dyskinesias/NNS
Aspirin/NNP induces/VBZ anomalies/NNS developmental/JJ
Aspirin/NNP induces/VBZ anomalies/NNS
acetylsalicylic/JJ -RSB-/NNP Aspirin/NNP induces/VBZ anomalies/NNS developmental/JJ
acetylsalicylic/JJ -RSB-/NNP Aspirin/NNP induces/VBZ anomalies/NNS
acid/NNP -RSB-/NNP Aspirin/NNP induces/VBZ anomalies/NNS developmental/JJ
acid/NNP -RSB-/NNP Aspirin/NNP induces/VBZ anomalies/NNS
ASA/NNP -RSB-/NNP Aspirin/NNP induces/VBZ anomalies/NNS developmental/JJ
ASA/NNP -RSB-/NNP Aspirin/NNP induces/VBZ anomalies/NNS
ASA/NNP administered/VBN strains/NNS Dawley/NNP Sprague/NNP results/NNS compare/VB test/VB confounds/VBZ detection/NN malformations/NNS
ASA/NNP malformations/NNS
ASA/NNP induces/VBZ focused/VBD suggested/VBD induce/VB defects/NNS ventricular/NN
ASA/NNP induces/VBZ focused/VBD suggested/VBD induce/VB defects/NNS septal/NN
ASA/NNP induces/VBZ focused/VBD suggested/VBD induce/VB defects/NNS
ASA/NNP induces/VBZ focused/VBD suggested/VBD induce/VB defects/NNS VSDs/NNP
ASA/NNP induces/VBZ focused/VBD suggested/VBD induce/VB defects/NNS VSDs/NNP
ASA/NNP induces/VBZ focused/VBD suggested/VBD induce/VB defects/NNS defects/NNS rats/NNS hernia/NN diaphragmatic/JJ
ASA/NNP induces/VBZ focused/VBD suggested/VBD induce/VB defects/NNS defects/NNS rats/NNS hernia/NN
ASA/NNP induces/VBZ focused/VBD suggested/VBD induce/VB defects/NNS defects/NNS rats/NNS DH/NNP
ASA/NNP induces/VBZ focused/VBD malformations/NNS
ASA/NNP induces/VBZ low/NN malformations/NNS
ASA/NNP administered/VBN similar/JJ Variations/NNS malformations/NNS
ASA/NNP induced/VBN titrating/VBG dose/NN achieve/VB dose/NN malformations/NNS
Suxamethonium/NNP induced/VBN arrest/NN cardiac/JJ
Suxamethonium/NNP induced/VBN arrest/NN
suxamethonium/NN use/NN hyperkalaemia/NN result/NN death/NN case/NN arrest/NN cardiac/JJ
suxamethonium/NN use/NN hyperkalaemia/NN result/NN death/NN case/NN arrest/NN
suxamethonium/NN use/NN hyperkalaemia/NN
suxamethonium/NN arrest/NN cardiac/JJ
suxamethonium/NN arrest/NN
suxamethonium/NN bradycardia/NN
suxamethonium/NN administration/NN hyperkalaemia/NN
suxamethonium/NN caused/VBN hypersensitivity/NN
bromocriptine/NN isoproterenol/NN pretreatment/NN Effects/NNPS tachycardia/NN
bromocriptine/NN shown/VBN mediated/JJ tachycardia/NN
bromocriptine/NN tachycardia/NN
Isoproterenol/JJ pretreatment/NN caused/VBD hypertrophy/NN cardiac/JJ
Isoproterenol/JJ pretreatment/NN caused/VBD hypertrophy/NN
bromocriptine/NN induced/VBN hypotension/NN
bromocriptine/NN induced/VBN hypotension/NN tachycardia/NN
Bromocriptine/NNP induced/VBN unaffected/JJ hypotension/NN
isoproterenol/JJ pretreatment/NN unaffected/JJ reversed/VBN bradycardia/NN
Bromocriptine/NNP induced/VBN unaffected/JJ reversed/VBN tachycardia/NN
domperidone/JJ i/FW reduced/VBN effect/NN bradycardia/NN
isoproterenol/NN pretreatment/NN abolished/VBD 15/CD induced/VBN bradycardia/NN
bromocriptine/NN reversed/VBD abolished/VBD 15/CD induced/VBN tachycardia/NN
bromocriptine/NN tachycardia/NN
dexmedetomidine/JJ sedation/NN associated/VBN incidence/NN bradycardia/NN
sulindac/JJ group/NN experienced/VBD loss/NN hearing/NN
sulindac/JJ group/NN experienced/VBD loss/NN
sorafenib/NN sunitinib/NN inhibitors/NNS number/NN found/VBN cause/VB hemolysis/NNS
sunitinib/NN inhibitors/NNS number/NN found/VBN cause/VB hemolysis/NNS
oral/JJ contraceptives/NNS women/NNS liver/NN hyperplasia/NN focal/JJ
oral/JJ contraceptives/NNS women/NNS liver/NN hyperplasia/NN nodular/NN
oral/JJ contraceptives/NNS women/NNS liver/NN hyperplasia/NN
contraceptives/NNS women/NNS liver/NN hyperplasia/NN focal/JJ
contraceptives/NNS women/NNS liver/NN hyperplasia/NN nodular/NN
contraceptives/NNS women/NNS liver/NN hyperplasia/NN
oral/JJ contraceptives/NNS women/NNS liver/NN hyperplasia/NN adenomas/NNS
contraceptives/NNS women/NNS liver/NN hyperplasia/NN adenomas/NNS
oral/JJ contraceptives/NNS use/NN associated/VBN hyperplasia/NN focal/JJ
oral/JJ contraceptives/NNS use/NN associated/VBN hyperplasia/NN nodular/NN
oral/JJ contraceptives/NNS use/NN associated/VBN hyperplasia/NN
contraceptives/NNS use/NN associated/VBN hyperplasia/NN focal/JJ
contraceptives/NNS use/NN associated/VBN hyperplasia/NN nodular/NN
contraceptives/NNS use/NN associated/VBN hyperplasia/NN
oral/JJ contraceptives/NNS use/NN associated/VBN hyperplasia/NN one/CD adenoma/NN
contraceptives/NNS use/NN associated/VBN hyperplasia/NN one/CD adenoma/NN
methamphetamine/NN associated/VBN gene/NN psychosis/NNS
methamphetamine/NN psychosis/NNS
METH/NNP methamphetamine/NN psychosis/NNS
METH/NNP gene/NN 5/CD induced/VBN psychosis/NNS
METH/NNS patients/NNS psychosis/NNS
METH/NNP associated/VBN rs/NN RESULTS/NNS patients/NNS psychosis/NNS
METH/CD HTR/NNP association/NN psychosis/NNS
METH/NNP pathophysiology/NN play/VB HTR/NNP CONCLUSION/NNP psychosis/NNS
tacrolimus/NNS induced/VBN hypertrophy/NN myocardial/JJ
tacrolimus/NNS induced/VBN hypertrophy/NN
tacrolimus/NNS induced/VBN Herein/NNP describe/VBP myocardial/NN
tacrolimus/NNS induced/VBN hypertrophy/RB
tacrolimus/NNS concentration/NN reducing/VBG resolved/VBD hypertrophy/NN Myocardial/JJ
tacrolimus/NNS concentration/NN reducing/VBG resolved/VBD hypertrophy/NN
tacrolimus/NNS induces/VBZ hypertrophy/NN myocardial/JJ
tacrolimus/NNS induces/VBZ hypertrophy/NN
ticlopidine/NN developed/VBD treatment/NN jaundice/JJ
ticlopidine/NN mechanisms/NNS unclear/JJ cholestasis/NNS
gold/NN caused/VBN anemia/NN aplastic/JJ
gold/NN caused/VBN anemia/NN
D/NNP case/NN caused/VBN anemia/NN aplastic/JJ
D/NNP case/NN caused/VBN anemia/NN
penicillamine/NN anemia/NN aplastic/JJ
penicillamine/NN anemia/NN
methylprednisolone/NN administration/NN CONCLUSIONS/NNS related/VBN incidence/NN effects/NNS nausea/NN
methylprednisolone/NN administration/NN CONCLUSIONS/NNS related/VBN incidence/NN effects/NNS nausea/NN vomiting/NN
methylprednisolone/NN administration/NN CONCLUSIONS/NNS related/VBN incidence/NN effects/NNS nausea/NN headache/NN
gentamicin/NN methylprednisolone/NN administration/NN CONCLUSIONS/NNS related/VBN incidence/NN effects/NNS nausea/NN headache/NN
gentamicin/NN methylprednisolone/NN administration/NN CONCLUSIONS/NNS related/VBN incidence/NN effects/NNS nausea/NN
gentamicin/NN methylprednisolone/NN administration/NN CONCLUSIONS/NNS related/VBN incidence/NN effects/NNS nausea/NN vomiting/NN
capsaicin/NN skin/NN stimulation/NN nociceptive/VB induced/VBN gabapentin/NN induced/VBN hyperalgesia/NN secondary/JJ
capsaicin/NN skin/NN stimulation/NN nociceptive/VB induced/VBN gabapentin/NN induced/VBN hyperalgesia/NN
dipyridamole/NN hyperemia/NN
dipyridamole/NN resulted/VBD stenosis/NNS hyperemia/NN
dipyridamole/NN analyzed/VBD demonstrated/VBD Thallium/NNP induced/VBN hyperemia/NN
lithium/NN feeding/NN Effects/NNPS failure/NN chronic/JJ
lithium/NN feeding/NN Effects/NNPS failure/NN renal/JJ
lithium/NN feeding/NN Effects/NNPS failure/NN
Lithium/NNP caused/VBD hypertension/NN proteinuria/JJ
Lithium/NNP caused/VBD hypertension/NN
Li/NNP associated/VBN proteinuria/NN
Li/NNP associated/VBN proteinuria/NN hypertension/NN
bromocriptine/NN induced/VBN psychosis/NNS
bromocriptine/JJ received/VBN seen/VBN psychosis/NNS
Bromocriptine/NNP associated/VBN psychosis/NNS
bromocriptine/NN cause/VB psychosis/NNS
appetite/NN suppressants/NNS associated/VBN incidence/NN hypertension/NN primary/JJ
appetite/NN suppressants/NNS associated/VBN incidence/NN hypertension/NN pulmonary/JJ
appetite/NN suppressants/NNS associated/VBN incidence/NN hypertension/NN
suppressants/NNS associated/VBN incidence/NN hypertension/NN primary/JJ
suppressants/NNS associated/VBN incidence/NN hypertension/NN pulmonary/JJ
suppressants/NNS associated/VBN incidence/NN hypertension/NN
appetite/NN drugs/NNS intake/NN associated/VBN disease/NN hypertension/NN Primary/JJ
appetite/NN drugs/NNS intake/NN associated/VBN disease/NN hypertension/NN pulmonary/JJ
appetite/NN drugs/NNS intake/NN associated/VBN disease/NN hypertension/NN
suppressant/NN drugs/NNS intake/NN associated/VBN disease/NN hypertension/NN Primary/JJ
suppressant/NN drugs/NNS intake/NN associated/VBN disease/NN hypertension/NN pulmonary/JJ
suppressant/NN drugs/NNS intake/NN associated/VBN disease/NN hypertension/NN
appetite/NN suppressants/NNS taken/VBN patients/NNS uncertain/JJ diagnosis/NN hypertension/NN primary/JJ
appetite/NN suppressants/NNS taken/VBN patients/NNS uncertain/JJ diagnosis/NN hypertension/NN pulmonary/JJ
appetite/NN suppressants/NNS taken/VBN patients/NNS uncertain/JJ diagnosis/NN hypertension/NN
suppressants/NNS taken/VBN patients/NNS uncertain/JJ diagnosis/NN hypertension/NN primary/JJ
suppressants/NNS taken/VBN patients/NNS uncertain/JJ diagnosis/NN hypertension/NN pulmonary/JJ
suppressants/NNS taken/VBN patients/NNS uncertain/JJ diagnosis/NN hypertension/NN
appetite/NN suppressants/NNS prescription/NN policy/NN lead/VB incidence/NN hypertension/NN primary/JJ
appetite/NN suppressants/NNS prescription/NN policy/NN lead/VB incidence/NN hypertension/NN pulmonary/JJ
appetite/NN suppressants/NNS prescription/NN policy/NN lead/VB incidence/NN hypertension/NN
suppressants/NNS prescription/NN policy/NN lead/VB incidence/NN hypertension/NN primary/JJ
suppressants/NNS prescription/NN policy/NN lead/VB incidence/NN hypertension/NN pulmonary/JJ
suppressants/NNS prescription/NN policy/NN lead/VB incidence/NN hypertension/NN
cocaine/NN Stroke/NNP
amphetamine/NN cocaine/NN Stroke/NNP
cocaine/NN use/NN stroke/NN
amphetamine/NN cocaine/NN use/NN stroke/NN
cocaine/NN stroke/NN
amphetamine/NN cocaine/NN stroke/NN
cocaine/NN 8/CD using/VBG admitted/VBD women/NNS matched/VBD ratio/NN stroke/NN
amphetamine/NN //NN cocaine/NN 8/CD using/VBG admitted/VBD women/NNS matched/VBD ratio/NN stroke/NN
cocaine/NN use/NN factor/NN stroke/NN
amphetamine/NN cocaine/NN use/NN factor/NN stroke/NN
busulfan/NN cystitis/NNS
busulfan/NN cystitis/NNS appearances/NNS radiation/NN cystitis/NNS
pyrazinamide/NN induced/VBN dysosmia/NNP
pyrazinamide/VB related/VBN disorder/NN olfactory/NN
pyrazinamide/VB related/VBN disorder/NN
pyrazinamide/JJ withdrawal/NN disappeared/VBD Dysosmia/NNP
lovastatin/NN dose/NN associated/VBN rare/JJ Myopathy/RB
capsaicin/NN elicited/VBD pain/NN
capsaicin/NN amount/NN administered/VBN evoke/VB sensation/NN painful/JJ
ketoprofen/NN administration/NN decreased/VBD aggregation/NN platelet/NN
ketoprofen/NN administration/NN decreased/VBD aggregation/NN
ketoprofen/NN group/NN patient/NN developed/VBD hematoma/NN
risperidone/NN syndrome/NN Neuroleptic/JJ
risperidone/NN syndrome/NN malignant/JJ
risperidone/NN syndrome/NN
risperidone/NN developed/VBD syndrome/NN neuroleptic/JJ
risperidone/NN developed/VBD syndrome/NN malignant/JJ
risperidone/NN developed/VBD syndrome/NN
risperidone/NN observed/VBN effects/NNS protection/NN ensure/VB syndrome/NN neuroleptic/JJ
risperidone/NN observed/VBN effects/NNS protection/NN ensure/VB syndrome/NN malignant/JJ
risperidone/NN observed/VBN effects/NNS protection/NN ensure/VB syndrome/NN
Quinidine/JJ phenylethylbarbiturate/NN induced/VBN hepatitis/NN
phenylethylbarbiturate/NN induced/VBN hepatitis/NN
quinidine/JJ phenylethylbarbiturate/NN administration/NN year/NN patient/NN affected/VBN hepatitis/NN
phenylethylbarbiturate/NN administration/NN year/NN patient/NN affected/VBN hepatitis/NN
phenylethylbarbiturate/NN itself/PRP responsible/JJ hepatitis/NN
cytosine/NN treatment/NN neuropathy/NN Peripheral/JJ
cytosine/NN treatment/NN neuropathy/NN
arabinoside/NN treatment/NN neuropathy/NN Peripheral/JJ
arabinoside/NN treatment/NN neuropathy/NN
cytosine/NN arabinoside/NN therapy/NN play/VB unclear/JJ mechanisms/NNS neuropathy/NN peripheral/JJ
cytosine/NN arabinoside/NN therapy/NN play/VB unclear/JJ mechanisms/NNS neuropathy/NN
arabinoside/NN therapy/NN play/VB unclear/JJ mechanisms/NNS neuropathy/NN peripheral/JJ
arabinoside/NN therapy/NN play/VB unclear/JJ mechanisms/NNS neuropathy/NN
Sorafenib/NNP induced/VBN due/JJ spasm/NN coronary/JJ
Sorafenib/NNP induced/VBN due/JJ spasm/NN artery/NN
Sorafenib/NNP induced/VBN due/JJ spasm/NN
sorafenib/NN induced/VBN spasm/NN coronary/JJ
sorafenib/NN induced/VBN spasm/NN artery/NN
sorafenib/NN induced/VBN spasm/NN
acetaminophen/NN overdose/NN failure/NN associated/VBN edema/NN cerebral/JJ
acetaminophen/NN overdose/NN failure/NN associated/VBN edema/NN
acetaminophen/NN overdose/NN failure/NN hepatic/JJ
acetaminophen/NN overdose/NN failure/NN
acetaminophen/NN patient/NN present/VBP induced/VBN unresponsive/JJ failure/NN signs/NNS edema/NN cerebral/JJ
acetaminophen/NN patient/NN present/VBP induced/VBN unresponsive/JJ failure/NN signs/NNS edema/NN
acetaminophen/NN patient/NN present/VBP induced/VBN unresponsive/JJ failure/NN fulminant/JJ
acetaminophen/NN patient/NN present/VBP induced/VBN unresponsive/JJ failure/NN hepatic/JJ
acetaminophen/NN patient/NN present/VBP induced/VBN unresponsive/JJ failure/NN
nitroglycerin/NN application/NN sided/VBD received/VBD patients/NNS migraine/NN
nitroglycerin/NN induced/VBN attacks/NNS migraine/NN
nitroglycerin/NN developed/VBD patients/NNS migraine/JJ
nitroglycerin/NN effect/NN inducing/VBG seems/VBZ migraine/NN
nitroglycerin/NN effect/NN inducing/VBG seems/VBZ suggesting/VBG importance/NN development/NN crisis/NN migraine/JJ
D/NNP treated/VBN cirrhosis/NNS case/NN polymyositis/NNS
penicillamine/VBP case/NN polymyositis/NNS
D/NNP complications/NNS one/CD develop/VB Polymyositis/NNS
penicillamine/VBP Polymyositis/NNS
D/NNP receiving/VBG developed/VBD polymyositis/NNS
penicillamine/JJ therapy/NN D/NNP receiving/VBG developed/VBD polymyositis/NNS
D/NNP followed/VBN polymyositis/NNS
penicillamine/JJ therapy/NN followed/VBN polymyositis/NNS
cocaine/NN LR/NNP mice/NNS treatment/NN pre/NN induced/VBN convulsions/NNS
cocaine/NN effects/NNS anti/JJ ligands/NNS involved/VBD validate/VB shown/VBN attenuate/VB effects/NNS convulsive/JJ
cocaine/NN effects/NNS convulsive/JJ
isoproterenol/NN A/NN effect/NN infarction/NN myocardial/JJ
isoproterenol/NN A/NN effect/NN infarction/NN
isoproterenol/NN induced/VBN infarction/NN myocardial/JJ
isoproterenol/NN induced/VBN infarction/NN
isoproterenol/NN induced/VBN infarction/NN myocardial/JJ
isoproterenol/NN induced/VBN infarction/NN
vancomycin/NN aminoglycoside/NN receiving/VBG patients/NNS confined/VBN occurred/VBD Thrombophlebitis/NNS
vancomycin/NN aminoglycoside/NN receiving/VBG patients/NNS confined/VBN nephrotoxicity/NN ototoxicity/NN
flutamide/NN intramuscularly/NN -RSB-/VBZ evaluated/VBN anemia/NN
leuprolide/NN acetate/NN 3/CD -RSB-/VBZ evaluated/VBN anemia/NN
acetate/NN 3/CD -RSB-/VBZ evaluated/VBN anemia/NN
LHRH/NNP acetate/NN 3/CD -RSB-/VBZ evaluated/VBN anemia/NN
A/NNP LHRH/NNP acetate/NN 3/CD -RSB-/VBZ evaluated/VBN anemia/NN
dobutamine/VB related/VBN myocarditis/NNS
dobutamine/VB related/VBN myocarditis/NNS hypersensitivity/NN
dobutamine/VB related/VBN myocarditis/NNS eosinophilic/JJ
Succinylcholine/NNP induced/VBN rigidity/NN masseter/NN
Succinylcholine/NNP induced/VBN rigidity/NN muscle/NN
Succinylcholine/NNP induced/VBN rigidity/NN
succinylcholine/JJ administration/NN describe/VBP case/NN rigidity/NN masseter/NN
succinylcholine/JJ administration/NN describe/VBP case/NN rigidity/NN muscle/NN
succinylcholine/JJ administration/NN describe/VBP case/NN rigidity/NN
succinylcholine/JJ administration/NN describe/VBP case/NN rigidity/NN jaw/NN
succinylcholine/JJ administration/NN describe/VBP case/NN rigidity/NN jaw/NN steel/NN of/IN
succinylcholine/JJ administration/NN describe/VBP case/NN rigidity/NN jaw/NN steel/NN
Sch/NNP administration/NN describe/VBP case/NN rigidity/NN masseter/NN
Sch/NNP administration/NN describe/VBP case/NN rigidity/NN muscle/NN
Sch/NNP administration/NN describe/VBP case/NN rigidity/NN
Sch/NNP administration/NN describe/VBP case/NN rigidity/NN jaw/NN
Sch/NNP administration/NN describe/VBP case/NN rigidity/NN jaw/NN steel/NN of/IN
Sch/NNP administration/NN describe/VBP case/NN rigidity/NN jaw/NN steel/NN
Ranitidine/NNP induced/VBN nephritis/NNS interstitial/JJ
Ranitidine/NNP induced/VBN nephritis/NNS
ranitidine/NN case/NN nephritis/NNS interstitial/JJ
ranitidine/NN case/NN nephritis/NNS
diethylstilbestrol/NN induced/VBN tumors/NNS Pituitary/JJ
diethylstilbestrol/NN induced/VBN tumors/NNS
DES/NNP diethylstilbestrol/NN induced/VBN tumors/NNS Pituitary/JJ
DES/NNP diethylstilbestrol/NN induced/VBN tumors/NNS
amiodarone/NN administration/NN pain/NN low/JJ
amiodarone/NN administration/NN pain/NN back/NN
amiodarone/NN administration/NN pain/NN
amiodarone/NN loading/NN initiation/NN experienced/VBD pain/NN low/JJ
amiodarone/NN loading/NN initiation/NN experienced/VBD pain/NN back/NN
amiodarone/NN loading/NN initiation/NN experienced/VBD pain/NN
pentazocine/NN affected/VBN muscle/NN due/JJ neuropathy/NN compression/NN
pentazocine/NN affected/VBN muscle/NN due/JJ neuropathy/NN
pentazocine/NN induced/VBN myopathy/RB
Paracetamol/NNP associated/VBN coma/NN acidosis/NNS metabolic/JJ
Paracetamol/NNP associated/VBN coma/NN acidosis/NNS
paracetamol/NNP ingestion/NNP failure/NN acidosis/NNS metabolic/JJ
paracetamol/NNP ingestion/NNP failure/NN acidosis/NNS
Penicillamine/NNP induced/VBN glomerulonephritis/NNS
D/NNP months/NNS presented/VBN rapidly/RB glomerulonephritis/NNS
penicillamine/JJ treatment/NN woman/NN arthritis/NN presented/VBN rapidly/RB glomerulonephritis/NNS
D/NNP months/NNS presented/VBN rapidly/RB glomerulonephritis/NNS RPGN/NNP
penicillamine/JJ treatment/NN woman/NN arthritis/NN presented/VBN rapidly/RB glomerulonephritis/NNS RPGN/NNP
D/NNP course/NN case/NN RPGN/NNP
penicillamine/JJ treatment/NN emphasizes/VBZ case/NN RPGN/NNP
D/NNP induced/VBN angiopathy/RB
penicillamine/JJ D/NNP induced/VBN angiopathy/RB
isoniazid/NN pretreated/VBD induced/VBN bradycardia/NNP
isoniazid/JJ hypotension/NN doses/NNS induced/VBN tachycardia/NN bradycardia/NN
isoniazid/JJ hypotension/NN
isoniazid/NN bradycardia/NN
Isoniazid/NNP increased/VBD bradycardia/NN
puromycin/NN amino/NNS injection/NN induced/VBN NS/NNP
amino/NNS injection/NN induced/VBN NS/NNP
nucleoside/NN amino/NNS injection/NN induced/VBN NS/NNP
PAN/NNP amino/NNS injection/NN induced/VBN NS/NNP
PAN/NNP injection/NN observed/JJ established/VBN NS/NNP
PAN/NNP induced/VBN NS/NN
Doxorubicin/NN cardiomyopathy/NN
doxorubicin/NN bed/NN experienced/VBD cardiomyopathy/NN
doxorubicin/NN interaction/NN fact/NN attributed/VBN cardiomyopathy/NN
tacrolimus/NNS triggered/VBN dysfunction/NN resulted/VBN dysfunction/NN myopathy/NN
tacrolimus/NNS triggered/VBN dysfunction/NN resulted/VBN dysfunction/NN tubular/JJ
tacrolimus/NNS triggered/VBN dysfunction/NN resulted/VBN dysfunction/NN
lamivudine/NN augmented/VBN triggered/VBN dysfunction/NN resulted/VBN dysfunction/NN tubular/JJ
lamivudine/NN augmented/VBN triggered/VBN dysfunction/NN resulted/VBN dysfunction/NN
lamivudine/NN augmented/VBN triggered/VBN dysfunction/NN resulted/VBN dysfunction/NN myopathy/NN
sertraline/NN fluoxetine/NN receiving/VBG women/NNS sexually/RB
sertraline/NN fluoxetine/NN receiving/VBG women/NNS dysfunctional/JJ
paroxetine/NN fluoxetine/NN receiving/VBG women/NNS sexually/RB
paroxetine/NN fluoxetine/NN receiving/VBG women/NNS dysfunctional/JJ
fluoxetine/NN receiving/VBG women/NNS sexually/RB
fluoxetine/NN receiving/VBG women/NNS dysfunctional/JJ
magnesium/NN administration/NN presenting/VBG gravis/VBZ Myasthenia/NNP
magnesium/NN administration/NN presenting/VBG gravis/VBZ
magnesium/NN administration/NN paralysis/NN described/VBN patients/NNS gravis/NNS myasthenia/NN
magnesium/NN administration/NN paralysis/NN described/VBN patients/NNS gravis/NNS
fat/JJ diet/NN sensitive/JJ rats/NNS obese/NN
fat/JJ diet/NN induces/VBZ obesity/RB
doxorubicin/NN dose/NN administered/VBN day/NN regimen/NN led/VBN cardiotoxicity/NN dysfunction/NN cardiac/JJ
doxorubicin/NN dose/NN administered/VBN day/NN regimen/NN led/VBN cardiotoxicity/NN dysfunction/NN
risperidone/JJ hyperprolactinemia/NN
risperidone/NN treated/VBN %/NN present/JJ Hyperprolactinemia/NNP
risperidone/NNP started/VBN occurred/VBD occurred/VBD hyperprolactinemia/NN
risperidone/NN link/VB study/NN induced/VBN treatment/NN hyperprolactinemia/NNP
disulfiram/NN intoxication/NN fold/VBP vocal/NNP
disulfiram/NN intoxication/NN fold/VBP
disulfiram/NN intoxication/NN fold/VBP palsy/NN
disulfiram/NN overdose/NN caused/VBN neuropathy/NN rare/JJ is/VBZ report/NN leading/VBG fold/VB vocal/NN
disulfiram/NN overdose/NN caused/VBN neuropathy/NN rare/JJ is/VBZ report/NN leading/VBG fold/VB
disulfiram/NN overdose/NN caused/VBN neuropathy/NN rare/JJ is/VBZ report/NN leading/VBG fold/VB palsy/NN
disulfiram/NN overdose/NN caused/VBN neuropathy/NN peripheral/JJ
disulfiram/NN overdose/NN caused/VBN neuropathy/NN
ketamine/VB buffers/VBZ decreases/VBZ duration/NN hallucinations/NNS
Warfarin/NNP induced/VBN accelerated/VBN calcification/NN artery/NN
Warfarin/NNP induced/VBN accelerated/VBN calcification/NN
Warfarin/NNP doses/NNS given/VBN rats/NNS enhance/VB extent/NN calcification/NN artery/NN
Warfarin/NNP doses/NNS given/VBN rats/NNS enhance/VB extent/NN calcification/NN
Warfarin/NNP calcification/NN artery/NN
Warfarin/NNP calcification/NN
Warfarin/NNP weeks/NNS Treatment/NNP caused/VBD calcification/NN
Warfarin/NNP weeks/NNS Treatment/NNP caused/VBD calcification/NN media/NNS of/IN
Warfarin/NNP weeks/NNS Treatment/NNP caused/VBD calcification/NN media/NNS the/DT
Warfarin/NNP weeks/NNS Treatment/NNP caused/VBD calcification/NN media/NNS artery/NN
Warfarin/NNP treatment/NN weeks/NNS detected/VBN calcification/NN artery/NN
Warfarin/NNP treatment/NN weeks/NNS detected/VBN calcification/NN
Warfarin/NNP growth/NN calcification/NN artery/NN
Warfarin/NNP growth/NN calcification/NN
Warfarin/NNP groups/NNS treatment/NN produced/VBD calcification/NN
Warfarin/NNP groups/NNS treatment/NN produced/VBD calcification/NN media/NNS of/IN
Warfarin/NNP groups/NNS treatment/NN produced/VBD calcification/NN media/NNS the/DT
Warfarin/NNP groups/NNS treatment/NN produced/VBD calcification/NN media/NNS artery/NN
Warfarin/NNP groups/NNS treatment/NN produced/VBD calcification/NN rats/NNS calcification/NN artery/NN
Warfarin/NNP groups/NNS treatment/NN produced/VBD calcification/NN rats/NNS calcification/NN
Warfarin/NNP resistant/JJ groups/NNS either/DT fed/VBN levels/NNS was/VBD determined/VBN explanation/NN association/NN calcification/NN artery/NN
Warfarin/NNP resistant/JJ groups/NNS either/DT fed/VBN levels/NNS was/VBD determined/VBN explanation/NN association/NN calcification/NN
Warfarin/NNP resistant/JJ groups/NNS either/DT fed/VBN levels/NNS was/VBD calcification/NN artery/NN
Warfarin/NNP resistant/JJ groups/NNS either/DT fed/VBN levels/NNS was/VBD calcification/NN
Warfarin/NNP resistant/JJ groups/NNS either/DT fed/VBN levels/NNS induced/VBN calcification/NN artery/NN
Warfarin/NNP resistant/JJ groups/NNS either/DT fed/VBN levels/NNS induced/VBN calcification/NN
Warfarin/NNP increased/VBD suggests/VBZ related/VBN calcification/NN artery/NN
Warfarin/NNP increased/VBD suggests/VBZ related/VBN calcification/NN
Warfarin/NNP D/NNP synergy/NN examined/VBD calcification/NN artery/NN
Warfarin/NNP D/NNP synergy/NN examined/VBD calcification/NN
Warfarin/NNP doses/NNS known/VBN calcification/NN
Warfarin/NNP doses/NNS known/VBN calcification/NN media/NNS of/IN
Warfarin/NNP doses/NNS known/VBN calcification/NN media/NNS the/DT
Warfarin/NNP doses/NNS known/VBN calcification/NN media/NNS artery/NN
Warfarin/NNP D/NNP treated/VBN rats/NNS found/VBN sites/NNS calcification/NN artery/NN
Warfarin/NNP D/NNP treated/VBN rats/NNS found/VBN sites/NNS calcification/NN
sirolimus/NNS Proteinuria/NNP
sirolimus/JJ therapy/NN consequence/NN reported/VBN proteinuria/NN
SRL/NNP conversion/NN displayed/VBD proteinuria/NN
SRL/NNP use/NN common/JJ proteinuria/NNP
DFO/NNP reduction/NN submitted/VBN Subjects/NNS SNHL/NNP
oxacillin/NN associated/VBN vasculitis/NNS Cutaneous/JJ
oxacillin/NN associated/VBN vasculitis/NNS leucocytoclastic/JJ
oxacillin/NN associated/VBN vasculitis/NNS
oxacillin/NN treated/VBN man/NN year/NN developed/VBD failure/NN renal/JJ
oxacillin/NN treated/VBN man/NN year/NN developed/VBD failure/NN
Oxacillin/NNP included/VBN drugs/NNS cause/VB vasculitis/NNS leucocytoclastic/JJ
Oxacillin/NNP included/VBN drugs/NNS cause/VB vasculitis/NNS
amphetamine/NN dose/NN sensitization/VBN cross/NN behavioral/JJ
amphetamine/NN dose/NN sensitization/VBN cross/NN
amphetamine/NN dose/NN sensitization/VBN
amphetamine/NN dose/NN sensitization/NN cross/NN behavioral/JJ
amphetamine/NN dose/NN sensitization/NN cross/NN
amphetamine/NN dose/NN sensitization/NN
amphetamine/VB hyperactive/VBN
amphetamine/JJ injection/NN followed/VBD libitum/NN groups/NNS amphetamine/VB hyperactive/VBN
amphetamine/JJ injection/NN followed/VBN chow/NN injection/NN followed/VBD libitum/NN groups/NNS amphetamine/VB hyperactive/VBN
amphetamine/JJ sucrose/NN chow/NN injection/NN followed/VBN chow/NN injection/NN followed/VBD libitum/NN groups/NNS amphetamine/VB hyperactive/VBN
sucrose/NN experienced/VBN animals/NNS hyperactive/VBN
sucrose/JJ %/NN followed/VBD libitum/NN groups/NNS amphetamine/VB hyperactive/VBN
sucrose/NN chow/NN injection/NN followed/VBN chow/NN injection/NN followed/VBD libitum/NN groups/NNS amphetamine/VB hyperactive/VBN
DX/NNP treated/VBN those/DT treated/VBN animals/NNS appeared/VBD proteinuria/NN
doxorubicin/NN treatment/NN prolonged/JJ intense/JJ 2/CD appeared/VBD Proteinuria/NNP
DX/NNP DXNP/NNP difference/NN 2/CD appeared/VBD Proteinuria/NNP
Cocaine/NNP use/NN predisposed/VBD rupture/NN aneurysmal/JJ
Cocaine/NNP use/NN predisposed/VBD rupture/NN
AraG/NNP attributable/JJ effects/NNS included/VBD 2/CD neuropathy/NN
AraG/NNP attributable/JJ effects/NNS included/VBD 2/CD neuropathy/NN pain/NN musculoskeletal/JJ
AraG/NNP attributable/JJ effects/NNS included/VBD 2/CD neuropathy/NN pain/NN
AraG/VBG greater/JJR toxicity/NN Haematological/JJ
AraG/VBG greater/JJR toxicity/NN
AraG/NNP giving/VBG safety/NN supports/VBZ monitored/VBN toxicity/NN neurological/JJ
AraG/NNP giving/VBG safety/NN supports/VBZ monitored/VBN toxicity/NN
rilmenidine/JJ rats/NNS operated/VBD elicited/VBD hypotension/NN
alpha/NN rilmenidine/JJ rats/NNS operated/VBD elicited/VBD hypotension/NN
methyldopa/NN elicited/VBD hypotension/NN
rilmenidine/NN effect/NN contrast/NN methyldopa/NN alpha/NN hypotension/NN enhanced/VBD response/NN hypotensive/JJ
rilmenidine/NN effect/NN contrast/NN methyldopa/NN alpha/NN hypotension/NN
alpha/NN hypotension/NN enhanced/VBD response/NN hypotensive/JJ
methyldopa/NN alpha/NN hypotension/NN enhanced/VBD response/NN hypotensive/JJ
alpha/NN hypotension/NN
methyldopa/NN alpha/NN hypotension/NN
alpha/NN hypotension/NN
methyldopa/NN hypotension/NN
alpha/NN interaction/NN hypotension/VB
methyldopa/NNP alpha/NN interaction/NN hypotension/VB
sirolimus/NNS due/JJ proteinuria/NN
sirolimus/NNS due/JJ remained/VBD observed/VBN proteinuria/NN
sirolimus/JJ therapy/NN observed/VBN remained/VBD due/JJ proteinuria/NN
sirolimus/JJ therapy/NN observed/VBN proteinuria/NN
sirolimus/NNS received/VBD patients/NNS observed/VBN' observed/VBN remained/VBD due/JJ proteinuria/NN
sirolimus/NNS received/VBD patients/NNS observed/VBN' observed/VBN proteinuria/NN
raloxifene/VB due/JJ thromboembolism/VBP risk/NN venous/NNS
raloxifene/VB due/JJ thromboembolism/VBP
nicotine/NN receptors/NNS induced/VBN hyperactivity/RB
Nicotine/NNP caused/VBD increase/NN
Nicotine/NNP caused/VBD activity/NN in/IN
Nicotine/NNP caused/VBD activity/NN locomotor/NN
Nicotine/NNP caused/VBD activity/NN
Nicotine/NNP blocked/VBN hyperactivity/RB
nicotine/NN PHNO/NNP induced/VBN hyperactivity/RB
nicotine/NN injection/NN induces/VBZ hyperactivity/NN
Suxamethonium/NNP induced/VBN apnea/NN
Suxamethonium/NNP causes/VBZ apnea/NN
organophosphorus/NNS deactivated/JJ poisons/NNS gets/VBZ apnea/NN
OP/NNP organophosphorus/NNS deactivated/JJ poisons/NNS gets/VBZ apnea/NN
poisons/NNS gets/VBZ apnea/NN
OP/NNP compound/NN attempt/NN information/NN concealed/VBN ensued/VBD apnea/NN
compound/NN attempt/NN information/NN concealed/VBN ensued/VBD apnea/NN
levodopa/NN involved/VBN unclear/JJ dyskinesia/NNP
3/CD induced/VBN anaemia/NN
azido/NN 3/CD induced/VBN anaemia/NN
3/CD dideoxythymidine/NN understood/VBN induced/VBN anaemia/NN
'/POS 3/CD dideoxythymidine/NN understood/VBN induced/VBN anaemia/NN
dideoxythymidine/NN understood/VBN induced/VBN anaemia/NN
AZT/NNP dideoxythymidine/NN understood/VBN induced/VBN anaemia/NN
AZT/NNP anaemia/NN
AZT/NNP produced/VBD anaemia/NN
AZT/NNP treated/NNP increased/VBD number/NN fold/VBP anaemia/NN
AZT/NNP treated/VBN appropriate/JJ observed/VBD degree/NN anaemia/NN
AZT/NNP treated/VBN degrees/NNS anaemia/NN
AZT/NNP observed/VBN anaemia/NN
AZT/NNP induced/VBN anaemia/NN
amisulpride/NN mg/NN doses/NNS man/NN hypertension/NN
tiapride/NN mg/NN mg/NN doses/NNS man/NN headache/NN vomiting/NN
tiapride/NN mg/NN mg/NN doses/NNS man/NN headache/NN
amisulpride/NN mg/NN doses/NNS man/NN headache/NN
tiapride/NN mg/NN mg/NN doses/NNS man/NN hypertension/NN
amisulpride/NN mg/NN doses/NNS man/NN headache/NN vomiting/NN
amisulpride/JJ therapy/NN crisis/NN hypertensive/JJ
tiapride/JJ amisulpride/JJ therapy/NN crisis/NN hypertensive/JJ
amisulpride/JJ crisis/NN hypertensive/JJ
tiapride/JJ amisulpride/JJ crisis/NN hypertensive/JJ
AZT/NNP induced/VBN cardiomyopathy/RB
zidovudine/VBP investigate/VB triggers/VBZ Fas/NNP pathway/NN model/NN DCM/NNP
3/CD azido/NNS zidovudine/VBP investigate/VB triggers/VBZ Fas/NNP pathway/NN model/NN DCM/NNP
'/POS 3/CD azido/NNS zidovudine/VBP investigate/VB triggers/VBZ Fas/NNP pathway/NN model/NN DCM/NNP
-/NN azido/NNS zidovudine/VBP investigate/VB triggers/VBZ Fas/NNP pathway/NN model/NN DCM/NNP
azido/NNS zidovudine/VBP investigate/VB triggers/VBZ Fas/NNP pathway/NN model/NN DCM/NNP
2/CD azido/NNS zidovudine/VBP investigate/VB triggers/VBZ Fas/NNP pathway/NN model/NN DCM/NNP
3/CD triggers/VBZ Fas/NNP pathway/NN model/NN DCM/NNP
deoxythymidine/JJ 3/CD triggers/VBZ Fas/NNP pathway/NN model/NN DCM/NNP
AZT/NNP 3/CD triggers/VBZ Fas/NNP pathway/NN model/NN DCM/NNP
AZT/NNP concentrations/NNS containing/VBG libitum/NN received/VBD triggers/VBZ Fas/NNP pathway/NN model/NN DCM/NNP
AZT/NNP -/NNP treated/VBD developed/VBD dilation/NN cardiac/JJ
AZT/NNP -/NNP treated/VBD developed/VBD dilation/NN
ribavirin/JJ treatment/NN b/NNS case/NN parasitosis/NNS delusional/JJ
ribavirin/JJ treatment/NN b/NNS case/NN parasitosis/NNS
pegylated/JJ alpha/NNS patient/NN parasitosis/NNS delusional/JJ
pegylated/JJ alpha/NNS patient/NN parasitosis/NNS
interferon/NN alpha/NNS patient/NN parasitosis/NNS delusional/JJ
interferon/NN alpha/NNS patient/NN parasitosis/NNS
alpha/NNS patient/NN parasitosis/NNS delusional/JJ
alpha/NNS patient/NN parasitosis/NNS
2/CD b/NNS case/NN parasitosis/NNS delusional/JJ
2/CD b/NNS case/NN parasitosis/NNS
b/NNS case/NN parasitosis/NNS delusional/JJ
b/NNS case/NN parasitosis/NNS
ribavirin/NNP b/NNS year/NN woman/NN developed/VBD parasitosis/NNS delusional/JJ
ribavirin/NNP b/NNS year/NN woman/NN developed/VBD parasitosis/NNS
pegylated/JJ alpha/NNS developed/VBD parasitosis/NNS delusional/JJ
pegylated/JJ alpha/NNS developed/VBD parasitosis/NNS
interferon/NN alpha/NNS developed/VBD parasitosis/NNS delusional/JJ
interferon/NN alpha/NNS developed/VBD parasitosis/NNS
alpha/NNS developed/VBD parasitosis/NNS delusional/JJ
alpha/NNS developed/VBD parasitosis/NNS
2/CD b/NNS year/NN woman/NN developed/VBD parasitosis/NNS delusional/JJ
2/CD b/NNS year/NN woman/NN developed/VBD parasitosis/NNS
b/NNS year/NN woman/NN developed/VBD parasitosis/NNS delusional/JJ
b/NNS year/NN woman/NN developed/VBD parasitosis/NNS
MPTP/NN rendered/VBN parkinsonian/NN
lidocaine/JJ group/NN %/NN fatal/JJ' fatal/JJ dose/NN convulsions/NNS
lidocaine/JJ group/NN %/NN fatal/JJ' fatal/JJ %/NN bupivacaine/NN induced/VBN seizures/NNS
chloroprocaine/JJ group/NN %/NN induced/VBN bupivacaine/NN %/NN fatal/JJ dose/NN convulsions/NNS
chloroprocaine/JJ group/NN %/NN induced/VBN seizures/NNS
bupivacaine/NN %/NN fatal/JJ dose/NN convulsions/NNS
bupivacaine/NN induced/VBN seizures/NNS
5/CD presented/VBD pain/NN chest/NN
5/CD presented/VBD pain/NN
fluorouracil/JJ administration/NN metastasis/NNS presented/VBD pain/NN chest/NN
fluorouracil/JJ administration/NN metastasis/NNS presented/VBD pain/NN
5/CD administration/NN metastasis/NNS presented/VBD pain/NN chest/NN
5/CD administration/NN metastasis/NNS presented/VBD pain/NN
FU/NNP 5/CD administration/NN metastasis/NNS presented/VBD pain/NN chest/NN
FU/NNP 5/CD administration/NN metastasis/NNS presented/VBD pain/NN
paroxetine/NN related/VBD syndrome/NN neuroleptic/JJ
paroxetine/NN related/VBD syndrome/NN malignant/JJ
paroxetine/NN related/VBD syndrome/NN
alprazolam/NN paroxetine/NN related/VBD syndrome/NN neuroleptic/JJ
alprazolam/NN paroxetine/NN related/VBD syndrome/NN malignant/JJ
alprazolam/NN paroxetine/NN related/VBD syndrome/NN
paroxetine/NN occur/VB presented/VBN symptoms/NNS syndrome/NN malignant/JJ neuroleptic/JJ
paroxetine/NN occur/VB presented/VBN symptoms/NNS syndrome/NN malignant/JJ
paroxetine/NN occur/VB presented/VBN symptoms/NNS syndrome/NN
paroxetine/NN occur/VB presented/VBN symptoms/NNS syndrome/NN NMS/NNP
paroxetine/NN occur/VB presented/VBN demonstrating/VBG NMS/NNP
alprazolam/NN treatment/NN paroxetine/NN occur/VB presented/VBN symptoms/NNS syndrome/NN malignant/JJ neuroleptic/JJ
alprazolam/NN treatment/NN paroxetine/NN occur/VB presented/VBN symptoms/NNS syndrome/NN malignant/JJ
alprazolam/NN treatment/NN paroxetine/NN occur/VB presented/VBN symptoms/NNS syndrome/NN
alprazolam/NN treatment/NN paroxetine/NN occur/VB presented/VBN symptoms/NNS syndrome/NN NMS/NNP
alprazolam/NN treatment/NN paroxetine/NN occur/VB presented/VBN demonstrating/VBG NMS/NNP
cocaine/NN toxicity/NN blockade/NN observed/VBN H/NNP reduced/VBN up/RB seizures/VBD
puromycin/NN aminonucleoside/NN injection/NN induced/VBN urea/NN syndromes/NNS proteinuria/NN hypoalbuminemia/NN
aminonucleoside/NN injection/NN induced/VBN urea/NN syndromes/NNS proteinuria/NN hypoalbuminemia/NN
puromycin/NN aminonucleoside/NN injection/NN induced/VBN urea/NN syndromes/NNS proteinuria/NN hypercholesterolemia/NN
aminonucleoside/NN injection/NN induced/VBN urea/NN syndromes/NNS proteinuria/NN hypercholesterolemia/NN
puromycin/NN aminonucleoside/NN injection/NN induced/VBN urea/NN syndromes/NNS proteinuria/NN
aminonucleoside/NN injection/NN induced/VBN urea/NN syndromes/NNS proteinuria/NN
puromycin/NN aminonucleoside/NN injection/NN induced/VBN urea/NN syndromes/NNS nephrotic/JJ
puromycin/NN aminonucleoside/NN injection/NN induced/VBN urea/NN syndromes/NNS
aminonucleoside/NN injection/NN induced/VBN urea/NN syndromes/NNS nephrotic/JJ
aminonucleoside/NN injection/NN induced/VBN urea/NN syndromes/NNS
amikacin/NN toxicity/NN retinal/JJ
amikacin/NN toxicity/NN
amikacin/NN treatment/NN toxicity/NN retinal/JJ
amikacin/NN treatment/NN toxicity/NN
chloramphenicol/NN administration/NN anemia/NN aplastic/JJ
chloramphenicol/NN administration/NN anemia/NN
chloramphenicol/NN beginning/VBG undergoing/VBG died/VBD anemia/NN aplastic/JJ
chloramphenicol/NN beginning/VBG undergoing/VBG died/VBD anemia/NN
chloramphenicol/VB associated/VBN pattern/NN anemia/NN aplastic/JJ
chloramphenicol/VB associated/VBN pattern/NN anemia/NN
chloramphenicol/NN treatment/NN report/NN anemia/NN aplastic/JJ
chloramphenicol/NN treatment/NN report/NN anemia/NN
ifosfamide/NN Hallucinations/NNS
ifosfamide/NN effect/NN Hallucinations/NNP
ifosfamide/NN cases/NNS reported/VBN hallucinations/NNS
ifosfamide/NN interviewed/VBN authors/NNS METHODS/NNS hallucinations/NNS
ifosfamide/NN hallucinations/NNS
picrotoxin/NN pentetrazol/NN induced/VBN convulsions/NNS inhibitors/NNS effects/NNS induction/NN seizure/NN
picrotoxin/NN pentetrazol/NN induced/VBN convulsions/NNS
flurothyl/NN pentetrazol/NN induced/VBN convulsions/NNS inhibitors/NNS effects/NNS induction/NN seizure/NN
flurothyl/NN pentetrazol/NN induced/VBN convulsions/NNS
pentetrazol/NN induced/VBN convulsions/NNS inhibitors/NNS effects/NNS induction/NN seizure/NN
pentetrazol/NN induced/VBN convulsions/NNS
PTZ/NNP prostaglandins/NNS induction/NN seizure/NN
PTZ/NNP prostaglandins/NNS induction/NN effects/NNS inhibitors/NNS convulsions/NNS
bicuculline/NN electroshock/NN evaluated/VBN investigate/VB relationship/NN prostaglandins/NNS induction/NN seizure/NN
bicuculline/NN electroshock/NN evaluated/VBN investigate/VB relationship/NN prostaglandins/NNS induction/NN effects/NNS inhibitors/NNS convulsions/NNS
picrotoxin/JJ convulsions/NNS fluorthyl/NN induced/VBN convulsions/NNS
picrotoxin/JJ convulsions/NNS
fluorthyl/NN induced/VBN convulsions/NNS
fluorthyl/NN convulsions/NNS
PTZ/NNP fluorthyl/NN induced/VBN convulsions/NNS
PTZ/NNP fluorthyl/NN convulsions/NNS
bicuculline/JJ picrotoxin/JJ convulsions/NNS fluorthyl/NN induced/VBN convulsions/NNS
bicuculline/JJ picrotoxin/JJ convulsions/NNS
azidothymidine/NN induced/VBN suppression/NN marrow/NN
azidothymidine/NN induced/VBN suppression/NN
AZT/NNP induced/VBN anemia/NN leukopenia/NN
AZT/NNP induced/VBN anemia/NN
AZT/NNP administration/NN rendered/VBN anemic/JJ leukopenic/JJ
AZT/NNP administration/NN rendered/VBN reversed/VBD induced/VBN anemia/NN leukopenia/NN
AZT/NNP administration/NN water/NN drinking/VBG days/NNS reversed/VBD rendered/VBN anemic/JJ leukopenic/JJ
AZT/NNP administration/NN water/NN drinking/VBG days/NNS reversed/VBD induced/VBN anemia/NN leukopenia/NN
AZT/NNP induced/VBN reversed/VBD rendered/VBN anemic/JJ leukopenic/JJ
AZT/NNP induced/VBN anemia/NN leukopenia/NN
AZT/NNP administration/NN rendered/VBN anemic/JJ
AZT/NNP administration/NN rendered/VBN reversed/VBD induced/VBN anemia/NN
AZT/NNP administration/NN water/NN drinking/VBG days/NNS reversed/VBD rendered/VBN anemic/JJ
AZT/NNP administration/NN water/NN drinking/VBG days/NNS reversed/VBD induced/VBN anemia/NN
AZT/NNP induced/VBN reversed/VBD rendered/VBN anemic/JJ
AZT/NNP induced/VBN anemia/NN
AZT/NNP coadministered/VBD reduced/VBD AZT/NNP induced/VBN toxicity/NN marrow/NN
AZT/NNP coadministered/VBD reduced/VBD AZT/NNP induced/VBN toxicity/NN
AZT/NNP induced/VBN toxicity/NN marrow/NN
AZT/NNP induced/VBN toxicity/NN
levodopa/NN overflow/NN dyskinesias/NNS
levodopa/NN therapy/NN complications/NNS assessed/VBD dyskinesias/NNS
levodopa/NN therapy/NN complications/NNS assessed/VBD dyskinesias/NNS LID/NNP
levodopa/NN complications/NNS assessed/VBD dyskinesias/NNS
levodopa/NN complications/NNS assessed/VBD dyskinesias/NNS LID/NNP
levodopa/NN with/IN LID/VBP
levodopa/NN dyskinesias/NNS
levodopa/NN dyskinesias/NNS disease/NN LID/NNP
levodopa/JJ assessed/VBN lift/VBP score/VBP dyskinesia/NN
levodopa/NN increased/VBN LID/NNP
apomorphine/NN Development/NNP induced/NNP behavior/NN aggressive/JJ
apomorphine/NN Development/NNP induced/NNP behavior/NN
apomorphine/NN induced/VBN behavior/NN aggressive/JJ
apomorphine/NN induced/VBN behavior/NN
apomorphine/NN treatment/NN induced/VBD development/NN behavior/NN aggressive/JJ
apomorphine/NN treatment/NN induced/VBD development/NN behavior/NN
apomorphine/NN treatment/NN induced/VBD evidenced/VBN intensity/NN aggressiveness/NN
apomorphine/NN induced/VBN behavior/NN aggressive/JJ
apomorphine/NN induced/VBN behavior/NN
isoproterenol/NN status/NN mangiferin/NN Role/NNP infarction/NN myocardial/JJ
isoproterenol/NN status/NN mangiferin/NN Role/NNP infarction/NN
isoproterenol/NN Anacardiaceae/NNP induced/VBN infarction/NN myocardial/JJ
isoproterenol/NN Anacardiaceae/NNP induced/VBN infarction/NN
isoproterenol/NN Anacardiaceae/NNP induced/VBN infarction/NN MI/NNP
ISPH/NNP Anacardiaceae/NNP induced/VBN infarction/NN myocardial/JJ
ISPH/NNP Anacardiaceae/NNP induced/VBN infarction/NN
ISPH/NNP Anacardiaceae/NNP induced/VBN infarction/NN MI/NNP
ISPH/NNP induced/VBN rats/NNS MI/NNP
ISPH/NNP exerts/VBZ due/JJ MI/NNP
quipazine/NN aggressiveness/NN induced/VBN deprivation/NN induced/VBN twitches/NNS head/NN
quipazine/NN aggressiveness/NN induced/VBN deprivation/NN induced/VBN twitches/NNS
apomorphine/NN deprivation/NN induced/VBN aggressiveness/NN
quipazine/JJ increased/VBN reduced/VBN twitches/NNS head/NN
quipazine/JJ increased/VBN reduced/VBN twitches/NNS
apomorphine/JJ increased/VBN induced/VBN aggressiveness/NN
oestrogen/NN Long/NNP increased/VBD risk/NN disease/NN embolism/NN stroke/NN
oestrogen/NN Long/NNP increased/VBD risk/NN disease/NN embolism/NN gallbladder/NN
oestrogen/NN Long/NNP increased/VBD risk/NN disease/NN
oestrogen/NN Long/NNP increased/VBD risk/NN thrombo/NN venous/JJ
oestrogen/NN Long/NNP increased/VBD risk/NN thrombo/NN
oestrogen/NN Long/NNP increased/VBD risk/NN disease/NN embolism/NN
cisplatin/NN observed/VBN limited/VBN dose/NN e/NNP g/NNP nephrotoxicity/NN ototoxicity/NN
cisplatin/NN associated/VBN toxicities/NNS dose/NN e/NNP g/NNP nephrotoxicity/NN ototoxicity/NN
cisplatin/NN observed/VBN limited/VBN dose/NN e/NNP g/NNP nephrotoxicity/NN
cisplatin/NN associated/VBN toxicities/NNS dose/NN e/NNP g/NNP nephrotoxicity/NN
cisplatin/NN trials/NNS suggested/VBD reduced/VBN incidence/NN cisplatin/NN induced/VBN nephrotoxicity/NN ototoxicity/NN
cisplatin/NN induced/VBN nephrotoxicity/NN ototoxicity/NN
cisplatin/NN trials/NNS suggested/VBD reduced/VBN incidence/NN cisplatin/NN induced/VBN nephrotoxicity/NN
cisplatin/NN induced/VBN nephrotoxicity/NN
cisplatin/NN trials/NNS suggested/VBD reduced/VBN incidence/NN cisplatin/NN induced/VBN nephrotoxicity/NN neuropathy/NN
cisplatin/NN induced/VBN nephrotoxicity/NN neuropathy/NN
amitriptyline/NNP less/JJR incidence/NN frequency/NN vision/NN mouth/NN dry/JJ
amitriptyline/NNP less/JJR incidence/NN frequency/NN vision/NN mouth/NN
amitriptyline/NNP less/JJR incidence/NN frequency/NN vision/NN blurred/JJ
amitriptyline/NNP less/JJR incidence/NN frequency/NN vision/NN
propylthiouracil/NN administration/NN caused/VBD observations/NNS patient/NN hepatitis/NN chronic/JJ
propylthiouracil/NN administration/NN caused/VBD observations/NNS patient/NN hepatitis/NN active/JJ
propylthiouracil/NN administration/NN caused/VBD observations/NNS patient/NN hepatitis/NN active/JJ aggressive/JJ
propylthiouracil/NN administration/NN caused/VBD observations/NNS patient/NN hepatitis/NN
adriamycin/NN dose/NN developed/VBD failure/NN congestive/JJ
adriamycin/NN dose/NN developed/VBD failure/NN heart/NN
adriamycin/NN dose/NN developed/VBD failure/NN
adriamycin/NN 2/CD mg/NN receiving/VBG developed/VBD leukemia/NN myeloblastic/JJ acute/JJ
adriamycin/NN 2/CD mg/NN receiving/VBG developed/VBD leukemia/NN myeloblastic/JJ
adriamycin/NN 2/CD mg/NN receiving/VBG developed/VBD leukemia/NN
Antituberculosis/JJ therapy/NN induced/VBN failure/NN acute/JJ
Antituberculosis/JJ therapy/NN induced/VBN failure/NN liver/NN
Antituberculosis/JJ therapy/NN induced/VBN failure/NN
Antituberculosis/JJ therapy/NN failure/NN acute/JJ
Antituberculosis/JJ therapy/NN failure/NN liver/NN
Antituberculosis/JJ therapy/NN failure/NN
Antituberculosis/JJ therapy/NN failure/NN ATT/NNP ALF/NNP
Antituberculosis/JJ therapy/NN failure/NN ALF/NNP
fentanyl/NN Omission/NNP reduce/VB incidence/NN nausea/NN postoperative/JJ
fentanyl/NN Omission/NNP reduce/VB incidence/NN nausea/NN
fentanyl/NN Omission/NNP reduce/VB incidence/NN nausea/NN and/CC
fentanyl/NN Omission/NNP reduce/VB incidence/NN nausea/NN vomiting/NN
fentanyl/NN %/NN discharge/NN moderate/JJ reduce/VB did/VBD reduce/VB incidence/NN nausea/NN postoperative/JJ
fentanyl/NN %/NN discharge/NN moderate/JJ reduce/VB did/VBD reduce/VB incidence/NN nausea/NN
fentanyl/NN %/NN discharge/NN moderate/JJ reduce/VB did/VBD reduce/VB incidence/NN nausea/NN and/CC
fentanyl/NN %/NN discharge/NN moderate/JJ reduce/VB did/VBD reduce/VB incidence/NN nausea/NN vomiting/NN
fentanyl/NN fentanyl/NN %/NN discharge/NN moderate/JJ reduce/VB did/VBD reduce/VB incidence/NN nausea/NN postoperative/JJ
fentanyl/NN fentanyl/NN %/NN discharge/NN moderate/JJ reduce/VB did/VBD reduce/VB incidence/NN nausea/NN
fentanyl/NN fentanyl/NN %/NN discharge/NN moderate/JJ reduce/VB did/VBD reduce/VB incidence/NN nausea/NN and/CC
fentanyl/NN fentanyl/NN %/NN discharge/NN moderate/JJ reduce/VB did/VBD reduce/VB incidence/NN nausea/NN vomiting/NN
fentanyl/JJ groups/NNS Combining/VBG revealed/VBD reducing/VBG nausea/NN postoperative/JJ
fentanyl/JJ groups/NNS Combining/VBG revealed/VBD reducing/VBG nausea/NN
fentanyl/JJ groups/NNS Combining/VBG revealed/VBD reducing/VBG nausea/NN and/CC
fentanyl/JJ groups/NNS Combining/VBG revealed/VBD reducing/VBG nausea/NN vomiting/NN
Fentanyl/NNP reduce/VB increased/VBD depression/NN hypotension/NN
Fentanyl/NNP reduce/VB increased/VBD depression/NN bradycardia/NN
Fentanyl/NNP reduce/VB increased/VBD respiratory/RB
Fentanyl/NNP reduce/VB increased/VBD depression/NN
fentanyl/NN exacerbated/VBD nausea/NN postoperative/JJ
fentanyl/NN exacerbated/VBD nausea/NN
fentanyl/NN exacerbated/VBD nausea/NN and/CC
fentanyl/NN exacerbated/VBD nausea/NN vomiting/NN
carrageenan/NN model/NN writhing/VBG
carrageenan/NN model/NN writhing/VBG induced/VBN acid/NN paw/NN model/NN edema/NN
